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ABSTRACT 
 
In this thesis, the mechanisms of damage and repair in clinically isolated optic neuritis 
(ON) were investigated in vivo, by combining magnetic resonance imaging (MRI), 
electrophysiology and optical coherence tomography (OCT). ON is a demyelinating, 
inflammatory condition of the optic nerve, which may be the first presentation of 
multiple sclerosis. The visual prognosis is generally good, despite optic nerve 
demyelination and axonal loss, but some patients fail to recover. The aim of this thesis 
was to determine the reasons underlying recovery. The hypothesis was that 
neuroplastic grey matter reorganisation might contribute to visual outcome.  
Structural MRI, electrophysiology and OCT were used to quantify optic nerve 
oedema, inflammation, myelination and neuroaxonal loss, and optic radiation and 
visual cortical pathology, in a cohort of patients with acute ON, followed up over the 
following year. Visual functional MRI (fMRI) was employed to investigate 
neuroplasticity.  
Acutely, measures of optic nerve inflammation and conduction block were associated 
with the severity of acute visual loss, and were used to inform an fMRI analysis, in 
order to dissect complex structure-function interactions. Evidence was found for 
neuroplasticity in dorsal higher visual areas, which may act to modulate acute visual 
dysfunction. 
Subsequent longitudinal analyses identified associations between early fMRI 
activation in the lateral occipital complexes, a ventral stream higher visual area, and 
longer term visual outcome, which were evident on stimulation of either eye, and 
independent of measures of myelination and neuroaxonal loss in the visual pathways. 
A quadrant-specific fMRI stimulation paradigm was used to investigate recovery from 
visual field defects, finding no evidence for field defect-specific neuroplastic 
responses. 
It was concluded that cortical neuroplasticity appears more important to recovery 
from ON than was previously thought, and its contribution is independent of measures 
of tissue damage. This may provide a target for future therapeutic approaches in 
demyelinating disease. 
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CHAPTER 1 
 
INTRODUCTION: DAMAGE AND REPAIR IN DEMYELINATING DISEASE 
 
The brain is the most complex organ in the mammalian body and in humans is unique, 
in evolutionary terms, in developing to the extent that it can be applied to study itself. 
In recent years, great progress has been made in understanding how the brain works, 
both in health and disease. Structural changes in the brain result in diverse functional 
consequences, which are the product of complex interactions between pathology and 
physiological responses to it. Studies in non-human primates have been vital in 
clarifying mechanisms underlying damage and repair, but humans are unique amongst 
primates in many regards, and in vivo studies are therefore essential to understand 
human pathophysiology. When human subjects are studied, it is necessary to use a 
non-invasive approach, and therefore inferences are sometimes necessarily more 
indirect. However, by combining knowledge gained from animal studies, human 
pathological studies and human in vivo studies, using techniques such as magnetic 
resonance imaging (MRI), electrophysiology and optical coherence tomography 
(OCT), many new insights may be achieved. In the past, it was thought that there was 
little potential for repair in the central nervous system (CNS) and that the brain was 
particularly vulnerable to permanent damage. In recent years, it has been appreciated 
that, in fact, brain repair does occur, and that disease processes constitute a complex, 
dynamic competition between pathology and physiology to influence clinical function 
and outcome. In vivo techniques have played an important role in elucidating this. 
Separating the structural and functional aspects of these competing processes, in order 
to improve our understanding of them, is the main theme of this thesis. 
 
This thesis aims to elucidate mechanisms of damage and repair in demyelinating 
disease of the CNS, using MRI, electrophysiology and OCT to study the disease 
model of optic neuritis (ON). Patients were studied during an acute attack of ON and 
followed up during recovery, over a year, with clinical, electrophysiological and 
multi-modal MRI assessments. OCT was introduced at 12 months to help quantify 
residual damage. Chapter 1 introduces the subjects of the human visual system, ON 
and its investigation to date. Chapter 2 focuses on the physical principles behind MRI 
and, in particular, quantitative techniques, such as diffusion tensor imaging (DTI) and   33
functional MRI (fMRI). In Chapter 3, different methods of presenting visual fMRI 
stimuli are considered and study design problems are discussed. The development of a 
novel technique used to address these difficulties is described. In Chapter 4, structural 
MRI and electrophysiology are used to quantify acute damage to the optic nerve, 
provide insights into the relative contributions of underlying pathological processes, 
and assess the impact ON has on the rest of the visual pathway. Structural and 
electrophysiological data are combined with fMRI to dissect structure-function 
interactions, in order to investigate neuroplasticity during the acute stage of ON, and 
determine whether it plays a role in modulating acute visual dysfunction. In Chapter 
5, longitudinal analyses are reported, investigating mechanisms of long-term recovery 
in ON and predictors of visual outcome. In Chapter 6, a quadrant-specific visual fMRI 
technique is applied to explore the role of the fellow eye in brain reorganisation 
following ON, and to assess mechanisms of resolution of visual field defects. Finally, 
in Chapter 7, the results are summarised, and conclusions are drawn as to the 
contribution of this thesis to our understanding of mechanisms of damage and 
recovery in demyelinating disease, and how this might be applied to help patients. 
Future research directions are discussed. 
 
Chapter 1 is split into four main sections. The first briefly describes relevant aspects 
of anatomical organisation and function of the visual system in health. The emphasis 
then shifts to the effects of disease. In the second section, the topic of ON is 
introduced and, in the third section, pathophysiological mechanisms underlying 
damage in the condition are discussed. The clinical and para-clinical methods used to 
investigate ON are considered, including clinical assessment tools, MRI, visual 
evoked potentials (VEPs) and OCT, and their role in identifying and quantifying 
pathology. The insights that these techniques have provided in terms of mechanisms 
of damage are considered. The fourth section considers mechanisms of CNS repair in 
demyelinating disease, and how the recovery process may be assessed, including a 
discussion of findings from fMRI studies, which have been used to investigate 
neuroplasticity. 
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SECTION 1: ANATOMY AND PHYSIOLOGY OF HUMAN VISION IN 
HEALTH 
 
This section will briefly discuss the elements of normal anatomy and physiology 
which are directly relevant to later discussions of mechanisms of damage and repair 
following ON.  
 
1.1.1 Organisation of the afferent visual system 
 
The afferent visual system is composed of four main types of cell: retinal 
photoreceptors, bipolar cells, ganglion cells (with their axons forming the retinal 
nerve fibre layer (RNFL), optic nerves, chiasm and tracts) (Figure 1.1), and cell 
bodies of the lateral geniculate nucleus (LGN) (with their axons forming the optic 
radiations).
 
Figure 1.1 Retinal organisation. A coronal view of the retina, as seen through the pupil, is shown, in 
order to demonstrate the organisation and orientation of fibres in the retinal nerve fibre layer. A cross-
sectional view perpendicular to the coronal plane is also shown to demonstrate the cellular layers of the 
retina. Modified from (Rizzo, 1998). 
 
Photoreceptor cells are located in the retina, comprising two different types: cones and 
rods. Cones are concentrated around the macula and are specialised for colour vision 
and fine spatial discrimination in photopic (high light intensity) conditions. There are 
three types, which each respond to different wavelengths of light, S-cones (blue), M-  35
cones (green) and L-cones (red). Rods are more numerous than cones and are 
distributed throughout the retina, except at the macula. They are specialised for 
scotopic (low light intensity) conditions and motion perception, with lower spatial 
resolution than cones. Both types of photoreceptor cells synapse within the retina with 
bipolar cells. The ratio of rod-bipolar synapses is higher than cone-bipolar synapses. 
Bipolar cells, in turn, synapse with ganglion cells. The axonal processes of the 
ganglion cells form the RNFL, which then becomes the optic nerve.  
The two optic nerves meet at the optic chiasm, where there is a partial decussation 
(crossing) of nerve fibres. Those supplying the temporal half of the visual field 
(located in the nasal half of the retina) cross to the opposite side. Fibres supplying the 
nasal visual field (from the temporal half of the retina) remain uncrossed (Figure 1.2). 
Posterior to the chiasm the optic nerves become the optic tracts, which synapse in the 
grey matter of the LGN of the thalamus.  
 
     
 
Figure 1.2 A schematic diagram demonstrating the homologous retinotopic organisation of the human 
visual system. Objects in the right hemi-field stimulate fibres in the right nasal hemi-retina and left 
temporal hemi-retina. Decussation of the nasal fibres from the right eye results in a representation from 
both eyes in left occipital cortex. A magnification of the posterior afferent pathway, from the lateral 
geniculate nuclei to primary visual cortex, is illustrated in inset. Modified from (Kahle and Frotscher, 
2003). 
 
There are six layers of the LGN, which are split according to size and function into 
parvocellular, magnocellular and koniocellular layers. The cells of the parvocellular   36
system are small and, broadly, are involved in processing colour perception and fine 
detail. The magnocellular cells are larger and conduct more rapidly, but at the expense 
of detail. They are involved in processing perception of motion and detection of 
coarser outlines.  Koniocellular cell function is still controversial. They may be 
involved in integrative function, and perhaps also colour processing. Axons emerge 
from the cell bodies of the LGN to form the optic radiations.  
The radiations sweep forwards into the temporal lobe to form Meyer’s loop, before 
turning posteriorly and terminating in the primary visual cortex of the occipital lobe, 
also known as striate cortex, or V1. There are six layers of visual cortex and the 
parvocellular and magnocellular inputs terminate in different sub-divisions of layer 4. 
Koniocellular input projects to layers 2 and 3. 
Visual cortex is organised in a retinotopic fashion, meaning that each point in the 
visual field corresponds to a given location in cortex. The macular region maps to a 
relatively large area of cortex in the occipital poles. The temporal hemi-field maps to 
the contralateral hemisphere i.e. points in the temporal hemi-field of the right eye are 
represented in the left occipital lobe. Conversely, the nasal hemi-field maps to the 
ipsilateral hemisphere. Generally, the calcarine sulcus in the occipital lobe separates 
the upper and lower hemi-fields. The upper hemi-field corresponds to visual cortex 
below the calcarine sulcus, and the lower hemi-field is represented in supra-calcarine 
visual cortex.  
From primary visual cortex (V1), visual information is then conveyed hierarchically 
through secondary processing areas to higher order areas, involved in multi-modal 
integration of sensory input. This occurs via two distinct streams (Goodale and 
Milner, 1992) (Figure 1.3).  
The ventral stream passes from V1 through area V2 in occipital cortex, anteriorly 
through area V4 and projects to the inferior temporal lobe. It includes the lateral 
occipital complexes (LOCs), which comprise parts of several different gyri and sulci, 
namely the lateral and inferior occipital gyri, fusiform gyrus and collateral sulcus. The 
ventral stream is concerned with recognition and identification of objects within the 
physical world.  
Visual information in the dorsal stream is transmitted from V1 through V2 to the 
dorsal part of V3 in occipital cortex and then through V5/MT, a motion processing 
region, before projecting to posterior parietal cortex. This stream is involved in 
localisation of objects within the physical world and guiding actions in this space. It   37
was thought that the parvocellular pathway was processed by the ventral stream and 
the magnocellular by the dorsal stream, but this is now controversial. 
 
                        
Figure 1.3 The two visual streams of higher visual processing. Modified from (Gray, 1918). 
 
1.1.2 Generation and propagation of neural action potentials 
 
The mechanism of transmission of neural impulses is similar throughout the CNS. A 
potential difference is maintained across neural cell membranes. The intra-cellular 
domain is relatively negatively charged, with respect to the extra-cellular domain. 
This potential difference is maintained by sodium/potassium exchange pumps, which 
export sodium ions and import potassium ions to the cell. In the resting state, the ratio 
of ion exchange in unequal, and leads to a net loss of positive charge from the cells. 
Depolarisation occurs when the membrane potential becomes less negative. This 
triggers voltage-gated polypeptide sodium channels, situated in the cell membrane, to 
open. Once this threshold is reached, there is a rapid influx of sodium into the cell, 
which causes further depolarisation, and a positive feedback loop is created. The 
resulting ion currents cause an action potential, which constitutes the nervous impulse. 
After a short time delay, potassium channels open and potassium ions diffuse out of 
the cell. This process restores the resting potential and is referred to as repolarisation. 
During the repolarisation refractory period, the axon is not able to conduct further 
nerve impulses. Afterwards, the sodium/potassium exchange pump acts to restore the 
original ion concentration gradients. 
Depolarisation in one region of an axon results in changes in the potential difference 
of adjacent regions and, therefore, the action potential is propagated along the axon.   38
The speed at which this occurs is dependent on axonal diameter, and the presence of a 
myelin sheath, produced by oligodendrocytes in the CNS. Axons less than two 
micrometres (μm) are usually unmyelinated, so conduction relies on the axon’s cable 
properties and is therefore relatively slow. In larger axons, with an insulating myelin 
sheath, regeneration of action potentials is limited to nodes of Ranvier, areas of axon 
without a sheath and with a high concentration of sodium channels. This saltatory 
mode of conduction is much faster. 
Coding for stimulus intensity in neurons is frequency modulated. The amplitude of 
action potentials is constant, as they are all-or-nothing phenomena, so greater intensity 
stimuli result in increasing frequency of axonal firing. In addition, axons differ in their 
threshold of depolarisation, so a higher intensity stimulus will activate more axons, a 
process known as recruitment. 
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SECTION 2: OPTIC NEURITIS 
 
1.2.1 Optic neuritis as a model for studying demyelinating diseases 
 
ON is defined as inflammation of the optic nerve. Whilst there are many different 
causes (Hickman et al., 2002b), the term is usually used to describe the most 
commonly encountered syndrome of acute idiopathic demyelinating optic neuropathy. 
This may present as an isolated event, a recurrent problem, or be followed later in life 
by inflammatory events elsewhere in the CNS. If subsequent events occur, which are 
generally restricted to the optic nerves and spinal cord, this constitutes neuromyelitis 
optica (NMO) (Wingerchuk et al., 2006). If subsequent events occur which are 
disseminated in time and space throughout the CNS, this constitutes multiple sclerosis 
(MS) (McDonald et al., 2001;Polman et al., 2005).  
ON is a good model for studying demyelinating diseases, such as MS, because they 
share clinical and pathological characteristics, the visual pathways are clearly defined 
anatomically, and visual outcome is more easily quantified objectively than other 
symptoms, such as sensory or motor disturbance. Therefore, insights into damage and 
repair derived from the study of ON may be generalised to MS in many cases.  
 
1.2.2 Epidemiology and aetiology 
 
The prevalence and incidence of ON varies across the world and, like MS, becomes 
more common with increasing latitude. A study from the UK reported a lifetime 
prevalence of 0.6 per 1000 and an age and sex adjusted incidence of 1 per 100 000 per 
year (McDonald et al., 2000). A similar study from the USA reported an age and sex 
adjusted prevalence of 115 per 100 000 and an incidence rate of 5 per 100 000 per 
year (Rodriguez et al., 1995). A Swedish study reported rather lower age-adjusted 
overall incidence rates of 1.40 per 100 000 per year (2.28 per 100 000 for females and 
0.53 per 100 000 for males) (Jin et al., 1998). This was somewhat surprising, given 
the high latitude of Scandinavia, but rates were still much higher than for people born 
outside of Nordic countries, for whom the rate was 0.28 per 100 000 per year. There is 
a seasonal pattern to the incidence, with rates highest in the spring (Jin et al., 1999). 
ON most commonly affects young Caucasian women in their late 20s and early 30s. 
The mean age of onset is 31 to 32 years (Optic Neuritis Study Group, 1991;Sorensen   40
et al., 1999), although it is well recognised both in children and the elderly. The 
female to male ratio is approximately 3:1 (Optic Neuritis Study Group, 1991).  
The cause of acute idiopathic demyelinating ON is unknown. As it is often associated 
with MS, it is thought that the two conditions share a common aetiology. This is 
probably a complex interaction between genetic predisposition and environmental 
triggers, which may include infectious agents, vitamin D deficiency and others 
(Ascherio and Munger, 2007a;Ascherio and Munger, 2007b). There are many rarer 
inflammatory and infectious causes of ON, which may present in an atypical manner, 
and have a different natural history, management, and prognosis.  
 
1.2.3 Clinical features 
 
Typically ON presents with subacute painful loss of vision in one eye. The pain is 
sometimes ill defined at first, but then usually localises in or around one eye. It is 
commonly worse with eye movements. The severity of the pain varies, but it is 
unusual for it to disturb sleep, or last longer than a few days.  
This is concurrent with, or followed by, a reduction of vision in the same eye. Typical 
patients’ reports of the early stages of visual loss, which indeed were used by patients 
involved in this study, are: “it is like looking through frosted glass” or “as if there is a 
smear of Vaseline on my eye”. The severity of visual loss is very variable, ranging 
from minimal blurring to inability to perceive light. Flashes of light on eye 
movements, called phosphenes or photopsia, may be reported. Visual loss usually 
progresses over a few days to two weeks, remains at a nadir for a period of days up to 
two weeks, and then begins to improve. Sometimes, during this period of recovery, 
patients notice that vision temporarily worsens with a rise in body temperature, for 
example, after a hot shower or exercise, which is termed Uhthoff’s symptom (Selhorst 
and Saul, 1995). This can also occasionally be the presenting symptom. Pulfrich’s 
phenomenon may also be reported (Slagsvold, 1978). This is an anomalous perception 
of motion in depth. An example was given by a patient in this study, who had 
difficulty judging the trajectory of a tennis ball, despite significant improvement in 
visual acuity.  
Clinical signs in the acute stage include reduced monocular visual acuity in 90% of 
cases (Optic Neuritis Study Group, 1991). Tests of low contrast acuity are sensitive to 
detecting deficits in the minority of people who have mild visual loss and are   41
abnormal in 98%. Colour vision is characteristically affected, sometimes more than 
other aspects of vision, and abnormalities on testing are detectable in 94% in the acute 
stage. The spectral location of colour deficits varies between patients and no 
consistent pattern is seen (Schneck and Haegerstrom-Portnoy, 1997). 
Visual field defects are detectable in 97% of people (Keltner et al., 1999). Due to the 
patchy nature of the underlying pathology, a wide variety of defects is possible. The 
most commonly encountered is a diffuse pattern of visual loss, seen in 48% of cases 
(Keltner et al., 1993b). Central field abnormality is seen more commonly than 
peripheral deficit, and peripheral defects may improve more rapidly (Keltner et al., 
1999). Isolated central and centro-caecal scotomas occur in 8% (Keltner et al., 
1993b). Altitudinal defects are seen in 20% and various other types make up 23%. 
Chiasmal and retro-chiasmal defects are less frequent, seen in only 3% of people. 
Incidental abnormalities of the unaffected eye are common (Keltner et al., 
1993b;Beck et al., 1993a). Recovery of visual field function is generally good and 
does not differ between diffuse and localised field defects (Fang et al., 1999).  
Nearly all patients with unilateral ON have a relative afferent pupillary defect (Cox et 
al., 1981), and this was an inclusion criterion in the North American Optic Neuritis 
Treatment Trial (ONTT) (Optic Neuritis Study Group, 1991), the largest clinical study 
of  ON, from which the symptom prevalences, cited above, were derived. Fundoscopy 
reveals a swollen disc in 35%, or may be normal, particularly if inflammation solely 
affects the posterior part of the nerve (retrobulbar ON). The retina is typically normal, 
except for perivenous sheathing (retinal periphlebitis), which is occasionally seen, and 
is associated with a higher risk of MS (Lightman et al., 1987). After around six weeks, 
the optic disc may become pale because of atrophy of the optic nerve. 
There appear to be some ethnic differences in the clinical profile. Acutely, disc 
swelling is more common in Japanese patients than Americans, and pain was less 
frequent in a Japanese cohort, compared to the patients in the ONTT (Wakakura et al., 
1999b).   
Recovery usually begins within the first month. In the ONTT, 79% of people had 
started to improve by three weeks, and 93% by five weeks (Beck et al., 1994). 
Improvement may continue after this, especially in patients who have been severely 
affected, in whom recovery is slower, and significant improvements may continue for 
up to six months. Subtle improvement may still be detectable a year or more after the 
acute attack, although by this time the patients do not tend to notice changes relevant   42
to function. Most patients make a good functional visual recovery, improving to a 
Snellen acuity of 6/12 or better, but around 5%-10% of people fail to recover (Beck 
and Cleary, 1993). Many more complain of residual symptoms and deficits of acuity, 
fields, colour vision and, especially, low contrast acuity may be detectable for years 
afterwards (Frederiksen et al., 1997;Optic Neuritis Study Group, 1997b). 
Atypical presentations occur and, whilst these may be seen in demyelinating ON, they 
can be a marker of a more unusual alternative aetiology. Atypical features include 
absence of pain, which is seen in 8% of people (Optic Neuritis Study Group, 1991), 
marked swelling of the nerve with retinal exudates and peripapillary haemorrhages, 
severe visual loss to no light perception, progression of visual loss or pain for more 
than two weeks and lack of recovery after three weeks (Beck et al., 2003;Hickman et 
al., 2002b). 
Bilateral ON may occur, either simultaneously or sequentially (Pirko et al., 2004). 
Simultaneous disease would also be unusual for idiopathic inflammatory 
demyelination (Hickman et al., 2002b) and may suggest an alternative, more unusual, 
aetiology. 
 
1.2.4 Diagnosis and association with multiple sclerosis 
 
The diagnosis of ON is essentially clinical, based upon a characteristic clinical 
presentation, with consistent physical signs, in a patient from the most commonly 
affected demographic group.  
If atypical features are present, further investigations are indicated to exclude 
differential diagnoses. The choice of investigation would depend upon the clinical 
features, but might include MRI of the optic nerves, especially to rule out compressive 
causes of optic neuropathy. Computerised tomography (CT) may help to delineate 
bony orbital lesions. Blood tests may be indicated if infections, such as syphilis and 
Lyme disease, or other inflammatory conditions, such as corticosteroid-responsive 
optic neuropathies due to neuromyelitis optica, sarcoidosis, systemic lupus 
erythematosis, Behcet’s disease, or CRION (chronic relapsing inflammatory optic 
neuropathy), were suspected. Other differential diagnoses include ischaemic optic 
neuropathy, toxic neuropathies, Leber’s hereditary optic neuropathy, posterior scleritis 
and retinal disease. Depending on the level of clinical suspicion, further more   43
specialised investigations, for example cerebrospinal fluid (CSF) examination, may 
occasionally be required to exclude these conditions (Hickman et al., 2002b). 
In typical idiopathic demyelinating ON with recovery, further investigation is not 
mandatory. Patients are informed of the association with MS. A brain MRI helps to 
stratify the risk of future inflammatory events, and is generally discussed with 
patients. If MRI shows radiological evidence of asymptomatic demyelination in the 
brain, which has been reported in 59% of patients presenting with isolated ON (Beck 
et al., 1993b), and 70% of clinically isolated syndromes in general (Brex et al., 2002), 
then the risk of developing MS is higher.  
 
1.2.5 Treatment 
 
At present, no therapy has been shown to improve long-term visual outcome in acute 
idiopathic demyelinating ON. Corticosteroids shorten the duration of the attack, but 
do not appear to change the long-term outcome (Beck et al., 1992; Beck et al., 1993c; 
Kapoor et al., 1998;Wakakura et al., 1999a;Brusaferri and Candelise, 2000). In the 
UK, they tend to be reserved for patients with atypical features, coincident problems 
in the fellow eye, if pain is particularly severe, or at the patient’s request.  
Beta-interferon and glatiramer acetate are established disease-modifying therapies in 
MS, which are known to reduce the rate of relapses by around a third over two years 
(IFNB Multiple Sclerosis study group, 1993;Johnson et al., 1995;PRISMS study 
group, 1998). The indications for their use following a single neurological episode 
suggestive of MS, such as ON, is still debated. In the USA, disease-modifying drugs 
are often prescribed after clinically isolated ON if the brain MRI is abnormal, 
indicating a higher risk of MS (Balcer, 2006). There is evidence that this delays the 
onset of the disease (Jacobs et al., 2000;Comi et al., 2001;Beck et al., 2002;Kappos et 
al., 2006;Comi et al., 2008), which is consistent with their known efficacy in 
preventing a proportion of relapses in established MS. There may be an effect on 
short-term disability (Kappos et al., 2007), but any long-term benefits are still unclear. 
In addition, in a significant proportion of patients with ON, no further clinical 
symptoms emerge for many years, and not all patients with an abnormal brain MRI 
subsequently develop MS, even after 30 years follow-up (Nilsson et al., 2005).  
In the UK, prescription of disease-modifying therapies is regulated by the National 
Institute for Clinical Excellence (NICE, 2002;NICE, 2003), following guidelines from   44
the Association of British Neurologists (ABN). Currently, disease-modifying 
therapies are not used routinely following clinically isolated ON in the UK, as two 
clinical relapses are required. In 2007, the ABN guidelines were revised to include the 
development of MS solely on MRI criteria, in the year following a clinically isolated 
syndrome, as an indication for treatment (ABN, 2007) but, to date, the NICE 
guidelines remain unchanged. The other treatments licensed in MS, mitoxantrone 
(LePage et al., 2006;LePage et al., 2008) and natalizumab (Polman et al., 
2006;Rudick et al., 2006) are reserved for patients with severe, aggressive disease 
because of a risk of serious side effects, and do not have a role in the management of 
clinically isolated ON. 
Intravenous immunoglobulin has been tried in patients with persistent visual loss, but 
this did not result in any clinically significant benefits in randomised trials 
(Noseworthy et al., 2001;Roed et al., 2005).  
 
1.2.6 Prognosis 
 
1.2.6.1 Visual prognosis 
 
The majority of people with idiopathic ON make a good visual recovery, even if 
visual loss is initially severe (Slamovitis et al., 1991;Beck et al., 1994). Improvement 
usually begins in the first month. Outcome at six months is associated with the degree 
of initial visual loss (Beck et al., 1994), and with vision at one month (Kupersmith et 
al., 2007). One year later, 95% of people have improved to Snellen 6/12 or better 
(Beck and Cleary, 1993), equivalent to logMAR score 0.3 or Snellen USA 20/40 (see 
Appendix I). After five years, 28% of people in the ONTT had had a further attack, 
but 87% still had acuities of 6/8 or better, 94% 6/12 or better and 97% 6/60 or better 
(Optic Neuritis Study Group, 1997b). Ten years later, 74% had a visual acuity of 6/6 
or better, and 92% and 97% still had acuities of  6/12 and 6/60 or better, respectively 
(Beck et al., 2004a). Recently, the 15 year final follow-up results were reported, and 
72% of patients still had acuities of 6/6 or better (Optic Neuritis Study Group, 2008a). 
However, many patients who are able to score well on the Snellen chart still have 
residual deficits of low contrast acuity, colour vision and visual field defects 
(Fleishman et al., 1987). Most patients report that their vision is not quite as good as it 
was before (Cleary et al., 1997).   45
1.2.6.2 Neurological prognosis 
 
The risk of developing MS depends predominantly on the length of follow-up, and 
whether the brain MRI at the time of presentation was normal. Five years after an 
attack of ON, 16% of people with a normal brain MRI had developed MS, compared 
with 51% of people who had three lesions or more (Optic Neuritis Study Group, 
1997a). Ten years after onset, in the same cohort, the risk was reported as 22% if the 
initial MRI was normal, increasing to 56% if it was abnormal (Beck et al., 2003). 
Female gender, absence of optic disc swelling and absence of atypical features were 
all associated with a higher risk profile. Other studies have reported retinal vascular 
abnormalities (Lightman et al., 1987), HLA-DR2 genotype (Hauser et al., 2000) and 
the presence of oligoclonal bands in the CSF (Cole et al., 1998) as additional risk 
factors.  Fifteen year follow up of the ONTT cohort subsequently reported conversion 
rates of 25% with a normal MRI, and 72% with an abnormal MRI (Optic Neuritis 
Study Group, 2008b). The longest reported follow-up is from a Swedish study, which 
found an overall 40% conversion rate after 31 years (Nilsson et al., 2005). 
A different study assessed people with a variety of clinically isolated syndromes, 14 
years after the acute attack (Brex et al., 2002). More than half of the patients had 
presented with ON, and the remainder had transverse myelitis or brainstem 
syndromes. The authors reported conversion rates of 19% in people who had a normal 
MRI at baseline, increasing to 88% if the scan was abnormal.  
If MS does subsequently develop, it is said to generally follow a more benign course 
if ON is the presenting symptom, rather than pyramidal or cerebellar symptoms. In the 
ONTT, 65% of people had an Expanded Disability Status Score (EDSS, see Appendix 
II) of 3.0 or less ten years later (Beck et al., 2004b). However, in this study a 
significant number did less well. Fourteen percent had severe disability (EDSS of 6 or 
more), and 2/127 patients unfortunately died as a result of complications of MS. 
 
1.2.6.3 Impact of optic neuritis 
 
Therefore, whilst most people have a favourable visual and neurological prognosis 
following ON, a significant proportion of patients will follow a less benign course. 
Moreover, acute idiopathic demyelinating ON is common, and thus these small 
percentages actually represent a large number of people, in whom visual impairment   46
has a significant impact on their quality of life (Noble et al., 2006). At present, it is 
not possible to predict with certainty which patients will recover poorly, as the 
mechanisms of damage and recovery are incompletely understood. For those people 
who fail to recover, there are at present no effective treatments. Therefore, a better 
understanding of these mechanisms is important in enabling accurate prognostication, 
and to devise better treatments in the future, and that is the goal of this thesis. 
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SECTION 3: DAMAGE 
 
1.3.1 Immunopathology of optic neuritis 
 
Evidence from experimental and pathological studies of MS indicates that 
inflammation, demyelination and axonal damage are important disease mechanisms 
(Lassmann et al., 2007). However, there are relatively few studies that focus 
specifically on the pathology of ON. As the optic nerve is part of the CNS, it is 
thought that the pathology of the optic nerve lesion in MS is the same as in the brain. 
Therefore, much of the available data on the optic nerve lesion is extrapolated from 
brain studies.  
In general, the demyelinating lesion develops on a background of inflammation, 
thought to be of autoimmune origin (Hohlfeld and Wekerle, 2004). There is 
breakdown of the blood-brain barrier, followed by infiltration of the tissue with 
lymphocytes and activated macrophages and microglia (Lassmann et al., 2007). The 
lymphocytes are predominantly MHC Class 1 restricted CD8+ T-cells, with relatively 
few CD4+ cells (Hayashi et al., 1988). MHC Class 1 antigens are expressed within 
MS lesions on inflammatory cells, neurons and glia (Hoftberger et al., 2004). Pro-
inflammatory cytokines and chemokines are released. B-cells and plasma cells may 
also be seen. Demyelination occurs, accompanied by a variable degree of axonal 
damage. Transection of axons may occur (Trapp et al., 1998) and lead to Wallerian 
degeneration (Waller, 1850). This term describes the secondary effects of damage to 
an axonal segment, in which the initial injury results in anterograde degeneration of 
the remaining axon distal to the lesion, with respect to the neuron cell body. This is in 
contrast to retrograde degeneration, which may also occur and, in this case, secondary 
damage proceeds along the proximal segment of axon, towards the cell body. 
Recently, four distinct patterns of demyelinating lesion have been described in the 
brain in MS (Lucchinetti et al., 2000). Inflammation is prominent in types 1 and 2, 
associated predominantly with T-cells and macrophages in type 1 lesions, and with 
both T and B-cells, with accumulation of immunoglobulins and complement, in type 
2. Type 3 and type 4 lesions appear different, in that inflammation is not as marked. 
Instead, there is evidence either of a pattern of damage similar to that seen in 
ischaemic stroke, with hypoxic injury secondary to mitochondrial dysfunction, as a   48
result of production of nitric oxide and oxygen free radicals, or of primary 
oligodendrocyte degeneration in the white matter surrounding plaques. 
Evidence from other sources, such as in vivo MRI studies (Youl et al., 1991), 
indicates that inflammation is prominent in ON, as seen in Type 1 or 2 lesions but, to 
date, the relative prevalence and importance of different pathological subtypes in ON 
is unknown. 
Another relatively recent development is an increasing appreciation of the role of 
sodium channels in contributing to permanent axonal damage, which is thought to be 
especially important in accumulation of disability. For years it has been recognised 
that pathological effects on sodium channels are important in producing symptoms in 
MS (Smith, 2007). When demyelination occurs, long segments of axon are left 
between the nodes of Ranvier, which have a low density of sodium channels (Ritchie 
and Rogart, 1977) and are relatively inexcitable, resulting in conduction block 
(Waxman, 1977). In addition, there is evidence that factors associated with an 
inflammatory response may affect axonal function through direct effects on sodium 
channels, independent from demyelination, for example, antibody binding (Waxman, 
1995) or through mediators, such as nitric oxide (Redford et al., 1997). Nitric oxide 
inhibits mitochondrial function (Bolanos et al., 1997), reducing production of 
adenosine triphosphate (ATP). ATP provides energy for sodium-calcium exchange 
pumps, present on axonal membranes. Axons which pass through inflammatory 
lesions, where nitric oxide abounds (Smith and Lassmann, 2002), may therefore 
become relatively ATP-deficient. This may make them vulnerable to energy demands 
associated with sustained impulse activity (Smith et al., 2001), and prone to failure of 
sodium homeostasis. The resulting rise in intra-axonal sodium concentration may 
eventually result in reversal of the exchange pump, culminating in a lethal influx of 
calcium ions which kills the axon (Stys, 1998). This mechanism of axonal damage is 
thought to be important in MS and, therefore, may be important in ON too. 
 
Of the few pathological data looking specifically at the optic nerve, most are derived 
from post-mortem studies of patients with established MS. A study from 1950s 
demonstrated retinal atrophy, temporal optic atrophy, with glial cells within the optic 
nerve and disc, and abnormal sclerosed blood vessels at the disc (Gartner, 1953). 
In the 1980s, a post-mortem study of patients with MS found that lesions of the visual 
pathway were common. They examined the optic nerve lesions and reported that the   49
lack of correlation between visual acuity and extent of demyelination in the optic 
nerve might be due to axonal loss (Toussaint et al., 1983). 
More recently, a post-mortem study focused on the anterior visual pathways, from 
optic nerve to LGN, comparing patients with MS to control subjects (Evangelou et al., 
2001). Patients had smaller optic nerves due to reduced axonal density, and the 
parvocellular cells of the LGN were particularly affected. The authors concluded that 
the disease process affecting the nerves was size-selective, affecting smaller diameter 
axons preferentially, and also that there was evidence for trans-synaptic degeneration, 
as the cells of the LGN were involved. Trans-synaptic degeneration differs from 
Wallerian and retrograde degeneration, in that it describes a mechanism of secondary 
damage that affects neurons and axons which were not damaged directly by the initial 
pathological insult. Instead, the damage occurs later, to other neurons in the tract, 
connected to the damaged axon through synapses. This was one of the first studies to 
consider the effects ON had on more distant parts of the visual pathway, an aspect of 
pathology which was subsequently further investigated in vivo, using MRI (Ciccarelli 
et al., 2005;Audoin et al., 2006). 
 
In addition to human post-mortem studies, animal disease models have been used to 
help understand pathology. The animal model of MS is experimental allergic 
encephalomyelitis (EAE) (Rivers et al., 1933), and a variant exists which causes an 
ON (Rao et al., 1977). These models have been extremely important tools with which 
to study the pathology and immunology of MS, but there are some concerns that the 
disease process differs significantly in animals and humans, and indeed therapies that 
have been effective in EAE have not always proven effective in MS (Gold et al., 
2006). Nonetheless, animal models continue to provide important insights into the 
nature of demyelinating disease, and there have been a few studies which have looked 
specifically at the optic nerve. 
In one study, pathological features were correlated with MRI features in guinea pigs 
with EAE (Guy et al., 1992a). There was early electron microscopic evidence of 
expansion of the extracellular space and an inflammatory cell infiltrate, within three 
days of sensitising the animals to antigen. Inflammation started at the globe and 
progressed towards the orbital apex, involving longer segments of nerve around 10 to 
14 days, and persisting at 30 days.   50
In a different study in guinea pigs, infiltration of the optic nerve with lymphocytes 
was seen, with multiple areas of demyelination (Rao et al., 1977). Inflammatory cell 
infiltrates were also observed in rhesus monkeys, together with extensive 
demyelination and axonal damage (Hayreh et al., 1981). A more recent study used a 
different technique to induce local demyelination in rat optic nerve, without first 
causing inflammation (Zhu et al., 1999). The authors reported cytoskeletal changes 
within demyelinated axons, with disassembly of neurofilaments and microtubules, and 
abundant macrophages. They suggested that acute demyelination might itself induce 
the axonal cytoskeletal changes, and that inflammation could then further damage the 
axons. 
A recent study described conduction block in the optic nerves of rats, induced by CSF 
from patients with MS. This was possibly due to an effect of soluble mediators, 
leading to a blockade of sodium channels (Centonze et al., 2005). 
 
1.3.2 Relation of pathology to clinical features of damage 
 
When trying to understand demyelinating diseases, it is important to consider how 
pathological processes translate into clinical symptoms in people. In general, acute 
neurological symptoms can be classified into negative or positive symptoms. Negative 
symptoms relate to loss of function, whereas positive symptoms reflect excessive 
function. 
The main positive symptom in acute ON is pain, which is probably due to the effects 
of inflammation within a closed space, such as the orbit and, particularly, the optic 
canal (Fazzone et al., 2003). Phosphenes are also reported. These visual phenomena 
are thought to be due to the spontaneous generation of trains of action potentials in 
hyperexcitable, demyelinated axons, similar to the mechanism of paraesthesia in MS 
(Smith and McDonald, 1980;Smith and McDonald, 1982). This hyperexcitability may 
be due to abnormal ion currents (Kapoor et al., 1993;Kapoor et al., 1997), generated 
through redistribution of sodium and potassium channels.  
The main negative symptom in acute ON is loss of vision.  Acutely, the mechanism 
underlying this can be split into two parts, reflecting different aspects of linked 
pathology: the effects of demyelination and the effects of inflammation. Visual 
deficits may be associated with neuroaxonal loss, which is also considered in the 
following sections.   51
1.3.2.1 Demyelination 
 
Loss of vision is due to loss of conduction in the optic nerve. An important cause of 
this is axonal conduction block, and there is extensive evidence that demyelination 
can cause conduction block. The block is localised to the affected segment of axon, 
and conduction in unaffected segments is usually considered to be normal (McDonald 
and Sears, 1969). The conduction block caused by this segmental demyelination lasts 
for several days (McDonald and Sears, 1970). In addition, lesser degrees of 
demyelination can still cause block, if they occur adjacent to nodes of Ranvier and 
increase the inter-nodal gap (Smith, 1994;Smith and McDonald, 1999a). This 
widening of the gap leads to dispersion of the electrical current over a more diffuse 
area of axon, and increases the electrical capacitance of the node (i.e. the ability of the 
node to hold an electrical charge). The latter effect reduces the safety factor for 
conduction, by increasing the current necessary for depolarisation. The safety factor is 
the ratio of the current usually used to depolarise a node, compared to the minimum 
current necessary. In normal axons it is between three and five. In demyelinated axons 
the safety factor is close to zero, which results in small environmental changes having 
a noticeable effect on conduction.  
During recovery, conduction is restored to demyelinated axons. However, frequently 
conduction remains abnormal and is prone to failure and block. This effect may be 
expressed clinically, for example, Uhthoff’s symptom, when a small rise in body 
temperature causes temporary conduction block in demyelinated axons with critical 
safety factor thresholds. Remodeling of the demyelinated axon occurs over time, and 
involves redistribution of sodium channels (Smith, 2007). 
 
1.3.2.2 Inflammation 
 
In ON, there is an influx of inflammatory cells, which release cytokines. Some of 
these cytokines, such as interferon-gamma (IFN-γ) and tumour necrosis factor alpha 
(TNF-α), may play a role in causing conduction block (Moreau et al., 1996). Both 
IFN-γ and TNF-α stimulate the formation of inducible nitric oxide synthetase, which 
leads to high levels of nitric oxide, known to occur in MS lesions (Bo et al., 1994). 
Nitric oxide blocks axonal conduction, through effects on sodium channels (Li et al., 
1998) and mitochondrial energy production (Bolanos et al., 1997).  It may also impair   52
synaptic transmission, along with other pro-inflammatory cytokines, such as 
interleukins. Inflammatory cytokines may also result in activation of glial cells (Chao 
et al., 1995), which may also exert toxic effects, perhaps mediated through production 
of free radicals. It is of note that the temporal course of early visual recovery in ON is 
consistent with resolution of inflammation.  
In summary, loss of vision in acute ON reflects conduction block, and it appears that 
both demyelination and inflammation contribute to this. 
 
1.3.2.3 Neuroaxonal loss 
 
Optic atrophy, which is thought to reflect mainly loss of axons in the optic nerve and 
the associated retinal ganglion cells, usually ensues in the weeks following acute ON. 
Neuroaxonal loss appears to be a substrate of residual visual deficit in ON. The 
mechanism underlying acute axonal damage is complex, and has been elucidated in 
the brain. Reversible conduction block may be induced by nitric oxide in normal rat 
axons (Redford et al., 1997). Following more prolonged exposure to inflammatory 
mediators (Smith et al., 2001), a more destructive sequence of events follows, with 
nitric oxide acting directly and indirectly on neuronal N-methyl-D-aspartic acid 
(NMDA) receptors (Golde et al., 2002), and involving glutamate excitotoxicity (Pitt et 
al., 2000). Activated microglia release factors which impair cytochrome oxidase 
function in mitochondria (Dutta et al., 2006), resulting in energy failure and altered 
ion exchange mechanisms across the axonal cell membrane. Energy failure is 
exacerbated by the spread of sodium channels away from the node of Ranvier, across 
the exposed demyelinated axonal cell membrane, with sodium influx into the cell. 
This is extruded by the exchange pump, resulting in a further increase in the metabolic 
load (Howell et al., 2006). Loss of trophic support by oligodendrocytes and myelin 
contributes to neuroaxonal loss, which has been shown in vitro to be dependent on 
insulin-like growth factor (Wilkins et al., 2001) and glial cell-derived nerve growth 
factor (Wilkins et al., 2003). These factors modulate the direct effects of nitric oxide 
on axons (Wilkins and Compston, 2005). The end result is axonal damage, although 
whether inflammation per se is important in causing ongoing neuroaxonal loss is still 
debated (Compston and Coles, 2008).    53
Patients with residual visual loss following acute ON often have evidence of axonal 
loss, but so do patients who recover well. Therefore, it appears that other factors may 
also be important in determining the clinical outcome.  
 
1.3.3 Assessment of damage using clinical tests 
  
The following sections will now consider how damage is identified and quantified in 
ON. Several clinical and paraclinical tools are available, for example, physical 
examination, electrophysiology, MRI imaging and OCT (a recently developed 
technique which allows visualisation and measurement of the RNFL and macula). 
Each of these methods provides a different perspective on an aspect of 
pathophysiology.  
This discussion will begin with a brief description of commonly used clinical 
examination techniques. The aim of these tools is to enable accurate and reproducible 
quantification of visual function, in a standardised manner. Different tools aim to 
capture different aspects of clinical function, for example, central, peripheral or colour 
vision. The use of these tools allows generation of continuous data, which facilitate 
correlation with paraclinical variables in subsequent statistical analyses. 
 
1.3.3.1 Visual acuity 
 
Whilst the most commonly used measure of visual acuity in clinical practice has 
traditionally been the Snellen chart, logMAR scoring, using a retro-illuminated Early 
Treatment Diabetic Retinopathy Study chart (ETDRS investigators, 1991), is now 
often preferred in research studies. LogMAR represents the four metre logarithm of 
the minimum angle of resolution, and the scoring system provides a continuous 
statistical variable. LogMAR scores may be directly converted to Snellen scores of 
both UK and USA convention, and these scoring systems are used interchangeably in 
visual studies. A conversion table is provided in Appendix I. 
The chart appears similar in style to a Snellen chart, but offers several advantages. 
There are an equal number of letters per row, the letters are equally spaced, and letters 
on each row are balanced for difficulty. The task is therefore of equal difficulty on 
each line, with the size of letters the only variable. 
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1.3.3.2 Low contrast acuity 
 
Low contrast acuity is more sensitive than standard contrast acuity in detecting visual 
dysfunction in ON, especially in mild cases, or following recovery (Trobe et al., 
1996). Several different measurement techniques are available. In the past, rear-
illuminated sine wave gratings were commonly used, such as the Arden grating 
(Arden and Gucukoglu, 1978), in which the observer was required to make a choice, 
for example, regarding the orientation of the gratings at different contrasts. In research 
practice, charts are now more commonly used, such as the Pelli-Robson (Pelli et al., 
1988) test or Sloan charts (Ferris, III et al., 1982). In the Pelli-Robson test, all letters 
are the same size, and contrast progressively decreases in each group of three letters 
across the chart. This was the method used to test low contrast acuity in the ONTT. 
Sloan charts appear similar in style to the ETDRS, but consist of several charts of 
progressively lower contrast, for example, 100%, 25%, 5%, and 1.25%. High 
measurement reproducibility has been demonstrated (Balcer et al., 2000). Low 
contrast charts have been used to detect visual dysfunction in MS (Baier et al., 2005), 
and it has been suggested that they should be included in composite disability scales 
(Balcer et al., 2003).   
 
1.3.3.3 Colour vision 
 
In clinical practice, Ishihara plates are frequently used (Ishihara, 1917). These consist 
of a set of chromatic plates in which it is necessary for the observer to distinguish 
between two different colours, in order to identify a camouflaged number.  
In research practice, the more comprehensive Farnsworth-Munsell 100-hue test 
(Farnsworth, 1943) is often used. In this test, the subject places 85 coloured caps in 
order of perceived hue, and an error score is calculated. Sensitivity is increased, 
compared with the Ishihara plates (Optic Neuritis Study Group, 1991), 
dyschromatopsia may be more accurately quantified, the data is normally distributed, 
and the spectral location of any deficits may be determined. 
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1.3.3.4 Visual fields 
 
The visual field may be measured quantitatively, using static targets with Humphrey 
perimetry, or qualitatively, using kinetic targets with the Goldmann method. Both 
techniques were applied in the ONTT.  
The Humphrey perimeter is fully automated. Different programmes are available, but 
usually the central 30 degrees of the field are tested using a grid spaced six degrees 
apart. The subject is asked to respond to luminant stimuli, presented at different points 
in their visual field, by pressing a button. The size of the target stimulus is constant 
and the luminance is varied several times at each location, in order to determine the 
minimum luminance detectable. Randomised repeat testing is performed to estimate 
reliability. False positive and negative rates, and the number of fixation losses, are 
reported. Scores at each point in the visual field are calibrated with control data, in 
order to estimate the deviation from normal.  
During Goldmann perimetry, a trained operator maps the field by moving a target 
from the periphery to the central field. The subject indicates when they can detect it. 
The luminance of the stimulus remains constant and targets of different sizes are used. 
The output is a qualitative map of the visual field to stimuli of different sizes. 
In both techniques, standardisation and optimisation of the test procedure is important 
to ensure reproducibility (Keltner et al., 1993a). 
 
1.3.3.5 Conclusions 
 
There is a wide choice of clinical assessment tools available for research studies, with 
different advantages and disadvantages. The choice of which to use is often a balance 
between obtaining maximum information in the minimum time, so that testing is 
acceptable to patients. For this study, logMAR acuity, Sloan charts, the Farnsworth-
Munsell 100-hue test and Humphrey perimetry were chosen. 
 
1.3.4 Assessment of damage using structural MRI 
 
The following sections will now consider paraclinical methods of assessing and 
quantifying damage in ON, beginning with MRI.    56
The development of MRI in the 1970s and 1980s (Lauterbur, 1973) allowed detailed 
in vivo imaging of CNS pathology in humans. This section will summarise the 
insights that structural MRI techniques have provided in understanding damage 
mechanisms in ON to date. A more detailed description of the principles underlying 
the various MRI techniques will follow in Chapter 2. 
 
1.3.4.1 Identification of the optic nerve lesion  
 
The optic nerves are difficult to image with MRI as they are small, mobile and 
surrounded by fat, CSF and air filled sinuses. The first study to overcome these 
challenges, and identify the optic nerve lesion, was performed in 1988 (Miller et al., 
1988a). A technique to suppress intra-orbital fat was used (short tau inversion 
recovery, STIR), and the lesion was identified as a region of high signal within the 
nerve on T2-weighted images. Thirty seven people with a recent or past history of ON 
were imaged, and high signal was seen in 84% of symptomatic, and 20% of 
unaffected, nerves. The average length of lesion was around 1cm, and slow or poor 
visual recovery was associated both with longer lesions, and lesions occurring within 
the bony optic canal. 
Two new techniques for suppressing fat were subsequently developed: SPIR (spectral 
presaturation by inversion recovery) and fat-suppressed fast spin-echo (Tien, 
1992;Gass et al., 1996), which had the advantages of shorter acquisition time and 
higher resolution. However, the presence of CSF continued to cause difficulties, until 
a fluid-attenuated inversion recovery (FLAIR) technique was developed to suppress 
this signal too (Jackson et al., 1998). The new technique improved sensitivity further 
and demonstrated that lesions were more longitudinally extensive than previously 
recognised. Recent research studies have used these fat suppressed fast spin-echo 
techniques to quantify optic nerve lesion length in ON (Hickman et al., 2004c).  
The observed changes in T2 signal in all of these sequences are due to changes in 
tissue water content and are thought to be non-specific, reflecting a mixture of 
oedema, inflammation, demyelination, axonal damage and gliosis (Barkhof and Van 
Walderveen, 1999). MRI correlates with pathology have been inferred from post-
mortem imaging studies and animal models of MS (Stewart et al., 1984;Stewart et al., 
1985). One animal study, focusing on the optic nerve, demonstrated a correlation 
between T2 signal characteristics and the extent of demyelination (Guy et al., 1992a),   57
and a human in vivo study found that optic nerve lesion length on MRI correlated with 
latency of VEPs (Davies et al., 1998).  
In humans, high signal present during the acute phase persists following recovery. In 
fact, the length of the T2 lesion in vivo in humans may increase following an acute 
episode of ON, which may be due to extension of the primary demyelinating lesion, 
or to Wallerian degeneration (Hickman et al., 2004c). The lesion length may correlate 
with visual acuity (Miller et al., 1988a;Thorpe et al., 1995). With conventional T2-
weighted imaging, it is not possible to distinguish the different aspects of pathology as 
they evolve. 
 
1.3.4.2 Gadolinium enhancement and breakdown of the blood-brain barrier 
 
In the early stages of inflammation of the CNS, cells gain access to the brain from the 
peripheral circulation. In health, this is prevented by interactions between the 
endothelial lining of blood vessels and astrocytes within the brain. At the start of a 
neuroinflammatory response, this blood-brain barrier becomes leakier, and immune 
cells enter the brain. An important development in MRI was the discovery that this 
process could be imaged in vivo using contrast agents, such as gadolinium-diethyl-
enetriaminepentacetic acid (Grossman et al., 1986;Miller et al., 1988b;Hawkins et al., 
1990;Katz et al., 1993). Gadolinium enhancement has been shown to correlate with 
the extent of inflammation in animal models, and it precedes T2 abnormalities (Guy et 
al., 1992a). As the optic nerves are part of the CNS, breakdown of the blood-brain 
barrier, indicating active inflammation, can be imaged in ON.  
In the first study to demonstrate this, gadolinium enhancement was seen in 13/13 
acutely symptomatic optic nerves, and was associated with worse vision, and reduced 
amplitude and increased latency of VEPs (Youl et al., 1991). After a mean period of 
34 days, enhancement ceased in 9/11 lesions and, at the same time, vision and VEP 
amplitude improved. The authors concluded that contrast-enhanced MRI reflected 
inflammation, which must play an important role in the production of acute clinical 
deficit and electrical conduction block because, as it resolved, vision and 
electrophysiological parameters improved.  
These findings were confirmed in other small studies (Guy et al., 1992b;Tien et al., 
1991). A larger study of 107 patients reported 94% sensitivity for lesion detection in 
acute ON, with no unaffected nerve enhancing, and visual function was found to   58
correlate with enhancing lesion length (Kupersmith et al., 2002). Lesions longer than 
17mm were associated with worse acute visual loss.  
The use of triple-dose gadolinium increased sensitivity further to 96% (Hickman et 
al., 2004c). In this study, the median duration of enhancement was 63 days, and was 
related to the initial lesion length. The length of the optic nerve lesion was again 
associated with the degree of acute visual loss. 
Together, the length of the gadolinium-enhancing segment and T2 lesion length 
provide a useful measure of the severity of structural damage caused by ON, and both 
were applied to the patients studied in this thesis. 
 
1.3.4.3 Optic nerve swelling and atrophy 
 
Inflammation is associated with oedema and, during the acute stage of ON, swelling 
of the optic nerve has been detected. A longitudinal study, using a fat-saturated 
FLAIR sequence (Hickman et al., 2001), demonstrated that the mean area of the intra-
orbital segment was 16.1mm
2, compared with 13.4mm
2 for unaffected nerves, and 
13.6mm
2 for control optic nerves (Hickman et al., 2004a). The measurements were 
made after a median delay of 13 days from onset of visual symptoms. Over time, 
swelling evolved to atrophy, with a mean area of 11.3mm
2 at 12 months. More 
swollen nerves were associated with worse acute visual loss, but not with the eventual 
degree of atrophy or visual function one year later. In addition, in this study, there was 
no correlation between optic nerve atrophy and visual outcome at 12 months.  
Other studies have found correlations between atrophy and visual outcome, but 
generally these have been modest (Hickman et al., 2002a;Inglese et al., 2002). This is 
of interest, as atrophy is thought to predominantly reflect axonal loss, with a smaller 
contribution from myelin (Miller et al., 2002). Axonal loss in other regions of the 
brain in MS correlates with disability. Several hypotheses have been postulated to 
explain this discrepancy between tissue loss in the optic nerve and clinical function. 
These include confounding associations, such as a detrimental effect of pathology in 
the posterior visual pathways on acuity, or a contribution from gliotic tissue to 
increase the area of the optic nerve. Neuroaxonal redundancy in the optic nerve has 
also been suggested, in which it is hypothesised that the axons of the optic nerve are 
able to maintain clinical function, despite loss of nerve fibres, up to a critical 
threshold, as a result of tissue reserve. Lastly, an alternative hypothesis is that   59
compensatory changes in grey matter processing of visual input may contribute to 
clinical recovery. This will be discussed in more detail later. To date, the relative 
importance of each of these mechanisms is still unclear, and this is one of the key 
questions that this thesis aims to answer. 
 
1.3.4.4 Magnetisation transfer imaging and myelination of the optic nerve 
 
Magnetisation transfer ratio imaging (MTR) is an MRI technique that can quantify 
constituents of the optic nerves, by measuring magnetisation exchange between free 
water protons and those bound to macromolecules. These include myelin and axonal 
membranes. MTR is higher in white matter than grey matter, and is usually 
interpreted as reflecting myelin content, although it is probably not entirely specific 
(Wolff and Balaban, 1989). Whilst MTR was not applied to the patient cohort 
described in this thesis, previous studies using this modality have provided relevant 
insights into demyelination and remyelination following ON, and these will be briefly 
summarised. 
Most studies have found reduced MTR in affected optic nerves, both during the acute 
stage (Boorstein et al., 1997) and later (Thorpe et al., 1995), suggesting 
demyelination. However, clinico-electrophysiological correlations have not always 
been consistent between studies. For example, in this latter study, MTR correlated 
with prolonged VEP latency, another marker indicating demyelination, but no 
correlation with visual acuity was found. However, another group compared optic 
nerve MTR in patients classified according to good or poor recovery (Inglese et al., 
2002). They found lower MTR values in those with poor recovery, but no correlation 
with VEP latency.  
One small study actually found increased MTR in the very early stages after the acute 
attack, before a subsequent fall (Melzi et al., 2007). The authors suggested that this 
could be due to inflammatory cell infiltrates present during the acute stage.  
Another cross-sectional study selected patients with poor visual recovery, and found 
correlations between MTR and a thinner RNFL, measured using OCT (Trip et al., 
2007). There was also an association with VEP latency in this study, suggesting that a 
relationship exists between MTR and both axonal loss and demyelination. The 
investigators also reported reduced MTR in unaffected nerves, compared with 
controls, suggesting that subclinical demyelination may occur in the fellow eye.    60
A longitudinal study traced MTR over time in a group of patients following acute ON 
(Hickman et al., 2004b). At baseline, there was no difference between patients and 
controls, but MTR fell over eight months to reach a nadir, before starting to increase 
again at 12 months (although the increase was not statistically significant). Time-
averaged MTR was lower in patients than controls. This study found complex 
interactions between MTR, visual function and time, with no clear linear 
relationships, either at baseline or one year. However, eventual visual recovery was 
better in patients with higher time-averaged ratios of diseased to healthy MTR. In 
addition, patients with lower time-averaged MTR had more prolonged VEP latencies. 
Therefore, it appeared that demyelination progressed over months after the initial 
insult, before beginning to recover, but there was not a clear relationship between the 
myelin status of the optic nerve and visual function at any given time-point. This is 
another example of the dissociation between markers of tissue damage and clinical 
function, which is investigated in this thesis. 
 
1.3.4.5 Diffusion tensor imaging, optic nerve integrity and axonal loss 
 
Diffusion tensor imaging (DTI) is a quantitative MRI technique, which is sensitive to 
tissue microstructure as a result of the diffusion behaviour of water molecules. It 
allows assessment of the integrity of white matter tracts, including the optic nerve. 
Parameters such as apparent diffusion coefficient (ADC), mean diffusivity (MD) and 
fractional anisotropy (FA) may be derived, which reflect fibre coherence. DTI was 
applied to the optic radiations of the cohort investigated for this thesis, but has also 
been applied to the optic nerve in recent studies, although this is technically 
challenging, and requires a long scan time. Optic nerve DTI is relevant to this thesis, 
in terms of future directions, so a brief discussion of current progress follows. 
An early study found increased ADC, suggesting reduced tissue integrity, in chronic, 
but not acute, ON (Iwasawa et al., 1997). In acute ON, the ADC was actually less than 
in controls, which may have been secondary to infiltration of inflammatory cells and 
oedema, resulting in restricted diffusion.  
A new technique, named ZOOM-EPI, was subsequently developed, which improved 
resolution (Wheeler-Kingshott et al., 2002). ADC was again found to be higher in 
patients with previous ON than in unaffected nerves and controls (Hickman et al.,   61
2005). This study also found that ADC correlated with clinical measures, and 
modestly with lesion length, but not with optic nerve area.  
Following further optimisation of the sequences to allow rotationally invariant 
measures to be obtained, such as MD and FA (Wheeler-Kingshott et al., 2006), DTI 
was applied to an ON cohort selected for poor recovery (Trip et al., 2006b). MD was 
increased and FA reduced in affected nerves, consistent with reduced fibre coherence. 
This correlated with smaller VEP amplitudes, and probably reflected axonal loss, 
although demyelination and gliosis could also have contributed. There was no 
association between DTI parameters and clinical scores in this study. 
A more recent study confirmed that optic nerve FA four years after acute ON 
correlated with VEP amplitude, but found no association with atrophy of the nerve on 
MRI (Kolbe et al., 2009). 
 
1.3.4.6 Impact of optic neuritis on the optic radiations 
 
In clinically isolated ON, there are frequently incidental lesions of the optic radiations 
(Hornabrook et al., 1992). These may sometimes affect vision, especially if they are 
large (Plant et al., 1992). In patients with MS, visual psychophysical deficits have 
been correlated with lesion load in the post-chiasmal pathways (Caruana et al., 2000). 
In addition, lesions in the optic nerve could potentially have effects on other parts of 
the visual pathway, either through retrograde, Wallerian, or trans-synaptic 
degeneration (Evangelou et al., 2001). 
To date, there has been only one study focused on the effects of an attack of ON on 
the optic radiations. The authors used DTI-based tractography to reconstruct the white 
matter tracts in vivo, in a group of patients one year after the acute episode (Ciccarelli 
et al., 2005). It was found that connectivity scores were reduced in the optic 
radiations. They showed that the reduced connectivity could not be fully explained by 
incidental lesions, and hypothesised that it could be due to trans-synaptic 
degeneration.  
 
1.3.4.7 Impact of optic neuritis on occipital cortex 
 
Brain MTR scans were obtained six months after an acute episode of ON in a group 
of 80 patients, in order to identify any regions of abnormality in grey matter (Audoin   62
et al., 2006). Reduced MTR was seen in the visual cortex bilaterally, which may 
reflect trans-synaptic degeneration, or cortical synaptic changes.  
An Italian cross-sectional study found regional cortical thinning in the occipital pole 
and calcarine sulcus, in a subgroup of 42 patients who presented with clinically 
isolated ON, studied at an average of eight months from symptom onset (Calabrese et 
al., 2007). Many of the patients fulfilled the MRI criteria for dissemination in space 
(Barkhof et al., 1997;Tintore et al., 2000), and could thus be considered at high risk of 
later developing MS. Although patients with MS may develop generalised grey matter 
atrophy, the localised and clinically relevant nature of the volume loss led the authors 
to conclude that these changes might reflect a contribution from tract-specific trans-
synaptic degeneration. 
These studies both represent further evidence that damage affecting the optic nerve 
may have consequences for the rest of the visual pathway, and it is important to 
consider these remote effects when investigating the balance between damage and 
repair mechanisms.  
Functional MRI has also been applied to patients with ON, in order to study occipital 
cortical physiological responses to visual stimuli in the presence of damage, and will 
be discussed in Section 4 of this chapter, when recovery mechanisms are considered.  
 
1.3.4.8 Conclusions  
 
MRI has contributed greatly to our understanding of the mechanisms underlying optic 
nerve damage in ON. Whilst not entirely pathologically specific, it allows in vivo 
estimation of the relative contributions of inflammation, oedema, demyelination and 
axonal loss. Optic nerve swelling and enhancing lesion length have been shown to 
correlate with the degree of acute visual loss, suggesting that the intensity of initial 
inflammation is an important determinant of acute visual symptoms. In addition, 
evidence is emerging from quantitative MRI studies that there may be secondary 
consequences on the rest of the visual pathway. For this reason, a comprehensive 
structural assessment of the visual pathway covering the optic nerves, optic radiations 
and occipital cortex was included in the work reported in this thesis, in order to take 
into account the effects of any secondary damage, or incidental lesions, when 
considering mechanisms of damage and repair. 
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1.3.5 Assessment of damage using electrophysiology 
 
In the previous section, the contribution of inflammation and demyelination to acute 
visual loss in ON was described. The effect of these processes on electrical 
conduction within the optic nerve and visual pathway will now be considered. This 
may be studied in patients in vivo using visual evoked potentials (VEPs), a technique 
developed in the 1950s (Berry and Harman, 1956), and optimised in the 1970s, with a 
series of experiments establishing an important role in the diagnosis of demyelinating 
diseases, and clarifying the nature of demyelination (Halliday et al., 1972;Halliday et 
al., 1973;Halliday and McDonald, 1977).  
 
1.3.5.1 The normal visual evoked potential 
 
To acquire VEP data, the subject observes a visual stimulus, usually through each eye 
in turn, with the other eye patched. The stimulus is commonly reversing black and 
white checkerboards presented on a computer screen. Electroencephalographic 
responses are recorded over the occipital lobe. Viewing distance, check size and 
averaging techniques are standardised within laboratories. The VEP is a measure of 
conduction of the whole afferent visual pathway, from retina to visual cortex. 
Therefore, any observed abnormalities are not anatomically specific. However, due to 
the organisation of the visual system, with decussation of fibres in the optic chiasm, 
the VEP is most useful and sensitive in assessing the anterior visual pathway, in 
particular the optic nerve. 
The normal VEP is triphasic. An initial negative peak occurs after approximately 
75ms, and is referred to as N75, or sometimes N1. A positive peak follows after 
around 100ms, which is called the P100, or P1. Lastly, a second negative peak occurs, 
called N135 or N2 (Figure 1.4). 
Usually, it is the P100 waveform which is of clinical interest, and its amplitude and 
latency are reported. Amplitude normally shows considerable between-subject 
variability, in the range 4-30μV. Latency shows less variation in healthy subjects, and 
a normal value is around 100ms. 
Several factors can influence normal VEP values including age (Mitchell et al., 1987), 
pupil size (Martins et al., 2003), blood glucose levels (Sannita et al., 1995) and 
medications such as anticonvulsants (Geller et al., 2005), as well as stimulus factors,   64
such as the size of the checkerboard squares (Chan et al., 1986). Women, on average, 
have slightly shorter VEP latencies than men (Gregori et al., 2006). 
 
 
Figure 1.4  The normal visual evoked potential (Odom et al., 2004) 
 
1.3.5.2 The visual evoked potential in optic neuritis 
 
Acutely, the amplitude of the VEP is associated with visual acuity, and is thought to 
reflect the number of optic nerve fibres in functional continuity (Frederiksen and 
Petrera, 1999;Jones and Brusa, 2003). It is usually reduced in acute ON, when 
inflammation and demyelination lead to conduction block. In severe cases, with 
complete block, it may be impossible to elicit a potential. Most of the subsequent 
recovery in VEP amplitude occurs over the following two to three months, as 
conduction block resolves, and occurs in parallel with improvements in vision (Jones, 
1993), and cessation of contrast enhancement on MRI (Youl et al., 1991).  
This is in contrast to the VEP latency. In the 1970s, it was first recognised that VEP 
latencies were delayed in patients with ON (Halliday et al., 1972), and delay in 
conduction was experimentally linked to demyelination (Koles and Rasminsky, 
1972;Rasminsky and Sears, 1972). In acute ON, if it is possible to elicit a potential, 
then delay is usually evident with a mean of approximately 30ms, as reported in one 
large study (Jones, 1993). Subsequently, in this group, the delay gradually reduced to 
a mean of 16ms after two years. Therefore, the time taken for optic nerve conduction 
velocity to improve was significantly longer than the time taken for vision to recover,   65
which was usually only weeks to months, and indeed VEP latency and acuity were not 
correlated.  
Delayed VEPs are thought to reflect demyelination, and gradual shortening of latency 
over time to be a marker of remyelination. Therefore, after an episode of acute ON, it 
appears that vision recovers despite persistent demyelination, and the resulting 
slowing of conduction in the optic nerve. Prolonged VEP latencies may persist for 
many years (Halliday et al., 1972), and this tends to be more marked in older patients 
(Jones, 1993).  
Subclinical demyelination in asymptomatic optic nerves is a common finding in MS 
(Halliday et al., 1973), is supportive evidence for the diagnosis, and is incorporated 
into the diagnostic criteria (McDonald et al., 2001;Polman et al., 2005). In prospective 
studies following patients with acute ON, in a mixed cohort of clinically isolated 
disease, recurrent ON and ON associated with MS, electrophysiological deterioration 
was noted in unaffected optic nerves (Brusa et al., 1999;Brusa et al., 2001). This 
manifested as a slight reduction of VEP amplitude during the second year, and 
prolongation of latency during the third. Clinically, contrast sensitivity worsened over 
time. Therefore, it appears that insidious ongoing demyelination in the fellow optic 
nerve occurs after ON, which may be independent of acute inflammation and oedema, 
and might affect axons as well. It is unclear if this process differs depending on 
whether the patient has ON in the context of MS or not. 
 
1.3.5.3 Conclusions  
 
VEP studies have demonstrated that acute conduction block occurs early in ON. This 
may be secondary to demyelination, at least in part, but it improves rapidly, 
coincident with resolution of inflammation, whereas demyelination persists. In 
addition, there is evidence for ongoing, more generalised and insidious optic nerve 
demyelination, and axonal damage, over the following years. Electrophysiology 
complements the structural information provided by MRI, elucidating its impact on 
nerve function, and was applied to the patients studied in this thesis. 
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1.3.6 Assessment of damage using optical coherence tomography  
 
OCT uses the echo time delay of low coherence light to visualise and measure the 
RNFL (Huang et al., 1991). This provides an opportunity to quantify axonal loss, 
independent from demyelination, as these fibres of the CNS are unmyelinated in more 
than 99% of people (Straatsma et al., 1981). Assessment of the macular volume 
provides an estimate of ganglion cell numbers.  
OCT measurements have been correlated with retinal morphology on light 
microscopy in monkeys (Toth et al., 1997), and in laser-excised human specimens 
(Chauhan and Marshall, 1999), although both studies reported an underestimation of 
RNFL thickness on OCT, in comparison with histology. These two studies used older 
OCT machines. A more recent study, using a newer generation instrument, 
demonstrated improved accuracy of OCT, although discrepancies were still evident if 
scans were taken too close to the optic nerve (Skaf et al., 2006).  
The first application of OCT to the study of demyelinating disease was in 1999, in 
patients with MS and an episode of ON up to a year previously (Parisi et al., 1999). 
Thinning of the RNFL was reported in affected eyes, compared to fellow or control 
eyes. This was confirmed in subsequent studies (Trip et al., 2005;Fisher et al., 
2006;Costello et al., 2006;Klistorner et al., 2008a). Experimental studies in animals 
suggested that these effects on retinal axons, secondary to pathology in the optic 
nerve, were due to retrograde “dying back” axonal degeneration (Quigley et al., 
1977). The primary insult affects the optic nerve, which comprises axonal processes 
from the retinal ganglion cells (section 1.1.1), and results in secondary damage to the 
axonal segment situated between the site of injury and the cell body. In squirrel 
monkeys, this was observed to occur simultaneously throughout the length of this 
segment, rather than progressively back along the optic nerve, over a period of three 
to six weeks. 
A group of patients with unilateral ON, three or more years after the acute episode, 
was investigated with OCT, VEPs and MRI of the optic nerves (Trip et al., 2005). The 
cohort included patients with clinically isolated ON and people with MS. The authors 
reported that a thinner RNFL correlated with worse visual acuity, colour vision and 
visual field mean deviation. A 10μm decrease corresponded to a 0.1 unit decrease in 
logMAR acuity (equivalent to a line of five letters on the chart). There were also 
associations between macular volume and visual measures, which were strong for   67
colour vision, but prone to outlier influence for acuity and visual field mean deviation. 
Both OCT measures correlated with VEP amplitudes, but not latencies. There were 
associations between optic nerve atrophy, measured with MRI, and RNFL thickness, 
macular volume, VEP amplitude and visual acuity (Trip et al., 2006a). These data 
suggested that optic atrophy on MRI, thinning of the RNFL, macular volume loss and 
reduced VEP amplitude share a common underlying substrate of axonal loss.  
A different group studied patients with MS and investigated differences in subgroups, 
with and without a prior history of ON (Fisher et al., 2006). As well as confirming a 
reduction in RNFL thickness in ON affected eyes, they also showed that eyes with no 
prior history of ON had thinner RNFLs than control subjects. This suggested that 
subclinical axonal loss occurred in the optic nerves of people with MS. Later work 
showed that this correlated with brain atrophy (Gordon-Lipkin et al., 2007), and OCT 
has been proposed for use in clinical trials as a surrogate marker of axonal loss 
(Balcer et al., 2007).  
A prospective study followed up patients after an acute episode of clinically isolated 
ON (Costello et al., 2006). They found that RNFL thinning appeared between three 
and six months after the acute episode. They also found correlations with visual 
function below a threshold of 75μm for visual field mean deviation, and 70μm for 
acuity.  
A recent study in progressive MS found some evidence that the temporal quadrant of 
the RNFL, which comprises fibres of the papillo-macular bundle, responsible for 
central vision, may be more sensitive to subtle degrees of axonal loss (Henderson et 
al., 2008).  
Another recent development was the finding of an association between RNFL 
thickness and VEP latency, suggesting that demyelination might promote axonal loss 
(Klistorner et al., 2008a). The results contrasted with the earlier results of Trip et al., 
but the cohort was unselected for recovery, and the VEP methodology differed, using 
a multifocal approach, which may be more sensitive (Klistorner et al., 2008b).  
In summary, OCT appears to be a relatively specific surrogate marker for neuroaxonal 
loss in ON. The stronger correlations with visual function, compared with the 
inconsistent and modest correlations seen between clinical function and atrophy of the 
optic nerve, may reflect this greater specificity. Therefore, it appears that neuroaxonal 
loss contributes significantly to permanent neurological deficit following ON, just as 
it does in MS. The finding of thresholds below which there are correlations with   68
worse vision may suggest some degree of neuroaxonal tissue reserve in the optic 
nerve, which is termed redundancy. OCT provides a method of indirectly assessing 
this effect, through quantification of neuroaxonal loss, and was used for this purpose 
in this thesis, together with MRI measures of optic nerve atrophy and VEP amplitude. 
OCT was applied to patients at the 12 month time-point.  
 
1.3.7 Conclusions 
 
The current level of understanding of the mechanisms of damage in ON has been 
achieved by combining the results of pathological studies in humans, EAE work in 
animals, and in vivo studies in patients, using MRI, electrophysiology and OCT. 
During the acute stage, inflammation and demyelination occur. These two distinct, but 
linked, processes have detrimental effects on neural conduction, which may lead to 
acute conduction block in the optic nerve, manifested clinically as visual loss.  
Subsequently, there is persistent demyelination, neuroaxonal loss and probably 
gliosis. There are secondary effects on the rest of the visual pathway, which are 
incompletely understood, but may involve retrograde, Wallerian and trans-synaptic 
degeneration. Atrophy is detectable in the optic nerve, and neuroaxonal loss occurs in 
the RNFL and macula. Despite this, most patients make a good clinical recovery, and 
the correlation between tissue loss and visual outcome is often relatively modest. 
Therefore, several unanswered questions remain, when considering how damage 
occurs. It appears from MRI studies that the initial severity of inflammatory insult is 
important in determining the degree of acute visual loss. However, the involvement of 
other factors has not been studied in detail. In particular, the potential contribution to 
visual loss from damage to the posterior visual pathways is not known. If lesions, or 
secondary degeneration, in the optic radiations had a significant impact on vision, this 
could partly explain why visual recovery is only weakly and inconsistently correlated 
with tissue loss in the optic nerve. In addition, it is increasingly evident that in acute 
inflammatory disease, there is a complex interplay between pathology and 
physiological responses. Therefore, it may be that during acute ON, physiological 
responses act to modulate the impact of damage on clinical function. This possibility 
has also not been studied before in depth.  
It is interesting that whilst the severity of inflammation in the optic nerve does appear 
to contribute to the magnitude of acute visual loss, it does not seem to be as important   69
in determining eventual visual outcome. This suggests that other factors, which are 
independent from the magnitude of post-inflammatory damage and tissue loss, may be 
important in recovery.  
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SECTION 4: REPAIR AND RECOVERY 
 
1.4.1 Difficulty of predicting visual recovery 
 
At the present time, it is not possible to predict which patients will recover from ON, 
and which will not. This causes uncertainty and anxiety for patients, and makes it 
difficult to select patients who might be candidates for experimental therapies, such as 
stem cells (Pluchino and Martino, 2005;Kolappan et al., 2008a). Several studies have 
looked for predictors of visual recovery, but the results have been conflicting. Early 
studies reported correlations between longer optic nerve lesions on fast spin-echo 
MRI sequences and slow or poor recovery (Miller et al., 1988a;Thorpe et al., 1995), 
but a more recent longitudinal study did not find any association (Hickman et al., 
2004c). Instead, this latter study found that patients with a longer gadolinium 
enhancing segment at baseline (using triple dose gadolinium), lower VEP amplitudes 
during recovery, and a less steep initial gradient of recovery had worse vision at 12 
months. However, a large study (using single dose gadolinium) found no association 
between enhancing lesion length and visual recovery at six months (Kupersmith et al., 
2002). 
In the ONTT, although baseline and six month visual acuity were associated (Beck et 
al., 1994), no single measure or combination of baseline measures was a significant 
predictor of a poor visual outcome (6/15 or worse), because relatively few patients 
had visual loss  to this level at six months. Visual acuity was 6/15 or worse at six 
months in 79% of patients with a baseline acuity of 6/60 or worse, compared with 
17% of patients with baseline vision 6/15 to 6/57,  and 7% of patients with acute 
visual loss of 6/12 or better (Beck et al., 1994). A more recent study reported no 
association between baseline acuity and visual outcome a year later (Hickman et al., 
2004c). However, a different study from the ONTT cohort, which investigated later 
cut-points, found that acuity at one month was significantly associated with a poor 
outcome (6/15 or worse) at six months (Kupersmith et al., 2007).  
No associations have been found between age, gender, ethnicity, abnormalities on 
brain MRI (Beck et al., 1994), VEP parameters during the acute stage (Hickman et al., 
2004c), or optic nerve MTR (Hickman et al., 2004b) and recovery. Therefore, 
although baseline acuity may be of some value, a clinical predictor of visual outcome, 
which can be used at the time of presentation, is still awaited, and there is no clear   71
consensus on which, if any, structural measures might be important in determining 
subsequent recovery. 
 
1.4.2 Correlations between structural damage and visual recovery 
 
Most patients with ON recover well, despite evidence of residual structural damage 
within the optic nerve, as outlined in the previous sections.  
Several studies have reported associations between atrophy in the optic nerve and 
visual recovery (Hickman et al., 2002a;Inglese et al., 2002;Trip et al., 2006a), but 
these have generally been relatively modest, and indeed some studies have found no 
correlation (Hickman et al., 2004a). RNFL thickness may be a more specific marker 
of axonal loss, and associations between a thinner RNFL and worse vision have been 
reported (Trip et al., 2005), with one study suggesting a threshold effect at 70-75μm 
(Costello et al., 2006). Taken together, these data suggest that whilst axonal loss in the 
optic nerve contributes to permanent visual disability in ON, there appear to be other 
factors influencing the clinical picture, which confound the association. 
The hypotheses as to what these factors might be were briefly outlined in section 
1.3.4.3: an impact of posterior pathway damage, gliotic tissue disguising optic nerve 
atrophy, optic nerve neuroaxonal redundancy, or differing efficacy of mechanisms 
which modulate damage or contribute to repair. Repair will now be considered in 
more detail. This could be mediated through a mechanism of redistribution of sodium 
channels in the optic nerve, remyelination, or adaptive grey matter plastic changes. 
Currently, it is unclear which, if any, of these mechanisms are important in 
determining differences in clinical recovery between individuals following ON.  
 
1.4.3 Pathophysiology of recovery  
 
Inflammatory conditions which affect the CNS, such as MS and ON, are often 
characterised by relapses and remissions. Previous work has identified several 
mechanisms by which remission might occur. Again, much of this work was carried 
out in MS and its animal models, and the data extrapolated to ON. 
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1.4.3.1 Resolution of inflammation 
 
As the immune response to the antigenic stimulus resolves, levels of pro-
inflammatory cytokines and nitric oxide fall, and hence their inhibitory effects on 
axons are removed. Conduction may then resume. This occurs despite significant 
demyelination being present in most cases (Felts et al., 1997). 
 
1.4.3.2 Redistribution of sodium channels 
 
It is perhaps surprising that demyelinated axons retain the ability to conduct nerve 
impulses. This may be facilitated through redistribution of sodium channels, even in 
the absence of remyelination (Bostock and Sears, 1976). These appear within two to 
three weeks of the acute episode, over the axonal segment which is denuded of myelin 
(Felts et al., 1997). This helps conduction to be restored, although it may now be of a 
continuous, rather than saltatory, morphology. The sodium channels in new locations 
were initially thought to be existing ones, which had been redistributed from the 
nodes, but subsequently it was shown that some develop de novo. Work in EAE first 
demonstrated that a proportion of the new channels differed from the usual subtype. 
Some were of the type seen during neural development prior to myelination (Nav-
1.2), rather than the usual type seen in adult myelinated nerves (Nav-1.6) (Craner et 
al., 2003). This was also observed in MS lesions (Craner et al., 2004). It has been 
suggested that this process might explain why demyelinating lesions can sometimes 
remain clinically silent, even if they are large and in eloquent locations such as the 
optic nerves (Smith, 2007). However, even after this redistribution of sodium 
channels, the velocity of conduction that is restored is slower than before. Refractory 
periods are prolonged from 0.5-1.4ms to 1.0-6.0ms, and times as long as 27ms have 
been recorded (Felts et al., 1997). Conduction is therefore less secure, and periods of 
successful conduction can be interspersed with intermittent complete conduction 
block (Felts et al., 1995). 
 
1.4.3.3 Remyelination 
 
Another important mechanism of repair is remyelination, which may occur 
extensively in some people with MS (Patrikios et al., 2006). It has been demonstrated   73
experimentally that central remyelination can restore conduction (Smith et al., 1979), 
although this experimental study was not focused specifically on MS. Remyelination 
may improve both the velocity and security of conduction, even with high frequencies 
of depolarising stimuli. There is evidence that this improves clinical function from 
experimental models of demyelination in rats (Jeffery and Blakemore, 1997). 
However, it occurs slowly, months to years after the initial insult in ON (Jones and 
Brusa, 2003), by which time most of the clinical improvement has already occurred. 
Recently, evidence has emerged that remyelination may also prevent subsequent 
degeneration of the axon (Lappe-Siefke et al., 2003), which has led to interest in 
remyelination as a therapeutic strategy to prevent neurodegeneration. Although 
remyelination is usually dependent on oligodendrocyte function in the CNS, it is also 
possible using a variety other different cell types, such as exogenous Schwann cells 
(Honmou et al., 1996), olfactory ensheathing cells (Imaizumi et al., 2000) and neural 
stem cells, derived from bone marrow (Pluchino and Martino, 2005).  
In both health and disease, maintenance of the myelin sheath in the CNS is a dynamic 
process. Following demyelination, remyelination may occur spontaneously (Woodruff 
and Franklin, 1999), through the action of oligodendrocytes recruited from precursor 
cells, expressing platelet-derived growth factor (Woodruff et al., 2004). The 
recruitment and differentiation of oligodendrocytes from these precursors appears to 
be critical for successful remyelination to occur. Sometimes remyelination fails, and 
this is either because oligodendrocytes are not present or, if present, are inactive. The 
reasons for this remain incompletely understood. Work in animals has suggested that 
differentiation, rather than recruitment, of oligodendrocytes from precursors is the 
main problem in MS (Arnett et al., 2004). The migration of precursors to the 
demyelinated lesion appears to be impaired, perhaps through dysregulation in cellular 
signalling molecules, such as semaphorins (Williams et al., 2007). A role has also 
been suggested for macrophages, as the presence of residual myelin debris appears to 
influence the effectiveness of remyelination (Kotter et al., 2006). 
It remains unclear how important remyelination of the optic nerve is to recovery from 
ON. Although the evidence from VEP studies suggests a minimal contribution to the 
rapid initial recovery of vision following acute ON, as significant VEP delays persist 
for months and years (Brusa et al., 1999;Brusa et al., 2001), it may be important later 
in the recovery process, to prevent subsequent axonal degeneration. 
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1.4.3.4 Neuroaxonal redundancy 
 
Following acute ON, a good visual recovery may occur despite residual axonal loss in 
the optic nerve, which is frequently associated with residual clinical dysfunction in 
demyelinating diseases (Miller et al., 2002), including ON (section 1.3.2.3). This 
restricted clinical impact despite neuroaxonal loss may be determined, in part, by the 
large number of axons in the optic nerve, in excess of the critical threshold necessary 
to maintain function. 
This hypothesis is supported by studies which correlated optic nerve fibre counts with 
visual acuity, in 14 patients with a variety of conditions resulting in optic atrophy 
(Frisen and Quigley, 1984). They found that a normal acuity of 6/6 could be 
maintained despite loss of 40% of the axons. As more axons were lost, visual 
dysfunction worsened (to 6/15 and 6/60 with axonal loss of 90% and 99%, 
respectively). 
Animal studies of optic nerve crush injury reported that vision improved in rats after 
two weeks, despite only 10% of retinal ganglion cells remaining viable and cortically 
connected (Sabel, 1999). They reported that cell survival in the retina did not correlate 
well with recovery of vision (although this is difficult to quantify in animals), and 
concluded that other factors must play a role.  
 
1.4.3.5 Grey matter plastic changes 
 
Lastly, plasticity of the CNS merits consideration. It is possible that reorganisation of 
central grey matter processing, in response to an altered afferent input, may 
compensate for tissue damage, and preserve clinical function. Neuroplasticity is a 
subject of increasing research interest. It used to be thought that cortical maps 
representing different neurological functions were permanent in the adult, and that 
damage to them was irreversible. However, this belief was challenged by 
experimental work, initially investigating sensory maps in animals (Merzenich et al., 
1984;Pons et al., 1991), which found that reorganisation occurred on a macroscopic 
scale of several centimetres of neural tissue (Pons et al., 1991). Subsequently, this was 
also recognised in the visual system, and the mechanism was observed to be through 
axonal sprouting at cortical level (Darian-Smith and Gilbert, 1994), rather than any 
change in projections from the thalamus (Darian-Smith and Gilbert, 1995). In these   75
animal studies, homologous lesions in the retina resulted in the primary visual cortical 
representation of that region shrinking, whilst the representation of adjacent areas 
increased in size. In humans, evidence for neuroplasticity has been derived 
predominantly from fMRI studies. 
Neuroplasticity is formally defined as reorganisation of distributed patterns of normal 
task-associated brain activity that accompany action, perception and cognition, and 
that compensate impaired function resulting from disease or brain injury (Frackowiak, 
1997). Plasticity may be maladaptive, which describes a “stress response” with no 
discernable benefit on function (or even occasionally a detrimental effect, for 
example, phantom pain following limb amputation), or adaptive, which implies a 
contribution to clinical recovery.  
Adaptive plasticity may result from several different mechanisms.  There may be 
changes at neuronal or axonal level, such as altered sodium channel expression 
(Smith, 2007), dendritic arborisation (Jones and Schallert, 1992), or axonal sprouting 
(Darian-Smith and Gilbert, 1994). Remodulation of synapses may occur through 
changes in distribution, density or strength of connection (Jacobs and Donoghue, 
1991). Neural circuits transform visual inputs into complex spatio-temporal patterns 
of electrical activity, and correlated cortical neuronal firing may influence cortical 
processing, through a mechanism of synaptic plasticity (Karmarkar and Dan, 2006).  
These effects at a cellular level may then be translated into differing patterns of 
reorganisation at systemic level. Four types have been suggested (Baker et al., 2005). 
In homologous area adaptation, functions localising to the damaged area of brain are 
transferred to undamaged homologous regions of the opposite hemisphere. When 
considering sensory processing, cross-modal reassignment describes the transfer of 
processing from a damaged region to an undamaged region, which is usually devoted 
to a different sensory modality. Map expansion describes an increase in the cortical 
representation of a function, either in response to repeated stimuli (a “learning 
effect”), or in order to compensate for damage to an adjacent area, as observed in the 
early animal work. Lastly, compensatory masquerade describes a change in cognitive 
strategy in order to achieve a task, which shifts processing from a damaged network to 
an alternative working one. Each of these mechanisms results in a change in location 
of cortical neural activity, which can be detected using fMRI. 
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1.4.4 Imaging plasticity using functional MRI 
 
Reorganisation of the CNS can be imaged in vivo in humans using fMRI. This 
technique exploits the magnetic properties of haemoglobin, which differ depending on 
whether it is oxygenated or not. Areas of increased neural activity have greater 
oxygen requirements, so areas of reorganisation in response to simple tasks can be 
identified.  
There is strong evidence for visual cortical reorganisation in human disease from 
studies of macular degeneration, a condition which results in progressive permanent 
central visual loss (Baker et al., 2005). It was demonstrated that peripheral field 
stimuli resulted in activation in regions usually reserved for the central field. 
In inflammatory disease of the CNS, such as ON, the insult is often more transitory, 
and so evidence for plasticity may be more subtle and indirect. Nonetheless, there 
have been several studies which have investigated plasticity in ON, as well as other 
neurological syndromes which occur in MS (Comi et al., 2004). 
The first fMRI studies in ON were carried out in the late 1990s (Rombouts et al., 
1998). In general, patients with ON have smaller fMRI responses in primary visual 
areas when the affected eye is stimulated. The magnitude of the response has been 
correlated with VEP latency (Gareau et al., 1999), VEP amplitude (Russ et al., 2002) 
and visual acuity (Langkilde et al., 2002). It is thought that this smaller response 
reflects a reduced afferent neuronal input, which is most marked during the acute 
stage, when there is active inflammation and conduction block in the optic nerve. 
The first evidence that fMRI responses were redistributed in areas outside primary 
visual cortex following ON was reported in 2000 (Werring et al., 2000). The authors 
studied seven patients, between six months and 14 years after acute ON, and seven 
controls. All of the patients had made a good visual recovery, but some still had 
delayed VEPs. The fMRI response maps to a simple visual checkerboard stimulus 
differed in patients and controls. Controls activated only visual cortex. In the patient 
group, visual cortical activation was seen but, in addition, there was activation in a 
large number of extra-striate areas, which included the insula-claustrum, corpus 
striatum, lateral temporal and posterior parietal cortices, orbitofrontal regions and the 
thalamus, on stimulation of the affected eye. In addition, when patients’ unaffected 
eyes were stimulated, insular activity was seen. Differences were also observed when 
patient and control activations were directly compared. Patients demonstrated greater   77
responses in the insula-claustrum, orbitofrontal and lateral temporal cortex, corpus 
striatum, cingulate and right inferior frontal gyri, as well as some areas of visual 
cortex. Controls activated more than patients in several areas of visual cortex and also, 
on stimulation of the left eye only, the right superior and middle temporal gyri. The 
authors concluded that the redistribution of fMRI responses seen in patients reflected 
functional reorganisation, in response to a persistently abnormal input. They noted 
that some of the areas identified had strong visual connections, and were involved in 
multi-modal sensory processing. Surprisingly, the extra-striate neural activity actually 
occurred during the rest condition of darkness, rather than during checkerboard 
stimulation. This was subsequently confirmed in a study which used longer duration 
blocks of stimuli to conclude that this was a phase-specific phenomenon, and truly 
reflected relative deactivation during checkerboard stimulation, rather than a delayed 
haemodynamic response (Toosy et al., 2002). Since these studies were performed, 
advances have been made in understanding and interpreting deactivations in fMRI. 
They are thought to reflect activity of the brain’s default mode networks. This term 
describes ongoing neural processing that occurs during rest, rather than being directed 
towards a specific task, and is a somewhat controversial area (Harrison et al., 2008). 
However, it is still not clear why neural reorganisation activity following ON was 
related to default mode processing, rather than to the task, in these studies. 
The nature of plasticity in ON was clarified further by a longitudinal study in 20 
patients with clinically isolated disease (Toosy et al., 2005). They were investigated 
with both structural and functional MRI imaging of the optic nerves. The authors used 
a novel methodology in order to identify areas of plasticity which contributed to 
clinical function, and could therefore be considered adaptive. They correlated fMRI 
activity indirectly with vision, after accounting for any variance in visual function 
which could be explained by structural MRI measures of optic nerve lesion length and 
swelling. An association was reported in the lateral occipital complexes (LOCs), 
which are higher visual processing areas, at the baseline time-point only, at a mean of 
15 days from symptom onset. The authors hypothesised that these data represented 
evidence for genuine adaptive plasticity, occurring within the ventral processing 
stream. 
A subsequent cross-sectional study used retinotopic mapping to identify hierarchical 
lower visual areas, and a specific localiser task to identify the LOCs, in patients with 
ON (Levin et al., 2006). Eight patients were studied between ten days and 69 months   78
after the acute episode. All the patients had good visual function (better than 6/9), but 
delayed VEP latencies. The aim was to investigate whether ON had differential 
effects in lower and higher visual areas. The authors reported that fMRI response 
profiles in the LOCs were similar on stimulation of the affected and fellow eyes and, 
in the inferior and lateral occipital gyri, the affected eye response was actually greater. 
This was in contrast to lower visual areas V1 and V2, where greater activation was 
seen, as expected, in the fellow eye. The authors offered two different hypotheses. 
Either LOC responses might be robust to disruption of visual input, or compensatory 
plastic responses could be occurring within them, on stimulation of the affected eye. 
A later longitudinal study reported evidence for plasticity in the LGN (Korsholm et 
al., 2007). These were defined using anatomical landmarks on structural MRI, and the 
fMRI data were then extracted. The authors also defined regions-of-interest in the 
LOCs and primary and secondary visual cortex, using atlas-based coordinates. In 
contrast to Levin et al., they reported that the fMRI response profiles were similar in 
lower and higher visual areas, and both were diminished on stimulation of the affected 
eye, compared with the fellow eye. As vision improved over time, the differences in 
LGN activation between the two eyes decreased. Most of this change was due to an 
increase in signal from the affected eye, as vision recovered, but a reduction in fMRI 
signal from the fellow eye also contributed. The authors hypothesised that this change 
represented plasticity, occurring at an early stage in the processing hierarchy, and it 
appeared that the fellow eye was involved. However, the study did not include a 
control group, which complicated interpretation of this longitudinal fMRI data. 
It is unclear whether structural plasticity occurs following ON, and how fMRI 
responses representing plasticity relate to the anatomy of the visual pathways. One 
study reported that the optic radiations were located more postero-laterally in patients 
a year after ON than in controls, using reconstruction with DTI-based tractography 
(Ciccarelli et al., 2005). The authors hypothesised that this might represent structural 
reorganisation. It is interesting, in this regard, that a study in healthy controls found 
correlations between  FA of the optic radiations and occipital fMRI responses, 
suggesting that cortical activity was constrained by external connections to the 
subserving white matter tracts (Toosy et al., 2004). 
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1.4.5 Brain repair: conclusions and unanswered questions 
 
Therefore, to date, evidence for adaptive plasticity in ON has been identified in both 
lower and higher visual processing areas, in several different regions. With regard to 
the timing of these changes, there is still no clear consensus, but it appears, from 
longitudinal studies, that the acute phase may be important. There is some evidence 
that processing in the fellow eye is abnormal, but its exact role requires further 
clarification. The pattern of response profiles to visual stimuli in lower and higher 
visual areas and how they relate to one another is still controversial. In addition, the 
relative importance of plasticity in explaining recovery despite tissue damage, 
compared with remyelination, neuroaxonal redundancy in the optic nerve and 
posterior pathway pathology, remains to be elucidated. 
No previous MRI studies have combined structural measures of the whole visual 
pathway with fMRI in ON. In addition, OCT has never been used in conjunction with 
fMRI in this condition. By combining these different in vivo techniques, each of 
which offers a different perspective, it may be possible to dissect the complex 
interactions between structure and function, pathology and physiology, damage and 
repair, in the anterior and posterior pathways. This approach has been used in this 
thesis, with the aim of answering the questions mentioned above.  
Therefore, the primary underlying hypothesis is that an inflammatory insult to the 
optic nerve results in damage to myelin and axons, which is still detectable a year 
later. This insult to the optic nerve may have secondary consequences on the rest of 
the visual pathway, and there might also be incidental lesions of the optic radiations, 
which could be clinically significant. Despite this, a good visual recovery occurs in 
the majority of people. The reasons for this may include optic nerve remyelination, 
neuroaxonal redundancy, or adaptive neuroplasticity, either at subcortical or cortical 
level. If neuroaxonal loss is severe, or if remyelination or neuroplastic compensatory 
mechanisms fail, then patients may fail to recover.  
The importance of investigating this hypothesis is, firstly, to develop better predictors 
of visual recovery, based on either markers of tissue damage, or the efficacy of 
responses to it. This would have important implications for clinical trials of 
experimental therapies, as patients with a poor prognosis could be identified. At 
present, no effective treatments exist for these patients, and future clinical trials may 
entail more invasive therapies, such as stem cells (Kolappan et al., 2008a), which may   80
necessitate careful patient selection. Secondly, elucidating the location and timing of 
any plastic responses, and the role of the fellow eye, is important when considering 
how to intervene to improve outcome, either with drugs, stem cell approaches, or even 
visual rehabilitation strategies (Kasten et al., 1998). Thirdly, a better understanding of 
mechanisms of damage and recovery in ON may also translate into MS, and form a 
basis for new therapeutic approaches. 
In order to investigate the hypothesis outlined above, it is necessary to answer several 
more specific questions, in stages, which reflect the order of the results chapters of 
this thesis. 
The first stage is to consider the acute phase of ON, to identify which structural and 
electrophysiological measures are associated with the severity of acute damage in ON, 
in this cohort, and what can be inferred regarding mechanisms of damage. Next, the 
effect of optic nerve damage on the rest of the visual pathway is studied, and the 
prevalence of incidental lesions of the optic radiations at this time. The role of 
neuroplasticity during the acute episode is investigated and, in particular, whether it 
has any role in modulating the impact of damage on clinical function. This may be 
complicated by complex interactions between visual acuity, structural damage and 
fMRI responses, which will require dissection. After this, the longer term 
consequences of ON are investigated. Residual structural damage is quantified, and 
evidence sought for secondary degeneration in the rest of the visual pathway, either of 
retrograde, Wallerian or trans-synaptic type. Recovery is considered, in particular, 
whether any paraclinical tests are able to predict the group of patients who fail to 
recover in the longer term. Important factors in recovery are investigated, focusing on 
the severity of acute inflammatory insult, magnitude of neuroaxonal injury in the optic 
nerve, damage to the posterior pathways and influence of reparative processes, such 
as remyelination and grey matter plastic responses. Plasticity is then investigated in 
more depth, and the location, timing, role of the fellow eye, and nature of interactions 
between lower and higher visual areas are elucidated. Recovery of visual field defects 
is used as a model to study homologous area adaptation, and the role of the fellow 
eye, by investigating neural processing in cortical regions mapping to field defects, 
and comparing affected and fellow eye stimulation. 
These questions have not been addressed previously, and the process of attempting to 
answer them required that the different in vivo techniques, discussed in this chapter, 
be combined, in order to account for the many complicating factors. It was also   81
necessary to develop several novel technical innovations. A new method of 
presentation of visual stimuli for fMRI is designed, in order to address sources of 
attention and loss-of-fixation bias. For the DTI-based tractography analysis, a strategy 
of combining structural and functional data is used, that has not been applied 
previously to the study of disease of the human visual system, with the aim of 
reducing operator-dependent bias in seed placement. The use of quadrant-specific 
fMRI stimulation to investigate recovery from visual field defects, and compare 
affected and fellow eye responses, exploiting the principle of homologous retinotopic 
cortical representation, is also novel work. 
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CHAPTER 2 
 
 
PRINCIPLES OF MAGNETIC RESONANCE IMAGING 
 
 
In this chapter, the physical principles underpinning MRI will be described. General 
principles will be discussed first, which are relevant to all MRI imaging techniques. 
The focus will then shift to the newer techniques of diffusion tensor imaging (DTI) 
and functional MRI (fMRI), which will be described in more detail. These two 
techniques enable detailed in vivo investigation of the structural integrity of white 
matter tracts, and physiology of cortical activity, and are central to the work described 
in this thesis. 
 
 
SECTION 1: PRINCIPLES OF MRI 
 
2.1.1 Electromagnetic properties of biological tissues 
 
MRI exploits the electromagnetic properties of protons. The biological tissues of the 
human body consist of organic molecules, which are abundant in hydrogen nuclei. 
Each hydrogen nucleus consists of one proton, and when subjected to a magnetic 
field, these protons precess. Precession describes a spinning motion about a central 
axis (Figure 2.1). Protons have a positive electrical charge, so this creates an electrical 
current, which induces a local magnetic field. 
 
Figure 2.1 A diagrammatic representation of proton precession 
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The frequency of precession of the protons is dependent on the strength of the 
external magnetic field and the gyromagnetic ratio, which is specific to each element. 
This relationship is described by the Larmor equation: 
 
ω0= γB0 
 
ω0 is the precession frequency in megahertz (MHz), B0 is the strength of the external 
magnetic field in Tesla (T) and γ is the gyromagnetic ratio. The gyromagnetic ratio of 
hydrogen protons is 42.5MHz/T.  
When an external magnetic field is applied to a group of mobile protons, they align 
themselves with it, because of this magnetic property of precession. This can occur in 
two different ways: the protons may align parallel, or anti-parallel, to the principal 
direction of the external field. The direction of alignment is dependent on the energy 
state of the protons. 
 
2.1.2 Longitudinal and transverse magnetisation and relaxation 
 
Therefore, when a patient is placed in the external magnetic field of the MRI scanner, 
protons in the biological tissues align with the external field. As parallel alignment 
requires less energy than anti-parallel alignment, there is a net magnetic moment in 
the direction of the external magnetic field. This directional magnetisation is called 
longitudinal magnetisation.  
If a radiofrequency (RF) pulse is then applied at the same frequency that the protons 
precess, energy is transferred to the protons, which results in resonance. This means 
that some protons change their alignment from parallel (lower energy state) to anti-
parallel (higher energy state). The result is a net decrease in longitudinal 
magnetisation, in the direction of the external field. In addition, the RF pulse causes 
the precessing protons to synchronise, so that they precess in phase. This creates a 
new magnetisation moment, perpendicular to the external magnetic field. This is 
called transverse magnetisation. 
After the RF pulse is switched off, the system gradually returns to the status quo. The 
protons return from the high energy anti-parallel alignment to their previous lower 
energy parallel alignment, with emission of thermal energy to the surrounding   84
environment, or lattice. The magnitude of the longitudinal magnetisation vector 
therefore increases in the direction of the external field. This change is termed 
longitudinal relaxation, or spin-lattice relaxation. When plotted against time, it 
follows an exponential curve. The shape of this curve is described by a constant, 
termed the T1 constant (Figure 2.2). 
 
       Figure 2.2 A T1-curve, showing relaxation of longitudinal magnetisation over time 
 
In addition to longitudinal relaxation, the transverse magnetisation also gradually 
returns to its previous state, before the RF pulse was applied. The protons 
desynchronise their precession frequencies, or dephase. This occurs because they are 
subject to small local variations in the magnetic field which, according to the Larmor 
equation, determine precession frequency. Some local inhomogeneity is inherent to 
any external magnetic field, but additional inhomogeneities also result from local 
effects of neighbouring protons, which have small magnetic fields of their own. This 
gradual dephasing of protons results in a net loss of transverse magnetisation, which is 
referred to as transverse relaxation. When plotted against time, it is also described by 
a constant, termed the T2 constant (Figure 2.3). 
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Figure 2.3 A T2-curve, showing relaxation of transverse magnetisation over time 
 
2.1.3 T1 and T2 characteristics of biological tissues 
 
There are differences in T1 and T2 relaxation characteristics between biological 
tissues. In human tissue, T1 generally varies between 300-2000ms, and T2 from 30-
150ms. This can help to differentiate tissues, for example, T1 and T2 times are longer 
in liquids than in fats. These differences are partly due to tissue composition. 
However, T1 is also affected by the structure of the surrounding lattice, and the 
strength of the external magnetic field. Longitudinal relaxation times are longer in a 
given tissue, if the surrounding lattice contains protons with precession frequencies 
that differ greatly from it. Most biological tissues have a much lower precession 
frequency than water, so energy exchange from water to a biological tissue lattice is 
slow. Therefore, in human tissue, liquids have a long T1. Fat precession frequencies 
are closer to those of biological tissues, so T1 is relatively shorter.  
In addition, as the strength of the external magnetic field increases, so does the 
precession frequency of protons in tissues. This will also affect the rate of transfer of 
energy to the lattice, which becomes slower. For this reason, stronger fields also result 
in longer T1. 
The rate of T2 relaxation is predominantly influenced by the degree of magnetic field 
inhomogeneity. In liquids, unrestricted diffusion of protons results in rapidly 
fluctuating fields, with no net magnetic moment. In this environment, there are fewer 
local field inhomogeneities, and T2 relaxation is therefore slower. In contrast,   86
biological tissues contain macromolecules which impede free diffusion, resulting in 
greater local field inhomogeneities, more rapid dephasing of protons, and shorter T2. 
 
2.1.4 Radiofrequency pulses and free induction decay signal 
  
The RF pulse may be varied in terms of its effect on the net magnetic moment vectors. 
If sufficient energy is applied to cancel all of the net longitudinal magnetisation, and 
only transverse magnetisation remains, due to phase coherence of protons, this 
corresponds to a magnetic vector 90
o to the perpendicular. This is called a 90
o RF 
pulse (Figure 2.4). If even more energy is applied, such that longitudinal 
magnetisation is reversed, this corresponds to an 180
o pulse. The net magnetic 
moment can also be tilted by smaller increments, or flip angles, which will be 
discussed later in this chapter. 
 
    
 
Figure 2.4 The effect of a 90
o pulse on longitudinal and transverse magnetisation. Energy from the RF 
pulse results in an equal number of protons in parallel and anti-parallel alignment, and phase 
coherence. Therefore, there is no net longitudinal magnetisation, and only transverse magnetisation 
remains. Modified from (Schild, 1990). 
 
After the RF pulse is switched off, both longitudinal and transverse magnetisation 
subsequently relax, or decay, to baseline. Longitudinal and transverse relaxations 
occur simultaneously and independently. Therefore, at any given time after the RF 
pulse, the net magnetisation can be represented by a sum vector, which spirals in the 
direction of precession. This moving magnetic field induces an electrical current, 
which is detected by a receiver coil, providing a nuclear magnetic resonance (NMR)   87
signal (Bloch et al., 1946). The signal magnitude is greatest straight after the RF pulse 
is switched off, when transverse magnetisation is maximal and longitudinal 
magnetisation minimal. Subsequently the signal decays over time. This is the basis of 
the free induction decay signal (Figure 2.5). 
 
 
 
Figure 2.5 Free induction decay signal 
 
2.1.5 Tissue contrast and pulse sequences 
 
Tissue contrast in MRI is based on differences in T1 and T2 relaxation times. In order 
to exploit this, more than one RF excitation is usually required. If a second RF pulse 
is applied before longitudinal relaxation is complete, then differences in relaxation 
times between tissues may be accentuated. Combining pulses in this way results in a 
pulse sequence. Sequences can be optimised to exploit differences in magnetic 
relaxation characteristics between tissues, to maximise contrast. The time between 
successive repetitions of the same pulse sequence is called the time to repeat (TR). 
The use of TR intervals which maximise tissue contrast, based on differences in 
longitudinal magnetisation, is referred to as T1-weighting.  
If a long TR is used, and longitudinal magnetisation returns to the resting state, then 
contrast is only dependent on differences in tissue composition itself, and not 
relaxation times. This results in a proton-density, or spin-density, image. TR is 
generally considered long if it is greater than 1500ms and short if it is less than 
500ms. 
Transverse relaxation occurs more rapidly than longitudinal relaxation. The 
application of successive 180
o RF pulses slows this process. Each pulse has the effect 
of reversing the direction of precession of the dephasing protons. Prior to the   88
application of the 180
o pulse, the most rapidly precessing protons will be most 
dephased from the resting state. After the pulse, these protons will then be least 
dephased. The converse will be true for the slowest precessing protons. After a time 
interval, the rapidly precessing protons will once again be in phase with the slower 
precessing protons. At this point of phase coherence, the net transverse magnetisation, 
and hence the MR signal, will be greater. The 180
o pulse can be repeated several 
times, each of which will sustain this signal echo. This sequence of 90
o pulse, 
followed by repeated 180
o pulses, is the basis of the spin echo technique (Figure 2.6). 
The time between successive echoes is called the TE. Again, this can be manipulated 
in order to exploit differences in characteristics of different tissues and achieve tissue 
contrast. If a long TE is used, so that differences in proton phase are maximised, the 
resulting image is said to be T2-weighted. A TE of greater than 80ms is usually 
considered long, and less than 30ms short. 
 
 
 
Figure 2.6 The spin echo sequence. After an initial 90
o pulse, successive 180
o pulses refocus the 
transverse magnetisation, resulting in the spin echo effect. T2* effects are not influenced by the 180
o 
pulse, therefore T2* decay is more rapid than T2 decay. 
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2.1.6 T2* effects 
 
The resulting signal echos become progressively weaker over time. This is because 
the 180
o pulse is only able to influence constant sources of inhomogeneity in the 
external magnetic field. There is no influence on inconstant local field 
inhomogeneities, and these T2* effects are responsible for the progressive diminuition 
of signal. If 180
o pulses are not applied, transverse magnetisation decays much more 
quickly, and this steeper decay curve is called the T2* curve (Figure 2.6). Exploitation 
of T2*-effects is an important principle of fMRI, which will be discussed later in this 
chapter. 
 
2.1.7 T1 and T2-weighting  
 
Combining the T1 and T2 curves can determine the signal intensity of a tissue, using a 
spin-echo sequence. The longitudinal magnetisation can be calculated from the T1 
curve, at time TR, and this serves as the starting point for subsequent T2 relaxation. 
The transverse magnetisation can then be calculated from the T2 curve, at time TE.  
Differences in T1 between tissues tend to be more marked with shorter TRs, as 
differences in longitudinal magnetisation are greatest at this point, and resolve over 
time. Conversely, differences in T2 between tissues are more marked with longer TEs, 
as phase differences become more pronounced over time.  
Combining a short TR with a short TE will therefore result in a T1-weighted image, 
and combining a long TR with a long TE will result in a T2-weighted image. 
 If TR is very long and TE very short, then tissue contrast will be predominantly 
determined by tissue composition, and a proton-density (PD) weighted image will be 
obtained.  
If TR is short and TE long, then there will be minimal longitudinal and transverse 
magnetisation, and the signal will be difficult to distinguish from background noise. 
For this reason, such pulse sequences are generally not useful. This illustrates an 
important issue in MRI that is the signal-to-noise ratio (SNR). For example, in T2-
weighted pulse sequences the improvement in tissue contrast that is achieved using 
longer TEs has to be balanced against the reduced SNR that is seen with increasing 
time.    90
PD, T1 and T2-weighting thus provide different tissue contrast, and are differentially 
sensitive to pathology. In healthy brain tissue, CSF is generally bright on T2-weighted 
images and dark on both T1-weighted and PD-weighted scans. With T1-weighting, 
grey matter is darker than white matter, whereas on PD the reverse is the case. The 
changes in signal intensity that occur in pathology such as ON are diverse, and will be 
discussed in later chapters. 
 
2.1.8 Spatial encoding 
 
The problem of anatomical localisation remains to be considered. The MR signal must 
be spatially localised, in order to reconstruct an interpretable image. This is achieved 
with additional magnetic fields (Lauterbur, 1973), superimposed on the main external 
field, using gradient coils. These additional gradient fields gradually increase in 
strength in a given direction.  
Firstly, a slice-selecting gradient is applied during the RF pulse, which localises the 
cross-sectional plane to be examined. This results in slight differences in precession 
frequency of protons, in a gradually increasing manner along the z-axis, for example, 
from the subjects’ feet to their head. A slight variation in frequency of the RF pulse 
will then selectively excite a fairly narrow band of protons, thus selecting the slice. 
Slice thickness can be determined either by changing the bandwidth of 
radiofrequencies of the RF pulse, or the gradient of the field.  
In order to localise protons within each slice, it is necessary to define their position in 
two planes. A second gradient field is applied shortly after the slice-select gradient is 
switched off, that enables localisation in one of these planes, for example, in the 
direction of the y-axis (anterior/posterior). This frequency-encoding gradient again 
results in slightly different precession frequencies, depending on location, which 
establishes the row of origin of the protons.  
A third gradient field is then applied in the remaining plane, for example, along the x-
axis (left/right), which results in dephasing of the protons. This phase-encoding 
gradient results in protons within the same row, which were precessing previously 
with the same frequency, each having a slightly different phase, allowing localisation 
of protons within that row.    91
A mathematical operation, the Fourier transform, allows conversion of this frequency 
and phase information into a spatial location, which can then be assigned a signal 
intensity to reconstruct an image. 
 
2.1.9 K-space 
 
Prior to the application of the Fourier transform, the MRI data exists in non-Euclidean 
theoretical space, called k-space. The data forms a matrix, and each data-point in the 
matrix corresponds to a point in k-space, which has experienced different 
combinations of dephasing along the x and y-axes. Sampling the whole of k-space 
results in one complete volume of interest, for example the brain. Most of the 
information is concentrated in the centre of k-space, and extra detail is then obtained 
by sampling points further away from the centre. Advances in the techniques used to 
sample k-space allowed development of the modern fast imaging sequences, used in 
DTI and fMRI, and are described in more detail later in this chapter. 
 
2.1.10 Tissue suppression 
 
Pulse sequences can be adapted based on the number and angle of RF pulses that are 
applied. The spin-echo sequence consisting of a 90
o pulse, followed by 180
o pulses, 
has already been discussed.  
Inversion recovery sequences differ from spin-echo, in that the 180
o pulse precedes 
the 90
o pulse. This has the effect of producing a strongly T1-weighted image, and can 
be used for tissue suppression, for example, orbital fat or CSF surrounding the optic 
nerve. This was applied to patients with ON in this thesis. The magnitude of T1-
weighting in this sequence is dependent on the time between the initial 180
o pulse and 
the subsequent 90
o pulse, which is termed the inversion time (TI). 
 
2.1.11 Towards faster imaging sequences 
 
It is important to minimise MRI acquisition time for patient comfort, to reduce motion 
artefacts and to make advanced techniques, such as DTI and fMRI, feasible. Imaging 
time is mostly dependent on the length of TR, so in order to develop faster imaging 
sequences, it was necessary to reduce TR. However, this was difficult for two reasons.   92
Firstly, in a spin-echo sequence, the rate-limiting step is the 180
o pulse and, as this is 
delivered during the TR, it is difficult to shorten it, unless an alternative method of 
rephasing protons is used. Secondly, with shorter TRs, longitudinal magnetisation 
recovers less completely, and there is therefore less magnetisation tilted transversely 
with subsequent RF pulses, resulting in a weaker signal. The first problem was 
overcome by using gradient fields to rephase the protons, instead of an 180
o pulse. 
The second problem was solved by using smaller flip angles, typically 10-35 degrees, 
to tilt magnetisation into the transverse plane. In general, smaller flip angles result in 
less T1-weighting.  
Faster acquisition may also be achieved using multi-slice imaging, by acquiring data 
from multiple slices during each TR. 
In addition to TR, imaging time is dependent on the number of excitations (NEX), and 
the size of the matrix. Several excitations are usually averaged, in order to increase 
SNR. Matrix size refers to the number of pixels which make up the final image, and 
results in a trade-off between resolution and acquisition time.  
 
2.1.12 Echo-planar imaging 
 
In conventional MRI, one phase-encoded line of k-space is collected every TR. 
Therefore, a large number of excitations are required to sample the whole k-space. 
Echo-planar imaging (EPI) was developed to speed up this sampling process. In 
single-shot EPI, an entire volume is acquired during each TR, by repeatedly 
refocusing the phase and frequency encoding gradients (Figure 2.7). This samples the 
data in k-space more efficiently. The EPI acquisition of the whole brain in a TR can 
be preceded either by a spin echo (spin echo EPI, resulting in T2 contrast), or by a 
gradient echo, in which the echo is refocused using gradient fields instead of an 180
o 
RF pulse (gradient recalled echo (GRE) EPI, resulting in T2* contrast). 
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Figure 2.7 Sampling k-space (left) using a spiral EPI technique (right). Modified from (Sykora, 2005, 
www.ebyte.it, and Miquel, 2008, www.scopeonline.co.uk). 
 
A limitation of this technique is that rapid switching of magnetic gradients creates 
eddy currents, which can distort the data, and may result in stimulation of the 
subject’s peripheral nerves. Data distortions include Nyquist ghost artefact, which is a 
result of cumulative phase errors, from repeated passes in opposite directions through 
k-space. These can be corrected by collecting a reference non-phase encoded dataset 
(Bruder et al., 1992).  
Another problem with EPI is susceptibility artefact at interfaces between different 
tissues, which may result in signal dropout, or distortion, through sensitivity to 
marked T2* effects in these regions. Air-bone interfaces are especially problematic, 
such as the paranasal sinuses and ear canals, and may result in artefact in the orbito-
frontal and temporal regions.  
 
2.1.13 Contrast enhancement 
 
MR signal may be manipulated using contrast agents, such as gadolinium, which is 
paramagnetic. This increases local magnetic inhomogeneity, and T2 relaxation times 
are therefore shortened. T1 relaxation time is also reduced, via magnetic dipole-dipole 
interactions between the paramagnetic contrast agent and the protons. Together these 
effects can be used to improve tissue contrast, by exploiting the differential perfusion 
of tissues with blood, for example, demonstrating inflammatory disruption of the 
blood-nerve barrier in ON (Figure 2.8). 
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Figure 2.8 Post-triple dose gadolinium T1-weighted MRI demonstrating left optic nerve enhancement 
(arrow). 
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SECTION 2: DIFFUSION TENSOR IMAGING 
 
2.2.1 Diffusion in biological tissues 
 
DTI exploits the principles of Brownian motion (Brown, 1828). This term describes 
random motion of molecules, such as water, and was first described in the 19
th 
century. Biological tissues are abundant in water, and the extent of random motion 
may be constrained by physical barriers, such as cell membranes. This differs 
according to tissue, for example, there is greater random diffusion in CSF than in 
brain tissue. In addition, diffusion is directionally sensitive to tissue microstructure. 
White matter consists of tightly packed tubular structures, such as axons, which 
facilitate diffusion along their long axis, but impede it in the perpendicular direction. 
In contrast, whilst grey matter contains cell membranes that impede random diffusion, 
these are less directionally coherent than white matter, and the two tissues may 
therefore be differentiated. 
The degree of directional selectivity imposed on diffusion is referred to as the degree 
of isotropy. Diffusion in CSF is highly isotropic, or non-directionally selective, which 
may be visually represented as a sphere at the scale of an imaging voxel. In contrast, 
diffusion within white matter is highly anisotropic, or directionally selective, and may 
be represented with a cigar-shaped diffusion ellipsoid (Figure 2.9). The overall 
diffusion behaviour within the ellipsoid may be summarised by three vectors, known 
as eigenvectors, describing diffusion along the x, y and z axes, with the principal 
eigenvector along the main axis of diffusion. 
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Figure 2.9 An illustration of different types of diffusion at voxel level. On the left, isotropic diffusion 
and, on the right, anisotropic diffusion, represented with a diffusion ellipsoid. Diffusion along the main 
axis is described by the principal eigenvector. 
 
2.2.2 Diffusion weighted MRI imaging 
 
The MRI signal is sensitive to diffusion of water. During a spin echo sequence, the 
precessing protons are first dephased then rephased. If random diffusion occurs in the 
intervening time interval, then rephasing will be incomplete, transverse magnetisation 
will be relatively less, and the MRI signal will be attenuated. The magnitude of this 
attenuation will depend upon factors related to both the tissue structure and the 
magnetic field. Specific pulse sequences have been developed, which are sensitive to 
diffusion. This was first achieved using a pulsed field gradient method (Stejskal and 
Tanner, 1965). This technique is based on a spin echo sequence, but two gradient 
fields are applied either side of the 180
o pulse (Figure 2.10).  
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Figure 2.10 Pulsed field gradient sequence. Δ represents the time period in which differences in 
diffusion are detectable. 
 
The additional two gradients induce a phase shift, and then reverse it. Less rephasing 
occurs following the second gradient, as diffusion increases. Comparing this 
acquisition to a non-diffusion-weighted acquisition, or b0 image, allows calculation of 
the magnitude of diffusion, using the Stejskal-Tanner equation. 
 
    S = S0 e
-bD 
 
S and S0 represent the MRI signal in the presence and absence of diffusion gradients, 
respectively. b refers to the diffusion weighting factor (Le Bihan et al., 1986), which 
may be experimentally manipulated. D is the diffusion coefficient, which can then be 
calculated at each voxel. 
From this equation, it may be seen that the greatest reduction in signal occurs when D 
is maximised. This means that in regions in which diffusion is anisotropic, such as 
white matter, signal will be attenuated when a diffusion gradient is applied parallel to 
the main axis of the ellipsoid (that is parallel to the axons). Therefore, regions of 
anisotropy parallel to the main direction of diffusion appear dark on a diffusion-
weighted image. From these measurements the apparent diffusion coefficient (ADC) 
is derived for each voxel. The word “apparent” indicates that the underlying diffusion 
process is constant; it is the interaction between water and macromolecular structures 
which results in changing values (Cercignani and Horsfield, 2001).  
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2.2.3 The diffusion tensor 
 
A major problem with diffusion-weighted imaging is that, as a result of the principles 
of directionality on which it is based, it is extremely sensitive to artefacts from head 
motion. This is inevitable during an MRI scan, even in cooperative subjects. In 
addition, ADC values only provide one-dimensional information, along a single 
diffusion direction. These limitations were overcome by the development of the 
diffusion tensor (Basser et al., 1994). A diffusion tensor (DT) is derived from a b0 
image and diffusion weighted images, acquired in six or more non-collinear 
directions, along the x, y and z axes, and their combinations, xy xz, yz. A 3x3 matrix 
is then created, which parameterises diffusion in three dimensions, along the x, y and 
z axes. The matrix is diagonalised, meaning that the off diagonal elements are 
mathematically reduced to zero. 
 
 
 
In this manner, diffusion direction can be fully characterised. ε1 ε2 and ε3 are referred 
to as eigenvectors, and they represent the magnitude of diffusion of water along the x, 
y and z axes, previously illustrated with the diffusion ellipsoid in Figure 2.9. They are 
ordered such that ε1 always represents the principle diffusion direction. λ1 λ2 and λ3 are 
the eigenvalues, which correspond to the ADC values for each eigenvector. 
 
2.2.4 Mean diffusivity and fractional anisotropy 
 
Scalar invariant values may be derived from the diffusion tensor, summarising aspects 
of diffusion.  
Mean diffusivity (MD) is simply the mean of the three eigenvalues. Higher values 
indicate more isotropic diffusion.   99
Fractional anisotropy (FA) is an estimate of directionality of diffusion. Higher values 
indicate more anisotropic diffusion. It is calculated from the MD and eigenvalues, as 
follows. 
 
FA= √( λ1-MD)
2+( λ2-MD)
2+( λ3-MD)
2 
    √ λ1
2+ λ2
2+ λ3
2 
 
 
In FA maps, areas of high anisotropy, such as white matter tracts, appear bright and 
areas of low anisotropy appear dark (Figure 2.11). This is the reverse of the diffusion-
weighted maps, from which they were originally derived. 
 
         
Figure 2.11 An FA map of a control subject. (A) Areas of high anisotropy appear bright, and represent 
white matter tracts. The optic radiations (OR), inferior fronto-occipital fasciculi (IFO) and cerebral 
peduncles are seen. In (B), the same map is colour coded to show the principal direction of diffusion. 
The ORs and IFOs are green, which represents a principal eigenvector in the anterior-posterior 
direction. In contrast, the CPs are blue/purple which represents superior-inferior diffusion. Voxels 
within tracts in red have principal eigenvectors orientated in the left-right direction. (C) A 
magnification of the optic radiations from the same FA map overlaid with the principal eigenvector 
map. The red line in each voxel demonstrates the principal direction of diffusion. 
 
2.2.5 Technical problems in DTI 
 
Minimisation of motion artefacts remains a technical challenge in DTI. The problem 
is compounded by the relatively long scan times necessary to acquire data in several 
different directions. Moreover, in order to improve SNR, either signal averaging or 
acquisition in more than the minimum six directions (plus b0) is usually required.   100
Motion effects may be reduced by using fast imaging sequences, such as EPI. 
However, cardiac pulsation and respiratory motion may still cause problems. In order 
to minimise pulsation artefact, sequences may be cardiac-gated, when data is only 
acquired during diastole. However, this further increases the scan time. 
Another problem is that the selection of principal diffusion axes, used to derive the 
tensor, introduces a directional bias. This is because voxel SNR characteristics vary, 
depending upon whether they are aligned with one of the principal diffusion axes. 
Therefore, a voxel’s directionality may subsequently influence the complex noise 
calculations, and introduce bias into the estimates. This problem may be reduced by 
sampling more diffusion directions. 
 
2.2.6 Diffusion-based tractography 
 
DTI provides directional information about the diffusion behaviour of water within 
each voxel. However, it does not provide information about connections between 
voxels. These relationships are of central interest when investigating white matter 
tracts of the brain, and further techniques have been developed to study them, such as 
diffusion-based tractography. 
An algorithm is applied to the diffusion tensor data, to assess the likelihood of 
connection of neighbouring voxels, based on the collinearity of the vectors in each 
voxel. If the angle between principal vectors in adjacent voxels is less than a 
predetermined threshold, it is inferred that the voxels are connected, and a pathway, or 
streamline, is propagated. If the angle is greater than threshold, then the pathway is 
terminated. Several different algorithms have been developed, with probabilistic 
tractography currently most commonly used. Probabilistic methods use uncertainty 
principles to estimate confidence of connections, between each voxel and a given 
seed-point (Parker et al., 2003).  
Tractography provides an important tool to investigate the structure of white matter 
tracts in vivo, and has been applied extensively to the study of neurological disease 
(Ciccarelli et al., 2008). However, there are some limitations. The diffusion tensor 
data contains noise, which may bias the estimates of the reconstructed tracts. Using a 
probabilistic method, estimation errors tend to accumulate as the distance from the 
seed-point grows, and can be influenced by the shape of the trajectory, anisotropy of 
the underlying tissues, and parameters related to the imaging technique used, such as   101
image resolution (Mori and van Zijl, 2002). In addition, it is not possible to determine 
if an identified pathway is functional, whether conduction occurs in an anterograde or 
retrograde direction, and where pathways break to synapse (Johansen-Berg and 
Behrens, 2006). Challenges also remain in tracking crossing, or kissing, fibre tracts 
and it is still difficult to fully eliminate operator-dependent bias in selecting seed-
points. Techniques have been developed to address some of these limitations, for 
example, smoothing may be applied to reduce noise in the tensor data. High angular 
resolution DTI (Frank, 2002), and processing algorithms which allow for multiple 
fibre orientations (Behrens et al., 2007), have been used to help accommodate 
crossing fibres, and fMRI has been combined with DTI to help define seed-points in 
an unbiased manner (Conturo et al., 1999;Guye et al., 2003;Powell et al., 2007). 
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SECTION 3: FUNCTIONAL MRI 
 
2.3.1 The BOLD effect 
 
The development of fMRI provided a powerful new tool to study the physiology of 
the CNS, in health and disease. The principle was first demonstrated in rats (Ogawa et 
al., 1990), and shortly afterwards human cortical activation was demonstrated (Ogawa 
et al., 1992;Bandettini et al., 1992;Kwong et al., 1992), with many of the early studies 
focusing on the visual system. The technique is based upon the principle of blood 
oxygenation level dependent (BOLD) responses, in which the MRI signal of blood 
differs, depending on whether it is oxygenated or not. In the brain, increased neural 
activity results in a greater metabolic demand, which results in increased local 
concentrations of oxygenated haemoglobin and less deoxyhaemoglobin 
(neurovascular coupling), and therefore regions of brain activity can be visualised 
using MRI. 
Typically, patients perform a task in the scanner, selected specifically to investigate a 
certain aspect of cortical processing. The task is presented intermittently with a 
control condition, and differences in BOLD response are observed. The sequence of 
physiological events that occurs during task performance has been clarified in recent 
years, although some aspects are still debated.  The following hypothesis is generally 
agreed. An increase in neuronal activity increases metabolic demand, and initially the 
deoxyhaemoglobin concentration increases in the local draining capillaries and veins 
(Vanzetta and Grinvald, 1999). Deoxyhaemoglobin is paramagnetic, whilst 
oxyhaemoglobin is diamagnetic (Pauling and Coryell, 1936). An increase in local 
deoxyhaemoglobin concentration therefore results in increased local magnetic field 
inhomogeneity, and MRI signal is attenuated (Thulborn et al., 1982). A rapid 
physiological response follows, with a marked increase in local blood flow and 
oxyhaemoglobin concentrations. This response greatly exceeds metabolic demand 
(Fox and Raichle, 1986), and the resulting change in oxyhaemoglobin concentration 
leads to an increase in MRI signal, as local magnetic inhomogeneities decrease. The 
increase in blood flow results in a greater volume of blood in the local veins, which 
have balloon-like elastic qualities (Buxton et al., 1998). These properties lead to a 
persistent increase in local blood volume, which lags behind local normalisation of 
flow to the resting state. Therefore, there is a late, transient local increase in   103
deoxyhaemoglobin concentration, after neural activity has ceased, which is thought to 
explain the observed post-stimulus undershoot of MRI signal. These haemodynamic 
changes occur over a longer time scale than the neural events which trigger them, over 
approximately ten seconds (Figure 2.12), although the exact temporal characteristics 
of the haemodynamic response differ slightly, depending upon the brain region and 
type of stimulus (Bandettini et al., 1997). In most fMRI studies, it is the main increase 
in BOLD signal which is of interest and is detected. Following visual stimulation, this 
corresponds to a change of around 1-3% intensity at 1.5T, and is a result of BOLD 
signal contributions from both the intravascular and extravascular compartments 
(Boxerman et al., 1995). 
 
 
Figure 2.12 The haemodynamic response function, which describes the temporal 
characteristics of the BOLD response. In this diagram, the amplitude of the dip and 
undershoot are exaggerated for display purposes. 
 
2.3.2 Neurophysiological correlates of the BOLD signal 
 
Studies in monkeys showed that BOLD signal increases reflect a greater contribution 
from neural local field potentials, compared to spiking activity (Logothetis et al., 
2001), although both were correlated with the BOLD signal. Local field potentials are 
believed to be predominantly due to sustained synchronised synaptic activity in   104
dendrites, from an area of a few millimetres of brain. On the other hand, spiking, or 
multi-unit activity, is thought to represent transitory neuronal firing near the recording 
electrode tip. In this important study, in which simultaneous data from fMRI and 
direct intracortical electrodes were collected, the authors concluded that BOLD signal 
change is influenced mainly by neural input and intracortical processing, rather than 
neural output. Other authors have since pointed out that local field potentials only 
accounted for 7.6% more variance in the BOLD response than multi-unit activity, and 
that the contribution of each may vary with the level of brain activation, so the 
association between BOLD response and local field potentials does not appear to be 
absolute (Bandettini and Ungerleider, 2001). 
 
2.3.3 Detecting changes in BOLD signal 
 
The BOLD signal is best detected using T2*-weighted MRI sequences, which are 
most sensitive to small changes in the homogeneity of the local magnetic field. 
Gradient echo sequences are used more frequently than spin echo, because using 
sequential RF pulses to rephase protons reduces sensitivity to T2* effects. Fast image 
acquisition techniques, such as EPI, are important to minimise motion artefacts, 
including cardio-respiratory effects. In order to maximise the difference between 
activation and resting T2* decay curves, short TEs are usually selected. The choice of 
TR depends on the number of slices required, and is usually longer than a second, in 
order to avoid flow velocity artefacts. Using higher field strength magnets improves 
SNR, but susceptibility artefacts may also be magnified. 
 
2.3.4 Experimental design 
 
This subject will be discussed in more detail in Chapter 3, in which the visual 
stimulation paradigm used for this study is described. In this section, a few basic 
principles will be outlined. 
Designs may be categorical or parametric. In categorical designs, two conditions are 
contrasted, one of which may be a control condition, and any differences in BOLD 
activation are interpreted as condition-specific cortical processing (Turner et al., 
1991). In parametric designs, stimuli are continuously varied (for example, visual 
stimulation at different flicker frequencies), and cortical responses are modeled to   105
observe which areas respond in a corresponding manner. More recently, interest has 
developed in brain default networks which are active during resting conditions. To 
investigate these, no specific task is required, and the method of data processing and 
interpretation is different, incorporating principal or independent components 
analysis. 
Design presentation may be epoch-based or event-related. During an epoch-based 
design, conditions are presented in blocks lasting many seconds, whereas in an event-
related design, stimuli are much more transitory and random. The choice of method 
depends upon experimental considerations, which include efficiency of effect 
detection, neuropsychological validity, the relative importance of avoiding adaptation 
and habituation effects, necessity of post-hoc categorisation (for example, correct or 
incorrect response), and whether the temporal characteristics of the BOLD response 
are of interest. 
Stimuli are repeated and averaged to increase SNR. A single attendance for scanning 
at a given time-point is referred to as a session. Within a session, there are usually 
several periods of stimulus presentation, and each of these time intervals is called a 
run. Within processing software packages, these two terms are sometimes used 
interchangeably. 
 
2.3.5 Data processing: statistical parametric mapping 
 
Functional MRI scans comprise a complex dataset, representing a four dimensional 
time series reflecting dynamic changes. For ease of interpretation, it is usually 
necessary to convert this into a three dimensional map, that summarises which 
anatomical regions of the brain are activated. This temporal dimension causes several 
problems, including an increased likelihood of motion artefacts, the different time 
scales over which neural and vascular responses occur, and the impossibility of 
acquiring each slice in a volume simultaneously. It usually takes a few seconds to 
acquire an entire brain volume, corresponding to the TR, which results in a slight time 
delay between slices in the phase of the haemodynamic response that is sampled. In 
addition, in order to generalise inferences regarding brain activity to population level, 
it is necessary to investigate group effects. This raises difficulties due to inter-
individual differences in anatomy. Finally, there are problems related to statistical 
testing. In particular, if a mass univariate approach is used, in which tests are carried   106
out simultaneously across all voxels, then the problem of correcting for multiple 
comparisons must be considered. 
Many of these difficulties may be addressed by pre-processing fMRI data. Several 
different software packages are available, which have the same core processes in 
common: data are spatially and temporally preprocessed, a statistical model is 
specified and estimated, and inferences are made. One of the most widely used is 
Statistical Parametric Mapping (SPM, Wellcome Department of Neuroimaging 
London, UK), which was used for all of the fMRI analysis described in this thesis. In 
SPM, preprocessing incorporates slice timing adjustment, realignment, normalisation 
and smoothing, a general linear model is used to model the data, and statistical 
inferences are made by specifying contrasts of interest (Figure 2.13). The statistics are 
calculated based on how closely the observed data fits the experimentally defined 
model, and multiple corrections are accounted for, using random field theory.  
 
 
Figure 2.13 A summary of the stages of processing an fMRI time series in SPM. Modified from 
(Friston, 2003). 
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2.3.5.1 Slice timing 
 
Differences in slice acquisition time within a volume, resulting from non-
simultaneous sampling, may be accounted for in two different ways. If the TR is 
relatively short, the data may be adjusted with respect to a reference slice. However, if 
the TR is longer than approximately two seconds this approach is less accurate, and 
instead a time derivative of the haemodynamic response function is incorporated into 
the model. This is convolved with the data, in addition to the haemodynamic response 
function, in order to capture variance in the data associated with differences in time of 
slice acquisition. The term convolution describes a mathematical operation, performed 
on two functions, to create a new function, and is used in fMRI pre-processing to 
reconcile the different time scales over which neural and haemodynamic events occur. 
This is discussed further in Chapter 3. This method was used to adjust for differences 
in slice acquisition time in the studies described in this thesis, as the TR was 
approximately four seconds. 
 
2.3.5.2 Realignment 
 
Over the course of a time series, patient motion may result in misallocation of data 
from a given voxel to one of its neighbours. In order to prevent this, the time series is 
realigned in a two stage procedure. Each brain volume is realigned to the first scan of 
each run (Friston et al., 1995a). These volumes are then all realigned to the first scan 
of the first run. This is achieved using a six parameter, rigid-body transformation. The 
six parameters refer to the directions of correction, and comprise translation in the x, y 
and z directions, and rotation in the pitch, roll and yaw planes. The sum of squared 
differences between each scan and the reference scan, in each of these directions, is 
estimated and applied to the data. This process results in an output of the corrections 
required in each of the six directions, which can be entered later as covariates into the 
general linear model. Realignment is generally effective, but persistent errors may 
remain if patients move during volume acquisition, rather than between runs 
(Grootoonk et al., 2000), and secondary to interactions between patient motion and 
local field inhomogeneities (Andersson et al., 2001). In addition, motion during 
previous volumes may influence later ones, through a mechanism of “spin history” 
effects (Friston et al., 1996b).   108
2.3.5.3 Spatial normalisation 
 
In order to draw group inferences about areas of brain activation, it is important that 
all subjects are in the same reference space. This is achieved using normalisation, in 
which each subject’s realigned brain volumes are registered to a standard template. In 
SPM5, the Montreal Neurological Institute (MNI) template, derived from 305 brains 
is used (Evans et al., 1993). This is broadly similar to the other commonly used 
template (Talairach and Tournoux, 1988). Firstly, a linear 12-parameter affine 
transformation is applied, which incorporates the six parameters used in a rigid body 
transformation and, in addition, six zoom and shear parameters. During linear 
registration, transformations are applied to the brain in a uniform manner. In the 
second stage, non-linear registration is applied. During non-linear registration, 
transformations are allowed that differentially affect different regions of the brain, a 
procedure known as warping. Constraints are placed on unlikely warps, which is 
called regularisation (Ashburner and Friston, 1999). 
 
2.3.5.4 Spatial smoothing 
 
During smoothing, data in a given voxel is averaged with that of its neighbours. This 
is performed using a smoothing kernel, which is of Gaussian shape, a three 
dimensional representation of a normal distribution (as shown in Figure 2.13). The 
purpose is to increase SNR, facilitate group averaging, and render the data more 
amenable to later statistical analysis, by making errors more normally distributed. The 
size of the smoothing kernel is decided by the operator, is described by its full width 
at half maximum (FWHM), and is typically two to three times the voxel size. 
 
2.3.5.5 Model specification 
 
At this stage, details of the experimental procedure are provided by the operator. The 
times of onset of stimulation are specified (stimulus onset asynchrony, SOA) for each 
condition of interest (regressor), and the duration of the stimulus. These data are 
convolved with a haemodynamic response function (illustrated in Figure 2.12), in 
order to adjust for the different temporal scales over which neural and haemodynamic 
events occur. The motion parameters from realignment may be entered as covariates   109
of no interest at this stage, to account for any associated signal variance. In this 
manner, it is ensured that any observed activations are not a result of patient motion. 
This is one of the strengths of the general linear modeling (Worsley and Friston, 
1995) approach, which is described further in the next section. Other covariates of no 
interest can also be entered at this point. 
 
2.3.5.6 Model estimation 
 
In SPM, a mass univariate approach is used, in which the experimental model is fitted 
to the data simultaneously at every voxel (Friston et al., 1995b). A general linear 
model is used, and the fit of this model to the observed data is then estimated and 
expressed as a beta value, or parameter estimate, for each regressor, leaving a residual 
error term. The following equation summarises the general linear model. 
 
    Y = Xβ+ε 
 
Y is the observed data. There may be multiple X terms, which each correspond to an 
explanatory variable, known as regressors, and may represent both effects of interest 
and covariates of no interest. In SPM, these are expressed as a design matrix, in which 
each column represents one regressor, and the rows correspond to observations over 
time, from the MRI scans. Beta is the parameter estimate, which describes how well 
each regressor fits the experimental model, and ε is the error term, which summarises 
any residual variance in the data that is not explained by any of the regressors in the 
model. 
 
2.3.5.7 Statistical inference 
 
To test effects of interest, weighted linear combinations of regressors are specified, 
known as contrasts. Examples of common contrasts include activation versus baseline 
(1 0), or patient activation versus control activation (1 -1). For each contrast, at each 
voxel, a t or F statistic is reported. These are derived by comparing the effect of 
interest (in terms of the change in signal intensity over time, which can be attributed 
to the regressor), and dividing it by its standard error (in terms of the overall variance   110
in signal intensity over the course of the experiment). At each voxel, the null 
hypothesis is that there is no change in signal intensity attributable to that regressor. 
The statistics are calculated based on the fit of the model, and corrected for multiple 
comparisons using random field theory (Worsley et al., 1996). At standard voxel 
sizes, an average brain volume may comprise more than 200 000 voxels. Accepting a 
conventional type I error rate of 5% will therefore result in 10 000 false positives. 
Using a Bonferroni correction would require application of a significance threshold of 
p<0.00000025. However, this is overly conservative, as the test assumes independent 
observations. This is not the case in the brain, in which groups of voxels represent 
integrated regional neural networks. Gaussian random field theory is applied to help 
define an appropriate statistical threshold. In this approach, the brain is considered in 
terms of resolution elements (resels), rather than voxels. A resel represents an 
independent observation, and is determined from an estimation of the smoothness of 
the data. The correction for multiple comparisons is then based on the number of 
resels, rather than voxels. Subsequent inferences may be made either at voxel or 
cluster level.  
 
2.3.5.8 Fixed and random effects analyses 
 
The process described up to this point is usually applied to a single subject, and 
results in a statistical parametric map that summarises regions of activation within that 
individual. This is known as a fixed effects, or first level, analysis, and the error 
variance is estimated between scans. In order to make group inferences, which may be 
generalisable to a population, a second level, random effects analysis is necessary, in 
which the error variance is estimated between subjects. In a random effects analysis, 
each individual contributes a first level contrast image, and these may then be 
interrogated using a variety of statistical models, such as one and two-sample t-tests, 
analysis of variance, and multiple regression models. More complex factorial designs 
allow interactions between different conditions to be assessed. Taking individual 
contrast images from the first level into group analyses at the second level is a 
summary statistic approach. 
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2.3.6 Conclusions 
 
The development of the techniques described in this chapter has allowed in vivo 
investigation of mechanisms of pathophysiology of neurological disease, such as ON. 
Conventional MRI enables visualisation of brain and optic nerve anatomy with 
superior resolution, DTI facilitates detailed investigation of the integrity of white 
matter tracts, and fMRI allows assessment of brain physiology. Together, these 
techniques provide a powerful tool with which to probe disease mechanisms. In this 
thesis, they are combined to study patients with ON, and the results are reported in 
chapters 4 to 6. First, in chapter 3, the development and testing of a novel visual 
stimulation paradigm is described, that was used during subsequent fMRI 
experiments. 
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CHAPTER 3 
 
AN FMRI VISUAL STIMULATION PARADIGM DESIGNED TO MINIMISE 
ATTENTION, ADAPTATION AND LOSS-OF-FIXATION BIASES 
 
In order to overcome some of the current limitations of visual stimulation fMRI 
paradigms, a novel methodology to facilitate visual stimulation was developed, which 
is described in this chapter. The paradigm was then applied to the subjects in this 
study in subsequent experiments. This chapter is divided into three sections. The first 
two sections deal with the main issues related to fMRI study design. An important 
general consideration is design efficiency, and issues related to this are discussed first. 
In the second section, problems specific to visual stimulation paradigms and the study 
of ON are outlined. Methodologies used in previous studies are summarised, and 
remaining difficulties are identified, which relate to attention, adaptation and loss-of-
fixation biases, in the context of monocular stimulation. These issues are then 
addressed in the third section of this chapter, which presents the description and 
validation of the experimental design in a pilot group of healthy subjects. Proof-of-
concept is tested in a patient with severe visual loss. 
 
 
SECTION 1: DESIGN EFFICIENCY  
 
In general terms, efficiency in the context of fMRI may be defined as a quantification 
of how well a design is able to answer the experimental question, through detecting 
effects of interest. When considering this further, the concept of efficiency may be 
approached from either a signal processing perspective, or in terms of the general 
linear model. 
 
3.1.1 Design efficiency in terms of the general linear model 
 
During fMRI processing, experimental conditions are convolved with the 
haemodynamic response function (Figure 2.12), which allows for the differing time 
scales over which haemodynamic and neural events occur (see section 2.3.5.1). The 
haemodynamic response function is convolved with a box-car function representing   113
the time scale of experimental events. This results in a new function, which is a 
prediction of fMRI responses and forms the basis for the experimental model. The 
model may be expressed in general linear terms, as discussed in Chapter 2: 
 
Y=Xβ + ε 
 
The observed data (Y) is then fitted to this model and parameter estimates (β) for each 
effect of interest (X) are calculated, leaving a residual error term (ε), which 
summarises unexplained variance in the data. The experimental aim is to minimise the 
variance in β. This will then be reflected in a higher sensitivity to detect statistical 
significance. As the variance in β is reduced, design efficiency is increased. Variance 
in β may be minimised either by the data itself, or by the experimental design. Factors 
in the design which affect efficiency include design type (epoch or event-related), 
noise filtering, sequencing and spacing of trials, and the temporal relationship 
between stimulus presentation and scan acquisition. These factors will be discussed in 
turn. 
 
3.1.2 Design efficiency in terms of signal processing  
 
Design efficiency is related to stimulus presentation, through signal processing 
considerations. Efficiency calculations for six commonly used fMRI designs are 
shown in Figure 3.1 (Friston et al., 1999). A fixed deterministic design refers to an 
event related design in which stimuli are presented at equal intervals, and is relatively 
inefficient. In a stochastic event-related design, the probability of stimulus 
presentation may be constant or varied, and the rate of variation may be slow or fast. 
All of these factors affect efficiency. A variable deterministic design is synonymous 
to a blocked design, and it may be seen from Figure 3.1 that this type of design is 
highly efficient.    114
 
Figure 3.1 Design efficiency calculations for different types of design. Modified from (Friston 
et al., 1999). 
 
The reasons for these differences in efficiency are related to the temporal 
characteristics of the haemodynamic response function (hrf). From an MRI signal 
processing perspective, design efficiency may be considered as the ability to detect 
signal related to effects of interest from surrounding noise. Efficiency may be 
optimised by using a design which maximises the predicted variability in signal 
between contrasting conditions, as illustrated in Figure 3.2. 
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Figure 3.2 Convolution of a neural stimulus with the haemodynamic response function. This results in 
a prediction of the fMRI signal, which varies widely in this experimental model. Modified from 
(Henson, 2005, http://imaging.mrc-cbu.cam.ac.uk).  
 
Therefore, the timing of delivery and duration of stimuli affects efficiency because, 
after convolution with the hrf, the variability of predicted signal is affected. This can 
be illustrated using an inefficient design, such as a fixed deterministic event-related 
design with short inter-stimulus intervals. The result is minimal variation of predicted 
signal, which merely oscillates around a raised baseline (Figure 3.3). 
 
 
Figure 3.3 An example of an inefficient design. Rapid, regular presentation of stimuli without spacing 
results, after convolution, in minimal variation of predicted MRI signal. Modified from (Henson, 2005, 
http://imaging.mrc-cbu.cam.ac.uk). 
 
The efficiency of the blocked design can then be explained in terms of wide variations 
in predicted signal, as shown in Figure 3.4. The optimal length of block has been 
shown to be 16 seconds (Friston, 2003). Shorter duration blocks result in less 
variability, because of the temporal characteristics of the hrf, and longer block 
durations encounter problems related to noise filtering. 
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Figure 3.4 An example of an efficient design. This epoch-based design has block lengths of 16s, 
resulting in wide variability in the predicted signal. Modified from (Henson, 2005, http://imaging.mrc-
cbu.cam.ac.uk). 
 
3.1.3 Noise filtering 
 
There are several different sources of noise in fMRI data. Head motion, cardiac 
pulsation and respiratory oscillation effects were discussed in Chapter 2. In addition, 
“white noise”, related to scanner hardware, is constant and randomly distributed 
throughout the image. There is also low frequency noise, which is thought to be 
related to slow periodic haemodynamic changes, involved in maintenance of tone in 
the cerebrovascular vessels. This is referred to as 1/f noise (Figure 3.5), and is 
removed using a high pass filter during processing. 
 
 
 
Figure 3.5 Sources of noise in fMRI data, plotted by frequency. 
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In order to explain how this relates to the decrease in efficiency of longer duration 
epochs, it is necessary to consider the Fourier transform, which converts MRI data 
from the time domain to the frequency domain (Figure 3.6). 
 
 
 
Figure 3.6 Fourier transform of design stimuli, hrf and predicted MRI signal from the time domain into 
the frequency domain. Modified from (Henson, 2005, http://imaging.mrc-cbu.cam.ac.uk). 
 
It may be observed from Figure 3.6 that in this design, following the Fourier 
transform, the majority of the predicted data is of low frequency. The frequency is 
determined by the length of stimulus blocks, with longer blocks resulting in lower 
frequencies. It is also clear that the shape of the hrf is transformed, so that low 
frequency data is removed and, indeed, the hrf may be considered as a high pass filter. 
Whilst this usefully removes 1/f noise, it also means that data of interest may be 
filtered, if stimulation blocks are long (Figure 3.7).  
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Figure 3.7 The effect of long duration blocks on predicted signal, after a Fourier transform. The hrf 
acts as a high pass filter, and removes the data along with low frequency noise. Modified from 
(Henson, 2005, http://imaging.mrc-cbu.cam.ac.uk). 
 
3.1.4 Sequencing and spacing of stimuli 
 
An epoch-based design with block lengths of 16 seconds was selected for this study, 
in order to optimise efficiency. Sequencing and spacing are more pertinent to event-
related designs, and so will not be discussed in depth. Spacing describes the time 
between events of the same type, and sequencing the presentation order of different 
trial types, and both these factors affect design efficiency. Optimal spacing depends 
upon whether the experimental effect of interest is the mean of two or more 
conditions, or the difference between them. This is also a consideration when 
considering the most efficient sequence, for example, alternating (e.g. ABABAB) or 
permutational (e.g. ABBABA). The decision to include null events, a “baseline” 
condition, also affects contrast efficiency. 
 
3.1.5 Stimulus presentation and scan acquisition 
 
Bias may be introduced if the duration of stimulus blocks is an exact multiple of the 
volume acquisition time, for example, a block length of 16s and a TR of 4s. This may   119
result in each slice of brain being sampled at the same point of the hrf, in each 
successive TR. This can cause a problem, as regions sampled near the peak of the hrf 
may show greater changes in BOLD signal. Therefore, it may be avoided either by 
choosing a block length which is not an exact multiple of TR, or introducing a jitter 
between stimulus onset and scan acquisition (Figure 3.8).  
For this study, as block durations of 16s were used, the TR was chosen to be 3.95s to 
avoid this effect. 
 
Figure 3.8 The relationship between block length and scan acquisition time. In the left graph 
(A), sampling of the hrf is illustrated when block length is an exact multiple of TR. In the right 
graph (B), sampling is shown when block length is not a multiple of TR, or jitter is introduced. 
Modified from (Jones, 2004, http://www.fil.ion.ucl.ac.uk/spm/). 
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SECTION 2: PROBLEMS IN VISUAL PARADIGM DESIGN 
 
3.2.1 Methodology of visual activation 
 
A variety of different methods of stimulus presentation have been used in previous 
visual fMRI studies, depending on the experimental aims. In particular, the selection 
depends upon whether a specific aspect of visual processing is of interest (for 
example, motion or colour), or if the goal is to deliver a stimulus which results in 
robust, generalised activation of visual areas. In the latter case, flashing or reversing 
checkerboards are most commonly used, and were applied in the earliest fMRI 
experiments (Ogawa et al., 1990;Ogawa et al., 1992), as well as in recent studies. 
Stimulation may be monocular or binocular. In studies of diseases which result in 
monocular blindness, such as ON, comparisons between affected and fellow eye 
responses are often of interest. Most previous fMRI studies in ON have therefore used 
paradigms which stimulate the monocular whole field* using flashing lights 
(Rombouts et al., 1998), or reversing checkerboards (Gareau et al., 1999;Werring et 
al., 2000;Russ et al., 2002;Toosy et al., 2002;Langkilde et al., 2002;Toosy et al., 
2005;Levin et al., 2006; Korsholm et al., 2007;Korsholm et al., 2008), although some 
early studies also applied binocular stimulation (Rombouts et al., 1998;Gareau et al., 
1999). Whole field paradigms produce activation in the entire primary visual cortex, 
which encompasses the calcarine fissure, and also in higher hierarchical visual 
processing areas. Hemi-field stimulation has also been applied, which selectively 
activates the contralateral hemisphere (Langkilde et al., 2002). The development of 
retinotopic mapping (Sereno et al., 1995) allowed more accurate localisation of 
activation, including identification of hierarchical visual areas (V1, V2, V3, V4, 
V5/MT, etc) in individual subjects, but this approach necessitates more extensive 
post-processing.  
 
 
 
 
*The term whole field is used to refer to a stimulus covering the whole projection screen or goggle, 
rather than just part of it, such a single hemi-field. It is not synonymous with the term Ganzfeldt 
stimulation, which describes stimulation of the entire extent of perceived visual field.   121
3.2.2 Stimulus presentation, attention, adaptation and loss of fixation 
 
With regard to the method of stimulus presentation, there is no universally agreed 
“gold standard”. Previous studies have used projection screens, with patching of the 
fellow eye (Russ et al., 2002;Langkilde et al., 2002;Korsholm et al., 2007;Korsholm 
et al., 2008), or voluntary eye closure (Russ et al., 2002), light proof light emitting 
diode (LED) goggles (Gareau et al., 1999;Werring et al., 2000;Toosy et al., 
2002;Toosy et al., 2005), and liquid crystal display (LCD) shutter glasses (Barnes et 
al., 2001). The alternative strategies of using glasses/goggles, or a projection screen, 
have different advantages and disadvantages.  
Maintaining fixation and monitoring attention are particular problems when using 
LED goggles, or LCD shutter glasses, to deliver monocular stimuli if visual acuity is 
reduced in one eye. During periods of affected eye stimulation, the patient may not be 
able to see the fixation cross, or respond to visual cues ensuring attention. This makes 
it very difficult to determine if the patient is fixating and attending to the stimulus, 
which can introduce errors, and confound subsequent data interpretation. Loss of 
fixation may be especially problematic, if the experimental aim is to alternately 
stimulate different regions of the visual field, for example, during retinotopic 
mapping.  
On the other hand, using goggles or glasses facilitates the alternation of a monocular 
stimulus between the two eyes, within the same scanning run. This is a practical 
problem when using projection screens, but it is important to do it, as attention and 
adaptation effects may vary across the course of a run, and influence the fMRI 
response to visual stimuli (Posner and Petersen, 1990;Watanabe et al., 1998;Chawla et 
al., 1999;Rees and Lavie, 2001;Haynes et al., 2005a). Adaptation refers to a 
decrement in fMRI response, seen with repeated stimulus presentation. A recent study 
showed that short-term adaptation effects were evident in controls, and preserved in 
patients with MS, over a series of four runs of a simple motor task, presented over a 
25 minute period (Mancini et al., 2009). 
 
3.2.3 Colour 
 
Different stimuli have been used in previous studies, for example, black and white 
checkerboards (Russ et al., 2002), chromatic stimuli, such as blue and yellow   122
checkerboards (Gareau et al., 1999), and red LED checkerboard displays (Werring et 
al., 2000;Toosy et al., 2002;Toosy et al., 2005). This may be a relevant consideration 
when studying patients with optic nerve diseases, as deficits of colour and contrast 
sensitivity may persist after recovery of acuity (Mullen and Plant, 1986;Plant and 
Hess, 1987). Therefore, the choice of whether to use a black and white or chromatic 
stimulus may have advantages and disadvantages. Black and white stimuli provide a 
strong luminance contrast. This is relatively reduced using chromatic stimuli, which 
could potentially result in less activation. However, it is possible that detection of 
differences between groups of patients with good and poor recovery might be 
enhanced, through an increased sensitivity to patients with incomplete recovery of 
colour vision. Achromatic stimuli are detected via the magnocellular pathway, 
whereas chromatic stimuli are detected via the parvocellular pathway. It is debated 
whether magnocellular (Regan et al., 1991;Phillips et al., 1994) or parvocellular fibres 
(Wall, 1990;Porciatti and Sartucci, 1996; Caruana et al., 2000; Evangelou et al., 2001) 
may be preferentially affected in ON, or whether they are equally susceptible to 
damage (Russell et al., 1991). Therefore, it is possible that selective stimulation of the 
parvocellular and magnocellular pathway could influence sensitivity to detect disease 
effects with fMRI, and this type of psychophysical manipulation has been performed 
in previous studies (Phillips et al., 1994; Caruana et al. 2000). 
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SECTION 3: EXPERIMENTAL DESIGN 
 
3.3.1 Introduction: aims and objectives  
 
The aim was to devise a practical strategy to overcome the difficulties outlined in the 
previous two sections, which could then be applied to subjects with monocular visual 
loss. In this section, the results of a pilot study are reported, involving a group of 
healthy control subjects. In addition, a patient with severe visual loss is included, to 
demonstrate proof-of-concept in a subject who represents an extreme example of the 
problems of fixation and confirmation of attention inherent in the main study group.  
The experimental objectives were as follows: (1) To achieve alternating monocular 
stimulation of each eye within the same scanning run (2) To ensure and confirm 
maintenance of attention in control subjects, and in conditions of monocular visual 
loss (3) To facilitate central fixation in controls, and in conditions of monocular visual 
loss. 
 
3.3.2 Methods 
 
3.3.2.1 Participants 
 
Seven healthy controls with normal vision (mean age 30, 6 females) were recruited, 
together with a patient (age 30, female) with severe acute unilateral ON. The patient 
had complete monocular visual loss (to no light perception), with normal vision in the 
fellow eye. All subjects gave informed written consent. The study was approved by 
the local Ethics Committee.  
 
3.3.2.2 MRI scanning 
 
Scans were performed on a 1.5T Signa Excite whole-body MRI System (GE, 
Milwaukee, USA), with an 8-channel head coil. FMRI data were acquired in 8-10 
runs using a T2*-weighted echo-planar imaging sequence. Thirty eight slices were 
acquired, each 2mm thick, with a 1mm inter-slice gap, parallel to the AC-PC line,   124
covering the whole brain, with TE 50ms, TR 3950ms, field of view 20cm, matrix size 
64x64 and an acquisition time of approximately 5 minutes per run.  
 
3.3.2.3 Paradigm design 
 
The idea of combining plano chromatic filter goggles with monochromatic 
checkerboards, presented on a projection screen, was devised to allow alternating 
monocular stimulation of both eyes within the same scanning run. The methodology 
has subsequently been implemented in another fMRI study (Levin et al., 2006). A 
rectangular projection screen was used, which covered 28 degrees of visual angle 
vertically and 30 degrees horizontally, at a viewing distance of 57cm. The goggles 
had one green filter, and one red filter (Haag-Streit, UK) (Figure 3.9).  
 
 
Figure 3.9 Transparent plano chromatic filter goggles used in visual fMRI experiments. 
 
Green checkerboards of a particular spectral density distribution, presented on the 
projection screen, were invisible through the red filter, and likewise for red 
checkerboards viewed through the green filter. Monocular stimulation could then be 
achieved, by alternately presenting green and red checkerboards, whilst subjects were 
instructed to fixate a blue central cross, visible to both eyes. During periods of 
affected eye stimulation in patients, the fellow eye could still see the fixation cross, 
and it was therefore possible to confirm that the patient was continuing to pay 
attention, by responding to visual cues. It was also possible to infer that the affected 
eye was aligned with the stimulus, through a mechanism of conjugate fixation.  
 
The experiment began with four runs of quadrant-specific activation, through 
chromatic goggles, to assess the feasibility of the technique using localised stimuli. 
This was followed by two runs of stimulation through the goggles, covering the whole   125
projection screen, and then two runs of whole screen black and white stimulation, 
without chromatic goggles, using an alternated eye patch. This was in order to 
compare the performance of the new technique with a more traditional method, using 
similar stimuli. The subjects remained in the head-coil between sessions. 
 
The experimental paradigm is summarised graphically in Figure 3.10. 
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Figure 3.10 Graphic summary of the main visual fMRI protocol, comprising eight runs.  
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In four of the controls, an additional experiment was performed for a further two runs, 
during which the degree of “crosstalk” between the goggles was assessed. In this 
experiment, the subjects wore a patch on one eye underneath the chromatic goggles, 
and the condition of interest was the epochs in which the subject was looking at the 
opposite colour checkerboard, which was supposed to be invisible (Figure 3.11).  
 
 
Figure 3.11 Graphic summary of the crosstalk experiment. 
 
3.3.2.3.1 Lateralisation and localisation of quadrant-specific activation 
Quadrant-specific checkerboards were used to demonstrate the feasibility of the 
approach using localised stimuli, and with later investigation of visual field defects in 
mind (Chapter 6). The hypothesis was that lateralised occipital activation, located 
appropriately above or below the calcarine sulcus, would be expected if attention and 
central fixation were generally well maintained, and each eye adequately isolated.  
Subjects were instructed to fixate a central blue cross, which appeared black to each 
eye through the goggles. They viewed 8Hz flickering checkerboard stimuli, which 
were either a peripheral quadrant or a central circle. The quadrants extended from 5 to 
15
o eccentricity horizontally, and 5 to 14
o vertically, in sectors of 70
o, centred on the 
45
o, 135
o, 225
o and 315
o radii. The central checkerboard extended from 0 to 5
o 
eccentricity, in a complete circle. The borders of the checkerboard squares were radii 
10
o apart. The size of the squares increased with distance from the centre in a linear 
manner, consistent with the cortical magnification factor (Slotnick et al., 2001) 
(Figure 3.12).   128
 
Figure 3.12 Dimensions of a quadrant. 
 
The luminances of the checkerboards were approximately equal (green 1.32cd/m
2; red 
1.23cd/m
2). The chromaticities (RGB gun intensities) of the checkerboard stimuli 
were as follows: 0.31 red and 0.46 green comprising the green checkerboard, and 0.44 
red and 0.34 green comprising the red checkerboard. These parameters resulted in red 
checkerboards that were judged to be of zero contrast when viewed through the green 
filter, and likewise for the green checkerboards through the red filter.  
 
This part of the experiment comprised four runs. The initial orientation of the goggles 
(i.e. red filter on right or left eye) was randomised. After two runs, the orientation of 
the goggles was reversed. Each of these runs consisted of ten epochs of stimulation 
and ten of rest. The duration of each epoch was 16 seconds. For sessions 1 and 3, the 
ten stimulation epochs were applied in pseudo-randomised sequence, to the central 
field and all four quadrants of each eye. In runs 2 and 4, this sequence was repeated in 
reverse. During rest, the subjects continued to fixate on the blue cross, presented on a 
grey background screen without checkerboards.  
 
3.3.2.3.2 Adequacy of isolation: assessment of crosstalk 
In addition to assessment of lateralisation, an additional experiment was performed in 
a subset of controls to quantify how well the goggles isolated each eye. A patch was 
applied to each eye, in turn, underneath the filter goggles. Activation was assessed 
during the epochs when the unpatched eye was looking at the opposite colour   129
checkerboard, which covered the whole screen. This was supposed to be invisible to 
the subjects, who were stimulated in this manner for four epochs, each of 16 seconds 
duration, interspersed with four epochs of visible checkerboards, in a pseudo-
randomised order. 
 
3.3.2.3.3 Goggles versus patches: assessment of attention 
The performance of the new technique, using chromatic goggles, was compared to a 
more traditional technique of alternated eye patching. The outcome measure was the 
number of correct responses to changes in the central fixation cross.  
For this part of the experiment, each subject underwent two runs of stimulation 
through the chromatic goggles, with checkerboards covering the whole screen, for a 
total of eight epochs, four for each eye, in pseudo-randomised order. Each epoch was 
of 16 seconds duration. The orientation of the goggles was reversed between runs.  
The chromatic goggles were then removed, and two runs of black and white 
checkerboard stimulation followed. An eye patch was applied, first to one eye, and 
then switched to the other, between runs. The black and white checkerboards covered 
the whole screen, and were presented for four epochs, followed by four of rest. Each 
epoch was again of 16 seconds duration.  
The subjects’ performance was assessed at a task, designed to ensure maintenance of 
attention, and assist fixation. The subjects were asked to press a button, with their 
right index finger, when the central fixation-cross changed to a hash symbol (#). This 
occurred at a random frequency several times during each of the sessions, during rest 
epochs. Responses were recorded, and entered as covariates into the design matrix, in 
order to account for any variance associated with activation of motor areas.  
 
3.3.2.4 Post-processing 
 
Post-processing was performed, using SPM5 (www.fil.ion.ucl.ac.uk/spm). Each fMRI 
series was realigned, normalised to MNI stereotactic space and smoothed, using an 
8mm isotropic Gaussian kernel. Realignment parameters and time derivatives were 
entered as covariates into the general linear model, together with the time-points at 
which the subjects pressed the button during the task to maintain attention. 
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3.3.2.4.1 Lateralisation and localisation of quadrant-specific activation 
For each subject, first-level fixed effect contrasts were specified for each eye 
individually (1 0 and 0 1 respectively), combining epochs of stimulation through the 
red and green filters. The effectiveness of the stimuli, and accuracy of lateralisation of 
quadrant-specific activation, was assessed using a first-level +1 contrast in SPM5, for 
each condition, in each subject. For each quadrant condition, successful activation 
was defined as a significant, lateralised maximal cluster (p<0.05 corrected), centred 
appropriately above, or below, the calcarine sulcus. For the central circle, successful 
activation was defined as significant bilateral occipital clusters. The number of 
successful stimulation conditions was divided by the total number of presented 
conditions, and expressed as a percentage, for the control group and the patient’s 
fellow eye. 
 
3.3.2.4.2 Adequacy of isolation: assessment of crosstalk 
The amount of crosstalk between the two eyes was quantified, in order to assess how 
effective the goggles were at isolating each eye, to ensure that stimulation was truly 
monocular. Data was extracted from a region-of-interest, placed in primary visual 
cortex, using a generic Brodmann area 17 brain atlas template (Rorden and Brett, 
2000). Mean activation was compared during the condition in which the controls were 
looking at a checkerboard designed to be invisible, and the condition when the 
checkerboard was visible, from the same run, by entering the contrast images from the 
first-level analysis into a second-level paired t-test. The hypothesis was that no 
significant fMRI activity would be evident in the visual cortex during observation of 
the invisible checkerboard, and that this would differ significantly from observation of 
the visible checkerboard. The results reported are parameter estimate units, which 
reflect the magnitude of BOLD signal change. 
 
3.3.2.4.3 Goggles versus patches: assessment of attention 
The number of correct responses to fixation cross changes was compared between the 
chromatic goggle and eye patch techniques in controls, using a paired t-test in Stata-
9.2 (StataCorp, Texas, USA). Two-tailed values of p<0.05 were considered 
significant. In addition, the percentage of correct responses was reported for the 
patient.  
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3.3.2.5 Visual phenomena 
 
The control subjects were asked to report any visual phenomena noted whilst in the 
scanner, by filling in a questionnaire. 
 
3.3.3 Results 
 
3.3.3.1 Lateralisation and localisation of quadrant-specific activation 
 
Following quadrant stimulation in the control subjects, and the patient’s unaffected 
eye, activation was seen localising, as anticipated, to the contralateral hemisphere of 
the occipital lobe, with the lower quadrants represented above, and the upper 
quadrants below, the calcarine fissure. Stimulation of the central circle resulted in 
bilateral occipital activation. Successful activation was seen 80% of the time. 
Examples of statistical parametric maps from a control subject (Figure 3.13), and the 
patient’s fellow eye (Figure 3.14), are shown. No activation was seen on stimulating 
the patient’s affected eye. 
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Figure 3.13 A statistical parametric map demonstrating fMRI responses to stimulation of a control 
subject’s left eye, using region-specific stimuli and the chromatic filter goggles. Activation clusters are 
thresholded at a voxel-level family-weighted-error rate of p<0.05, and overlaid on to the patient’s 
structural image, and the SPM5 glass brain. (A) Bilateral occipital activation is demonstrated following 
stimulation with the central circle. (B) Following stimulation of the upper nasal quadrant, left sided 
activation below the calcarine sulcus is seen. (C) Lower nasal quadrant stimulation resulted in left sided 
supra-calcarine activation. (D) Lower temporal stimulation resulted in right sided supra-calcarine 
activation. (E) Upper temporal stimulation resulted in right sided infra-calcarine activation.  
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Figure 3.14 A statistical parametric map demonstrating fMRI responses to stimulation of the patient’s 
fellow left eye, using region-specific stimuli and the chromatic filter goggles. Activation clusters are 
thresholded at a voxel-level family-weighted-error rate of p<0.05, and overlaid on to the individual’s 
structural image, and the SPM5 glass brain. (A) Bilateral occipital activation is demonstrated following 
stimulation with the central circle. (B) Following stimulation of the upper nasal quadrant, left sided 
activation below the calcarine sulcus is seen. (C) Lower nasal quadrant stimulation resulted in left sided 
supra-calcarine activation. (D) Lower temporal stimulation resulted in right sided supra-calcarine 
activation. (E) Upper temporal stimulation resulted in right sided infra-calcarine activation.  
 
3.3.3.2 Adequacy of isolation: assessment of crosstalk  
 
There was no evidence of any significant crosstalk. Results are plotted in Figure 3.15. 
Mean activation during the epochs observing the invisible checkerboard was 0.028 
units (95%CI -0.22, 0.28), with the confidence interval including zero. This was 
compared to a mean parameter estimate of 0.880 units for the stimulation condition   134
(95%CI 0.64, 1.11, t=8.55, p<0.001). 
 
Figure 3.15 Graphs demonstrating the magnitude of activation in primary visual cortex in controls, 
during (A) the crosstalk test condition, and (B) following checkerboard stimulation through chromatic 
goggles, during the same run. The scale on the y-axis is in parameter estimate units, representing 
blood-oxygenation level dependent (BOLD) signal change. 
 
3.3.3.3 Goggles versus patches: assessment of attention  
 
The patient was unable to perceive light in the affected eye at the time of the scan, but 
successfully detected 93% of fixation cross changes, using the chromatic goggles, 
compared with 0% with patches. 
In controls, there were no significant differences between the two techniques 
(chromatic goggles mean 94%, patches 81%, t=1.75. p=0.14).  
 
3.3.3.4 Visual phenomena 
 
The control subjects reported some transient instability of the visual percept, when 
using the chromatic goggles: six of the seven reported seeing the fixation cross move, 
four said that the cross disappeared intermittently, two said that parts of the 
checkerboard disappeared intermittently, and one reported double crosses.    135
3.3.4 Discussion 
 
The results of this study demonstrated that using the chromatic goggles: (1) 
Alternating monocular stimulation of each eye was achievable, allowing both to be 
tested within the same scanning run, minimising problems with varying attention and 
adaptation effects across the session. (2) Attention was generally well maintained and 
could be confirmed in control subjects, and in a patient with severe monocular visual 
loss. (3) Central fixation was maintained sufficiently to allow accurate detection of 
cross changes, and lateralised and localised fMRI activation to be demonstrated.   
Therefore, several sources of bias were addressed which could be problematic using 
patches, which have been commonly used to isolate each eye in previous fMRI 
studies. In addition, there are potential advantages over techniques such as LED 
goggles, with regard to facilitating fixation and confirming attention, in eyes with 
severe visual loss. 
 
3.3.4.1 Lateralisation and localisation of quadrant-specific activation 
 
Lateralisation and localisation of fMRI responses to region-specific stimuli was 
observed, consistent with the retinotopic organisation of the visual system. This was 
important for later studies of visual field defects in patients, and also suggested that 
central fixation was generally well maintained. If large fixation losses had occurred, 
then fMRI activity might be expected to be poorly lateralised. In addition, the 
feasibility of stimulation using goggles together with localised stimuli was 
demonstrated. 
It should be noted that although homonymous quadrantopias may help clinically 
localise lesions to V2/V3, rather than V1 (Horton and Hoyt, 1991), quadrant-specific 
visual stimulation is not designed to accurately distinguish the borders of hierarchical 
visual areas within an individual, which may vary considerably between subjects, and 
requires formal retinotopic mapping. However, it does improve anatomical resolution, 
compared with whole field stimulation, and may provide a balance between spatial 
localisation and maximising effect size. For this reason, this approach was chosen to 
investigate visual field defects, as described in Chapter 6.  
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3.3.4.2 Adequacy of isolation: assessment of crosstalk 
 
The results of the crosstalk experiment demonstrated that the goggles effectively 
isolated each eye. The confidence interval of the parameter estimate included zero, 
indicating that no significant positive or negative fMRI activity occurred in primary 
visual cortex.  
 
3.3.4.3 Goggles versus patches: assessment of attention 
 
The new technique also helped enable confirmation of attention during stimulation of 
an eye with complete visual loss, as the fellow eye was still able to respond to visual 
cues. This difficulty was not addressed using the traditional eye patch technique. 
Using patches, both attention and gross fixation losses could occur, during stimulation 
of the affected eye, and the investigator would be unaware. The new methodology 
therefore may facilitate data interpretation, by detecting and quantifying these 
potential confounds.  
Using chromatic goggles may also facilitate patient adherence to the stimulation 
protocol, by providing a fixation point for the fellow eye, which is not available using 
eye patches. This might indirectly assist fixation of the affected eye, through a 
mechanism of conjugate fixation, provided the subject does not have a latent phoria 
(tendency of the eyes to deviate when fusion is suspended). However, this was 
difficult to confirm, as a direct measure of eye movements was not included, which is 
a limitation of the study. In addition, some subjects reported perceiving small fixation 
cross movements. These movements were likely to be due to brief disturbances in 
maintenance of conjugate gaze, due to the limited points of reference in the scanner 
environment, and may indicate that the strategy used to maintain fixation was 
imperfectly achieved. However, any such errors are likely to be transient and small, in 
comparison with eye patching. There is some support for this from the observations of 
well lateralised quadrant-specific activation in controls, and the high accuracy of 
responses to fixation cross changes. This suggests that conjugate fixation is 
reasonably well maintained, at least for the practical purposes of most fMRI 
experiments.  
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3.3.4.4 Visual phenomena 
 
The goggles effectively isolated each eye, and this may have led to some of the visual 
phenomena reported by control subjects in the scanner. Some people reported 
transitory instability of the visual percept, when using the chromatic goggles. Part of 
the checkerboard stimulus disappearing could be due to binocular rivalry, and 
subconscious alternation of the fixating eye (Lumer et al., 1998;Haynes et al., 
2005b;Tong et al., 2006). Disappearance of the fixation cross itself may be due to the 
“filling-in” phenomenon that can occur, in the context of competing visual stimuli (in 
this case, cross and checkerboard), resulting in an artificial scotoma, which is filled in 
by the background (Ramachandran and Gregory, 1991;Weil et al., 2007).
 This could 
potentially affect the ability of the subjects to detect the cross changing to a hash 
symbol, but the accuracy of detecting changes actually remained high. The perception 
of double crosses is probably due to instability of vergence at small viewing distances 
(<1 metre), resulting in failure of fusion. These effects do not appear to significantly 
inhibit activation, perhaps because they are so fleeting, often disappearing when 
subjects blinked. In addition, although the luminance contrast associated with the use 
of colour filters may be lower than black and white stimulation, activation was still 
reliably detected in the majority of cases.  
 
3.3.5 Conclusions 
 
In conclusion, a new visual stimulation technique was devised, in order to facilitate 
monocular visual stimulation in patients with monocular visual loss. This technique 
was tested in a control group, and in a single patient with a severe unilateral visual 
deficit. It was demonstrated that the new technique allowed both eyes to be tested 
within the same scanning run, effectively isolated each eye in controls, and was 
superior to a traditional eye patching method, in terms of confirming maintenance of 
attention. It is also likely that fixation was facilitated, and there was no evidence of 
gross fixation losses. The technique was therefore applied to the subjects involved in 
this thesis, and may also be useful for other investigators interested in studying 
patients with monocular visual loss, using fMRI.   138
In the next chapters, the fMRI protocol described here is applied to a cohort of 
patients with acute ON. The same patients also performed structural imaging, to 
investigate mechanisms of damage and responses to it. 
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CHAPTER 4 
 
COMBINING MULTI-MODAL MRI AND ELECTROPHYSIOLOGY TO 
PROBE PATHOPHYSIOLOGICAL MECHANISMS IN ACUTE OPTIC 
NEURITIS 
 
In this chapter, fMRI is combined with structural MRI and electrophysiology in a 
group of patients with acute ON. The objective of this study was to elucidate the 
pathophysiological mechanisms occurring during the acute phase of ON, with a 
particular focus on neuroplastic responses to damage. The aim was to determine why 
there is such a wide variation in the severity of acute visual loss in ON. In order to 
answer this question, it was necessary to dissect complex structure-function 
interactions between inflammation, demyelination and conduction block in the optic 
nerve, pathology in the optic radiations and pericalcarine cortex, and cortical 
responses to visual stimuli in the presence of damage. In particular, the interpretation 
of fMRI measures is complicated by a two-way interaction with visual function. On 
one hand, poor vision is associated with a reduction in afferent input, resulting in a 
smaller BOLD response, and better vision is associated with a higher BOLD response 
to visual stimuli. On the other hand, greater fMRI activity can reflect plasticity, which 
may contribute to better vision. Therefore, the different and complementary 
perspectives that each MRI and electrophysiological test provides into structural 
pathology, the consequences for neural conduction, and cortical responses were 
exploited in order to separate these interactions. To this end, a comprehensive 
structural MRI assessment of both the anterior and posterior visual pathways was 
necessary, in order to identify important mechanisms of damage and their impact on 
acute vision. Structural and electrophysiological predictors of visual loss were then 
used to inform the fMRI analysis, to explore the role of neuroplasticity, after 
separating out the effects of damage on vision.  
The hypothesis was that grey matter plastic responses to visual stimuli might play a 
role in reducing the impact of damage on the acute clinical deficit.  
A novelty of this study is that the impact of damage on both the anterior and posterior 
visual pathways on vision in acute ON was assessed. Therefore, it was important to 
assess the structural integrity of the optic radiations, which were reconstructed using 
diffusion-based tractography. The development of a methodology designed to address   140
sources of bias in this technique, related to placement of the seed, is described in 
section 1. This methodology used the approach of combining structural and functional 
data. In section 2, this methodology was then applied to the patient cohort, together 
with the other structural, electrophysiological and functional measures, to test the 
hypothesis outlined earlier. 
 
 
SECTION 1 DIFFUSION-BASED TRACTOGRAPHY OF THE OPTIC 
RADIATIONS 
 
4.1.1 Development of a methodology for tracking the optic radiations, using 
diffusion and functional MRI data 
 
Diffusion-based tractography (Basser and Pierpaoli, 1996;Mori et al., 1999;Ciccarelli 
et al., 2008) is a sensitive method of assessing the integrity of white matter tracts, and 
represents an important tool in the assessment of tissue damage in the optic radiations 
in vivo. Tractography has provided many insights into white matter tract pathology in 
demyelinating disease (Ciccarelli et al., 2008), and several different techniques are 
available. One of the most commonly used algorithms is probabilistic tractography, 
and this approach was used in this study to reconstruct the optic radiations, using 
FMRIB Software Library (FSL) tools (http://www.fmrib.ox.ac.uk 
/fsl/fdt/fdt_probtrackx.html (Behrens et al., 2003a;Behrens et al., 2003b)).  
A general limitation of all tractography techniques is that extracted tract parameters, 
such as FA, may be significantly influenced by the choice of seed-point, which is 
usually an operator-dependent step. An example of this effect is shown in Figure 4.1. 
Reconstruction of the right optic radiation was performed, using a seed voxel placed 
in the apex of the right Meyer’s loop. The estimates of the tracts, and the extracted 
mean tract FA, differed significantly (>5%) if the seed voxel was shifted laterally by 
just one voxel, from 0.359 for the illustrated red/yellow tract, to 0.380 for the tract 
shown in blue.  
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Figure 4.1 The effect of variability in seed-point placement on the mean FA of the reconstructed tract. 
(A) Seed voxels in the apex of the right Meyer’s loop are shown, on an axial slice of the FA map, 
overlaid with the principal eigenvector map, and (B) a magnification of Meyer’s loop is shown. The red 
arrow indicates a seed voxel, placed at MNI coordinate 42 51 12, and the blue arrow indicates a second 
seed, placed in the immediately adjacent voxel 43 51 12. (C) The reconstructed tract estimates are 
displayed overlaid on to an axial slice of the FA map. The blue tract corresponds to the seed voxel 
indicated by the blue arrow, and the red/yellow tract to the seed voxel indicated by the red arrow. In 
each case, identical coronal and sagittal exclusion masks were applied, and the maps were thresholded 
at a voxel-scale connectivity value of 75. The extracted mean FA values were 0.359 for the red/yellow 
tract, and 0.380 for the blue tract. 
 
Previous studies have used various methods to attempt to minimise this variability, for 
example, following strict operator rules for voxel selection (Ciccarelli et al., 2005), or 
normalising the seed coordinates, using a group-specific template (Toosy et al., 2004). 
A different approach is to use fMRI data to define seed-points. An early study used 
fMRI to identify the LGN and visual cortex, and applied tractography to demonstrate 
proof-of-concept in individual healthy subjects (Conturo et al., 1999). This approach 
was later applied to patients to study the motor system, in order to investigate 
individual differences in corticospinal tract anatomy, related to brain tumours 
(Holodny et al., 2001;Krings et al., 2001). A more recent study combined fMRI 
definition of seed-points with diffusion-based group mapping (Guye et al., 2003). 
FMRI seeds were identified in the motor cortex in native space, coregistered to the 
individual’s DTI data, the tractography algorithm was run, and the resulting 
connectivity maps were normalised. This technique permitted comparisons between a 
group of controls and a single patient with a frontal tumour. The reduction of operator   142
bias in seed placement, that is the advantage of using the functional data, could be 
exploited to investigate group-level differences, by normalising the fMRI data to 
define cohort-specific seed-points, and then reverse normalising them back into native 
space for tractography. This approach has been used to investigate temporal lobe 
epilepsy, applying an fMRI language paradigm to define the cortical seeds (Powell et 
al., 2007), but has not been previously applied in the visual system. 
The operator is required to make other decisions when performing tractography, such 
as whether to include a target mask and exclusion masks, and, if so, in which location. 
In addition, the levels of curvature thresholding used to terminate the algorithm, and 
noise thresholding, must be decided. These variables may be optimised for a given 
cohort, using pilot data, and then should be kept constant for all subjects, when they 
are applied to the study group. For this thesis, experiments were first performed using 
the control data from the baseline time-point, with the aim of choosing the parameters 
for the tractography algorithm, in order to achieve the most reliable and accurate 
reconstructions of the optic radiations in this cohort. Examples of the problems 
addressed by these pilot experiments are described in the following sections. 
 
4.1.2 Target mask 
 
In order to test whether a target mask was required, the right optic radiation was 
reconstructed by choosing a seed-point in the apex of Meyer’s loop on the right side. 
The tractography algorithm provided by FSL was run without, and with, a target 
mask, leaving all other parameters as default. The target mask chosen was the primary 
visual cortex, which was outlined in each subject using a previously described 
methodology (Ciccarelli et al., 2006). It consisted of manually drawing the visual 
cortex on the standardised T1 image, that is the individual T1-weighted image 
coregistered into a standardised space defined by the Montreal Neurological Institute 
(MNI152), using affine transformation, as employed by FSL (Jenkinson and Smith, 
2001). This was done by using, as a guide, a region-of-interest derived from area 17 in 
the Brodmann atlas. The visual cortical areas were then transferred back to the 
individual T1 images, and their correct location was confirmed by visual inspection in 
all cases. Probabilistic tissue-type segmentation and partial volume estimation were 
then performed on the individual T1-weighted images (Zhang et al., 2001). The output 
images were thresholded to include only voxels estimated at >30% grey matter and   143
the results were used to mask the visual cortical areas to obtain the final target masks. 
The T1 target mask was then transformed into native diffusion space before running 
tractography (an example is given in Figure 4.2). 
 
  
Figure 4.2 Target mask, in native space, overlaid on to an axial section of the FA map. 
 
The results of tractography without, and with, a target mask are shown in Figure 4.3. 
 
 
Figure 4.3 The effect of using a target mask. Results of tractography are shown for a control subject 
(A) without, and (B) using, a target mask. The reconstructed, unthresholded optic radiations are 
illustrated in red/yellow, with yellow indicating a higher probability of connection, overlaid on to an 
axial slice of the FA map, in native space, without exclusion masks. 
 
The inclusion of a target mask substantially reduced the number of false positive 
streamlines, although some were still seen in the contralateral optic radiation, as a 
result of crossing via the corpus callosum, and in the inferior fronto-occipital   144
associative tracts. Therefore, a primary visual cortical target mask was included in the 
tractography algorithm used in the work described in this thesis. 
 
4.1.3 Exclusion mask 
 
In order to test whether an exclusion mask was required, the left optic radiation was 
reconstructed using a seed-point in the apex of Meyer’s loop on the left side. The FSL 
tractography algorithm was run without, and with, an exclusion mask, leaving all 
other parameters as default. Separate experiments were performed, using a mid-
sagittal mask, a coronal mask placed immediately anterior to the apices of Meyer’s 
loops, and both together. A primary visual cortical target mask was added (section 
4.1.2). The results showed that, if an exclusion mask was not used to constrain the 
tractography algorithm, white matter tracts outside the optic radiations were also 
tracked from the seed-point, such as the inferior longitudinal fasciculus, inferior 
fronto-occipital fasciculus and corpus callosum (examples shown in Figure 4.4A and 
B). These tracts were not of interest to this study, and the problem occurred despite 
the use of a target mask. When exclusion masks were used, only the tracts belonging 
to the optic radiations were displayed. The best results were obtained using a 
combined mid-sagittal and coronal exclusion mask (illustrated in Figure 4.4C), which 
was selected for the experiments described in this thesis. 
 
 
Figure 4.4 Results of tractography without using an exclusion mask, showing erroneous tracking across 
(A) the corpus callosum and (B) inferior fronto-occipital fasciculus. These problems may be solved 
using (C) coronal and sagittal exclusion masks. 
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4.1.4 Defining seed-points using fMRI data 
 
4.1.4.1 Defining the LGN using fMRI 
 
The effect of small differences in the placement of seed-points was illustrated in 
Figure 4.1. In order to reduce the bias associated with operator-dependent placement, 
an approach was chosen in which seed-points were derived from the fMRI data. The 
lateral geniculate nuclei (LGN) were selected, as they represented grey matter 
structures, adjacent to the anterior optic radiations, near Meyer’s loops. In order to test 
this approach, both optic radiations were reconstructed using fMRI-derived seed-
points in the LGN. At 1.5T, it was not always possible to visualise the LGN with 
fMRI. Therefore, it was necessary to define them using a second-level group fMRI 
contrast, derived from the main study cohort, and then transform the group LGN 
estimates from normalised fMRI space into native diffusion space. 
For each subject in the study, the visual fMRI data were realigned, normalised and 
smoothed in SPM5, as described in Chapter 3. First-level +1 contrasts were specified 
for each of the whole field conditions, separately, for the chromatic and black and 
white checkerboard conditions, for each eye. The resulting contrast images from all 
subjects were combined in a second-level analysis. A one-sample t-test model was 
specified, entering all of the contrast images together combining both conditions (i.e. 
both chromatic and black and white checkerboard stimulation of the whole field), and 
both groups (i.e. both patients and controls). This was repeated at each time-point. 
Consideration was given to combining data across all time-points, but there was 
concern that subject dropout might introduce bias into the estimates, and it was 
important to include all available subjects’ data, to optimise statistical power. 
Therefore, at the second level, time-point specific contrast images were estimated. 
The resulting statistical parametric maps were thresholded at a family-weighted error 
level p<0.05 and the baseline time-point result is shown in Figure 4.5.  
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Figure 4.5 Statistical parametric group map, demonstrating the results of visual stimulation, at the 
baseline time-point, combined for all the patients and controls involved in the main study, and 
combined for black and white and chromatic whole field stimulation. Activation is seen in the bilateral 
occipital cortex and left (blue arrow) and right (red arrowhead) LGN. The results are overlaid on to the 
SPM5 glass brain, shown in (A) sagittal, (B) coronal and (C) axial projections, and (D) a coronal 
section of the MNI305 template. The maps are thresholded at a voxel-level family-weighted error rate 
of p<0.05. 
 
The results demonstrated that it was possible to identify the LGN using fMRI, at 
group level, in this cohort. However, there was slight left/right asymmetry in the size 
of the fMRI estimates, which might bias the subsequent tract estimates if these 
clusters were used as seed-points for tractography. This was addressed in the next 
stage. 
 
4.1.4.2 Construction of LGN-based seed-points 
 
In order not to introduce a laterality bias, symmetrical seed-points were constructed, 
based on the LGN estimates. This was performed using the MarsBar region-of-
interest SPM5 toolbox (Brett et al., 2002). Spherical regions were defined, centred on 
the global maximal coordinates of each LGN. These were at MNI coordinates 22 -24 -
4 on the right, and -22 -26 -4 on the left. The reconstructed spheres centred on these 
points were each of 3.5mm radius, resulting in volumes of 180mm
2. These dimensions 
were chosen to approximate the published volumes of the LGN (i.e. 5x6x9mm), 
which are of spatulate shape (Horton et al., 1990).  The spheres were then reverse   147
normalised into each subject’s native space, using the SPM5 algorithm, and 
coregistered to each individual’s brain diffusion data. The coregistration was a two 
stage procedure, in which the whole brain fMRI data was first registered to a whole 
brain b0 image. This whole brain b0 image was then registered to the main DTI 
dataset, which comprised a partial brain acquisition (details in section 4.2.2.5.2). The 
spheres were resliced in native diffusion space, binarised and used as seed-points for 
tractography. In order to reconstruct both optic radiations, seed-points were placed in 
the region of the right and left LGN, in turn, and the FSL tractography algorithm was 
run, using a primary visual cortical target mask (section 4.1.2) and an exclusion mask 
(section 4.1.3), leaving all other parameters as default, including the curvature 
thresholding (0.2 radians). The results from two different control subjects are shown 
in Figure 4.6. 
 
 
Figure 4.6 Results of tractography in two different control subjects, unthresholded and overlaid on to 
axial slices of the FA maps. The default curvature threshold of 0.2 radians was applied. The images 
demonstrate tracking round the angle of Meyer’s loop (A) successfully and (B) unsuccessfully. Seed 
masks are shown in green, probabilistic streamlines in red/yellow. (C) Magnification of the right 
Meyer’s loop, overlaid with a principal eigenvector map from the unsuccessful tractography, 
demonstrates difficulties related to tracking round the sharp angle, and from beginning tracking within 
the grey matter.  
 
The approach was only partially successful. In some control subjects accurate 
reconstruction of the optic radiations was achieved (Figure 4.6A) but, in others, the 
algorithm failed to track round Meyer’s loops (Figure 4.6B). This was probably due to 
inter-individual differences in the anatomy of the loop of Meyer and the estimated 
location of the LGN, resulting in difficulties tracking round a sharp angle in some   148
subjects, and difficulties tracking from within isotropic grey matter to white matter in 
others (see also Figure 4.7). Therefore, the next stage was to attempt to address the 
problem of tracking round the sharp angle. 
 
4.1.4.3 Curvature thresholding 
 
Tractography algorithms incorporate a curvature threshold, which constrains the angle 
between eigenvectors in adjacent voxels, and connectivity is inferred at a given 
threshold. If the angle between eigenvectors is more acute than this threshold, the 
streamline is terminated. The FSL tractography algorithm applies default settings of 
5000 samples and a curvature threshold of 0.2 radians (11.5 degrees) 
(http://www.fmrib.ox.ac.uk/fsl/fdt/fdt _probtrackx.html). In order to facilitate tracking 
round Meyer’s loop, the curvature threshold was reduced. A seed-point was placed in 
the right LGN, and the algorithm re-run, with all of the parameters left identical to the 
previous experiment (section 4.1.4.2), except that now the curvature threshold was 
reduced to 0.1 radians. The experiment was then repeated again with a threshold of 0 
radians, and these results are shown in Figure 4.7. 
 
 
Figure 4.7 The effect of changing the curvature threshold. Results of tractography are demonstrated, 
using (A) a standard curvature threshold of 0.2 radians, and (B) a threshold of zero. Results are overlaid 
on to FA maps, with seed masks shown in green. 
 
This approach was unsuccessful, as reducing the threshold resulted in unacceptable 
noise, with many erroneous streamlines passing through the grey matter.  
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4.1.4.4 Tracking from Meyer’s loop 
 
In order to overcome these difficulties, the methodology was modified, as follows. 
The LGN-derived seed points were shifted laterally into the apex of Meyer’s loops, 
within coherently oriented, anisotropic white matter. This was performed manually, in 
each subject’s native space, using FSL, following a standardised guideline. Each seed-
point was shifted 8-10 voxels laterally, and the maximum number of voxels was 
always used for this shift. This shift allowed the seed voxels to be placed within the 
apex of the loop, as confirmed visually in all cases. In order to assess the 
reproducibility of this approach, the seed-point shift was repeated in eight datasets, 
more than a month later, by the same operator, blinded to image identity, and the 
intra-observer coefficient of variation was calculated. 
The results demonstrated that this approach was fully reproducible, with a coefficient 
of variation of 0%. Therefore, despite this modification, the methodology continued to 
minimise operator dependence. The optic radiations were reconstructed successfully 
in all cases. This methodology was used for the experiments described in this thesis, 
and is summarised in Figure 4.8. 
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 Figure  4.8 Using fMRI to define seed-points for probabilistic tractography. (A) The LGN group 
activation clusters are shown, overlaid on to a coronal section of the MNI152, T1-weighted average 
brain map in SPM5, thresholded at voxel-level p<0.05 corrected. (B) The reconstructed LGN seed 
masks are shown at their original locations in native diffusion space in green, and following a 10 voxel 
lateral shift in blue, within the apex of Meyer’s loop, in one of the control subjects. The seed masks are 
overlaid on to an axial section of the FA map, with the principal eigenvector map superimposed in red. 
(C) The results of tractography for the same control subject are shown. The exclusion mask is shown in 
grey, the target region in white, and the reconstructed optic radiations in red/yellow, where yellow is 
the highest probability of connection. 
 
4.1.5 Connectivity map thresholding 
 
Thresholding of the connectivity map, which results from tractography, is generally 
used to limit the effect of image noise, and reconstruct only the tracts under 
investigation (Guye et al., 2003;Ciccarelli et al., 2006;Thottakara et al., 
2006;Ciccarelli et al., 2007). There is no general consensus on the optimum threshold 
to use, which may vary depending on the dataset and tract of interest, and the choice 
essentially represents a trade-off between sensitivity and specificity. In this pilot 
group of controls, experiments were performed to compare the effect of applying 
different voxel-scale connectivity thresholds. Seed-points were placed in each   151
Meyer’s loop, in turn, in order to reconstruct both optic radiations, using the 
methodology summarised in figure 4.8. The FSL algorithm was run, using a primary 
visual cortical target mask (section 4.1.2), an exclusion mask (4.1.3), and leaving all 
other parameters as default. Connectivity thresholds of 0, 50, 75, 100 and 200 were 
applied. The results are shown in Figure 4.9. 
 
 
Figure 4.9 Noise thresholding. Results of tractography in a single control subject, overlaid on to an 
axial slice of the FA map, illustrating the effect of thresholding, at voxel-scale connectivity levels of 
(A) 0, (B) 50, (C) 75, (D) 100 and (E) 200. 
 
In this pilot study, a threshold of 75 was judged to maximise specificity, compared 
with the lower thresholds, whilst higher thresholds did not significantly improve 
sensitivity, and true positive voxels were sometimes discarded, especially in subjects 
with relatively low overall tract connectivity. Therefore, a noise threshold of 75 was 
used in this thesis. 
The final thresholded connectivity maps were transformed into binary images, which 
were used to mask the anisotropy maps, to delineate the optic radiations, in both the 
patient and control groups. The mean voxel values of fractional anisotropy (FA) 
within this tract were obtained, for each subject, which is a well established measure 
of the integrity of the posterior visual pathways (Schmierer et al., 2007). 
 
4.1.6 Summary 
 
In summary, the results of these pilot experiments, in the cohort of control subjects, 
were used to decide on the parameters for the tractography algorithm to apply in 
subsequent experiments, described in this thesis. The methodology included a primary 
visual cortical target mask and mid-sagittal and coronal exclusion masks. The seed-
points were defined, by reconstructing spheres centred on the fMRI estimates of the 
LGN, which were then shifted into the apices of Meyer’s loops. A voxel-level   152
connectivity noise threshold of 75 was applied to the resulting maps. These 
modifications of a previously published technique, combining fMRI and diffusion 
data, resulted in reproducible estimates of the optic radiations, which appeared 
reliable and anatomically accurate. However, some limitations of this technique must 
be borne in mind, with regard to tractography in general, and specifically combining 
multi-modal data.  
In general, the results reflect a probability of connection to the optic radiations for 
each voxel, and false positives and negatives may occur. It is not possible to 
distinguish afferent from efferent fibres, and pathological modifications may lead to 
partial volume effects between the eigenvectors in neighbouring voxels. Using group 
fMRI data to define the seed-points may introduce registration errors, as a result of 
different susceptibilities and other artefacts between functional and diffusion MRI 
(Powell et al., 2007). The normalisation step could also potentially result in errors, 
due to inter-individual anatomical variability. For the same reason, the sensitivity to 
detect subtle effects between individuals is also likely to be reduced. Despite these 
limitations, the method of defining seed-points using fMRI group activation peaks 
reduced operator bias, and permitted the assessment of group-level differences, which 
is discussed in the next section. 
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SECTION 2: DISSECTING STRUCTURE-FUNCTION INTERACTIONS IN 
ACUTE OPTIC NEURITIS TO INVESTIGATE NEUROPLASTICITY 
 
4.2.1 Introduction 
 
A striking clinical characteristic of ON is the wide variability in severity of acute 
visual loss. Some people experience only mild blurring, whilst others are unable to 
perceive light. It is unclear whether this depends solely on the degree of structural 
damage within the optic nerve itself, or if it is influenced by other factors, such as 
pathology elsewhere in the visual pathways, or compensatory brain responses. In this 
study, structural MRI, electrophysiology and fMRI techniques were combined in vivo 
in a group of patients with acute ON, in order to attempt to define the structural and 
functional contributions underlying this variability in acute clinical deficit. 
 
4.2.1.1 Damage to the optic nerve  
 
Paraclinical in vivo techniques have previously been applied individually to clarify 
aspects of pathology in the optic nerve in ON. Previous MRI studies have identified 
measures of optic nerve damage that correlate with acute visual dysfunction in ON. 
For example, swelling of the optic nerves has been shown to correlate with the 
severity of acute visual loss (Hickman et al., 2004a). Visual loss has been associated 
with gadolinium enhancement, and its recovery with cessation of enhancement, this 
evolution suggesting that inflammation per se contributes to the acute reversible 
visual deficit (Youl et al., 1991). Correlations have been demonstrated between acute 
visual dysfunction and the length of the enhancing segment (Kupersmith et al., 
2002;Hickman et al., 2004c). Lesions on non-contrast-enhanced T2 weighted 
sequences reflect non-specific changes in intra and extra-cellular water, which may be 
due to oedema, inflammation, demyelination, gliosis or axonal loss (Barkhof and 
VanWalderveen, 1999). These are seen in the acute phase, persist, and may correlate 
with lower acuity (Miller et al., 1988a;Dunker and Wiegand, 1996). 
Electrophysiological studies have demonstrated acute prolongation of VEP latencies, 
which remained evident even after vision had recovered (Halliday et al., 1972;Brusa 
et al., 2001). Overall, the data from previous MRI and electrophysiological studies   154
suggest that the important pathological processes in acute ON are oedema, 
inflammation, and demyelination within the optic nerve, and that these factors may be 
associated with the severity of acute visual loss. 
More recently, the possibility of combining newer quantitative MRI techniques, such 
as diffusion-based tractography and fMRI, has provided an opportunity to investigate 
pathological mechanisms and physiological responses in greater detail.  
 
4.2.1.2 Damage to the posterior pathways  
 
The impact of changes in the rest of the visual system which result from acute ON is 
less clear, and has not been investigated in depth. Posterior visual pathway 
involvement and occipital cortical responses may contribute to the clinical picture, 
either by sustaining damage, or modulating its effects on visual function. For 
example, patients with clinically isolated ON commonly have inflammatory lesions 
on brain MRI and, as these are often periventricular in location, they may involve the 
optic radiations (Hornabrook et al., 1992). These lesions may affect vision, especially 
if they are large (Plant et al., 1992). In addition, inflammation in the optic nerve may 
have secondary consequences for the posterior pathways. The occurrence of trans-
synaptic degeneration in the LGN following an optic nerve insult is recognised 
(Goldby, 1957;Madigan et al., 1996). This term describes a phenomenon in which 
damage to one part of a neural pathway results in secondary degenerative 
consequences for other neurons connected through synaptic junctions. Evidence for 
trans-synaptic degeneration in the LGN following ON has been demonstrated by a 
histological study (Evangelou et al., 2001), and supported by the results from in vivo 
MRI studies. A diffusion-based tractography study demonstrated reduced connectivity 
in the optic radiations a year after acute ON (Ciccarelli et al., 2005), and another study 
reported reduced MTR in occipital cortex, six months after ON (Audoin et al., 2006). 
At present, it remains unclear when these changes first appear. 
In the work reported in this chapter, the impact of incidental lesions in the posterior 
visual pathways on acute visual loss was studied, and whether any secondary changes 
in the integrity of the optic radiations were detectable at this early stage. The 
morphology of the occipital cortex was also investigated to detect any abnormalities 
of pericalcarine cortical surface area, volume or thickness. 
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4.2.1.3 Functional responses to visual stimuli in optic neuritis 
 
The brain functional response to visual stimuli in ON appears to be complex. Previous 
studies have shown that during the acute episode there is a widespread reduction in 
the fMRI activation throughout the grey matter of the afferent visual pathway, which 
correlates with visual acuity (Rombouts et al., 1998;Langkilde et al., 2002;Toosy et 
al., 2005;Korsholm et al., 2007). This can be explained by a reduced afferent input, 
secondary to active inflammation and conduction block in the anterior pathway. 
However, it appears that fMRI activation reflects more than the magnitude of visual 
input to primary visual cortex. Activation has been demonstrated in extra-striate areas, 
thought to represent neuroplastic reorganisation, which may contribute to visual 
recovery (Werring et al., 2000;Toosy et al., 2005;Levin et al., 2006;Korsholm et al., 
2007). The timing of these changes remains somewhat uncertain, but at least some of 
them appear to occur soon after the initial insult.  
It is not known whether cortical responses to visual stimuli can modulate visual acuity 
during the acute stage, or whether they are just consequent to it. For example, an 
observed region of fMRI activation which correlates with visual acuity could be 
interpreted in two ways. It may be that patients with better vision have a greater 
afferent input to occipital cortex, and hence greater fMRI activity. Alternatively, 
increased fMRI activity may reflect a compensatory grey matter plastic response to 
pathology, which is actively contributing to preservation of vision. These two 
possibilities are difficult to disentangle, but elucidating this is important when 
considering how the brain responds to injury, and if it contributes to recovery.  
In order to dissect out cause and effect, structural MRI, electrophysiology and fMRI 
were combined in a cohort of patients with acute ON. The objectives of the study 
were twofold: firstly, to identify which structural and electrophysiological measures in 
the afferent pathways were associated with acute visual loss. Secondly, to use these 
important structural and electrophysiological measures to inform a further analysis, in 
which fMRI data were also entered. This strategy aimed to separate the effects of a 
reduced afferent input from any cortical influence on vision. It was hypothesised that 
any fMRI activity correlating with vision, independent from measures of the structural 
and electrophysiological integrity of the optic nerve, might represent a neuroplastic 
modulatory effect.    156
In a model such as this, it was important that the structural assessment was 
comprehensive, to include any potential influences on vision from the posterior, as 
well as the anterior, pathways. To this end, the combination of optic nerve, optic 
radiation and visual cortical structural imaging, together with visual fMRI, 
represented the most detailed MRI assessment of the visual system in ON to date.  
 
4.2.2 Methods 
 
4.2.2.1 Participants 
 
Patients with a typical, acute, unilateral, clinically isolated ON were recruited from 
Moorfields Eye Hospital. This was defined as a painful unilateral loss of vision, which 
progressed over a few days to two weeks, without any additional neurological 
symptoms (Hickman et al., 2002). Healthy age and sex matched controls were also 
studied. Patients with a diagnosis of MS, bilateral ON, or other chronic neurological 
conditions were excluded. The presence of brain inflammatory lesions was not 
considered an exclusion criterion. Treatment with steroids was noted. Patients were 
invited for clinical assessment, VEPs, structural and functional MRI, on the same day, 
within a month from symptom onset. All subjects gave informed written consent. The 
study was approved by the local Ethics Committee. 
 
4.2.2.2 Clinical assessment 
 
On the day of scanning, the patients’ best corrected visual acuity, using glasses and 
pinhole correction if necessary, was measured using a retro-illuminated Early 
Treatment Diabetic Retinopathy Study Chart. Scores were recorded as 4m logMAR 
visual acuity (Ferris, III et al., 1982). When no letters could be correctly identified, a 
score of 1.7 was assigned (Optic Neuritis Study Group, 1991). 
 
4.2.2.3 Electrophysiological assessment 
 
Each patient was invited to have a whole field, pattern-reversal visual evoked 
potential (VEP) study on the day of scanning. The screen subtended 28
o of visual 
angle horizontally and 22
o vertically, and check size was 40'. Luminance was 4cd/m
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and 60cd/m
2 for the black and white checks, respectively. An occipital electrode 5cm 
above the inion was used to reference Fz. The amplitude of the response and the 
latency of the P100 waveform were calculated. 
 
4.2.2.4 MRI acquisition and analysis  
 
Two 1.5T GE Medical Systems scanners (Milwaukee, WI, USA) were used to acquire 
MRI data, using an 8-channel receive-only head-coil. The scanners were chosen based 
on their dedicated setup. Structural imaging of the optic nerves and brain was 
performed in all subjects with a 1.5T Signa Echospeed MRI system, with a maximum 
gradient strength of 33mTm
-1, whilst functional imaging was performed, on the same 
day, on a 1.5T Signa Excite whole-body MRI system, with a lower gradient strength 
of 22mTm
-1, but with the equipment for paradigm presentation for visual stimulation 
(described in Chapter 3). 
 
4.2.2.5 Structural MRI imaging 
 
4.2.2.5.1 Optic nerves 
(1) A coronal-oblique fast spin echo sequence (TR 2300ms, TE 68ms, 2 excitations, 
echo train length 8, matrix size 512x384, field of view (FOV) 24x18cm, 16 
contiguous 3mm slices) was acquired to calculate lesion length, which was 
determined by an experienced neuroradiologist (Dr. Katherine Miszkiel), blinded to 
image identity and side affected, by multiplying the number of consecutive slices of 
optic nerve returning abnormal signal by the slice thickness. The intra-observer 
coefficient of variation, which is equal to the ratio of the standard deviation to the 
mean, multipled by 100%, and was calculated on eight patients, was 2.8%. 
(2) Post triple-dose gadolinium-enhanced coronal-oblique fat-saturated T1-weighted 
spin echo was acquired in patients only (TR 600ms, TE 20ms, 1 excitation, matrix 
size 256x192, FOV 24x18cm, 16 contiguous 3mm slices). 
 (3) Coronal-oblique FLAIR imaging (TR 2500ms, TE 12.7ms, TI 995ms, 6 
excitations, echo train length 6, matrix size 512x384, FOV 24x18cm, 16 contiguous 
3mm slices) was performed to obtain the optic nerve cross-sectional area, which I 
calculated, blinded to image identity, from five contiguous slices anterior from the 
orbital apex (Hickman et al., 2001), using a semi-automated contouring technique   158
(Plummer, 1992). The intra-observer reproducibility coefficient of variation was 
4.6%. In order to account for normal inter-individual variability, the ratio of affected 
to fellow nerve area was calculated. 
 
4.2.2.5.2 Optic radiations 
(1) Axial-oblique dual-echo fast spin echo of the whole brain (TR 2000ms, TE 
17ms/102ms, echo train length 8, matrix size 256x256, FOV 24x18cm, 28 contiguous 
5mm slices) were used to calculate the optic radiation lesion load, after lesions were 
identified by Dr. Miszkiel, using standard anatomical landmarks. The intra-observer 
coefficient of variation was 2.6%. 
(2) DTI of the optic radiations and occipital lobe was obtained using an optimised 
single-shot, cardiac-gated, diffusion-weighted echo-planar imaging sequence (TR 10 
RR~11-13s, TE 82ms, 1 excitation, matrix size 96x96 (reconstructed to 128x128), 
FOV 22x22cm
2, in-plane resolution 2.3x2.3mm
2 (reconstructed to 1.7x1.7mm
2), 30 
contiguous 2.3mm slices, parallel to the AC-PC line, diffusion gradients applied along 
61 directions (Cook et al., 2007), b=1200s/mm
2, optimised for white matter), and 
seven interleaved non-diffusion-weighted b0 scans, acquisition time 10-15 minutes, 
depending on cardiac cycle). One additional b0 volume was acquired, covering the 
whole brain (60 slices, extended from the original 30), to assist coregistration of 
partial brain diffusion data to whole brain fMRI data, which was necessary for 
tractography. Head motion and eddy-current induced distortions were corrected and 
the diffusion tensor was then calculated on a pixel-by-pixel basis, using FSL tools 
(http://www.fmrib.ox.ac.uk/fsl/). 
The optic radiations were reconstructed, using the probabilistic tractography 
algorithm provided by FSL (http://www.fmrib.ox.ac.uk/fsl/fdt/fdt_probtrackx.html, 
(Behrens et al., 2003a;Behrens et al., 2003b). The seed-points were defined in each 
Meyer’s loop using fMRI data, as described in the first section of this chapter, and 
summarised in Figure 4.8. The mean FA within the tractography-derived tract was 
obtained for each side, in each subject. 
 
4.2.2.5.3 Visual cortex 
Three dimensional fast prepared spoiled gradient recall (3D-FSPGR) of the whole 
brain was acquired (TR 14.3ms, TE 5.1ms, 1 excitation, matrix size 256x128, FOV 
31x31cm, 156 contiguous 1.2mm slices).    159
The images were analysed with FreeSurfer software (http://surfer 
.nmr.mgh.harvard.edu), in which they were reconstructed as 1x1x1mm axial images, 
and the brain extracted. The skull-strip was assessed visually in all cases, and I 
performed manual correction if necessary, blinded to image identity. Fully automated 
cortical parcellation was then performed, and pericalcarine cortical surface area, 
volume and thickness estimates were obtained (Dale et al., 1999;Fischl et al., 
1999;Fischl and Dale, 2000;Fischl et al., 2004). This surface-based methodology 
assigns labels to each cortical region, based on the gyral and sulcal anatomy of the 
individual patient data, prior probability information, and after taking into account the 
labels of neighbouring regions. The prior probabilities are derived from a manually 
segmented cortical atlas model, which includes geometric information and elements 
of neuroanatomical convention. The surface area and volume of each cortical region 
may then be calculated, and representations of cortical thickness extracted, calculated 
from the minimum distances from the grey-white matter boundary to the grey matter-
CSF boundary. The maps produced are therefore not simply reliant on absolute signal 
intensity, and are not restricted to the voxel resolution of the original data, which 
allows detection of sub-millimetre differences in thickness between groups. These 
methods have been shown to be reliable (Han et al., 2006), and have been validated 
against manual segmentation (Desikan et al., 2006) and histology (Rosas et al., 
2002;Hinds et al., 2008). 
An SPM5 segmentation-based methodology was used to extract whole brain grey 
matter fractional volume (Chard et al., 2002), which was quantified using in-house 
software (http://www.nmrgroup.ion.ucl.ac.uk/atrophy/). The grey matter fraction was 
calculated by dividing the grey matter volume by the total intracranial volume (the 
sum of the grey matter, white matter and CSF), for each patient, as in previous studies 
(Dalton et al., 2004;Fisher et al., 2008). 
 
4.2.2.6 Functional MRI imaging 
 
The fMRI imaging acquisition protocol and experimental design were described in 
Chapter 3. Only the data from the whole field stimulation conditions were used for the 
analyses described in this chapter. The data from the conditions of whole field stimuli 
using the chromatic goggles were used for the main analyses. The data using black 
and white checkerboards and patches were only used to help define the LGN-derived   160
seed-points used for tractography. Post-processing was performed using SPM5. Each 
fMRI series was realigned, normalised to MNI stereotactic space and smoothed, using 
an 8mm isotropic Gaussian kernel. Realignment parameters and time derivatives were 
entered as covariates into the general linear model, together with the time-points at 
which the subjects pressed the button during the task to maintain attention. The 
patients responded correctly to the cross changing 74% of the time, and controls 97% 
of the time, indicating generally good attention and fixation, despite visual loss which 
was severe in some cases. 
For each subject, first-level fixed effect contrasts were specified for affected and 
fellow eyes individually (1 0 and 0 1 respectively), combining epochs of stimulation 
through the red and green filters. Controls right and left eyes were pseudo-randomised 
arbitrarily to “affected” or “fellow”, in order to maintain exactly the same 
methodology as the patients. The subsequent contrast images, representing the main 
effect of stimulation for each eye were entered into the second-level regression 
models, described in the next section.  
 
4.2.2.7 Statistical analysis 
 
Statistical analysis was performed using Stata-9.2 (StataCorp, Texas, USA), and 
variables were considered significant and reported at p<0.05, unless otherwise stated. 
 
4.2.2.7.1 Structural and functional differences between patients and controls 
Two-tailed unpaired t-tests were used to compare the following parameters between 
patients and controls (which were normally distributed): optic nerve area, optic 
radiation FA, pericalcarine cortical surface area, volume and thickness, whole brain 
cortical volume and grey matter fraction, VEP amplitude and latency. For the 
controls, optic nerve area, VEP amplitude, and VEP latency were averaged for the 
two eyes, to maximise use of the available data. Paired t-tests were used to compare 
affected and fellow eye parameters in patients. The group means, standard deviation 
(SD) and p value were reported for each t-test.  
As there were no differences between the right and left optic radiations (using the 
Wilcoxon test) in either the patient or control groups, mean FA values of the right and 
left optic radiation were calculated, and compared between patients and controls.   161
For pericalcarine cortical surface area and volume, measurements were combined for 
the two hemispheres, as each hemisphere receives input from both eyes. The 
pericalcarine cortical thickness was averaged across both hemispheres. A 
multivariable regression approach was used, and adjusted for age and gender, with 
patient or control status always the binary dependent variable (0-control, 1-patient). 
Each cortical variable was entered, in turn, together with age and gender as dependent 
variables. Pericalcarine volumetric comparisons were also adjusted for whole brain 
grey matter volume. Group differences were quantified by dividing the patient group 
parameter by the control parameter, and multiplying by 100%.  
A further post-hoc analysis was performed, in the case of finding significant 
differences in brain volumetric parameters between patients and controls, to determine 
whether there were any relationships between brain volumes and the presence of T2 
lesions in the brain, T2 lesions in the optic radiations, and optic radiation FA. 
Voxel-wise differences in fMRI activity between patients and controls were compared 
for affected and fellow eyes, using SPM5. A second-level two-sample t-test model 
was used to identify any regions where patients activated more than controls (contrast 
1 -1), or vice versa (-1 1). The resulting statistical parametric maps were thresholded 
at cluster-level p<0.05 (corrected). Regions of significant activation were localised 
using the SPM5 Anatomy toolbox (Eickhoff et al., 2005). 
 
4.2.2.7.2 Associations between structural and electrophysiological measures and 
vision 
Separate linear regression models were estimated to identify any imaging, 
electrophysiological or demographic variables which were associated with logMAR 
visual acuity. LogMAR visual acuity scores were always the dependent variable, and 
the following variables were entered individually as predictors: fast spin echo and 
gadolinium-enhanced optic nerve lesion length, optic nerve area, optic radiation lesion 
load and mean FA, pericalcarine cortical surface area, volume and thickness, VEP 
amplitude and latency, age, gender, side affected and the number of days from 
presentation to assessment. Acuity in the fellow eye was always entered into the 
model, to correct for any normal inter-subject variability.  
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4.2.2.7.3 Associations between fMRI activation and vision 
In order to identify areas of brain functional activity associated with visual acuity, 
after adjusting for structural damage in the visual system, conduction defects and 
demographic characteristics, any significant variables from the previous analysis were 
entered into a whole brain voxel-based multiple regression analysis in SPM5, together 
with the fMRI data, affected eye visual acuity scores, age, gender, and side of ON. 
Positive and inverse associations between visual acuity in the affected eye and fMRI 
activity were assessed, by specifying +1 and -1 contrasts, respectively, with zeros for 
all other variables. Separate models were specified, in turn, for the affected and fellow 
eye fMRI data.  
A further post-hoc analysis was performed, in order to separate the individual 
influence of structural and electrophysiological variables in these models.  
 
4.2.3 Results 
 
4.2.3.1 Patient characteristics 
 
Twenty eight consecutive patients were recruited. Their mean age was 32 years (SD 
7) and 23 were female. The ten controls were age and sex matched, with a mean age 
of 30 years (SD 3) and eight females.  
In the patient group, the median duration of symptoms was 22 days (range 7-34) and 
the median number of days from presentation to assessment was 19 days (range 3-33). 
Patients’ mean logMAR score was 0.72 for the affected eye (SD 0.69, range -0.06, 
1.7, for conversion to Snellen see Appendix I) and -0.05 (SD 0.10) for the fellow eye. 
The ON affected the left eye in 14 patients and the right eye in the other 14. Seven 
patients (25%) were treated with steroids, three prior to MRI assessment, and four 
after the initial scans.  
With regard to the timing of assessments, all were performed on the same day in 
19/28 patients, and within two days of each other in 25/28. In two patients, the 
structural scans (and, in addition, the VEP in one of these two) were performed five 
days after the clinical and fMRI assessment. In one patient, the fMRI scan could not 
be performed until 21 days after the other assessments.    163
Gadolinium-enhanced scans were obtained for 26 of the 28 patients, with the 
remaining two patients declining an intravenous injection.  
In one patient, DTI data was unavailable and, in another, the connectivity of one of 
the reconstructed optic radiations was too low to survive thresholding. These data 
were omitted from further analysis. 
 
4.2.3.2 Structural and functional differences between patients and controls 
 
Differences in structural and electrophysiological measures between patients and 
controls are summarised in Table 4.1.  
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ANTERIOR PATHWAY STRUCTURE  Patients  Controls  p 
value 
T2-weighted optic nerve lesion length (mm)  21.6 ± 10.4          
Gad-enhanced segment lesion length (mm)  23.5 ± 13.3          
Affected optic nerve area (mm
2)  14.6 ± 3.2     NS 
Fellow optic nerve area (mm
2)  12.3 ± 1.3 
12.8 ± 1.4  
   NS 
POSTERIOR PATHWAY STRUCTURE  Patients  Controls  p 
value 
Optic radiation lesion load (mm
2)       63 ± 117           
Mean FA optic radiations    0.35 ± 0.03   0.36 ± 0.03     NS 
Pericalcarine surface area (mm
2)   2440 ± 483   2780 ± 532     NS 
Pericalcarine cortical volume (mm
3)   3630 ± 981   4232 ±722    0.047 
Pericalcarine cortical thickness (mm)    1.61 ± 0.13    1.63 ± 0.10     NS 
Whole brain grey matter volume (cm
3)     715 ± 54     740 ± 53     NS 
Grey matter fraction    0.44 ± 0.04    0.45 ± 0.02     NS 
ELECTROPHYSIOLOGY  Patients  Controls  p 
value 
Affected VEP amplitude (μV)   5.30  ± 3.90    0.003 
Fellow VEP amplitude (μV)  12.00 ± 4.4 
9.70 ± 3.34 
   NS 
Affected VEP latency (ms)     120 ± 18  <0.001 
Fellow VEP latency (ms)      95  ± 7 
   95 ± 6 
   NS 
Table 4.1 MRI and VEP parameters from the anterior and posterior visual pathways in patients and 
controls. Means ± standard deviations are reported. Significant between-group differences are 
highlighted in bold font. Gad-gadolinium, FA- fractional anisotropy, NS- non-significant, VEP-visual 
evoked potential. 
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4.2.3.2.1 Optic nerves 
T2 lesions were visible in the patients’ affected optic nerve in 96% of cases and, in 
one case, a segment of high T2 signal was seen in the fellow nerve.  
Contrast enhancement was detected in 92% of affected optic nerves and no fellow 
nerve enhanced. 
The patients’ affected optic nerves were swollen during the acute phase, compared 
with the fellow eye (19% greater area, p<0.001), and the difference from controls was 
of borderline significance (patients 14% greater area, p=0.088). There were no 
differences in the area of patients’ fellow nerves, compared with controls.  
  
4.2.3.2.2 Optic radiations 
Seventy five percent of patients had asymptomatic brain lesions, and in 50% the optic 
radiations were involved. The brain lesions fulfilled the MRI criteria for diagnosis of 
dissemination in space (McDonald et al., 2001;Polman et al., 2005) in four cases 
(14%). There were no significant differences in FA of the optic radiations between the 
patient and control groups. 
No optic nerve abnormalities or brain lesions were found in controls. 
 
4.2.3.2.3 Visual cortex 
The volume of the pericalcarine cortex was 14% smaller in patients than controls 
(p=0.047). The mean whole brain grey matter volume was 3% less in patients, which 
was not statistically significant, and there were no differences in the grey matter 
fraction between patients and controls. The difference in pericalcarine cortical 
volumes retained significance after correction for age and gender (p=0.049), and 
retained borderline significance after adjustment for whole brain grey matter volume 
(p=0.080) and grey matter fraction (p=0.051). Pericalcarine cortical surface area was 
12% smaller in patients, which was of borderline significance before (p=0.071), and 
after (p=0.067), adjustment for age and gender. There were no differences in 
pericalcarine cortical thickness between patients and controls. 
Significant associations were found between smaller volumes and the presence of 
lesions, both in the brain (p=0.020) and optic radiations (p=0.030). These associations 
were independent of age, gender, whole brain grey matter indices and the number of 
days from symptom onset to MRI. There was no association between pericalcarine 
volume and FA of the optic radiations. There were no associations between whole   166
brain grey matter indices and the presence of brain lesions, optic radiation lesions or 
FA. 
 
4.2.3.2.4 Cerebral cortical function 
Differences in fMRI activity between patients and controls are summarised in Table 
4.2. For the affected eye, ON patients exhibited lower fMRI activation than controls 
within the bilateral visual cortex. There were no areas where ON patients’ affected 
eyes activated more than controls. 
For the fellow eye, ON patients activated more than controls in a region centred on 
the right pre-central gyrus, extending into the right post-central gyrus. There were no 
areas where controls activated more than patients, with respect to the fellow eye. 
 
FMRI RESPONSE  Patients>Controls  Controls>Patients 
Eye tested  Fellow  Affected 
Region (MNI   
coordinates) 
Right pre-central gyrus 
(48 -16 56) 
Bilateral visual cortex  
(-24 -82 -14) 
Spatial extent (voxels)  576  3208 
Voxel-level t-score  3.70  5.64 
Cluster-level p value  0.041  <0.001 
Table 4.2 Regions of differential fMRI activation between patients and controls. The location, Montreal 
Neurological Institute (MNI) coordinates, spatial extent, global maximal t-score and cluster-level p 
value are reported. 
 
 4.2.3.3. Associations between structural and electrophysiological measures and vision  
 
Among all the parameters tested, fast spin echo lesion length, enhancing lesion length 
and VEP amplitude were found to be significantly associated with visual acuity 
(Table 4.3). 
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PREDICTOR  
 
Partial correlation  
coefficient (r) 
p value 
Fast spin-echo optic nerve lesion 
length 
 0.55   0.001 
Gad-enhanced optic nerve lesion 
length (n=26) 
 0.47   0.010 
Optic nerve cross-sectional area   0.35    NS 
Optic radiation lesion load  -0.01    NS 
Optic radiation FA (n=27)   0.21    NS 
Pericalcarine surface area  -0.15    NS 
Pericalcarine volume  -0.07    NS 
Pericalcarine thickness   0.18    NS 
VEP amplitude   -0.84  <0.001 
VEP latency  
(n=23, 5 flat responses) 
-0.08    NS 
Age  -0.09    NS 
Gender  -0.06    NS 
Side affected   0.00    NS 
Number of days from presentation  -0.08    NS 
Table 4.3 Structural, electrophysiological and demographic associations with visual acuity. Partial 
correlation coefficients are reported, with the associated p value. Only significant p values are reported. 
The sample size was 28, unless otherwise stated. Significant variables are highlighted in bold font.  FA-
fractional anisotropy, Gad-gadolinum, NS-non-significant, VEP- visual evoked potential. 
  
A more positive logMAR score, indicating worse vision, was associated with longer 
lesions and smaller VEP amplitudes. None of the optic radiation or occipital cortical 
parameters was associated with visual acuity. Therefore, fast spin echo and 
gadolinium-enhancing measures of lesion length, and VEP amplitude, were entered 
into the next step of the analysis (i.e. the whole brain voxel-based SPM5 multivariable 
regression model). 
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4.2.3.4 Associations between fMRI activation and vision 
 
There was a significant association between greater fMRI activation, in response to 
stimulation of the affected eye, and better vision (i.e. lower logMAR) in the bilateral 
visual association cortex of the cuneus, when adjusting for lesion length, VEP 
amplitude, age, gender and side of ON (Figure 4.10).  
No associations were identified between vision in the patients’ affected eye and 
fellow eye fMRI activity.  
 
 
Figure 4.10 Statistical parametric map, showing group correlations between fMRI response and visual 
acuity, after correcting for fast spin echo lesion length, gadolinium-enhanced lesion length, VEP 
amplitude, age, gender and side affected. A correlation was seen in the region of the cuneus bilaterally, 
where better visual acuity was associated with a greater fMRI response. The graph plots logMAR 
visual acuity against the mean corrected fMRI response (approximate percentage blood oxygenation 
level dependent (BOLD) signal change), at the peak voxel. The statistical parametric map is 
thresholded at cluster level p<0.05 (corrected), and overlaid on to the MNI-305 template. The scale bar 
indicates the voxel-level t-scores. 
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The model was re-estimated with VEP amplitude taken out, in order to separately 
assess any fMRI associations with vision, after accounting only for markers of 
inflammation in the optic nerve, and demographics. More extensive correlations were 
seen in similar areas to the full model, but also extending into the precuneus of the 
parietal lobe, and involving primary visual cortex (Figure 4.11). 
 
 
Figure 4.11 Statistical parametric map, showing group correlations between fMRI response and visual 
acuity, after correcting for fast spin echo lesion length, gadolinium-enhanced lesion length, age, gender 
and side affected. VEP amplitude has been removed from the model. The correlation in the region of 
the bilateral cuneus remains, and extends into the precuneus. Activation is also seen in primary visual 
cortex. The direction of the correlations again indicates that better visual acuity is associated with a 
greater fMRI response. The map is thresholded at cluster level p<0.05 (corrected), overlaid on to the 
MNI-305 template, and (A) sagittal, (B) coronal and (C) axial sections are shown, centred on the global 
maximum.  
 
4.2.4 Discussion 
 
The most important finding of this study is the association between visual acuity at 
presentation, and extra-striate cortical activation, located in the cuneus, part of the 
dorsal stream of visual processing. This was identified following a voxel-based whole 
brain multivariable regression analysis, after taking into account structural and 
electrophysiological measures of the effects of pathology on both the anterior and 
posterior visual pathway. It can be argued that this may represent an influence of 
neuroplasticity on acute visual function. 
In this section, first the differences between patients and controls will be discussed, 
and then the associations between vision, structure, and function in patients, followed 
by a discussion of neuroplasticity in ON. 
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4.2.4.1 Structural and functional differences between patients and controls 
 
Structural and electrophysiological measures were abnormal during the acute stage of 
ON, which confirm the presence of optic nerve inflammation and oedema, and 
consequent conduction delay and block. Half the patients had incidental lesions in the 
optic radiations, but optic radiation FA did not differ between patients and controls, 
suggesting that tract integrity is preserved. However, there was a suggestion of 
volume loss in the patients’ pericalcarine cortex. This novel finding appeared to be 
partly independent of whole brain grey matter volume loss, which has been reported 
in clinically isolated syndromes (Anderson et al., 2007;Fisher et al., 2008). The 
smaller calcarine cortex could be due to trans-synaptic degeneration (Evangelou et al., 
2001;Calabrese et al., 2007), but this explanation is not in agreement with a normal 
integrity of the subserving optic radiations. An alternative hypothesis is that this may 
reflect a generalised susceptibility of the visual system to damage from demyelinating 
disease. It is known that the optic nerve is particularly vulnerable (McDonald and 
Barnes, 1992), as ON is the presenting symptom of MS in approximately 20% of 
patients (Sorensen et al., 1999), optic radiations lesions are common (Hornabrook et 
al., 1992), and it is conceivable that occipital grey matter may also be susceptible to 
damage.  
This could be either through a mechanism of discrete cortical lesions, which are more 
difficult to visualise at 1.5T than white matter lesions, or through primary grey matter 
neurodegenerative change. There was a correlation between pericalcarine atrophy and 
the presence of white matter lesions in the brain, suggesting that these subclinical grey 
matter changes are associated with the subsequent development of MS, although 
longitudinal studies are required to confirm this, and will follow in Chapter 5. The 
question of whether grey or white matter damage appears first in MS has been 
debated in the literature (Geurts and Barkhof, 2008). It is not possible to provide an 
answer from this study, but the observation of grey matter atrophy which is, to some 
degree, region-specific in patients presenting with clinically isolated syndromes is of 
interest. 
In the direct voxel-wise comparison of fMRI responses, controls’ eyes activated more 
in visual cortex than patients’ affected eyes. This can be explained by a reduced 
afferent input in patients, and is consistent with the findings of previous studies. There 
was no evidence of differential activation in the cuneus between patients and controls,   171
which might be anticipated if adaptive plastic changes were genuinely occurring in 
this region. However, the sensitivity of the voxel-based whole brain analysis approach 
to detect neuroplasticity in this region may be limited in patients with ON; these 
patients have structural damage in the optic nerve which reduces the afferent input, 
resulting in a generally small BOLD signal in all visual areas. 
It is interesting that there was, to some degree, a structure-function dissociation. 
Patients had smaller pericalcarine volumes and less activation in V1 than controls on 
stimulating the affected eye, but no there were no differences in V1 activation on 
stimulating the fellow eye. Patients with better vision had more activation in the 
cuneus than patients with poor vision (after correcting for structural damage in the 
optic nerve and demographics), but there were no differences in V1. In this study, 
cortical thickness in the cuneus was not measured, and investigation of structure-
function associations in this region could be of potential interest. However, direct 
comparisons could prove practically problematic, as the Freesurfer cortical 
parcellation of the cuneus may not map precisely to the identified area of fMRI 
activation.  
The finding of differential activation in the right precentral gyrus was somewhat 
surprising, and could represent a noise spike artefact. Alternatively, it could relate to 
the motor task, in which the subjects pressed a button when the fixation-cross 
changed, although the times of motor responses were entered as covariates into the 
analysis. It could reflect an abnormal spatial and temporal profile of motor processing 
in the patient group. Abnormal motor processing is known to occur in MS (Rocca et 
al., 2005), although whether it occurs in clinically isolated ON is unknown. In the 
future, studies could correct for possible motor task related activation by introducing a 
“control” condition during the fMRI experiment, such as pressing a button while 
watching the grey background. 
 
4.2.4.2 Associations between structural and electrophysiological measures and vision 
  
It was found that the severity of acute visual loss in ON was associated with measures 
of the extent of optic nerve inflammation (lesion length) and conduction block (VEP 
amplitude). This is in line with previous experimental and clinical imaging, 
electrophysiological and pathological studies, which have demonstrated that 
inflammation and demyelination in CNS lesions each contribute to conduction block   172
and clinical deficit (Smith and McDonald, 1999). These results confirm that acute 
visual loss is related to the magnitude of the insult locally within the optic nerve, 
rather than in the posterior visual pathways.  
 
4.2.4.3 Associations between fMRI activation and vision 
 
An association was detected between greater fMRI activity in the cuneus and better 
vision, when correcting for optic nerve inflammation and conduction block. This 
suggests a possible adaptive neuroplasticity in this extra-striate cortex during the acute 
stage of the disease. The cuneus is an area of visual association cortex, outside 
primary visual cortex, which is part of the dorsal processing stream, involved in 
spatial localisation of objects in the physical world. Whilst this study did not include a 
retinotopic mapping sequence to identify the borders between hierarchical visual areas 
within individual subjects, the cuneus generally corresponds to Brodmann areas 18 
and 19, with the region adjacent to the parieto-occipital sulcus encompassing dorsal 
area V3. This area is sensitive to coherent motion stimuli (Braddick et al., 2001), and 
receives major, excitatory feed-forward projections from lower areas such as V2 
(Anderson and Martin, 2005).  
Extra-striate activation has been reported before in several areas: the insula, 
claustrum, thalami, corpus striatum, orbitofrontal and lateral temporal cortices, and 
the posterior parietal cortex, which is also part of the dorsal stream (Werring et al., 
2000). More recent longitudinal MRI studies have suggested that adaptive 
neuroplasticity might occur during the acute stage of ON. Both lower visual areas, 
such as the LGN (Korsholm et al., 2007) and higher visual areas, such as the lateral 
occipital complexes (LOCs) (Toosy et al., 2005), located in the ventral processing 
stream (Goodale and Milner, 1992), have been implicated. At present, it remains 
unclear whether the location of extra-striate neuroplastic reorganisation is important, 
in terms of the relative ability of neurons in different regions to adapt their normal 
function in response to pathological insult (a process known as cross-modal 
reassignment, see section 1.4.3.5). Location might be important if neuroplastic 
processes, such as dendritic arborisation or synaptic plasticity (Johansen-Berg, 2007), 
were facilitated in certain regions, through a mechanism of reorganisation of existing, 
but previously inactive, neural networks. The location of such networks could be 
patient-specific, or common across groups of patients. Alternatively, location may not   173
be important, and reorganisation may represent a non-specific map expansion from 
adjacent primary visual areas, in response to a reduced afferent input. With regard to 
the remaining mechanisms of brain reorganisation, this does not appear to be a case of 
homologous area adaptation, as the primary clinically affected region is in the optic 
nerve, and the resulting neural input is normally processed by bilateral visual cortex. 
Compensatory masquerade also does not appear relevant as alternative visual 
strategies are limited. The finding of novel regions, such as the cuneus, and previous 
reports implicating several different areas, may suggest that either non-specific map 
expansion, or subject-specific cross-modal reassignment, is more likely than a 
population-level common “emergency” anatomical network. Interestingly, a 
subsequent longitudinal study on the same patient cohort which used a region-of-
interest analysis, has found that the baseline activation in the cuneus in patients was 
not associated with visual acuity at one year (see Chapter 5). Further longitudinal 
studies in larger cohorts are needed to confirm the role of the extra-striate, associative 
cortices in modulating clinical function in response to pathology in both the acute 
stage and long-term phase. It is possible that different regions play a role in adaptive 
plasticity during different stages of the injury.  
It is interesting to consider whether the triggers for neuroplastic reorganisation 
originate at optic nerve, optic tract, optic radiation or visual cortical level. Triggers 
local to the pathological insult in the optic nerve could include trophic factors, such as 
cytokines related to inflammation, or stimulation of damaged optic nerve axons. More 
remote triggers might include a reduction in afferent input to central grey matter, 
either in the LGN or primary visual cortex, or a combination of both.  
Smaller scale mechanisms of reorganisation also merit some consideration, such as 
changes at cellular level. The time scale of days to weeks in which changes were 
evident in this and other studies (Toosy et al., 2005), may provide some guidance as 
to which of the various proposed mechanisms are more likely. It is unclear whether 
axonal sprouting or dendritic arborisation could occur over this short temporal scale. 
A change in the expression and distribution of sodium channels appears more feasible, 
or perhaps synaptic changes, with an alteration in the strength, density, and 
distribution of connections, or in neurotransmitter function. Over a time period of 
days to weeks, it might be considered that processing would be more likely to be 
redistributed along previously existing, but quiescent, pathways, rather than involving 
the development of entirely new neural circuits. These observations are speculative,   174
and cannot be answered by the data from this study, requiring further work in animal 
models. Nevertheless, the results of this study contribute to an assessment of the 
balance of probabilities, with regard to these mechanisms, by clarifying the temporal 
course over which neuroplastic changes appear to occur.  
 
There is an alternative explanation for the findings of this study, which is that the 
observed association reflects a smaller afferent input as vision worsens, independent 
of the structural and electrophysiological measures included in the model. 
Correlations were also observed in primary visual cortex when VEP amplitude was 
removed from the model, suggesting that this part of the variance in fMRI activity did 
indeed relate to a reduced afferent input, secondary to conduction block. Therefore, it 
is possible that there is a particular aspect of visual processing occurring in the 
cuneus, in which the variance in fMRI signal was not captured by the measures 
included in our model, for example, sensitivity to motion of the checkerboard 
stimulus. However, if this was the case, correlations might be expected in other 
motion-sensitive visual areas, such as V5/MT. Moreover, as the structural and 
electrophysiological measures included in the model reflect disruption to neural 
transmission through inflammation and conduction block within the optic nerve, it 
might be expected that all aspects of visual information would be affected together at 
such an early stage in the afferent pathway. 
 
4.2.4.4 Study limitations  
 
The patient cohort included a small proportion of people in whom structural and 
functional scans were separated by more than two days, and acute ON is a time of 
dynamic pathophysiological change. In particular, in one patient the scans were 
separated by a much longer period. In addition, there was some heterogeneity within 
the cohort in the time from symptom onset to assessment. To investigate the influence 
of these factors, the SPM5 multivariable regression model was respecified, firstly, 
omitting the subject with a delay and, secondly, including an additional regressor, 
representing the number of days from symptom onset. In both cases, the associations 
between vision and fMRI activity in the cuneus remained significant (results not 
shown). 
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In addition, the influence of steroids on the fMRI response remains unknown, but an 
influence on the electrophysiological parameters has been reported (Trauzettel-
Klosinski et al., 1995). However, in this study, only three patients had steroids before 
their imaging and electrophysiological assessment. There were no differences in the 
fMRI response and VEP amplitude and latency between patients treated with steroids 
and those untreated (results not shown). 
 
Whilst this study incorporated the most comprehensive structural MRI assessment of 
the visual pathways to date in ON, it is possible that an influence of optic tract 
pathology was missed, as it was not assessed. Diffusion-based tractography of the 
optic tract may be possible, but would necessitate longer scan-times. For this reason, 
it was unfeasible to include either optic nerve or optic tract DTI in the present study. 
Prohibitive scan-times remain a limiting factor when aiming for a comprehensive 
MRI assessment of the visual system. In the future, this may be addressed with 
advances in technology, such as higher strength magnetic fields (Chapter 7).  
 
Finally, a two stage analysis strategy was applied in order to dissect structure-function 
relationships. This helped to limit the number of variables in the final analysis. Future 
studies may incorporate a larger sample size, which would allow a more complete 
assessment of all structural and electrophysiological variables in a single regression 
model with brain fMRI response. The relatively large number of variables 
investigated also raises the issue of multiple comparisons. The p values reported in 
this chapter are uncorrected. This issue is discussed in detail in section 5.1.4.5. 
 
4.2.4.5 Conclusions 
 
In summary, MRI and electrophysiological techniques were combined to assess 
structural damage, and its effects on neural conduction, within the anterior and 
posterior visual pathways in acute ON, and the results used to inform an analysis of 
cortical responses, measured using fMRI. Whilst structural abnormalities were 
detectable throughout the afferent pathway, the severity of acute visual loss was 
determined predominantly by direct damage to the optic nerve. Cortical activity was 
identified within the dorsal stream of visual processing, which was associated with 
better vision, after adjusting for the influence of structural damage in the optic nerve,   176
and its electrophysiological consequences. This suggested some degree of adaptive 
neuroplasticity within the dorsal stream of higher visual processing, occurring during 
the acute episode of ON, which may act to modulate acute clinical deficit.  
The next goal of this thesis is to elucidate the nature of neuroplasticity in ON further, 
to investigate how fMRI responses change over time in different regions of the brain, 
how this relates to dynamic clinical and structural changes and, in particular, long-
term visual recovery. A longitudinal methodology is required to clarify these aspects, 
and follows in the next chapters. 
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CHAPTER 5  
 
A LONGITUDINAL STUDY OF MECHANISMS OF DAMAGE AND 
RECOVERY IN ACUTE OPTIC NEURITIS 
 
In this chapter, structural and functional data are combined in a longitudinal study, in 
order to assess the evolution of damage following ON, and to investigate mechanisms 
of recovery. The chapter is divided into three sections. In the first, visual recovery is 
considered. The aim was to identify the factors associated with visual outcome, a year 
after the acute episode. This is important from a clinical perspective, and also to 
determine why some patients recover well despite significant tissue loss. In particular, 
the relative importance of myelination, axonal loss and neuroplasticity are considered, 
as evidenced by VEP, OCT and MRI measures. 
In the second section, variables resulting from the first analysis are explored in more 
detail, with a particular focus on relationships between fMRI activity, structure and 
clinical function. More complex analysis techniques are employed to explore 
changing temporal relationships.  
In the final section, neurological outcome is considered, by investigating the 
development of MS following ON, with a particular focus on associations with 
measures of cortical tissue loss. 
 
 
SECTION 1 MECHANISMS OF DAMAGE AND RECOVERY IN OPTIC 
NEURITIS  
 
5.1.1 Introduction 
 
Most patients with acute, idiopathic, demyelinating ON make a good visual recovery. 
However, 5-10% recover poorly (Beck et al., 2004a), and many more notice residual 
qualitative deficits (Cleary et al., 1997). For these people, there are no effective 
treatments to improve vision. It is not clear why some people fail to recover whereas 
others recover well, even following severe visual loss and despite evidence of residual 
tissue damage. The focus of this section is to investigate the mechanisms underlying   178
damage and recovery, and to identify any predictors of visual outcome during the 
acute episode which could be of potential clinical utility. 
 
5.1.1.1 Acute inflammation 
  
During the acute episode, there is inflammation, oedema, demyelination and 
conduction block in the optic nerve (Smith and McDonald, 1999). In Chapter 4, it was 
demonstrated that inflammation and conduction block were associated with the 
severity of acute visual loss, and this must be taken into account when considering 
visual outcome. Intuitively, it might be expected that patients with a more severe 
acute inflammatory insult would have a worse outcome and, indeed, there was a 
statistical association between baseline visual loss and visual outcome in the ONTT 
(Beck et al., 1994). However, studies in the same cohort found that this association 
did not usefully predict recovery at six months at the level of the individual, as most 
patients with severe baseline visual loss still had potential for a good recovery. In a 
clinical setting, worse visual function at one month was found to be more useful at 
predicting poor eventual recovery (Kupersmith et al., 2007). A study in a different 
cohort found no association at all between baseline visual loss and recovery at 12 
months (Hickman et al., 2004c). With regard to paraclinical measures of the severity 
of acute inflammation, the data are also inconsistent. A longer gadolinium-enhancing 
lesion in the optic nerve during the acute episode was associated with worse visual 
outcome in one study (Hickman et al., 2004c), but not in another (Kupersmith et al., 
2002).  
 
5.1.1.2 Myelination and axonal loss 
 
In the weeks following acute ON, inflammation resolves and electrical conduction, 
and consequently vision, begins to improve. However, there is frequently evidence of 
persistent optic nerve demyelination, such as a prolonged VEP latency (Jones, 1993) 
and reduced optic nerve MTR (Hickman et al., 2004b). Neuroaxonal loss occurs and 
optic atrophy generally ensues, becoming clinically evident as disc pallor on 
fundoscopy at around six weeks, and detectable later using optic nerve MRI (Inglese 
et al., 2002;Hickman et al., 2004a), and OCT of the RNFL (Trip et al., 2005;Costello 
et al., 2006). Evidence for remyelination, such as shortening VEP latency, may be   179
seen later but generally not until clinical recovery is almost complete (Jones, 1993). 
Therefore, it is of interest that most patients make good visual recoveries, considering 
the frequency of residual tissue damage, including axonal loss, a phenomenon usually 
associated with permanent disability in demyelinating diseases (Miller et al., 2002). 
 
5.1.1.3 Visual recovery despite tissue damage 
 
The key factors determining visual recovery following acute ON remain unclear. 
Early initial improvement appears to be temporally related to resolution of acute 
oedema and inflammation in the optic nerve (Youl et al., 1991), and occurs despite 
residual tissue damage. Hypotheses to explain the relative dissociation between optic 
nerve tissue damage and degree of visual recovery include an influence of pathology 
in the posterior pathways. Alternatively, the restricted clinical impact despite optic 
nerve axonal loss may be partially explained by the large number of axons in the optic 
nerve, in excess of the critical threshold necessary to maintain function, a concept 
known as neuroaxonal redundancy. Remyelination of the visual pathways may occur. 
An independent hypothesis implicates compensatory reorganisation of cortical 
processing, which is known as adaptive neuroplasticity, and was introduced in earlier 
chapters of this thesis.  
 
5.1.1.4 Predicting prognosis during the acute episode 
 
Currently, it is not possible to predict reliably which patients will fail to recover from 
an attack of ON. Worse visual acuity at one month (Kupersmith et al., 2007), a less 
steep initial gradient of improvement of acuity and smaller amplitude VEPs during the 
recovery phase (Hickman et al., 2004c) have been associated with a worse visual 
prognosis, but are not helpful at the time of diagnosis. Similarly, whilst measures of 
tissue loss such as thinning of the RNFL (Trip et al., 2005;Costello et al., 2006), optic 
nerve atrophy (Hickman et al., 2002a;Inglese et al., 2002) and reduced optic nerve 
MTR (Inglese et al., 2002) have been associated with a worse outcome, they are not 
evident until months or years after the event. Therefore, prognostication in patients 
with ON currently follows an expectant approach. This is a problem when counselling 
patients at the time of diagnosis, and also causes difficulties when selecting patients   180
for trials of experimental therapies, for example, neural stem cells (Kolappan et al., 
2008a). 
 
5.1.1.5 Aims  
 
The aims of this serial ON study were in part hypothesis-driven, based on previous 
reports implicating the lateral occipital complexes (LOCs), a ventral stream higher 
visual processing area, in neuroplasticity (Toosy et al., 2005). The primary hypothesis 
was that early LOC activation would be significantly associated with visual outcome, 
after accounting for markers of anterior and posterior visual pathway damage. The 
relative contributions of acute inflammation, myelination, and neuroaxonal loss in 
determining the visual outcome from ON were also investigated. It was possible to 
address these questions through a comprehensive structural and functional imaging 
protocol over time. Structural and diffusion MRI techniques assessed optic nerve and 
radiation involvement. VEP latency and amplitude reflected myelination and 
surviving axonal populations, respectively. OCT (Huang et al., 1991;Fercher et al., 
1993) assessed macular volume and RNFL thickness, reflecting loss of retinal 
ganglion cells and their axons, secondary to retrograde degeneration from pathology 
within the optic nerve (Quigley et al., 1977). Visual fMRI investigated 
neuroplasticity.  
 
5.1.2 Methods 
 
Many of the methodological details have been described previously in Chapter 4, and 
are not replicated here. Aspects of the methodology specific to the longitudinal studies 
described in this chapter are reported in depth in the following sections. 
 
5.1.2.1 Participants 
 
The longitudinal cohort of patients with acute, clinically isolated ON was the same as 
for the cross-sectional study, described in Chapter 4. Patients were invited for clinical 
assessment, VEPs, structural and functional MRI, on the same day, within a month 
from onset and three, six and 12 months later. In addition, at one year follow-up,   181
patients were invited for OCT imaging. A summary of the different techniques used, 
and the different perspectives they provided, is shown in Figure 5.1. 
Healthy age and sex matched controls were recruited at baseline, and were invited for 
follow-up MRI at each time-point, and one VEP and OCT assessment. All subjects 
gave written informed consent. The study was approved by the local Ethics 
Committee. 
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Figure 5.1 Techniques used to assess mechanisms of damage and recovery in ON in this 
study. (A) Coronal optic nerve MRI: post-gadolinium sequence shows right sided optic nerve 
enhancement. (B) T2-weighted sequence shows high signal in the right optic nerve. (C) Fluid 
attenuated inversion recovery (FLAIR) sequence shows right optic nerve swelling. (D) Axial 
T2-weighted fast spin echo (FSE) of the brain shows a lesion suggestive of demyelination in 
the left optic radiation. (E) DTI-based tractography allows reconstruction of the optic 
radiations. Parameters were extracted, such as fractional anisotropy (FA), which summarise 
the integrity of the tracts. (F) T1-weighted fast spoiled gradient echo (FSPGR) was used to 
assess pericalcarine cortical surface area, volume and thickness. This coronal slice shows the 
calcarine sulcus. (G) A follow-up optic nerve FLAIR from the 12 month time-point shows 
right optic nerve atrophy.  (H) Optical coherence tomography (OCT): an example of a retinal 
scan and the results, demonstrating a reduction in the thickness of the right retinal nerve fibre 
layer. (I) LogMAR chart for assessment of visual acuity. (J) Visual evoked potentials may 
detect conduction delay representing demyelination in the visual pathways. (K) FMRI scans 
demonstrating regions-of-interest in the lateral occipital complexes (LOCs) and primary visual 
cortex (V1). (L) A reduced fMRI response is seen on stimulating the affected eye, compared 
with the fellow eye. 
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5.1.2.2 Clinical assessment 
 
LogMAR scores were used to assess visual acuity. The testing methodology was 
identical to the description in Chapter 4. 
 
5.1.2.3 Electrophysiology 
 
Each patient had longitudinal VEP assessments, whilst each control had a single VEP 
study. Both whole field and central field VEPs were acquired. The whole field 
procedure was identical to that used in Chapter 4. VEPs were also recorded to 
interleaved (cyclic) stimulation of five different areas, comprising the central field and 
the four quadrants. The radius of the circular central field was 4
o at the eye. For the 
interleaved central field and each quadrant, the interval between reversals was 265ms, 
and three averages of 100 responses were obtained for each eye, after assessment of 
their consistency. The quadrant data was not used in the analyses described in this 
chapter, and will be reported in more detail in Chapter 6.  
 
5.1.2.4. Optical coherence tomography  
 
This examination was performed only at the 12 month time-point. OCT imaging was 
acquired with a Stratus OCT Model 3000 (Carl Zeiss MediTec, Dublin, Ca, USA). 
RNFL images were averaged from three 3.4mm diameter scans centred on the optic 
disc (Fast RNFL protocol). Macular thickness maps were calculated by taking six 
linear radial scans centred on the fovea (Fast macular thickness map scanning 
protocol). The OCT Model 3000 assesses signal strength and assigns a score. Images 
were only accepted if the score was >7/10, and the inter-eye difference was <2/10. 
This is in line with previous OCT studies (Henderson et al., 2008). All scans were 
performed by the same operator (Dr. Andrew Henderson). 
 
5.1.2.5 MRI acquisition and analysis 
 
Both the structural and functional MRI acquisition protocols were identical to those 
described in Chapter 4. During the fMRI protocol, the percentage of correct responses   184
to the fixation cross changing, averaged across time-points, was 88% for patients and 
97% for controls. This indicated generally good attention and fixation. 
 
5.1.2.6 Functional MRI analysis: regions-of-interest 
 
The whole field fMRI data acquired with the chromatic goggles was analysed using a 
region-of-interest approach. The regions were selected based on previous work 
(Toosy et al., 2005;Korsholm et al., 2007;Jenkins et al., 2008 and Chapter 4 of this 
thesis). Each region chosen represented a different area of the visual processing 
hierarchy. This was in order to determine the relative importance of changes at 
different levels of processing, how the regions interacted with one another, and how 
each was related to structural damage and clinical recovery. Regions were as follows: 
1) the primary visual cortex, 2) the LGN, 3) the LOCs, which represented the ventral 
stream of the higher visual processing areas, and 4) the cuneus, identified in Chapter 
4, which represented the dorsal stream of the higher visual processing areas. The 
primary visual cortex and cuneus comprised bilateral regions. For the LGN and 
LOCs, there was one region for each side of the brain, and the data was combined, as 
each side receives neural input from both eyes. The primary visual cortex region was 
specified utilising a normalised Brodmann area 17 mask, as described in section 4.1.2, 
since it was also used as a target for tractography. The LGN region was defined using 
two spherical seed regions, centred on the global maximal voxels, derived from the 
fMRI data, as reported in section 4.1.4, since they were used as seed-points for 
tractography. Essentially, the LGN clusters were identified at group level in SPM5, 
averaging checkerboard stimulation through the goggles, and also the two sessions of 
black and white checkerboard stimulation, for both affected and fellow eyes, from all 
patients and controls, at each time-point.  The LOCs were defined using two spherical 
regions-of-interest, each of 1cm
3 volume, centred on the coordinates reported from 
previous studies (+/-43, -70, -13) (Toosy et al., 2005). This methodology was used by 
previous investigators (Korsholm et al., 2007), and is an alternative to the use of a 
localiser task to identify the LOCs. Finally, the cuneus was selected on the basis of the 
results reported in Chapter 4. The identified cluster within the bilateral cuneus, 
comprising 580 voxels, with its global maximum at MNI -10 -84 32, significant at 
p<0.05 (corrected), was used to investigate longitudinal changes in the dorsal stream 
of higher visual processing.    185
Mean parameter estimates were extracted from each region-of-interest, from each 
subject, at each time-point, using the MarsBar SPM toolbox (Brett et al., 2002). The 
results reported are parameter estimate units, which reflect the magnitude of BOLD 
signal change. 
 
5.1.2.7 Statistical analysis 
 
All statistical analysis was performed using Stata-9.2 (StataCorp, Texas, USA), unless 
otherwise stated. The analysis proceeded in several stages, detailed below. P<0.05 
was chosen to represent statistical significance.  
 
5.1.2.7.1 Longitudinal analysis 
To explore longitudinal changes, mixed effects models were specified separately, for 
each variable, in patients and controls, and the resulting predicted means, using all 
available data, were reported at each time-point (Results: Table 5.4). In addition, for 
variables in which changes were significant, the median and inter-quartile ranges were 
reported for change between baseline and 12 months (section 5.1.3.3). This approach 
was used in preference to reporting rates of change, as some changes were non-linear.  
Unpaired t-tests were used to assess differences in VEP and OCT parameters between 
patients and a randomly selected control eye, at the 12 month time-point. Differences 
in the same parameters between patients’ affected and fellow eyes were assessed 
using paired t-tests.  
 
5.1.2.7.2 Associations between visual outcome and baseline (or 12 month) variables 
Visual outcome was defined as logMAR (affected eye) at 12 months. To identify 
baseline predictors of visual outcome, regression models were separately specified, 
entering baseline structural MRI, VEP and fMRI measures, and demographic 
parameters as independent variables, with logMAR acuity at 12 months as the 
dependent variable. The model was repeated, in turn, for each independent variable. 
The number of days from symptom onset to initial assessment and acuity in the fellow 
eye were included as covariates in the model, to allow for any inter-individual 
differences in the stage of evolution of pathology, and pre-morbid acuity. To identify 
variables measured at 12 months that were associated with visual outcome at 12   186
months, regression models were specified, with logMAR acuity at 12 months as the 
dependent variable, and the 12 month structural MRI, VEP, OCT and fMRI measures 
as independent variables. For the OCT data, fellow eye parameters were also added to 
the model, to adjust for normal inter-individual variability (Alamouti and Funk, 
2003). 
 
5.1.2.7.3 Relationship between baseline LOC responses and visual outcome 
As a result of significant associations between LOC activation and visual outcome 
(see Results) the two variables were plotted. A threshold of affected eye LOC fMRI 
response was visually determined that would dichotomise visual outcome into two 
groups of better relative outcome, and worse relative outcome, with high sensitivity 
and specificity.  
 
5.1.2.7.4 Inter-variable structure-function relationships and visual outcome 
The five significant variables found in the analysis described in 5.1.2.7.2 were 
investigated further. Two of these were affected and fellow eye LOC fMRI responses. 
The others were baseline acuity, age and 12 month macular volume. Multivariable 
regression models were specified, with logMAR at 12 months as the dependent 
variable as before, except now each of the other demographic, structural and 
functional variables was also added, in turn, to the model to assess its influence on the 
relationship between the variable of interest and logMAR at 12 months. This was 
performed for the dependent variables separately at baseline and 12 months. These 
analyses involved numerous statistical tests and raised the issue of multiple 
comparisons. Although there is no ideal method to address this for the family wise 
error rate (FWER), it was felt to be prudent to report p values both uncorrected and 
corrected for multiple comparisons (by variable), using the relatively conservative 
Holm procedure (Holm, 1979;Aickin and Gensler, 1996). For analyses of LOC 
activation, based on the a priori hypothesis of their neuroplasticity-related 
contribution to visual outcome, greater attention should be paid to the uncorrected p 
values (first two columns of Tables 5.7 and 5.8). 
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5.1.3 Results 
 
5.1.3.1 Patient characteristics 
 
The patients’ clinical and demographic data is presented in Table 5.1. Twenty eight 
patients and ten age and sex-matched controls were recruited at baseline. The median 
duration from symptom onset to baseline assessment was 22 days (range 7-34).  
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                                LogMAR   Patient    Age  
(years) 
Sex  Side 
Baseline  3 months  6 months  12 months 
1  38 F  R 0.4     
2  27 F  L   -0.02  -0.02  0.08  0.1 
3
a  24 F  L   1.7  0.5  0.4  0.32 
4  27 F  R 0.5 0.1  0  0.06 
5  20 M  L 0.4 0.4  0.06 0.22 
6  25 F  L 0.14 0.1  0  0.02 
7  39 F  L 0.06 -0.1  0.02  -0.1 
8  36 F  R 0  -0.06    -0.04 
9  33 F  L 0.12       
10  33 M  R 0.3 0.02     
11  32 F  L -0.06  -0.06 -0.04 -0.08 
12  44 F  L 0  -0.08  -0.06  0.02 
13  30 F  L 1.46 0.04 -0.04 0.02 
14  43 F  R 1.62       
15  38 M  R 0.02  -0.14 -0.06 0.04 
16  31 F  L 1 0.02  0  0 
17
b  33 M  L 1.7 1.26 0.34 0.28 
18  41 F  R 1.7 0.04 -0.1  -0.1 
19  42 F  R 0.22  0  0.02 -0.08 
20  30 F  R -0.06  -0.18 -0.06 -0.12 
21  34 F  R 1.6 0.18 0.22 0.22 
22  26 F  L 1.44  1  1.06  0.92 
23  34 F  L 0.42 0.1  0.08  0.02 
24  24 F  R 0.32  0  0.02  0.02 
25  23 F  R 0.66    0.28  0.22 
26  30 F  R 1.7 0.06  0  -0.06 
27  35 F  R 1.08 0.22 -0.04 0.02 
28  25 M  L 1.7 0.54 0.32 0.26 
Patients  Mean 32  5M 23F
Controls  Mean 30  2M  8F 
14R 14L 
 
0.72 (0.69)   0.16 (0.35)        0.11 (0.25)        0.09 (0.22) 
 
Table 5.1 Patient characteristics. The mean visual acuities of the patients are reported in the bottom 
row, with the standard deviations in brackets. 
aThis patient had a recurrence of mild ON in the fellow eye at three months (worst logMAR 0.3), from 
which she recovered well (logMAR -0.08 by the six month time-point), and was included in the 
analysis.  
bThis patient had coexistent bilateral keratoconus with best corrected acuity of 0.18, and was included 
in analyses which included fellow eye acuity as a covariate, but excluded when looking at predictors in 
which recovery was classified purely on the basis of affected eye logMAR, without entering the fellow 
eye as a covariate. 
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5.1.3.2 Patient adherence 
 
The number of patients and controls who attended each of the follow-up visits is 
reported in Table 5.2.  
 
  Baseline  3 months  6 months  12 months 
 
No. patients 
attending 
28 24 23 24
  
No. controls 
attending 
10 8  8  8 
Table 5.2 Longitudinal dataset. The number of participants who returned for follow-up at each time-
point. 
 
The reasons for the missing visits were as follows: three patients and two controls 
decided they did not want to continue in the study after the first visit and a further one 
patient after the second visit. One patient missed the three months visit due 
claustrophobia in the scanner, but decided subsequently to return. One patient missed 
the six months time-point due to pregnancy, but returned after delivery for her 12 
months assessment. 
With regard to the tests performed, all of the controls had all of the MRI scans at each 
time-point, and one VEP examination. Nine of the ten controls had one OCT 
examination; one control missed this test because she had moved away from the 
region. The tests that were performed in each patient, at each time-point, are 
summarised in Table 5.3.  
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  Baseline  3 months  6 months  12 months 
 
No. of optic 
nerve FSE 
acquired 
28 24 22 20
a 
No. of optic 
nerve Gad 
acquired 
26
b      
No. of optic 
nerve FLAIR 
acquired 
28 24 22 20 
No. of brain 
FSPGR 
acquired 
28 24 21
c 20 
No. of brain 
FSE acquired 
28 24 22 20 
No. of DTI OR 
acquired 
27
c 24  21
c 17
c 
No. of OCT 
acquired 
   18
d 
No. of VEP 
acquired 
28 24 23 21
c 
No. of fMRI 
acquired 
28
e 24  22  20
e 
No. of patients 
with a delay 
between tests 
of >2 days
f 
3 2 3 4 
Table 5.3 Tests performed in the patient group. DTI-diffusion tensor imaging, FLAIR-fluid attenuated 
inversion recovery, FSE-fast spin echo, FSPGR-fast spoiled gradient echo, Gad-gadolinium-enhanced 
MRI scan, OCT-optical coherence tomography, OR-optic radiations. 
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The explanations to the superscripts in Table 5.3 are as follows: 
a The reasons for the missing tests were the following: Five patients became pregnant 
during the study, three missing MRI at 12 months, one MRI at six and 12 months, and 
one all tests at six months. Four of these patients, who could not have MRI scans, did 
attend for clinical assessment, VEPs and OCT during pregnancy. 
b Two patients declined an intravenous injection. 
c Test unavailable, due to time constraints, technician availability, or technical failure. 
d OCT became available on-site during the course of the study. Patients in the study 
who had not yet reached the 12 month time-point were eligible for the OCT 
examination. 
e In one patient at baseline, and two patients at 12 months, a parameter estimate for 
LOC extraction was unobtainable, due to temporal signal dropout. For the analysis in 
which the clinical utility of baseline fMRI as a predictor of visual outcome was 
evaluated, data was available for 23/28 patients. This included one patient who had 
recovered well at three months and was then lost to follow-up. Visual outcome data 
was not available for the three patients who were lost to follow-up after baseline. In 
addition, a patient with coexistent keratoconus was excluded from this analysis (see 
also Table 5.1). 
f The patients had all the tests on the same day in 81% of time-points, and within two 
days in 88% of cases. In the remainder, the median delay was 10.5 days. At baseline, 
there were three delays of 5, 5 and 21 days, with the delayed tests being structural 
MRI, structural MRI and VEP, and fMRI, respectively. All analysis was repeated 
excluding the patient with a 21 day delay, and the results were materially unaffected. 
 
5.1.3.3 Longitudinal analysis 
 
These data are summarised in Table 5.4 and Figure 5.2. 
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PATIENTS    Baseline 
mean 
(95%CI) 
3 months 
mean 
(95%CI) 
6 months 
mean 
(95%CI) 
12months 
mean 
(95%CI) 
Change 
from 
baseline to 
12 months  
(p value) 
OPTIC 
NERVE 
FSE lesion 
length (mm)
a 
22.07 
(18.35-
25.79) 
24.82 
(20.98-
28.66) 
29.82 
(25.92-
33.72) 
31.26 
(27.28-
35.23) 
<0.001 
  Gad lesion 
length (mm) 
23.54        
  Area ratio 
(Affected: 
Fellow) 
1.19 
(1.13-
1.24) 
1.01 
(0.94-
1.07) 
1.00 
(0.93-
1.06) 
0.89 
(0.82- 
 0.95) 
<0.001 
OPTIC 
RADIATIONS 
Lesion load 
(mm
2) 
63 
(3-123) 
85 
(25-146) 
102 
(41-162) 
118 
(57-179) 
<0.001  
  FA
b 0.36 
(0.34-
0.37) 
0.36 
(0.34-
0.37) 
0.35 
(0.34-
0.37) 
0.36 
(0.34- 
0.38) 
  0.693 
OCCIPITAL 
CORTEX 
Pericalcarine 
surface area 
(mm
2) 
1212 
(1123-
1301) 
1215 
(1124-
1307) 
1196 
(1103-
1289) 
1218 
(1124-
1312) 
  0.836 
  Pericalcarine 
volume (mm
3) 
1808 
(1666-
1950) 
1824 
(1679-
1969) 
1764 
(1616-
1911) 
1798 
(1650-
1946) 
  0.830 
   
  Pericalcarine 
cortical 
thickness(mm) 
1.61 
(1.57-
1.66) 
1.61 
(1.56-
1.66) 
1.60 
(1.55-
1.65) 
1.60  
(1.55- 
1.65) 
  0.441 
WHOLE 
BRAIN  
Grey matter 
fraction 
0.44 
(0.43-
0.45) 
0.44 
(0.42-
0.45) 
0.44 
(0.42-
0.45) 
0.44 
(0.43- 
0.45) 
  0.461 
VISUAL 
EVOKED 
POTENTIALS 
Whole field 
amplitude 
(μV) 
5.30 
(3.97-
6.64) 
6.57 
(5.17-
7.98) 
6.67 
(5.24-
8.09) 
7.14  
(5.68- 
8.61) 
  0.008 
 Central 
latency (ms)
c 
123  
(115-
131) 
123  
(115- 
131) 
119  
(111- 
127) 
114  
(106- 
122) 
  0.020 
CONTROLS 
OPTIC NERVE  Area ratio  1.03 
(0.98-
1.07) 
1.00 
(0.95-
1.05) 
1.01 
(0.96-
1.06) 
0.97  
(0.92- 
1.03) 
  0.091 
OPTIC 
RADIATION 
FA 0.36 
(0.34-
0.38) 
0.37 
(0.35-
0.39) 
0.37 
(0.35-
0.40) 
0.38  
(0.36- 
0.41) 
  0.072 
OCCIPITAL 
CORTEX 
Pericalcarine 
surface area 
(mm
2) 
1390 
(1241-
1538) 
1342 
(1185-
1500) 
1376 
(1218-
1533) 
1391 
(1233-
1548) 
  0.989 
  Pericalcarine 
volume (mm
3) 
2116 
(1827-
2405) 
2066 
(1771-
2362) 
2148 
(1853-
2444) 
2062 
(1767-
2358) 
  0.447 
  Pericalcarine 
cortical 
thickness(mm) 
1.63 
(1.56-
1.70) 
1.64 
(1.56-
1.72) 
1.69 
(1.61-
1.77) 
1.60  
(1.52- 
1.68) 
  0.523 
WHOLE 
BRAIN 
Grey matter 
fraction 
0.45 
(0.43-
0.46) 
0.45 
(0.43-
0.46) 
0.44 
(0.42-
0.46) 
0.45 
(0.44- 
0.47) 
  0.393 
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Table 5.4 (on the previous page). Longitudinal changes in structural and electrophysiological measures 
in patients and controls. Significant changes are highlighted in bold font. CI-confidence interval, FA-
fractional anisotropy, FSE-fast spin echo, Gad-gadolinium-enhanced MRI, LGN-lateral geniculate 
nuclei, LOC-lateral occipital complex, NS-non-significant, V1-primary visual cortex. Note that the 
reported pericalcarine cortical surface area and volume estimates are averaged for each hemisphere. 
 
 
 
 
 
 
 
Figure 5.2 Graphs showing longitudinal changes in clinical, electrophysiological and MRI parameters: 
(A) visual acuity, (B) optic radiation lesion load, (C) optic nerve cross-sectional area, (D) optic nerve 
lesion length, (E) VEP amplitude and (F) VEP latency. Significant changes from baseline are indicated 
by the associated p-value. The bars show standard errors. Higher logMAR scores indicate worse acuity. 
 
Over the year, patients’ vision improved by a median of 0.42 logMAR units (inter-
quartile range (IQR) 0.11, 1.38). Seventy four percent of patients recovered acuity to 
logMAR<0.2 (better than Snellen equivalent 6/10). Optic nerve lesion length   194
increased by 9mm over the year (IQR 6, 13), and optic nerve area ratio decreased by 
25% (IQR 10%, 38%). The median increase in optic radiation lesion load was 15mm
2 
(IQR 0, 78). VEP amplitude improved by 2.63µV (IQR -0.49, 4.44) and VEP latency 
reduced by 11.7ms (IQR 5.6, 20.2). For some variables, the rates of change varied 
over time (Table 5.4, Figure 5.2) 
In controls, there were no significant changes over time in the variables examined.  
 
Longitudinal changes in fMRI responses in patients are plotted in Figure 5.3. In lower 
visual areas (LGN and primary visual cortex), affected eye responses showed the 
greatest increase over the first three months, and the observed decreases in fellow eye 
responses did not reach statistical significance. In contrast, in higher visual areas 
(LOCs and cuneus), responses were more complex and decreases in fellow eye 
activation were evident over time. These included significant decreases in the fellow 
eye responses in the LOCs. There were no changes in controls between baseline and 
12 months. 
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Figure 5.3 Graphs showing longitudinal changes in fMRI activity, on stimulation of the affected and 
fellow eyes, in the four regions-of-interest implicated in neuroplastic responses by previous studies: (A) 
primary visual cortex, (B) LGN, (C) LOCs and (D) cuneus. Affected eye responses are plotted in green 
and fellow eye responses in blue. Significant changes from baseline are indicated by the associated p-
value. The bars show standard errors. BOLD-blood oxygenation level dependent. 
 
At 12 months, macular volume and RNFL thickness were reduced and VEP latency 
was prolonged in the patients’ affected eyes, compared to controls (Table 5.5). There 
were no significant differences in fellow eye parameters between patients and 
controls. 
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Patients vs controls t-tests 
 
  Patients: 
affected 
eye 
Patients: 
fellow 
eye 
Controls 
Affected 
eye 
Fellow 
eye 
Macular 
volume 
(mm
3) 
6.01  6.62  6.82 p=0.001  0.085 
RNFL (μm)  79  100  106 p<0.001  0.167 
VEP 
amplitude 
(μV) 
7.2  9.4  9.5 p=0.054  0.930 
VEP latency 
(ms) 
112  96 97  p=0.020  0.826 
Table 5.5 Residual damage at 12 months. Results of OCT and VEP at 12 months are reported for 
patients’ affected and fellow eyes, and controls. The p values are derived from two-sample unpaired t-
tests. Significant differences between patients and controls are highlighted in bold font. NS-non-
significant, RNFL-retinal nerve fibre layer. 
 
The macular volume in the patients’ affected eye was reduced by 9%, compared with 
the fellow eye, and 12% compared with controls  
The RNFL thickness in patients’ affected eye was reduced by 21%, compared with 
the fellow eye, and 27% compared with controls. 
 
5.1.3.4 Associations between visual outcome and baseline (or 12 month) variables 
 
The strongest baseline predictor was fMRI response in the LOCs, on stimulating the 
affected eye (Table 5.6, Figure 5.4); greater fMRI activity was associated with better 
logMAR acuity at 12 months (p=0.007). There was also an association in the same 
region between fMRI response and visual outcome, when the fellow eye was 
stimulated (p=0.020). No acute structural measures were significantly associated with 
visual outcome. There was an association with the initial severity of visual loss and a 
weak influence of age, with older patients tending to have better acuities at 12 
months. At 12 months, the only significant result was a weak association between 
smaller macular volume and worse outcome (Table 5.6). An increase in macular   197
volume of 1mm
3 corresponded to an improvement in logMAR acuity of 0.33 
(approximately three lines on the chart). 
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Association between variable and 
visual outcome at 12 months 
BASELINE 
VARIABLES 
12 MONTHS 
VARIABLES 
  Patient variable 
r  p  r  p 
RETINA Macular  volume  -  -  -0.52  0.045 
  RNFL  -  - -0.10  0.734 
OPTIC NERVE  FSE lesion length   0.03  0.910  -0.17  0.505 
 Gad  lesion 
length 
 0.27  0.229   -  - 
  Optic nerve area   -0.08  0.740   0.03  0.898 
OPTIC RADIATIONS  Lesion load   0.09  0.696  -0.05  0.853 
 FA  -0.06  0.789    0.03  0.915 
OCCIPITAL CORTEX  Pericalcarine surface 
area 
-0.11 0.479 -0.10 0.703 
 Pericalcarine  volume  -0.02  0.834  -0.12  0.627 
 Pericalcarine  cortical 
thickness 
 0.39 0.074   0.02  0.941 
VEP Amplitude  -0.41 0.056 -0.13 0.575 
 Latency    0.31  0.267  -0.13  0.592 
fMRI  Affected V1  -0.40 0.067  0.09  0.714 
  Affected LGN  -0.23  0.298  -0.06  0.826 
 Affected  LOC  -0.57 
 
0.007   0.02  0.943 
  Affected cuneus   0.07  0.240   0.24  0.336 
  Fellow V1   0.11  0.615   0.20  0.415 
  Fellow LGN   0.08  0.725   0.06  0.818 
 Fellow  LOC  -0.51 
 
0.020  -0.12 0.646 
  Fellow cuneus   0.07  0.756   0.23  0.357 
SEVERITY OF 
BASELINE VISUAL 
LOSS 
Baseline visual acuity    0.52 
 
0.014  - - 
DEMOGRAPHIC Age  -0.43  0.040  - - 
  Gender -0.10  0.653  -  - 
  Side of ON  -0.30  0.163  -  - 
Table 5.6 Associations between structural, electrophysiological, functional and demographic variables, 
and visual outcome (logMAR acuity at 12 months). Partial correlation coefficients are reported, 
together with the associated p-value. Significant associations are highlighted in bold and borderline 
results in italics. FA-fractional anisotropy, FSE-fast spin echo, Gad-gadolinium-enhanced MRI scan, 
LGN-lateral geniculate nuclei, LOC-lateral occipital complexes, NS-non-significant, RNFL-retinal 
nerve fibre layer, V1-primary visual cortex. 
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Figure 5.4 Scatter-plots of affected eye acuity at 12 months against baseline LOC fMRI response on 
(A) affected and (B) fellow eye stimulation. Higher logMAR scores indicate worse acuity. BOLD-
blood oxygenation level dependent, LOC-lateral occipital complexes. 
 
5.1.3.5 Relationship between baseline LOC responses and visual outcome 
 
Figure 5.4 demonstrates increasing baseline LOC responses associated with better 
visual outcome. Visual recovery could be divided into a better relative outcome group 
(logMAR<0.2, Snellen better than 6/10), or a worse relative outcome group, on the 
basis of thresholding the baseline LOC activation. Baseline LOC fMRI responses 
were positive in the better relative outcome recovery group (mean parameter estimate 
0.57 [95%CI 0.16, 0.98]), and negative in the worse relative outcome group (mean -
0.59 [95%CI -1.1, -0.023], t=3.28, p=0.004). For an individual patient, a negative 
baseline LOC response was associated with a logMAR acuity of 0.2 or worse (Snellen 
>6/10), a year after ON with a sensitivity of 83% (95%CI 36%, 100%), specificity of 
88% (95%CI 64%, 99%) and accuracy of 87% (95%CI 66%, 97%). Seventeen 
patients were in the group with relatively better outcome, whereas six were in the   200
other group. Visual outcome or fMRI data was unavailable for a further five patients 
(see section 5.1.3.2 for details).  
 
5.1.3.6 Inter-variable structure-function relationships and visual outcome 
 
There were complex interactions between the identified variables of interest and the 
other structural and functional variables, representing pathology in the acute phase 
(Table 5.7), and residual damage at 12 months (Table 5.8). However, the association 
between baseline affected eye fMRI response in the LOCs and visual outcome was 
independent of any demographic, structural or electrophysiological factors, from 
either the baseline or 12 month time-points. The relationship between baseline fellow 
eye fMRI response in the LOCs and visual outcome also generally maintained 
significance, although not as consistently as the affected eye LOC response.  
Neither baseline visual acuity nor age was statistically significant in the models that 
adjusted for affected eye fMRI response in the LOCs, nor the models that adjusted for 
fellow eye responses in the LOCs. The relationship between macular volume at 12 
months and visual outcome lost significance following adjustment for several of the 
other variables, notably baseline acuity and age. 
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VARIABLE OF INTEREST 
  fMRI affected 
LOC BL 
regression 
coefficient 
(p value) 
fMRI fellow 
LOC BL 
regression 
coefficient  
(p value) 
BL acuity  
regression 
coefficient 
(p value) 
Age 
regression 
coefficient  
(p value) 
OPTIC NERVE 
             FSE lesion length 
-0.13 (0.008) 
[0.088]
-0.10 (0.022) 
[0.198]
0.19(0.005) 
[0.010] 
-0.01 (0.046) 
[0.644]
             Gad lesion length  -0.11 (0.037) 
[0.148]
-0.09 (0.042)  
[0.252]
0.13(0.056) 
[0.280] 
-0.02 (0.032) 
[0.544]
             Cross-sectional area  -0.13 (0.006) 
[0.075] 
-0.10 (0.020) 
[0.220] 
0.17(0.005) 
[0.010] 
-0.01 (0.081) 
[0.162] 
OPTIC RADIATIONS 
             Lesion load 
-0.13 (0.009) 
[0.086] 
-0.09 (0.017) 
[0.204] 
0.14(0.015) 
[0.233] 
-0.01 (0.046) 
[0.644] 
             Mean FA  -0.12 (0.026) 
[0.156] 
-0.09 (0.039) 
[0.273] 
0.14(0.027) 
[0.311] 
-0.01 (0.071) 
[0.213] 
OCCIPITAL CORTEX 
             Pericalcarine surf. area 
-0.13 (0.010) 
[0.080] 
-0.08 (0.021) 
[0.210] 
0.14(0.042) 
[0.315] 
-0.01 (0.019) 
[0.380] 
             Pericalcarine volume  -0.14 (0.006) 
[0.075]
-0.11 (0.013) 
[0.169]
0.14(0.042) 
[0.315] 
-0.01 (0.016) 
[0.336]
             Pericalcarine thickness  -0.13 (0.002) 
[0.028] 
-0.08 (0.043) 
[0.215] 
0.12(0.036) 
[0.324] 
-0.10 (0.059) 
[0.472] 
VEP     Amplitude  -0.10 (0.046) 
[0.092] 
-0.07 (0.184) 
[0.184] 
0.13(0.140) 
[0.140] 
-0.01 (0.027) 
[0.704] 
             Latency  -0.06 (0.043) 
[0.129] 
-0.06 (0.061) 
[0.183] 
0.14(0.050) 
[0.300] 
-0.01 (0.044) 
[0.704] 
FMRI  Affected V1  -  -  0.12(0.098) 
[0.294] 
-0.01 (0.026) 
[0.494] 
             Affected LGN  - - 0.13(0.027) 
[0.311] 
-0.01 (0.056) 
[0.504] 
             Affected LOC  -  - 0.09(0.131) 
[0.262] 
-0.01 (0.209) 
[0.209] 
             Affected cuneus  - - 0.13(0.031) 
[0.310] 
-0.01 (0.062) 
[0.062] 
             Fellow V1  - - 0.16(0.006) 
[0.108] 
-0.01 (0.064) 
[0.320] 
             Fellow LGN  - - 0.14(0.015) 
[0.233] 
-0.01 (0.046) 
[0.644] 
             Fellow LOC  -  -  0.11(0.097) 
[0.388] 
-0.01 (0.050) 
[0.525] 
             Fellow cuneus  - - 0.18(0.004) 
[0.084] 
-0.01 (0.050) 
[0.525] 
BASELINE ACUITY  -0.09 (0.079) 
[0.079] 
-0.06 (0.181)  
[0.362] 
-  -0.01 (0.060) 
[0.420] 
DEMOGRAPHIC  
             Age 
-0.10 (0.036) 
[0.180] 
-0.08 (0.052) 
[0.208] 
0.12(0.019) 
[0.247] 
- 
             Gender  -0.12 (0.009) 
[0.086] 
-0.12 (0.008) 
[0.112] 
0.14(0.018) 
[0.252] 
-0.01 (0.049) 
[0.588] 
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             Side of ON  -0.12 (0.021) 
[0.147]
-0.09 (0.038) 
[0.304]
0.14(0.013) 
[0.221] 
-0.01 (0.068) 
[0.272]  202
Table 5.7 (on the previous page) Structure-function interactions during the acute episode: results of 
multivariable regression modeling. The variables of interest associated with visual outcome (logMAR 
at 12 months) are listed in the columns. All baseline variables are listed in the rows. The regression 
coefficients are reported, together with the associated p values in parentheses, representing the 
significance of the association between the variable of interest with visual outcome at 12 months, after 
adjusting for the interaction variable in that row. P values uncorrected for multiple comparisons are 
reported in curved brackets, and following a Holm correction in square brackets. Significant results are 
highlighted in bold, and trends in italics. BL-baseline, FA-fractional anisotropy, Gad-gadolinium-
enhanced MRI, LGN-lateral geniculate nuclei, LOC-lateral occipital complexes, V1-primary visual 
cortex. 
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VARIABLE OF INTEREST 
  fMRI 
affected 
LOC BL 
regression 
cooefficient 
(p value) 
fMRI fellow 
LOC BL 
regression 
coefficient 
(p value) 
BL acuity 
regression 
coefficent 
(p value) 
Age 
regression 
coefficent 
(p value) 
Macular 
volume 
12M 
regression 
coefficent 
(p value) 
RETINA     
Macular volume 
-0.14(0.039) 
[0.098] 
-0.11(0.028) 
[0.182] 
0.16(0.222) 
[0.396] 
-0.01(0.342) 
[0.342] 
- 
RNFL thickness  -0.16(0.016) 
[0.144] 
-0.10(0.090) 
[0.090] 
0.19(0.068) 
[1] 
-0.02(0.234) 
[0.468] 
- 
OPTIC NERVE 
FSE lesion length 
-0.12(0.030) 
[0.150] 
-0.13(0.007) 
[0.077] 
0.15(0.047) 
[0.799] 
-0.01(0.089) 
[0.801] 
-0.85(0.001) 
[0.022] 
Cross-sectional area  -0.10(0.046) 
[0.046] 
-0.10(0.026) 
[0.208] 
0.12(0.087) 
[1] 
-0.01(0.119) 
[0.595] 
-0.59(0.029) 
[0.551] 
OPTIC  
RADIATIONS 
Lesion load 
-0.11(0.039) 
[0.098] 
-0.11(0.021) 
[0.210] 
0.11(0.105) 
[0.840] 
-0.01(0.079) 
[0.830] 
-0.45(0.074) 
[0.814] 
Mean FA  -0.13(0.032) 
[0.128] 
-0.12(0.030) 
[0.150] 
0.11(0.174) 
[0.696] 
-0.02(0.114) 
[0.684] 
-0.46(0.086) 
[0.344] 
OCCIPITAL  
CORTEX 
Pericalcarine surf. 
area         
-0.12(0.025) 
[0.175] 
-0.10(0.031) 
[0.124] 
0.13(0.045) 
[0.968] 
-0.01(0.062) 
[0.992] 
-0.34(0.088) 
[0.675] 
Pericalcarine 
volume 
-0.12(0.020) 
[0.160] 
-0.10(0.028) 
[0.182] 
0.14(0.034) 
[1] 
-0.02(0.049) 
[0.882] 
-0.34(0.086) 
[0.578] 
Pericalcarine 
thickness       
-0.10(0.028) 
[0.168] 
-0.09(0.022) 
[0.198] 
0.10(0.102) 
[0.918] 
-0.02(0.077) 
[0.924] 
-0.45(0.083) 
[0.457] 
VEP Amplitude  -0.16(0.007) 
[0.070]  
-0.11(0.049) 
[0.098] 
0.16(0.022) 
[0.396] 
-0.02(0.011) 
[0.209] 
-0.37(0.041) 
[0.656] 
Latency  -0.18(0.003) 
[0.033] 
-0.11(0.040) 
[0.120] 
0.18(0.007) 
[0.133] 
-0.02(0.071) 
[0.994] 
-0.38(0.031) 
[0.558] 
FMRI Affected V1 
 
- -  0.11(0.144) 
[0.936] 
-0.02(0.063) 
[0.945] 
-0.43(0.090) 
[0.270] 
Affected LGN  -  -  0.09(0.186) 
[0.558] 
-0.01(0.097) 
[0.776] 
-0.42(0.076) 
[0.646] 
Affected LOC  -  -  0.13(0.144) 
[0.936] 
-0.01(0.143) 
[0.572] 
-0.47(0.076) 
[0.646] 
Affected cuneus  -  -  0.12(0.080) 
[1] 
-0.01(0.111) 
[0.777] 
-0.44(0.083) 
[0.457] 
Fellow V1  -  -  0.08(0.295) 
[0.295] 
-0.01(0.079) 
[0.830] 
-0.56(0.046) 
[0.644] 
Fellow LGN  -  -  0.12(0.098) 
[0.980] 
-0.01(0.076) 
[0.988] 
-0.45(0.075) 
[0.750] 
Fellow LOC  -  -  0.10(0.164) 
[0.820] 
-0.01(0.159) 
[0.477] 
-0.49(0.082) 
[0.574] 
Fellow cuneus  -  -  0.13(0.070) 
[1]
-0.01(0.059) 
[1] 
-0.31(0.065) 
[0.780]
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BASELINE 
ACUITY 
- -  -  - -0.29(0.152) 
[0.152]   204
DEMOGRAPHIC 
Age 
- -  -  - -0.29(0.109) 
[0.218] 
Gender -  -  -  -  -0.33(0.055) 
[0.715] 
Side of ON  -  -  -  -  -0.35(0.028) 
[0.574] 
Table 5.8 Structure-function interactions with residual damage at 12 months: results of multivariable 
regression modeling. The variables of interest associated with visual outcome (logMAR at 12 months) 
are listed in the columns. All 12 month variables are listed in the rows. The regression coefficients are 
reported, together with the associated p values in parentheses, representing the significance of the 
association between the variable of interest with visual outcome at 12 months, after adjusting for the 
interaction variable in that row. P values uncorrected for multiple comparisons are reported in curved 
brackets, and following a Holm correction in square brackets. Significant results are highlighted in 
bold, and trends in italics. BL-baseline, FA-fractional anisotropy, LGN-lateral geniculate nuclei, LOC-
lateral occipital complexes, RNFL-retinal nerve fibre layer, V1-primary visual cortex, 12M-12 months. 
 
5.1.3.7 Effect of outlier 
 
Patient 22 had significantly worse residual visual dysfunction than the rest of the 
group (Table 5.1, Figure 5.4). The analyses were repeated without this subject, and all 
associations remained significant, except for macular volume. 
 
5.1.4 Discussion 
 
The most important finding from this study is the direct association between acute 
fMRI responses in the LOCs and visual outcome (logMAR acuity at 12 months), 
evident on stimulation of either eye. Visual outcome was also associated with the 
severity of acute visual loss, and 12 month macular volume, but not with any other 
markers of neuroaxonal loss in the optic nerve, demyelination, or damage to the 
posterior pathways. These data suggest that early adaptive neuroplasticity in the LOCs 
is an important determinant of visual recovery in clinically isolated ON, independent 
of measures of tissue damage.  
 
5.1.4.1 Longitudinal analysis 
 
The changes in clinical, structural and electrophysiological variables are consistent 
with the known pathophysiology of ON (Smith and McDonald, 1999). Acutely,   205
oedema, inflammation, demyelination and conduction block were evident and, as they 
resolved, vision improved. This is consistent with previous MRI and 
electrophysiological studies (Hickman et al., 2004a;Youl et al., 1991;Kupersmith et 
al., 2002;Hickman et al., 2004c;Frederiksen and Petrera, 1999;Jones, 1993;Brusa et 
al., 2001). Despite clinical recovery, there was evidence of ongoing tissue damage, 
such as progressive lengthening of the optic nerve lesion, which may represent 
secondary tract degeneration (Kapoor et al., 1998;Hickman et al., 2004c). At 12 
months, VEP latencies demonstrated persistent demyelination, despite evidence for 
remyelination between six and 12 months, which has been seen previously, both at 
this time (Brusa et al., 1999) and earlier, between three and six months after the acute 
episode (Brusa et al., 2001). Neuroaxonal loss in the optic nerve was evident from a 
reduction in macular volume and RNFL thickness, in line with previous studies (Trip 
et al., 2005;Costello et al., 2006;Klistorner et al., 2008a), and from optic nerve 
atrophy, which is well recognised following ON (Hickman et al., 2001;Inglese et al., 
2002;Hickman et al., 2004a).  
FMRI responses in lower visual areas improved over the first three months, in parallel 
with vision, and consistent with an increased afferent input, as noted in previous 
longitudinal fMRI studies (Toosy et al., 2005;Korsholm et al., 2007). Responses in 
higher visual areas were more complex, with dynamic changes evident on fellow eye 
stimulation over time, and have not been reported previously. 
 
5.1.4.2 Associations between visual outcome and baseline (or 12 month) variables 
 
The strongest predictor of visual outcome was fMRI response in the LOCs, and this 
was evident on stimulation of either eye. The LOCs are higher order visual areas, 
located within the ventral processing stream, involved in identification and 
recognition of objects in the physical world (Eger et al., 2008). They have previously 
been identified as potentially important areas for neuroplasticity in ON (Toosy et al., 
2005). Toosy et al used an indirect methodology, in a longitudinal cohort, to correlate 
the residual variance in clinical function with the fMRI response, in voxels throughout 
the whole brain, after accounting for acute optic nerve inflammation. The LOCs 
correlated with the residual variance in clinical function only at the baseline time-
point.    206
A later cross-sectional study by Levin et al applied retinotopic mapping, and a 
specific LOC-localiser task, to a group of patients at differing stages of recovery, from 
weeks to years after acute ON. The aim was to clarify where in the visual hierarchy 
changes occurred. This study found that affected eye responses were smaller than 
fellow eye responses in lower visual areas but, in the lateral and inferior occipital gyri 
of the LOCs, responses were actually higher in the affected eye. All of their patients 
had made a good visual recovery, and no correlations with acuity were reported. They 
concluded that their results could be supportive of adaptive plasticity, and that higher 
visual areas might be robust to disruption of visual input. 
A subsequent longitudinal fMRI study by Korsholm et al used a region-of-interest 
approach, similar to the one applied in this study. V1 and V2 were identified using 
cytoarchitectonic templates, and the LOCs were specified using spheres centred on 
their published landmarks. A different method was used to define the LGN. They 
were identified using anatomical landmarks on T1-weighted scans, and the functional 
data were extracted from manually drawn regions. The authors reported that in the 
acute stage, LOC responses in the affected eye were reduced compared with the 
fellow eye. Over time, this difference declined, following the pattern of V1 and V2. 
They reported no evidence for plasticity in the LOCs and, instead, found that in LGN 
the decrease in the difference between the two eyes was due not only to an increasing 
fMRI response from the affected eye, but also to a decreasing response from the 
fellow eye, which was evident between 120-180 days after the acute episode. In 
contrast to Levin et al, they concluded that fMRI activity in higher visual areas 
followed the same pattern as lower areas, in response to a reduced visual input. These 
findings are supported by the results of the present study, with regard to the LOCs, but 
a different pattern was evident in the cuneus, in which affected eye responses were not 
directly associated with vision. In addition, Korsholm et al hypothesised that plasticity 
might occur within the LGN themselves, although also considered the possibility that 
the changes were secondary to back-projection from cortical regions.  
It appears from the present study that the LOCs play a critical role in neuroplastic 
responses to ON, and are not robust to disruption of afferent input. This study adds to 
our current knowledge, by demonstrating that reorganisation in this area appears to 
contribute directly towards a better visual outcome, independent of measures of tissue 
damage. The present study is the first to investigate neuroplasticity in the context of 
these complicating structure-function interactions, involving both the anterior and   207
posterior pathways, and the first to take into account both acute inflammation and 
residual tissue injury. 
A reduction in macular volume (demonstrated by OCT at 12 months) is most likely to 
represent loss of retinal ganglion cells, secondary to axonal damage in the optic nerve 
(Quigley et al., 1977) (although macular volume loss is not layer-specific), and 
supports a role for the extent of neuroaxonal loss in determining clinical outcome. 
However, this study did not confirm the previously reported association between 
RNFL thickness and visual loss (Trip et al., 2005;Costello et al., 2006;Klistorner et 
al., 2008a). This may be because of differences in the study cohorts; all of the patients 
in the present study had clinically isolated ON, unselected for visual function. 
Alternatively, the lack of association could reflect type II error. There was also no 
association between optic nerve atrophy on MRI and visual outcome, and previous 
studies have reported either modest correlations between visual outcome and tissue 
loss in the optic nerve (Hickman et al., 2002a;Inglese et al., 2002), or none (Hickman 
et al., 2004a). Of the hypotheses postulated to explain this dissociation between tissue 
loss in the optic nerve and clinical function, there was no evidence for an impact of 
damage within the posterior pathways. The restricted clinical impact despite macular 
volume loss may represent a degree of neuroaxonal redundancy, but the relatively 
strong fMRI associations suggest that acute grey matter plastic changes appear to 
exert a greater influence. 
Increasing age was also associated with a better visual outcome. This finding is 
somewhat surprising as, in general, increasing age is associated with a worse 
prognosis, for example, in studies of MS (Weinshenker et al., 1991;Confavreux and 
Vukusic, 2006;Debouverie et al., 2008). In MS, the worse prognosis appears to be 
due, in part, to a higher prevalence of secondary progression. In the ONTT, increasing 
age was associated with slightly worse vision, although the magnitude of the 
association was small and not thought to be clinically important; patients between the 
ages of 18 to 35 could read an average of two more letters on the 6/6 acuity line, 
compared with patients aged between 35 and 45 years (Beck et al., 1994). The reasons 
that age was associated with a better prognosis in the present study are not clear, 
although one could speculate that a late presentation might represent a more benign 
form of demyelination, which had previously remained quiescent, in this cohort 
sampled at a time when the disease was clinically isolated.  
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5.1.4.3 Relationship between baseline LOC responses and visual outcome 
 
A negative affected eye fMRI response in the LOCs appears to be associated with a 
worse relative outcome, whilst a positive response is associated with a better relative 
outcome. This threshold effect suggests a genuine physiological role for 
compensatory plasticity in this cohort. A positive fMRI response may represent 
synaptic reorganisation or dendritic arborisation contributing to recovery. Conversely, 
negative responses may indicate a failure of neuroplastic mechanisms, resulting in a 
persistent visual deficit. In this context, fMRI deactivation might even reflect 
maladaptive change, and this merits further study. Acutely, a negative fMRI response 
in the LOCs appears to help identify individuals with a relatively worse visual 
prognosis, and the results reported for sensitivity, specificity and accuracy are 
promising from a clinical perspective, although the confidence intervals are wide, and 
the degree of dysfunction in the group with relatively worse visual dysfunction was 
variable. Further studies in larger groups of patients are required to determine whether 
these results are generalisable. 
 
It is interesting that the association between visual outcome and fMRI response in the 
LOCs was evident on stimulation of either eye. Abnormal fellow eye responses have 
been reported previously, although their role in recovery was unclear. Toosy et al 
found that acute fMRI responses to fellow eye stimulation correlated with acute vision 
in the affected eye (Toosy et al., 2005). The findings of this study extend these results, 
by associating fellow eye responses with visual recovery. This might be explained 
through a mechanism of subclinical pathology in the fellow optic nerve. However, 
there was little evidence of this from the present study, as only one subject in this 
cohort had an asymptomatic optic nerve lesion, and there were no differences from 
controls in the other structural and electrophysiological measures. Therefore, these 
findings suggest that cortical fMRI responses are remodulated holistically, in response 
to pathological insult, and are detectable on visual stimulation, independent of neural 
conduction through the region of damage. This might indicate that stimulation of 
damaged axons is not necessary to trigger neuroplastic reorganisation. These 
observations may also be of practical use in future studies of plasticity in patients with 
severe visual loss, when it may be difficult to detect any fMRI response from the 
affected eye, due to acute conduction block.    209
After the acute episode, fMRI responses within the LOCs, in either the affected or 
fellow eye, were no longer associated with visual outcome, suggesting that the acute 
phase is critical in terms of brain reorganisation (Johansen-Berg, 2007). 
 
5.1.4.4 Inter-variable structure-function relationships and visual outcome 
 
The relationship between affected eye (and, to some degree, fellow eye) fMRI activity 
in the LOCs and visual outcome remained independent of measures of acute 
inflammation, residual demyelination and neuroaxonal loss. The severity of acute 
visual loss was associated with subsequent recovery, and some of the variance in 
visual outcome attributable to fMRI responses in the LOCs was also explained by this 
variable, although fMRI response remained a stronger predictor. This collinearity was 
not surprising, as a two-way relationship exists between visual acuity and fMRI 
response; on one hand a reduction in neuronal input results in a smaller fMRI 
response whilst, on the other hand, plastic reorganisation may influence acuity. 
However, the association between baseline fMRI response in the LOCs and visual 
recovery cannot be explained solely through a mechanism of severity of acute visual 
loss. This alternative mechanism should operate via the primary visual areas and when 
the affected eye is stimulated. However, firstly, affected eye LOC activity was a 
stronger predictor than the primary visual areas which were non-significant (Table 
5.6). Secondly, it would be difficult to physiologically explain the significant 
associations between baseline fellow eye LOC activity and 12 month visual outcome 
purely on the basis of reduced visual acuity (resulting from stimulation of the affected 
eye only) at baseline. Thirdly, LOC fMRI activity generally maintained greater levels 
of significance, even after incorporating other interaction variables (for baseline and 
12 months) into the model (Tables 5.7 and 5.8), whilst baseline acuity did not, 
implying a more critical role for LOC activity in predicting visual outcome. These 
results still imply, however, that higher visual areas, such as the LOCs, are not robust 
to disruption of visual input, a point which has been debated following contrasting 
results from two previous studies (Levin et al., 2006;Korsholm et al., 2007). 
The relationships between visual outcome, baseline acuity, age and 12 month macular 
volume were more complex, and structure-function interactions were evident. 
Two potential sources of error were investigated post-hoc. Firstly, it was determined 
whether the baseline fMRI responses in the LOCs were influenced by between-subject   210
variation in attention, potentially related to differences in baseline acuity. However, a 
regression analysis found no association between attention scores and baseline acuity 
(p=0.860). Secondly, it was considered whether it was appropriate to consider 
linearity for the relationship between baseline and final acuity in the multivariable 
regression analysis. Separate regression analyses were performed to respectively 
investigate three relationships between baseline and final acuity: 1) linear, 2) a 
combination of linear and quadratic and 3) logarithmic. The strongest association was 
found to be linear (p=0.031). No significant associations were found for quadratic 
(p=0.487) and logarithmic (p=0.142) terms. The unstandardised residuals after 
regression between baseline and final acuity (assuming the linear relationship) were 
then extracted. These residuals were, in turn, regressed with baseline LOC activation 
for the affected (p=0.227) and fellow (p=0.137) eye, respectively. These non-
significant p values implied that there were no residual confounding factors between 
baseline acuity predicting final acuity that relate to LOC activation and, consequently, 
assuming linearity whilst controlling for baseline acuity in the multivariable 
regression was probably sufficient. 
 
5.1.4.5 Methodological considerations 
 
There are several methodological considerations for this study. Firstly is the issue of 
correcting for multiple comparisons. This study comprised in part hypothesis-driven 
aims. The key results suggesting LOC neuroplasticity are based on an a priori 
hypothesis and so, for these, multiple comparisons corrections were felt to be less 
essential, and the reader could place greater weight on the uncorrected p values (first 
two columns of Tables 5.7 and 5.8, curved brackets). Issues of multiple comparisons 
correction for family wise error rate (FWER) occur perennially in research. 
Unfortunately, there is no ideal method to adjust for them. Conventional approaches 
that control the FWER, such as Bonferroni, Holm and Sidak have several 
disadvantages (Rothman, 1990;Perneger, 1998). They are intrinsically conservative, 
risking an increase in type II errors, they assume that the tests are independent (which 
is usually not the case) and are concerned with the general null hypothesis (that all 
null hypotheses are true simultaneously), which is rarely of interest to researchers. In 
these contexts, where there is considerable biological similarity in the relationships 
assessed by individual tests, a biological pattern of moderately significant results (or   211
multiple convergent associations) is very unlikely to occur by chance, and applying a 
naïve FWER multiple comparisons correction may eliminate genuine associations. As 
an example, for the LOC analysis in Table 5.7, 28 tests were performed. Twenty three 
significant results (uncorrected) are tabulated, making it extremely unlikely that they 
have all arisen by chance. What is important in these contexts is to highlight the 
patterns, and to treat with great caution any moderately significant individual results 
which are biological isolated. Nevertheless, for the exploratory analyses in Table 5.7 
and 5.8, it was important to be aware that the large number of tests performed 
represents a limitation of the dataset, and this potential interpretational difficulty was 
further addressed by applying a Holm correction. Both the uncorrected and corrected 
p values were reported, so that the relative statistical strength of each association was 
clear. It was felt that this was a sensible way to address the multiple comparisons 
issue. 
Secondly, there were some missing data-points, which is difficult to avoid, despite 
making every effort, when conducting a comprehensive longitudinal study. In a 
minority of subjects, it was not possible to obtain all tests on the same day (Table 5.3). 
However, these problems were addressed during the analysis stage, by using mixed 
effects models, which allow for missing time-points and maximised efficient use of 
the available data, and by including time-to-test variables in the multivariable 
regression models.  
Thirdly, in order to minimise scanning times, the LOCs and primary visual cortex 
were defined on the basis of published coordinates, rather than using a localiser task 
and retinotopic mapping, which better account for inter-subject variability. This 
approach is thus less sensitive and more prone to type II errors, but should not 
influence the type I error rate, so any positive results obtained may be confidently 
interpreted as true positives. 
  
5.1.4.6 Conclusions 
 
In summary, this study identified associations between fMRI activity in the LOCs 
during acute ON and visual outcome, which were independent of measures of optic 
nerve inflammation, myelination and neuroaxonal loss. These data suggest that early 
neuroplasticity contributes to recovery from clinically isolated ON, and helps explain 
the dissociation between tissue damage in the optic nerve and visual recovery,   212
independent of optic nerve myelination, the extent of neuroaxonal loss, or posterior 
pathway pathology.  
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SECTION 2 EXPLORING VISUAL STRUCTURE-FUNCTION 
RELATIONSHIPS  
 
5.2.1 Introduction 
 
In this section, the variables found to be associated with visual outcome, resulting 
from the analyses reported in section 5.1, are investigated in more detail. These were 
(1) affected and fellow eye fMRI responses in the LOCs at baseline, (2) visual acuity 
at baseline, (3) age, and (4) macular volume at 12 months. In this section, the 
associations between these variables and other measures of visual outcome are 
considered, and inter-variable relationships are investigated in greater depth. The 
fMRI data are also explored further, to examine changing relationships with vision in 
different regions of the processing hierarchy, and longitudinal changes between time-
points other than baseline and 12 months. Structural and electrophysiological 
influences on these relationships are studied. Lastly, associations between the rates of 
change of the various structural, electrophysiological and fMRI variables are 
considered.  
 
5.2.1.1 Associations with alternative visual outcome measures 
 
In section 5.1, visual outcome was measured with logMAR acuity, 12 months after 
acute ON. The logMAR score essentially measures the function of the neural 
pathways arising from the macula and synapsing in primary visual cortex, in the 
region of the occipital poles. However, visual outcome may be measured in other 
ways, relating to the function of different retinal areas and specific aspects of visual 
processing. The relationship of each identified variable-of-interest to the following 
measures of visual outcome was assessed: low contrast acuity, Humphrey visual field 
and colour vision. The hypothesis was that there would be significant associations 
with each of these different aspects of visual function. 
 
5.2.1.2 Age interactions 
 
An association between visual outcome and age was identified in section 5.1. 
Therefore, the influence of age on the relationship between each of the other   214
variables-of-interest and visual outcome was considered. The hypothesis was that 
different factors might be important in determining visual recovery in patients of 
different ages. In particular, it was hypothesised that neuroplastic recovery 
mechanisms might become less efficient with increasing age.  
 
5.2.1.3 Clinical-fMRI relationships 
 
In section 5.1, it was seen that longitudinal changes in fMRI responses differed 
between lower and higher visual areas. The relationships between visual acuity and 
fMRI activity at different levels of the processing hierarchy were now investigated 
directly, by assessing cross-sectional associations at each time-point. The hypothesis 
was that visual acuity would be associated with the fMRI response in lower visual 
areas (primary visual cortex and LGN) during the acute phase. Elucidating the 
relationship between visual acuity and higher visual areas was of interest, in order to 
determine how the LOCs and cuneus responded to a disruption of visual input at 
different stages of recovery.  
 
5.2.1.4 Changing longitudinal visual structure-function relationships  
 
The changing relationships between fMRI activity and visual outcome over time were 
explored using a longitudinal modeling approach, incorporating lagged variables, to 
allow investigation of associations between visual function, fMRI activity and 
structural pathology, later in the recovery process. The hypothesis was that fMRI 
responses in different regions might be associated with visual outcome at different 
times, reflecting a dynamic reorganisation process, which might reflect changing 
responses to structural and electrophysiological factors. 
 
5.2.1.5 Modeling associations between changes 
 
Lastly, the relationships between the rate of change of visual acuity and the rates of 
change of the various structural, electrophysiological and fMRI variables were 
investigated. The hypothesis was that changes in measures of structural damage and 
fMRI activity would be associated with changes in visual function, demonstrating   215
interplay between pathology, its clinical consequences, and physiological responses, 
over time. 
 
5.2.2 Methods 
 
The participants and data acquisition were identical to section 5.1. The additional 
visual testing protocol is described here. 
 
5.2.2.1 Visual assessment 
 
Low contrast acuity was assessed using Sloan charts (Ferris, III et al., 1982), of 25%, 
5% and 1.25% contrast, compared with the standard 100% ETDRS chart. When no 
letters could be correctly identified, a score of 1.7 was assigned (Optic Neuritis Study 
Group, 1991). The scoring system was identical to standard logMAR scoring, with 
higher scores indicating worse vision. 
Visual fields were assessed using the 30-2 programme on the Humphrey automated 
field analyser (Allergan-Humphrey Inc., San Leandro, Ca., USA). The global visual 
field mean deviation (HMD) was calculated, which incorporates both central and 
peripheral visual function into an error score. More negative error scores indicate 
worse vision. 
Colour vision was measured using the Farnsworth-Munsell 100-hue test (Farnsworth, 
1943), and scored as the square root of the error score. If the visual acuity was too 
poor to attempt the test, an error score of 36.6 was assigned (Optic Neuritis Study 
Group, 1991). Higher error scores indicate worse vision. 
 
5.2.2.2 Statistical analysis 
 
5.2.2.2.1 Associations with alternative visual outcome measures 
The variables associated with logMAR at 12 months, reported in section 5.1 (i.e. 
affected and fellow eye fMRI responses in the LOCs at baseline, visual function at 
baseline, age and macular volume at 12 months), were investigated. The association 
of each of these variables with the following measures of visual outcome was 
investigated: Sloan charts (25%, 5%, and 1.25%, to assess associations with 
progressively lower contrast acuity), Humphrey mean deviation score (to assess   216
associations with a measure incorporating peripheral vision) and Farnsworth-Munsell 
root error score (to assess colour vision). Separate multivariable regression models 
were specified, in which the score using each of these measures, at 12 months, was 
entered instead of logMAR as the dependent variable. Baseline LOC fMRI responses 
for the affected and fellow eye, baseline acuity, age and 12 month macular volume 
were entered, in turn, as independent variables. Visual function in the fellow eye, and 
the number of days to assessment, were entered as additional independent variables, 
to adjust for normal inter-individual variability, and the stage of evolution of 
pathology.  
Correlations between logMAR and each of the alternative visual measures were 
assessed using the Pearson test, at the baseline and 12 month time-points. 
 
5.2.2.2.2 Age interactions 
The variables associated with logMAR at 12 months, and reported in section 5.1 (i.e. 
affected and fellow eye fMRI responses in the LOCs at baseline, visual function at 
baseline and macular volume at 12 months), were investigated. The relationship of 
each of these variables with age was investigated, by adding age, and an age 
interaction term, to the multivariable regression models. The interaction term was 
generated by multiplying age by each variable-of-interest. Models were specified 
separately with logMAR at 12 months always the dependent variable. Each of the 
following was entered, in turn, as an independent variable: affected eye fMRI 
response in the LOCs, fellow eye fMRI response in the LOCs, baseline acuity and 
macular volume. Age and the interaction term between each variable and age were 
added as independent variables to each model. Fellow eye acuity and the number of 
days to assessment were always entered as additional independent variables. 
 
5.2.2.2.3 Clinical-fMRI relationships 
The relationship between vision and each of the fMRI variables (i.e. affected and 
fellow eye responses in V1, LGN, LOCs and the cuneus) at the same point in time 
was investigated, for each time-point, in turn.  
Separate regression models were specified. The logMAR score in the patients’ 
clinically affected eye was the dependent variable, and fMRI activity at the same 
time-point was entered as the independent variable. 
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5.2.2.2.4 Changing longitudinal visual structure-function relationships  
A longitudinal modeling approach was used to investigate changes in the relationship 
between vision and each of the fMRI variables (i.e affected and fellow eye responses 
in V1, LGN, LOCs and the cuneus) over time, and how this relationship was 
influenced by longitudinal changes in structural and electrophysiological measures.  
Lagged fMRI variables were generated from the fMRI data for each region-of-
interest, to facilitate investigation of associations between variables at different time-
points. A lagged variable describes data derived from a given time-point, in a 
longitudinal dataset, which is referred to a preceding time-point, either the previous 
one (lag 1 model), or the one before that (lag 2 model). The advantage of this 
approach is that all available data is included in a single model, for each variable that 
is explored, permitting the assessment of associations between variables at different 
times. For example, using a single lag 1 model, it is possible to determine whether 
fMRI activity in a given region at baseline is associated with visual function at three 
months, whether fMRI at three months is associated with vision at six months, and 
whether fMRI activity at six months is associated with vision at 12 months. 
It is not possible to generate a lagged variable if the preceding time-point is missing. 
Two patients had a missing intermediate time-point (patient 25 at three months, and 
patient 8 at six months). Therefore, in these two subjects, the other intermediate time-
point was omitted from the analysis (i.e. six months and three months respectively), in 
order to be consistent with the lagged variable definition.  
Each lagged variable was then entered into a separate linear mixed effects regression 
model, which investigate within-subject changes over time. The number of days 
between symptom onset and fMRI assessment was always entered as a covariate. The 
first model (lag 1) assessed associations between the baseline fMRI response and 
vision at three months. Linear combinations of the interactions between each fMRI 
variable and each time-point were derived from this model, which permitted 
assessment of associations between three month fMRI and six month acuity, and six 
month fMRI and 12 month acuity. The second model (lag 2) assessed for any 
associations between baseline fMRI and six month acuity, and a linear combination 
assessed for associations between the three and 12 month time-points. 
For any fMRI variables resulting in significant associations with vision, additional 
models were specified. These were identical to the models described in the preceding 
paragraph, except that each model now also included each of the structural and   218
electrophysiological variables (i.e. optic nerve FSE lesion length, gadolinium-
enhancing lesion length, optic nerve area ratio, optic radiation lesion load and FA, 
pericalcarine cortical surface area, volume and thickness, VEP amplitude and 
latency), in turn, lagged to correspond to the same time-point as the fMRI variable. 
This permitted investigation of the influence of concomitant structural and 
electrophysiological factors on the relationship between fMRI activity and visual 
outcome, between time-points other than baseline and 12 months. 
 
5.2.2.2.5 Modeling associations between changes 
Multivariable regression models were used to investigate associations between the 
change in vision between baseline and 12 months and the change in each of the 
structural, electrophysiological and fMRI variables (i.e. optic nerve FSE lesion length, 
gadolinium-enhancing lesion length, optic nerve area ratio, optic radiation lesion load 
and FA, pericalcarine cortical surface area, volume and thickness, VEP amplitude and 
latency, affected and fellow fMRI responses in primary visual cortex, LGN, LOCs 
and the cuneus).  
Firstly, change variables were generated for each structural, electrophysiological and 
fMRI parameter, in each subject, by subtracting the baseline data from the 12 month 
data. Each of these change variables was then entered, in turn, as an independent 
variable in a multivariable model, in which logMAR at 12 months was always the 
dependent variable. Fellow eye logMAR, the number of days from symptom onset to 
assessment and logMAR at baseline in the affected eye were always entered as 
additional independent variables. The inclusion of the affected eye baseline logMAR 
score as an independent variable had the effect of testing associations with the change 
in vision over 12 months, rather than the visual outcome per se. 
 
5.2.3 Results 
 
5.2.3.1 Associations with alternative visual outcome measures 
 
These data are summarised in Table 5.9. 
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    12M  
Sloan  
25% 
12M 
Sloan  
5% 
12M 
Sloan 
1.25% 
12M 
Humphrey 
MD 
12M  
Colour  
vision 
r  -0.56 -0.55 -0.59 0.48  -0.41  BL fMRI LOC  
affected  p  0.008 0.009 0.005 0.028 0.063 
r  -0.53 -0.52 -0.60 0.35 -0.25  BL fMRI LOC 
fellow  p  0.013 0.016 0.004 0.118 0.284 
r  0.58 0.50 0.17  0.41  0.45  BL visual score 
p  0.005 0.017 0.455  0.055  0.036 
r  -0.50 -0.42 -0.50 0.30 -0.18  Age 
p  0.015 0.048 0.016 0.162 0.423 
r  -0.47  -0.41 -0.14 0.55  -0.43  12M macular 
volume  p  0.076  0.129 0.609 0.035  0.108 
Table 5.9 Associations between variables-of-interest and measures of visual outcome other than 
logMAR. For each association, the partial correlation coefficient, r, is reported, together with the 
associated p value. Significant associations are highlighted in bold and borderline associations in 
italics. More positive Sloan and colour vision scores are associated with worse visual function. More 
negative Humphrey scores are associated with worse visual function. BL-baseline, LOC-lateral 
occipital complexes, MD-mean deviation. 
 
The variables associated with logMAR acuity were generally also correlated with the 
low contrast acuity outcome measures. In contrast, associations were not always seen 
with the Humphrey score, although correlations were evident for the affected eye 
fMRI response in the LOCs at baseline, and macular volume at 12 months. There was 
a significant association between colour vision at baseline and 12 months, and 
borderline significance for an association between the affected eye fMRI response in 
the LOCs at baseline and colour vision at 12 months. The direction of the associations 
was the same for all significant associations: a better visual outcome was associated 
with greater fMRI activity, better vision at baseline, increasing age and larger macular 
volume. 
 
In general, the visual measures were highly correlated with logMAR acuity. The 
correlation between logMAR and 1.25% Sloan low contrast acuity (at baseline), and   220
logMAR and colour vision (at 12 months) were less strong, and were of borderline 
significance. These data are summarised in Table 5.10. 
 
BASELINE  12 MONTHS   
Visual measure  Correlation 
coefficient (r) 
p value  Correlation 
coefficient (r) 
p value 
Sloan 25%   0.98  <0.001   0.96  <0.001 
Sloan 5%   0.78  <0.001   0.85  <0.001 
Sloan 1.25%   0.33    0.085   0.73  <0.001 
Humphrey MD  -0.80 <0.001  -0.70 <0.001 
Colour vision   0.93  <0.001   0.38    0.065 
Table 5.10 Correlations between alternative measures of visual function and logMAR. Significant 
results are highlighted in bold and borderline significance is indicated by italics. MD-mean deviation. 
 
5.2.3.2 Age interactions 
 
For the affected eye fMRI response in the LOCs, the age interaction term was 
significant (p=0.013), with the direction of the association indicating that the fMRI 
response was more strongly associated with visual outcome in younger patients. For a 
patient of mean age in the cohort (32 years), logMAR improved by 0.12 (6 letters) per 
unit increase in fMRI response (p=0.006). For a patient age 26 (lower quartile), the 
improvement was 0.22 (11 letters, p=0.001) for the same increase in fMRI response, 
whereas for a patient age 37 (upper quartile), the improvement was just 0.03 and non-
significant (1-2 letters, p=0.551). 
For the fellow eye fMRI response, the interaction term was not significant, indicating 
that there was no influence of age on the relationship between fMRI and visual 
outcome. 
Baseline acuity was more strongly associated with outcome in younger patients 
(p=0.035). For a patient age 32, logMAR at 12 months improved by 0.07 (3-4 letters) 
for each 0.1 (5 letter) improvement in baseline acuity (p=0.014). For a patient age 26, 
the improvement was 0.08 at 12 months (4 letters, p=0.016) for the same 
improvement in baseline vision. For a patient of age 37, the improvement at 12 
months was 0.06 (3 letters, p=0.012) per 5 letter improvement in baseline acuity.   221
Macular volume was more strongly associated with outcome in younger patients 
(p=0.016). For a patient age 32, logMAR improved by 0.23 (11-12 letters) per 
0.1mm
3 increase in macular volume (p=0.010). For a patient age 26, the improvement 
was 0.27 (13-14 letters, p=0.009), whereas for a patient age 37, the improvement was 
0.20 (10 letters, p=0.008). 
 
5.2.3.3 Clinical-fMRI relationships  
 
Associations between vision and fMRI responses at the same time-point were only 
found at baseline. These data are summarised in Table 5.11. Patients demonstrated 
associations in several areas between worse vision and a reduction in the fMRI 
response. In lower visual areas, associations were seen only on stimulating the 
affected eye. There was a strong correlation between vision and the fMRI response in 
primary visual cortex, and a weaker association within the LGN. Responses in higher 
visual areas appeared more complex. Strong associations between vision and fMRI 
activity were seen in the LOCs, and were evident on stimulation of either eye. In the 
cuneus, there was a borderline association, which was only evident when stimulating 
the fellow eye. 
 
FMRI region-of-interest  Correlation coefficient (r) p value  
Affected eye: V1  -0.65  <0.001 
Aff. LGN  -0.33    0.085 
Aff. LOC  -0.52    0.005 
Aff. cuneus  -0.28    0.154 
Fellow eye: V1  -0.31    0.104 
Fell. LGN   0.00    1.000 
Fell. LOC  -0.50    0.008 
Fell. cuneus  -0.36    0.057 
Table 5.11 Associations between visual acuity and fMRI responses in the affected eye, in patients, at 
baseline. Significant associations are highlighted in bold and borderline associations in italics. 
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5.2.3.4 Changing longitudinal visual structure-function relationships 
 
5.2.3.4.1 Lag 1 models 
These models revealed that a greater baseline fMRI response in the LOCs was 
associated with better visual function at three months, on stimulation of the affected 
eye. There were no associations between fMRI activity in this region after baseline 
and visual outcome. None of the other fMRI variables were significantly associated 
with visual function at any of the other time-points, although there was borderline 
significance for an association between greater activity in the affected LGN at six 
months, and better visual acuity at 12 months. These data are summarised in Table 
5.12. 
 
BL to 3M  3M to 6M  6M to 12M  FMRI variable 
coeff  p value  coeff  p value  coeff  p value 
Affected V1  -0.059     NS  -0.019     NS   0.022     NS 
Affected LGN  -0.161     NS  -0.198     NS  -0.070   0.073 
Affected LOC  -0.100   0.026   0.027     NS   0.036     NS 
Affected cuneus  -0.005     NS   0.029     NS   0.012     NS 
Fellow V1   0.002     NS   0.001     NS   0.040     NS 
Fellow LGN   0.061     NS  -0.025     NS   0.071     NS 
Fellow LOC  -0.057     NS  -0.045     NS   0.021     NS 
Fellow cuneus  -0.005     NS   0.029     NS   0.012     NS 
Table 5.12 Results of the lag 1 models. The regression coefficients are reported, which summarise the 
association between each fMRI variable and vision in the affected eye at the subsequent time-point. 
Significant results are highlighted in bold and borderline results in italics, together with the associated p 
value. P values >0.1 are reported non-significant (NS). BL-borderline, coeff.-regression coefficient, 
LGN-lateral geniculate nuclei, LOC-lateral occipital complexes, M-months, V1-primary visual cortex. 
 
5.2.3.4.2 Lag 2 models  
There was an association between a greater affected eye fMRI response in the LGN at 
three months and worse vision at 12 months. There was borderline significance for an 
association between a greater baseline fMRI response in the LOCs and visual acuity at 
six months. These data are summarised in Table 5.13. 
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BL to 6M  3M to 12M  FMRI variable 
coeff  p value  coeff  p value 
Affected V1  -0.018     NS    0.019      NS 
Affected LGN   0.024     NS    0.127     0.026 
Affected LOC  -0.040     0.094   -0.015      NS 
Affected cuneus   0.021     NS   -0.028      NS 
Fellow V1  -0.012     NS    0.017      NS 
Fellow LGN  -0.023     NS    0.018      NS 
Fellow LOC  -0.032     NS    0.009      NS 
Fellow cuneus  -0.009     NS   -0.035     0.062 
Table 5.13 Results of the lag 2 models. The regression coefficients are reported, which summarise the 
association between each fMRI variable and vision in the affected eye two time-points later. Significant 
results are highlighted in bold and borderline results in italics, together with the associated p value. P 
values >0.1 are reported non-significant (NS). BL-borderline, coeff.-regression coefficient, LGN-lateral 
geniculate nuclei, LOC-lateral occipital complexes, M-months, V1-primary visual cortex. 
 
5.2.3.4.3 Structural influences  
The influence of structural variables was investigated on the significant associations 
between fMRI and vision in the LOCs between baseline and three months (Table 
5.14), and in the LGN between three and 12 months (Table 5.15). 
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  Structural variable 
added to model 
Significance of the 
association between BL 
fMRI LOCs and 3M 
logMAR 
   P  value 
(fMRI) 
 P value 
 (structural) 
OPTIC NERVE  FSE lesion length  0.026  0.771 
 Gad  lesion  length  0.077  0.310 
 Area    0.025  0.754 
OPTIC RADIATIONS  Lesion load  0.028  0.957 
 Mean  FA  0.088  0.421 
OCCIPITAL CORTEX  Surface area  0.045  0.055 
 Volume  0.035  0.160 
 Thickness  0.031  0.779 
VEP Amplitude  0.059  0.018 
 Latency  0.004  0.889 
Table 5.14 Structure-function interactions: the influence of structural variables on the relationship 
between fMRI response in the LOCs at baseline and logMAR at three months. The first column of p 
values indicates the significance of the association between fMRI in the LOCs at baseline and visual 
outcome at three months, following adjustment for each structural variable, when combined in a lagged 
multivariable regression model. The second column of p values indicates the significance of each 
structural variable in that model. The models in which fMRI in the LOCs retained significance are 
highlighted in bold font, and those in which borderline significance was retained are highlighted in 
italics. BL-baseline, FA- fractional anisotropy, FSE-fast spin echo, Gad-post gadolinium-enhanced 
MRI, LOCs-lateral occipital complexes, M-months, VEP-visual evoked potential. 
 
The associations between fMRI response in the LOCs and vision retained significance 
or borderline significance, on adding each of the structural variables to the model. 
 
 
 
 
 
 
 
   225
  Structural variable 
added to model 
Significance of association 
between 3M fMRI LGN and 
12M logMAR 
   P  value 
(fMRI) 
P value  
(structural) 
OPTIC NERVE  FSE lesion length  0.093  0.525 
 Gad  lesion  length  0.041  0.307 
  Area    0.024  0.274 
OPTIC RADIATIONS  Lesion load  0.024  0.337 
 Mean  FA  0.045  0.931 
OCCIPITAL CORTEX  Surface area  0.021  0.288 
 Volume  0.022  0.314 
 Thickness  0.033  0.609 
VEP Amplitude  0.006  0.122 
 Latency  0.359  0.173 
Table 5.15 Structure-function interactions: the influence of structural variables on the relationship 
between fMRI response in the LGN at three months and logMAR at 12 months. The first column of p 
values indicates the significance of the association between fMRI in the LGN at three months and 
visual outcome at 12 months, following adjustment for each structural variable, when combined in a 
lagged multivariable regression model. The second column of p values indicates the significance of 
each structural variable in that model. The models in which fMRI in the LOCs retained significance are 
highlighted in bold font, and those in which borderline significance was retained are highlighted in 
italics. FA- fractional anisotropy, FSE-fast spin echo, Gad-post gadolinium-enhanced MRI, LGN-
lateral geniculate nuclei, M-months, VEP-visual evoked potential. 
 
The associations in the affected LGN retained significance, or borderline significance, 
except when VEP latency was added to the model. 
 
5.2.3.5 Modeling associations between changes 
 
A significant association was found between worse vision at 12 months, after 
adjusting for acuity at baseline, and a greater change in optic nerve area ratio 
(regression coefficient 0.47 [95%CI 0.28, 0.91], p=0.039).    226
There was also an association between better vision at 12 months, after adjusting for 
acuity at baseline, and a smaller change in fMRI activity in the LOCs, on stimulation 
of the affected eye (regression coefficient 0.10 [95%CI 0.02, 0.19], p=0.025). 
No other significant associations were found. 
 
5.2.4 Discussion 
 
The results of these more detailed analyses extend the findings described in Section 1 
of this chapter, and provide more insights into the complex structure-function 
interactions which occur at different times following recovery from ON. 
 
5.2.4.1 Associations with alternative visual outcome measures 
 
There were significant associations between the affected eye fMRI response in the 
LOCs and visual outcome, measured using low contrast acuity and Humphrey scores, 
and borderline significance for an association with colour vision. Although this 
suggested that neuroplastic mechanisms, evident on stimulation of the affected eye, 
were important for recovery of all aspects of vision, and not only central acuity, the 
interpretation was complicated by the fMRI results following fellow eye stimulation. 
Here, there were associations with low contrast acuity, but not with Humphrey scores, 
or colour vision. This was also the case for several of the other variables; generally 
correlations were present with low contrast acuity scores, but there were fewer 
associations with the other outcome measures, especially colour vision. This suggests 
that the influence of different factors involved in recovery differs, depending on the 
modality of vision. The reasons for this are not clear from this study, but clinically 
important dissociation in recovery of the various aspects of visual function does occur 
following ON (Optic Neuritis Study Group, 1991;Frederiksen et al., 1991;Cleary et 
al., 1997). For example, deficits of low contrast acuity or colour vision may remain, 
despite a good recovery of central acuity (Beck and Cleary, 1993;Optic Neuritis Study 
Group, 1997b;Frederiksen et al., 1997;Beck et al., 2004a;Optic Neuritis Study Group, 
2008a). Previous fMRI studies in ON have generally investigated clinical-fMRI 
associations using measures of central acuity at standard contrast (Russ et al., 
2002;Langkilde et al., 2002), measures of central and peripheral vision, such as 
Humphrey field mean deviation (Langkilde et al., 2002;Korsholm et al., 2008), or a   227
composite measure of the two (Toosy et al., 2005). One study found an association 
between fMRI activation and low contrast acuity, using a different measurement 
technique, Arden gratings (Langkilde et al., 2002). The finding of associations 
between fMRI activation and colour vision in ON is novel. 
In general, the visual measures were highly correlated, which was not surprising, as 
an acute insult to the optic nerve will typically affect all modalities of vision. An 
exception to this was very low contrast acuity at baseline, which was not correlated 
with logMAR. This may be explained through a greater sensitivity of the Sloan 1.25% 
chart to detect subtle abnormalities in patients with relatively mild visual loss, who 
may have had preserved logMAR acuity. The dissociation between logMAR and 
colour vision at 12 months may be explained by residual deficits of colour vision, in 
patients who had recovered central acuity. 
 
5.2.4.2 Age interactions 
 
The interactions with age were interesting. In particular, the stronger association 
between fMRI activity in the LOCs and visual outcome in younger patients suggests 
that compensatory plastic processes become less important with increasing age. The 
associations between outcome, the severity of initial visual loss and macular volume 
were also stronger in younger people. It was seen in section 5.1 that, overall, older 
patients had a better visual outcome, and this must reflect interplay between these 
contrasting influences. It could be that the stronger association between initial visual 
loss and outcome in younger people reflects a more aggressive demyelinating process, 
resulting in more axonal damage (and hence a stronger correlation between visual 
outcome and macular volume), and therefore more dependence on neuroplastic 
compensatory mechanisms, which might also be more effective. 
 
5.2.4.3 Clinical-fMRI relationships at baseline 
 
Associations between visual acuity and the fMRI response from the affected eye, at 
the same time-point, were only evident at baseline. During the acute episode of ON, 
worse vision was associated with a reduction in the fMRI response in lower visual 
areas (LGN and primary visual cortex). The associations with responses in higher 
visual areas were more complex. In the LOCs of the ventral stream, worse vision in   228
the affected eye was associated with a reduction in the fMRI response from both the 
affected and fellow eyes. In contrast, in the cuneus there was only an association 
between worse vision in the affected eye and a reduction in the fMRI response from 
the fellow eye. Therefore, at lower levels of the processing hierarchy, there were 
direct relationships between afferent input and the resulting BOLD response. 
However, at higher levels of the visual hierarchy, processing appears to become more 
holistic, the input-response relationship becomes more indirect, and may be mediated 
through the intact fellow eye pathways. 
 
5.2.4.4 Changing longitudinal visual structure-function relationships 
 
The lagged variable analysis identified an association between baseline fMRI activity 
in the LOCs and visual outcome at three months. There was also a borderline 
association with vision at six months. This showed that baseline fMRI activity was 
also associated with early visual outcomes, and is consistent with the temporal course 
of clinical recovery in ON, much of which occurs in the first few months following 
the acute episode. The fMRI response in the LOCs after the baseline time-point was 
not associated with visual outcomes, suggesting that clinically relevant neuroplasticity 
in this region occurs during the acute phase. 
An association with visual outcome at 12 months was found for fMRI activity in the 
LGN at three months. The direction of the association indicated that greater activity 
was associated with a worse outcome. This result is surprising, as fMRI activity in the 
LGN generally increased in parallel with improvements in vision. The possibility of a 
type I error should be considered. An alternative explanation is that this association 
may reflect decompensation in patients who fail to recover. An increase in fMRI 
activity in the LGN at three months in patients who are failing to recover might reflect 
unsuccessful attempts at a secondary reorganisation strategy, either occurring 
primarily in this region, or relating to backprojection from connected cortical areas. 
In general, the associations between fMRI response in the LOCs and vision were 
relatively independent of structural influences. The association between LGN activity 
and vision was confounded by VEP latency, which did not itself contribute to the 
model. This suggested that there was some collinearity between the two variables and, 
therefore, the association between LGN activity at three months and vision after a 
year might be partly explained by changes in myelination. For example, at three   229
months, a more prolonged VEP latency resulting from demyelination in the optic 
nerve delaying conduction to the LGN might be associated with changes in the profile 
of the BOLD response in the LGN at three months, and also with vision at 12 months. 
 
5.2.4.5 Visual improvement, optic atrophy and early neuroplasticity in the LOCs 
 
The associations between the change variables were complex. The correlation 
between a progressive decrease in optic nerve area and relatively worse vision at 12 
months, after adjusting for vision at baseline, could represent either more severe acute 
oedema, more marked axonal loss at 12 months, or a combination of both. A more 
severely swollen optic nerve has been associated with worse acute visual loss in ON, 
but not with visual outcome (Hickman et al., 2004a). Subsequent optic atrophy has 
been associated with visual function, but the correlations have been relatively modest 
(Hickman et al., 2002a;Inglese et al., 2002), and some investigators have found no 
association (Hickman et al., 2004a). The results of the present study may reflect a 
contribution of axonal loss to residual dysfunction, but it appears from section 5.1 that 
this relationship is complicated by other factors.  
The association of a relatively smaller increase in affected eye fMRI response in the 
LOCs and a greater improvement in vision could represent either a relatively large 
response at baseline (probably, at least in part, through neuroplastic reorganisation 
activity), or a smaller response at 12 months. These associations have not been 
previously investigated directly in ON, but the results of section 5.1 suggest that the 
magnitude of the baseline response is of more importance, in terms of associations 
with visual improvement. In addition, no other studies have found reduced affected 
eye fMRI responses in the LOCs at 12 months; one found no difference between the 
affected and fellow eyes (Korsholm et al., 2007), and one even found a greater 
response on stimulation of the affected eye (Levin et al., 2006). Another study did not 
find any clinical-fMRI correlations in the LOCs at 12 months (Toosy et al., 2005). 
Therefore, the results of the present analysis appear likely to reflect complex 
associations between changing vision, resolving oedema, progressive axonal loss in 
the optic nerve and early neuroplastic reorganisation activity in the LOCs, which 
subsequently becomes less evident over time. 
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5.2.4.6 Conclusions 
 
In summary, this study found that the affected eye fMRI responses in the LOCs at 
baseline remained associated with visual outcome measures, reflecting low contrast 
acuity, visual fields and colour vision. However, there was some dissociation for some 
of the other variables which had correlated with visual outcome when it was measured 
using logMAR.  
There were complex interactions between visual outcome, age and the other variables 
of interest: fMRI responses in the LOCs, baseline visual function and macular 
volume. In particular, compensatory neuroplastic processes appeared to become less 
important in determining visual outcome in older people. 
In lower visual areas, there were direct associations between visual loss during the 
acute episode and the affected eye fMRI response at that time. Associations in higher 
visual areas were more complex and involved the fellow eye. This suggested that 
responses to a reduction in afferent input differed in hierarchical visual processing 
areas, but that the higher areas were not robust to disrupted input. 
Early neuroplastic responses relevant to visual outcome at all subsequent time-points 
were seen in the LOCs. At later time-points, no clinically relevant changes were found 
in this region. Complex interactions between vision, electrophysiological measures 
and fMRI activity were found in the LGN. 
There were associations between changes in vision, changes in the fMRI response in 
the LOCs, and changes in optic nerve area, reflecting acute oedema and residual 
atrophy. These associations exemplify the dynamic longitudinal interactions between 
clinical symptoms, cortical responses and ongoing tissue damage in the optic nerve. 
Tissue damage following ON will be considered in more general terms in the next 
section. 
 
 
 
 
 
 
 
   231
SECTION 3 TISSUE DAMAGE IN THE VISUAL PATHWAY AND 
DEVELOPMENT OF MULTIPLE SCLEROSIS 
 
5.3.1 Introduction  
 
In the first two sections of this chapter, visual outcome following ON was considered. 
In this section, the focus will shift to the association between damage detected along 
the optic pathway and the development of MS in the year following the acute episode.  
In section 5.1, it was seen that progressive tissue loss occurred in the optic nerve 
following ON. In addition, there was evidence of retrograde neuroaxonal 
degeneration, with loss of retinal ganglion cells and a reduction in the thickness of the 
RNFL, as measured by OCT. Lesions accumulated in the optic radiations over time, 
although there was no generalised decrease in the integrity of the posterior pathways. 
A reduction in the surface area and volume of the pericalcarine cortex was evident at 
the time of presentation with acute ON (Chapter 4), but no longitudinal changes in 
either pericalcarine or whole brain grey matter volume ensued in the following year 
(section 5.1). Therefore, it appeared that optic nerve inflammatory damage had 
resulted in secondary retrograde degeneration in the anterior pathway, but the effects 
on the posterior pathway were less clear. In particular, pericalcarine atrophy was 
evident very early, and in the absence of evidence for trans-synaptic degeneration in 
the optic radiations. 
In this section, the reasons underlying this early pericalcarine cortical atrophy are 
considered in more detail. The main hypothesis, that it may represent a susceptibility 
of the visual system to damage from demyelinating disease, was discussed in Chapter 
4. Potential mechanisms of this damage are now investigated. One hypothesis is that 
tract-specific visual cortical damage could occur, secondary to local pathology in 
other regions of the visual pathways. An alternate hypothesis is that damage is 
mediated through a more generalised neurodegenerative process. Similarly, tissue 
damage in other regions of the visual pathway could be secondary either to local or 
generalised disease effects. 
In order to determine the contribution of local pathology to tract degeneration, 
associations were investigated between optic nerve atrophy and tissue damage in the 
visual pathways, both anterior and posterior to the site of primary insult. Finding 
associations between local measures of damage in different parts of the visual system   232
would suggest tract-specific secondary degeneration. In order to determine the role of 
generalised pathology, associations were investigated between measures of tissue loss 
in the visual system and the development of MS over the subsequent year.  
 
5.3.2 Methods 
 
The participants and data acquisition were identical to section 5.1. 
 
5.3.2.1 Associations between areas of damage within the visual pathway  
 
The influence of optic atrophy on the retina, optic radiations and pericalcarine cortex 
was assessed, by investigating associations between optic nerve area and retinal OCT 
measures at 12 months (to assess retrograde degeneration in the anterior pathway), 
and between optic nerve area and MRI measures of the integrity of the optic 
radiations and the surface area, volume and thickness of the pericalcarine cortex (to 
assess trans-synaptic degeneration in the posterior visual system). Multivariable 
regression models were specified, with optic nerve area ratio as the dependent 
variable. The following variables were each entered, in turn, as the independent 
variable: macular volume, RNFL, optic radiation FA, pericalcarine surface area, 
volume and thickness. For the OCT measures, the fellow eye parameter was entered 
to adjust for normal inter-individual variability (Alamouti and Funk, 2003). 
The influence of damage in the optic radiations on the pericalcarine cortical measures 
was assessed, by investigating associations between optic radiation lesion load and 
FA with pericalcarine surface area, volume and thickness, at baseline and 12 months. 
Multivariable regression models were specified with each pericalcarine cortical 
measure, in turn, as the dependent variable. Each of the optic radiation variables was 
entered, in turn, as the independent variable.  
All associations were adjusted for age and gender. 
 
5.3.2.2 Development of MS 
 
The percentage of patients who were diagnosed with MS over the year of the study 
was calculated, using clinical (Poser et al., 1983) and MRI criteria (McDonald et al., 
2001;Polman et al., 2005). In addition, the percentage of patients with brain lesions at   233
each time-point was reported, and whether they fulfilled the MRI criteria for 
dissemination in space or time (Barkhof et al., 1997;Tintore et al., 2000), by the 12 
month time-point.  
 
5.3.2.3 Associations between tissue damage and MS 
 
Associations between the development of MS and markers of tissue damage in the 
retina, optic nerve, optic radiations, pericalcarine and whole brain grey matter were 
investigated. A multivariable regression approach was used, with clinical MS status at 
the end of the study as a binary dependent variable (0-no MS, 1-clinical diagnosis of 
MS). Separate models were specified, entering data for each of the following as an 
independent variable: optic nerve lesion length, optic nerve area ratio, optic radiation 
lesion load and FA, pericalcarine cortical surface area, volume and thickness, and 
whole brain grey matter fraction. Models were specified separately for each of these 
variables at the baseline time-point, 12 month time-point, and for the change between 
baseline and 12 months. For gadolinium-enhanced lesion length, models were 
specified for the only available time-point at baseline. For the OCT measures 
(macular volume and RNFL thickness), models were specified at 12 months. 
Associations were adjusted for age and gender.   
 
5.3.3 Results  
 
5.3.3.1 Associations between areas of damage within the visual pathway 
 
There were no associations between optic nerve atrophy and any of the retinal, optic 
radiation or pericalcarine cortical measures at 12 months. 
There were no associations between the pericalcarine MRI measures and any of the 
optic radiation variables, either at baseline or 12 months. 
 
 5.3.3.2 Development of MS 
 
Over the course of the study, 43% of patients developed MS, diagnosed on clinical 
criteria, and all of these patients also fulfilled the MRI criteria for MS.    234
An additional 32% of patients had T2 lesions suggestive of demyelination on their 
MRI scan by 12 months (examples shown in Figures 5.5 and 5.6), which were 
insufficient to fulfill the McDonald criteria in all cases. Of these nine patients, three 
fulfilled the criteria for dissemination in space only, four dissemination in time only, 
and two neither criterion. One patient had a normal brain MRI at baseline but 
subsequently developed lesions at 12 months (Figure 5.5). This was the only patient 
with a normal baseline MRI scan to subsequently develop lesions over the course of 
the year (classified as dissemination in time only). 
The remaining 25% of patients had a normal brain MRI both at baseline and at last 
contact, one of whom was lost to follow-up after the baseline time-point. 
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Figure 5.5 Serial MRI scans from a patient in the study, demonstrating the appearance of a first lesion 
suggestive of demyelination at 12 months. Axial slices are shown from the (A) baseline, (B) three 
month, (C) six month, and (D) 12 month time-points. The scans are normal from baseline to six months 
but, at 12 months, a left sided frontal periventricular lesion is seen. 
 
 
Figure 5.6 Serial MRI scans from a different patient, demonstrating lesions at baseline and new lesions 
developing over the course of the study. Axial slices are shown from the (A) baseline, (B) three month, 
(C) six month and (D) 12 month time-points. At baseline, periventricular lesions are seen on the right, 
adjacent to the frontal and occipital horns. In addition, there is ill-defined signal change adjacent to the 
occipital horn of the left lateral ventricle. A more peripheral left frontal lesion is seen. New lesions are 
seen at six months, with the appearance of a right frontal juxtacortical lesion. and a new discrete lesion 
adjacent to the occipital horn of the left lateral ventricle. At 12 months, the left frontal lesion appears 
less conspicuous. 
 
5.3.3.3 Associations between tissue damage and MS 
 
Variables which were significantly associated with the development of MS are listed 
in Table 5.15. 
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BASELINE    r  p 
Optic nerve  FSE lesion length  -0.47  0.019 
 Gad  lesion  length  -0.50  0.013 
Optic radiation  Lesion load   0.51  0.010 
Occipital cortex  Pericalcarine volume  -0.43  0.032 
  Pericalcarine thickness  -0.40  0.049 
12 MONTHS       
Optic radiation  Lesion load   0.50  0.024 
Occipital cortex  Pericalcarine thickness  -0.46  0.038 
CHANGE       
Optic radiation  Lesion load   0.48  0.032 
Table 5.16 Variables associated with the development of MS at 12 months. The correlation coefficient 
(r) is reported, together with the associated p value. FSE-fast spin echo, Gad-gadolinium-enhanced 
scan. 
 
At baseline, the following factors were associated with the development of MS by the 
end of the study: a shorter optic nerve lesion, on both fast spin echo and gadolinium-
enhanced MRI, a greater lesion load in the optic radiations, a smaller pericalcarine 
volume and a thinner pericalcarine cortex.  
At 12 months, associations remained between MS and the following factors: a greater 
optic radiation lesion load and a thinner pericalcarine cortex.  
With regard to the change variables, an increase in optic radiation lesion load was the 
only parameter associated with the development of MS.  
All associations survived correction for age and gender, except pericalcarine cortical 
thickness, which retained borderline significance (p=0.065 and 0.057 at baseline and 
12 months, respectively). The association of pericalcarine cortical volume with MS 
remained after correction for whole brain grey matter volume (p=0.038).  
There were no associations for any of the other tested variables, either at baseline, 12 
months, or for change over time.   
 
5.3.4 Discussion 
 
The most important finding of this study was the association between pericalcarine 
cortical atrophy, evident at baseline, and the subsequent development of MS. These   237
results suggest that early pericalcarine cortical atrophy in clinically isolated ON 
relates to damage from generalised disease, rather than tract-specific pathology, and 
may indicate that the visual system is especially susceptible to damage in 
demyelinating disease. In the following sections, damage within the visual system, the 
development of generalised disease, and associations between tissue damage and MS 
will each be discussed, in turn. 
 
5.3.4.1 Lack of associations between areas of damage within the visual pathway 
 
No associations were found between measures of tissue loss in the optic nerve and 
damage in either the anterior or posterior visual pathways. In the retina, this could be 
because the measurement of optic nerve area may be confounded by changes in 
tissues other than axons, for example, glial cells. In addition, the relationship between 
axonal loss in the optic nerve and secondary neuroaxonal degeneration in the retina 
might not be one-to-one. The extent of secondary effects could be under the influence 
of other factors, for example, remyelination. Alternatively, the MRI and OCT 
measures might not be sufficiently sensitive to detect an existing association.  
In the posterior visual system, it was not possible to confirm the findings of previous 
studies, which have found evidence for trans-synaptic degeneration affecting the optic 
radiations and occipital cortex, following ON (Ciccarelli et al., 2005;Audoin et al., 
2006;Calabrese et al., 2007). This may be due to methodological differences in the 
studies, or related to the different size and composition of the cohorts. For example, 
the majority of the subgroup of patients in which associations were found by 
Calabrese et al fulfilled the MRI criteria for dissemination in space. Therefore, these 
patients represented a more advanced disease stage than the present cohort. It may be 
that tract-specific trans-synaptic changes become increasingly evident later in the 
course of demyelinating disease, or that they are not an invariable consequence of 
optic nerve damage and are also under the influence of other factors. 
 
5.3.4.2 Development of MS 
 
The proportion of patients who developed MS in this study was slightly higher than 
the ONTT cohort from the USA, and an Italian study, but similar to a previous UK 
study of a mixed cohort with various clinically isolated syndromes.    238
In the ONTT, the overall risk of MS at five years was 30%, increasing to 51% in those 
with an abnormal baseline MRI (Optic Neuritis Study Group, 1997a). The number of 
patients with an abnormal MRI scan at baseline was also higher in the present study 
than the 49% reported in the ONTT (Optic Neuritis Study Group, 1991). An Italian 
study of patients with ON reported that 37% developed clinically definite MS at a 
mean of two years following their first clinical episode (Ghezzi et al., 1999). In 
contrast, a study from the UK reported an MS conversion rate of 48% at one year, 
using the McDonald criteria, although the proportion with clinically definite MS at 
this time was smaller (20%) (Dalton et al., 2002). These disparities may be related to 
differences in risk profiles between the American, Italian and British populations that 
were studied, or to random sampling differences. In general, there has been some 
variability in reported conversion rates from different regions, even after considering 
differing durations of follow-up.  
 
5.3.4.3 Associations between volume loss in the visual cortex and MS 
 
A shorter acute lesion in the optic nerve was associated with the development of MS. 
This is consistent with previous clinical studies, which have reported that severe optic 
nerve inflammation is relatively unusual in ON related to MS, although it does occur. 
Severe symptomatology is recognised as a “red flag” in ON, to consider alternative 
aetiologies, such as the steroid-responsive optic neuritides (Hickman et al., 2002b). 
None of the patients in this study were diagnosed with any conditions other than MS 
over the course of the study, although it is possible that alternative diagnoses may 
emerge in the future. These results are consistent with clinical observations that ON, 
in the context of MS, is typically of mild to moderate severity. 
The strong associations between lesions in the optic radiations and the development of 
MS are not surprising. It is well recognised that asymptomatic brain MRI lesions are 
associated with a much higher risk of subsequent MS (Optic Neuritis Study Group, 
1997a;Brex et al., 2002;Beck et al., 2003;Optic Neuritis Study Group, 2008b), and the 
optic radiations are a common site for incidental lesions (Hornabrook et al., 1992). 
Higher numbers of lesions have been linked to a higher risk of MS (Optic Neuritis 
Study Group, 1997a). 
The most interesting associations were between the pericalcarine cortical measures 
and the development of MS over the ensuing 12 months. Pericalcarine volume loss   239
was evident at baseline, compared to controls (Chapter 4). The finding from this study 
of an association with MS suggests that this region-specific atrophy may be related to 
generalised damage from subclinical MS, rather than the effects of local pathology, 
such as damage in the optic nerve or optic radiations. This was further supported by 
associations between a reduced pericalcarine cortical thickness and MS, which were 
evident at baseline, as well as 12 months. It is worth noting that the association 
between pericalcarine cortical volume and MS lost significance at 12 months. This 
may reflect a loss of statistical power, as fewer patients were able to perform MRI at 
this time (see section 5.1.3.2).  
It has been reported previously that progressive generalised cerebral cortical atrophy 
occurs following a clinically isolated syndrome in patients who develop MS (Dalton 
et al., 2004;Fisher et al., 2008;Fisniku et al., 2008), but not in those whose disease 
remains isolated (Fisher et al., 2008), even after 20 years (Fisniku et al., 2008). In the 
present study, pericalcarine cortical atrophy was evident in the absence of detectable 
generalised grey matter volume loss. The patients were recruited early following their 
first clinical attack. Therefore, these data appear to support the hypothesis that the 
visual system is especially susceptible to damage early in MS. It is known that the 
white matter of the visual system is commonly affected early, and it appears that the 
grey matter of the pericalcarine cortex is similarly vulnerable. The reasons for this are 
not clear from this study. Possible explanations could include anatomical factors, 
related to vascular supply or adjacency to CSF spaces, or antigenic factors, specific to 
the neurons of the visual system. The observation is of interest, as studying damage in 
the visual system may offer insights into the factors which are important at an early 
stage of MS. 
 
5.3.4.4 Conclusions 
 
In summary, this study found an association between measures of pericalcarine 
cortical atrophy, in patients presenting with acute ON, and the development of MS 
over the following year. No associations were found between measures of tissue 
damage at different sites in the visual system. Together, these results suggest that 
pericalcarine cortical atrophy, evident at baseline, is more likely to reflect an early 
manifestation of generalised grey matter volume loss in people with early subclinical 
MS, rather than secondary tract-specific degeneration. The grey matter of the visual   240
system may be particularly susceptible to damage in demyelinating disease, in a 
similar manner to the white matter. 
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CHAPTER 6 
 
INVESTIGATING RECOVERY OF VISUAL FIELD DEFECTS AND THE 
ROLE OF THE FELLOW EYE IN OPTIC NEURITIS, USING QUADRANT-
SPECIFIC FMRI 
 
In this chapter, the mechanisms of damage and repair of the optic nerve that underlie 
visual field defects in ON are considered. A wide variety of visual field defects are 
seen in ON, reflecting the patchy nature of the underlying inflammatory pathology. 
Differential involvement of fibres within the optic nerve leads to different patterns of 
visual loss in the individual patient. Whilst any field defect can occur, some are more 
common than others, and it is not known whether some fibres are more susceptible to 
injury. The pattern of visual loss seen on field testing reflects the retinotopic nature of 
visual organisation, and is a direct representation of regions of disruption of the 
afferent input to occipital cortex. However, this inter-individual variability in clinical 
deficit makes recovery from visual field defects particularly difficult to study at group 
level, as the clinical features are so heterogeneous. Selective stimulation of individual 
quadrants of the visual field was performed during the fMRI experiment and the 
neurophysiological assessment, in order to constrain anatomically the region of the 
afferent pathway investigated with each stimulus condition. The aim was to reduce 
heterogeneity in patterns of visual field defect at group level in this manner, 
improving sensitivity to detect region-specific plastic reorganisation responses. In 
addition, this approach allowed investigation of cortical activation, in regions which 
usually process input from identical areas of retina in each eye, as a result of 
homologous retinotopic organisation. This provided an opportunity to directly 
contrast processing in response to normal and abnormal afferent input and, in 
particular, to study fellow eye responses in more depth.  
 
6.1 Introduction 
 
6.1.1 Pathophysiology of visual field defects  
 
Any type of visual field defect may occur in acute ON, and abnormality is detectable 
in 97% of patients, which may be diffuse or localised. However, some patterns are   242
more common than others. For example, three years after the acute episode, residual 
defects are more common in the central field than peripherally (Keltner et al., 1999). 
A diffuse pattern is commonest, and altitudinal and centro-caecal patterns are also 
found relatively frequently (Keltner et al., 1993b) Generally, recovery is good and 
does not differ between diffuse and localised deficits (Fang et al., 1999), but some 
people are left with residual areas of visual loss.  
The mechanisms of damage underlying ON have been discussed in previous chapters, 
and involve inflammation and conduction block in the optic nerve. The nature of the 
resulting visual field defect reflects the affected fibres involved, and the retinotopic 
regions of retina that they serve. Recovery may follow resolution of inflammation and 
restoration of conduction, but residual demyelination and axonal loss can occur. 
Intuitively, it might be anticipated that any regions of persistent defect might reflect 
areas of retina supplied by fibres that have sustained more axonal damage, but this is 
difficult to demonstrate experimentally in vivo. It is not known if there is differential 
sensitivity of axons to damage, or differential predisposition to repair, within the optic 
nerve in demyelinating diseases. In established progressive MS, OCT studies have 
reported greater loss of axons in the temporal quadrant (Henderson et al., 2008). 
Therefore, the factors contributing to a permanent visual field defect in ON remain 
unclear, and it is possible that the relative importance of each factor varies, depending 
on the location of the defect. For example, there might be differential sensitivity to 
demyelination, axonal loss or gliosis, or the margin of axonal redundancy could vary 
in different parts of the optic nerve. Finally, it is possible that the location and 
importance of cortical reorganisation might differ, depending on the anatomical 
location of the defect. 
The heterogeneity in clinical pattern of visual field defects, both with regard to 
location of scotomas and rate of improvement, leads to problems when studying 
mechanisms of recovery with fMRI. It is challenging to capture and characterise 
differences in visual function within individuals which affect fMRI responses at the 
subject level, whilst remaining sensitive to group-level fMRI effects, which may 
represent repair mechanisms that can be generalised to the whole patient population. 
Previous studies have applied whole field stimulation and addressed this problem at 
the analysis stage. Different data modeling approaches have been used, including a 
fixed-effects analysis strategy, the exclusion of patients with little clinical change in 
their field defects over time, and higher level design matrices (Korsholm et al., 2008).   243
Inter-session differences in lower visual areas were demonstrated but, using this 
approach, it was more difficult to generalise inferences to the whole population of 
patients with ON. The idea in the present study was that region-specific stimulation 
would address the issue of clinical heterogeneity at the stage of data acquisition, by 
refining anatomical localisation of activation, and increase sensitivity to region-
specific effects, allowing generalisable inferences at the analysis stage. 
 
6.1.2 Homologous retinotopic representation and the fellow eye 
 
The results reported in Chapter 5 indicated that fellow eye responses are abnormal in 
higher visual areas, during the first few weeks following acute ON. Acute fellow eye 
responses in the LOCs directly correlated with visual outcome in the affected eye. 
Previous studies have reported abnormal responses in lower visual areas following 
ON. In one study, fellow eye fMRI response in primary visual cortex during the acute 
episode correlated with affected eye acuity (Toosy et al., 2005). In another, sustained 
supra-normal responses were found in the LGN for four months following ON, 
reducing subsequently to the same level as the affected eye by six months (Korsholm 
et al., 2007). Therefore, it was of interest to determine if fellow eye responses were 
abnormal in retinotopic regions of primary visual cortex, perhaps indicating 
compensatory plasticity at this level of the visual hierarchy. 
The homologous retinotopic organisation of the visual system facilitates investigation 
of the role of the fellow eye in recovery from ON. Previous studies reporting 
abnormalities of fellow eye responses have all applied visual stimulation to the whole 
visual field, including central areas. This type of stimulus results in diffuse cortical 
activation, which differs slightly between the two eyes, as some peripheral regions 
have only monocular representation. However, region-specific peripheral 
checkerboard stimulation, using the quadrant method described in detail in Chapter 3, 
presented, in turn, to the affected and fellow eyes should normally result in activation 
of an identical, well localised, region of visual cortex, due to homologous retinotopic 
organisation. Studying responses in this region then provides an opportunity to 
directly compare cortical responses from a diseased region of optic nerve, 
representing a discrete visual field defect, with the corresponding healthy region of 
visual field, optic nerve, and cortex representing the fellow eye. 
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6.1.3 Aims  
 
The underlying objectives of this chapter were to elucidate the mechanisms of damage 
and recovery underlying visual field defects in ON, and the role of the fellow eye in 
recovery. The specific aims were derived from three separate hypotheses: 
 
 (1) Firstly, mechanisms of damage were considered, in terms of the susceptibility of 
different fibres to damage, and the reasons for the differing patterns of acute field 
defect, both acutely and during recovery. The hypothesis was that the fibres of the 
temporal disc quadrant, representing the central field, might be particularly 
susceptible to axonal damage. This was investigated by examining region-specific 
clinical data, complemented by region-specific VEP amplitudes and latencies, to 
assess axonal function and myelination, respectively. 
 
(2) Secondly, mechanisms of recovery were considered, with a focus on cortical 
plasticity. The hypothesis was that different patterns of visual field defect might result 
in different anatomical, and perhaps temporal, patterns of extra-striate cortical 
reorganisation during recovery, consistently within individuals.  
 
(3) Lastly, the role of fellow eye responses in visual recovery was considered. The 
hypothesis was that supra-normal activation in the fellow eye might be seen acutely, 
compared with subsequent time-points, indicating a compensatory regional increase in 
brain activity, which might indicate plasticity. This might also be evident as greater 
activity on stimulation of patients’ fellow eyes, compared with control eyes.  
 
In the course of addressing these hypotheses, the feasibility of using region-specific 
stimuli to investigate patients with visual field defects was tested. In particular, the 
use of quadrant-specific VEP and fMRI stimuli, and their combination with quadrant-
specific clinical data, was a novel approach. Correlations between clinical, 
electrophysiological and fMRI parameters were investigated during the acute episode, 
as it was hypothesised that between-subject variance would be maximal at this time. 
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6.2 Methods 
 
Aspects of the methodology which been described in preceding chapters will not be 
replicated. In particular, the region-specific fMRI visual stimulation paradigm is 
described in detail in Chapter 3. New elements, specific to this part of the study, will 
be fully reported in this section. 
 
6.2.1 Participants 
 
The same cohort of subjects was studied that participated in the experiments reported 
in Chapter 5, at the same time-points (baseline, three months, six months and 12 
months).  
 
6.2.2 Region-specific clinical assessment 
 
Visual fields were examined using the 30-2 programme on the Humphrey automated 
field analyser (Allergan-Humphrey Inc., San Leandro, Ca., USA). Patients were 
assessed longitudinally, and each control was assessed once. The field was split into 
four peripheral quadrants and a central circle. The central circle comprised the central 
6
o of the field, and the rest of the test-points in each field were allocated to four 
quadrants, divided according to the vertical and horizontal meridians, and extending 
up to 15
o from the fixation point, covering a similar proportion of field (30
ox30
o) as 
the visual fMRI display. There were four test-points in the central circle, and either 
seven or eight in each quadrant, depending on the presence or absence of the blind-
spot. Data summarising the total deviation from the mean at each point of the field 
were averaged for each region, as a measure of the regional field defect. The 
quadrants were referred to as upper left, upper right, lower left, lower right and central 
circle for each eye (Figure 6.1). Therefore, for each quadrant category, cortical 
representation was the same, regardless of which eye was affected. 
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Figure 6.1 Method of extraction of region-specific Humphrey data. An example of a Humphrey visual 
field printout from a patient’s left eye is shown. The qualititative grey map corresponds to each 
quantitative numbered map. Each number indicates the allocated score for that point in the field. The 
upper numbered map, adjacent to the grey map, show how the field was divided to extract the raw 
scores. The numbers represent the minimal luminance stimulus that the subject could detect at that 
point in the visual field. The divisions used in this study are outlined on this map, in blue for the 
quadrants: (A) left upper, (B) right upper, (C) left lower and (D) right lower, and (E) in red for the 
central field. The lower numbered fields contain the corresponding data, adjusted for age with respect 
to the reference population and was the dataset actually used in this study. 
 
6.2.3 Region-specific electrophysiology 
 
Quadrant-specific VEP data was collected longitudinally for the patients, and once for 
the controls. The screen subtended 28
o of visual angle horizontally and 22
o vertically, 
and the central circle extended from 0 to 4
o. Each quadrant extended 14
o from the 
horizontal meridian and 11
o from the vertical meridian, excluding the region occupied 
by the central circle. Check size was 40'. An occipital electrode 5cm above the inion   247
was used to reference Fz. The amplitude of the response and the latency of the P100 
waveform were calculated. 
 
6.2.4 Region-specific functional MRI 
 
Quadrant-specific fMRI stimuli were presented, as described in Chapter 3. The 
presentation screen subtended 30
o horizontally and 28
o vertically, and the central 
circle extended from 0 to 5
o. Thus, there were minimal differences in the dimensions 
of the display media for the clinical, electrophysiological and fMRI stimuli. The 
central circle varied between 4-6
o, the horizontal extent of the quadrants between 28-
30
o, and the vertical extent between 22-30
o. This variability was the minimum that 
could be achieved, given practical constraints in the apparatus used. It is of note that 
activation following VEP stimuli is mostly dependent on the central 10
o of stimulation 
(Rinalduzzi et al., 2001). 
 
6.2.5 Statistical analysis 
 
6.2.5.1 Clinical data 
The raw grey maps were copied and displayed, in order to illustrate to the reader 
qualititative changes in visual field defects over time. In order to quantify field defects 
in each quadrant and the central circle, the region-specific total deviation data were 
extracted, for each region, for each eye, for each subject, at each time-point. Means 
and standard deviations were calculated for each region, at each time-point. A one-
way analysis of variance model was estimated, in Stata-9.2, to assess differences in 
clinical scores between regions, at each time-point. Mixed effects linear regression 
models were used to analyse changes over time. The type of model was identical to 
those described in Chapter 5. Paired t-tests were used to assess residual differences 
between affected and fellow eyes at 12 months. 
The Humphrey analyser had a minor calibration error, identified at the start of the 
study, which resulted in an overestimation of error scores. Therefore, data from the 
control group, who were age and sex-matched to the patient group, were used to 
recalibrate the patient data. The mean total error score was calculated in the control 
group and averaged for right and left eyes. The resulting value (-5.066) was taken to   248
represent a true error score of zero and, therefore, this value was subtracted from the 
patient data, at each point in the visual field. 
 
6.2.5.2 Electrophysiology 
Mixed effects linear regression models were used to assess changes in region-specific 
VEP amplitude and latency over time. 
 
6.2.5.3 Voxel-based and region-of-interest approaches to fMRI data 
Two different analysis approaches were used: a voxel-based whole brain analysis and 
a region-of-interest approach, and the results of both are reported.  
The location of any brain reorganisation contributing to region-specific recovery of 
field defects in ON is not known. In this situation, as there is no anatomical a priori 
hypothesis, a whole brain voxel-wise analysis is the preferred approach, as it is 
unbiased and may identify hitherto unsuspected important areas. However, the large 
number of multiple comparisons inherent in this method requires relatively stringent 
statistical correction and this, combined with normal inter-subject variability, can lead 
to a lack of sensitivity to detect subtle effects at group level. 
In contrast, to investigate the role of the fellow eye, it was possible to identify 
regions-of-interest, based on areas of maximal group activation, corresponding to the 
relevant areas of retinotopic visual cortex. Although this approach constrains the 
anatomical hypothesis, it has the advantage of a greater sensitivity to subtle effects, as 
statistical correction for every voxel in the brain is not required. 
Therefore, both methods were used. The voxel-based approach was used to assess any 
cortical reorganisation across the whole brain, by testing the following: (1) Cross-
sectional fMRI response to affected and fellow eye stimulation at each time-point; (2) 
Longitudinal changes in fMRI response in affected and fellow eyes over time; (3) 
Differences between affected and fellow eye responses at each time-point; (4) 
Differences between patients and controls at each time-point. Each of these tests was 
repeated individually for each condition of region-specific stimulation.  
The region-of-interest approach was used to investigate the role of the fellow eye, by 
testing the following: (1) Longitudinal differences in affected and fellow eyes over 
time; (2) Cross-sectional differences in affected and fellow eye responses at each 
time-point; (3) Cross-sectional differences between patients and controls at each time-  249
point. Each of these tests was again repeated, in turn, for each condition of region-
specific stimulation.  
In addition, in order to assess the feasibility of the quadrant-specific approach, both 
methods were used to assess correlations between clinical, electrophysiological and 
fMRI data during the acute episode, and the results compared.  
Therefore, each of the following sections is split into two parts, first describing the 
voxel-based approach and then the region-of-interest approach. 
All voxel-based analysis was performed in SPM5, and all region-of-interest analysis 
in Stata-9.2. Results were considered significant at p<0.05, unless otherwise stated. 
 
6.2.5.4 FMRI activation in patients and controls 
6.2.5.4.1 Voxel-based  
One-sample t-tests were specified in order to identify the main effect of stimulation 
and any areas of extra-striate activation, for each quadrant, at each time-point, in 
patients and controls. Covariates indicating whether ON affected the left or right side 
were entered into the model. For controls, a randomly selected eye was designated 
“affected”, so that the methodology was identical to the patients.  
This analysis was performed twice. Firstly all available data were entered at each 
time-point. The analysis was then repeated including only those subjects who had 
fMRI data available at every time-point. This was to allow a meaningful visual 
comparison of the activation patterns at each time-point within an identical group. The 
cohort with fMRI data available at all time-points comprised 16 patients, and 8 
controls. Of the remainder, reasons for missing time-points are described in Results 
section 6.3.1. Images were thresholded at cluster-level p<0.05 (corrected). 
The spatial extent of activation was assessed in each patient, at each time-point, by 
extracting the total number of activated voxels from each map, thresholded at cluster-
level p<0.05 (corrected). Linear mixed effects models were used to assess the 
significance of any changes over time. 
 
Flexible factorial models were specified, in order to quantitatively assess differences 
between patients’ affected and fellow eyes, longitudinal changes over time, and 
differences between patients and controls. The flexible factorial model in SPM5 
allows for missing data-points, so all available data were used for this analysis.    250
Three factors were specified: (1) Subject, (2) Group (affected/fellow or 
patient/control) and (3) Time-point. The distribution of errors and error variances 
were specified as follows: (1) within-subject level- independent and equal; (2) group 
level for affected/fellow comparisons- non-independent and equal; group level for 
patient/control comparisons- independent and unequal; (3) time-point level- non-
independent and equal. The interaction between group and time was specified, and 
side affected was entered as a covariate. This resulted in the following model (Figure 
6.2), which allowed two-sample t-tests to compare groups at each time-point. For 
example, to test patients at baseline versus controls at baseline, the contrast (1 0 0 0 -1 
0 0 0 0) was entered. 
 
    
Figure 6.2 SPM5 flexible factorial design matrix for two-group comparisons. 
 
To assess longitudinal effects, linear and second order changes were investigated. In 
addition, an exponential model was specified, which aimed to capture any changes in 
fMRI signal which paralleled the temporal pattern of clinical improvement in ON 
(Figure 6.3).  
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Figure 6.3 An illustration of contrasts used to assess different patterns of change over time. 
 
The contrasts illustrated above were specified as follows: 
Linear increase (-1.5 -0.5 0.5 1.5) 
Linear decrease (1.5 0.5 -0.5 -1.5) 
Second order positive change (-1 1 1 -1) 
Second order negative change (1 -1 -1 1) 
Exponential increase (-5 0 2 3) 
 
Interpretation of longitudinal changes using a voxel-based approach over the whole 
brain can be difficult, because fMRI is sensitive to changes over time due to scanner 
drift, attention and adaptation/habituation effects. These may cause artefacts, which 
can be difficult to separate from genuine disease effects. For these reasons, and 
because of concerns that the region-specific approach might result in lower signal-to-
noise than whole field stimulation, a preliminary analysis was performed in the 
control group to identify an appropriate threshold to apply to the maps, in which 
artefact was minimised. A cluster-level threshold of p<0.001 (corrected) was selected, 
which was subsequently applied to the patient group. A further discussion of problems 
inherent to longitudinal fMRI studies is included in Appendix III for the interested 
reader. 
 
6.2.5.4.2 Regions-of-interest  
The cortical regions-of-interest involved in processing afferent input from each 
corresponding region of stimulated visual field were specified using the group fMRI 
data from the study cohort. In this manner, retinotopic areas of early visual cortex   252
were identified, in which it was possible to directly compare affected and fellow eye 
activation. This methodology involved extracting data from SPM5 and analysing it, 
together with the corresponding VEP and clinical data, in Stata-9.2. This was a useful 
benefit of the approach as, in SPM5, fMRI response is constrained as the dependent 
variable whereas, in the investigation of disease, clinical outcomes may be of interest.  
 
The steps involved in specifying the regions-of-interest were as follows: firstly, fMRI 
scans were combined, for all patients and all controls, at all time-points, for affected 
and fellow eyes, for each of the four quadrants and the central circle conditions, in 
turn, using one-sample t-tests in SPM5. All time-points were combined, rather than 
averaging at each individual time-point, to increase signal-to-noise, in order to 
optimise the estimates for this group. This was felt to be more important for region-
specific stimuli than the potential disadvantage of introducing a bias to the estimates 
from subject dropout, as previously discussed in Chapter 4. 
Regions-of-interest were then created, using the MarsBar SPM toolbox (Brett et al., 
2002), above and below the calcarine fissure, on the right and left sides, 
corresponding to stimuli in the lower and upper quadrants, on the left and right sides, 
respectively. Bilateral clusters at the occipital poles were used for the central circle. 
The size of the regions was standardised by specifying spheres of radius 1cm, 
contained within the clusters, centred on the group global maxima (Figure 6.4).  
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Figure 6.4 The regions-of-interest from which fMRI data were extracted are shown, overlaid on to a 
normalised brain in MNI space. In (A), the bilateral regions responding to central stimulation are 
shown in axial, coronal, left sagittal and right sagittal section. In (B), the regions of response to lower 
right quadrant stimulation are shown in red, and to upper right quadrant stimulation in blue. In (C), 
regions of response to lower left quadrant stimulation are shown in blue, and upper left stimulation in 
red. L-left, R-right. 
 
The mean parameter estimates were extracted, representing the mean BOLD response 
in each region over the course of the experiment, for each subject, at each time-point. 
For the central circle, data from the two spheres were averaged. 
Longitudinal changes were assessed using mixed effects linear regression models, for 
the patients’ affected eye, fellow eye, and a randomly selected control eye. The 
magnitude of any differences at a given time-point was calculated from the difference 
in predicted means at that time, calculated from the regression slopes, in order to use 
all available data. Differences were calculated by dividing the affected eye parameter 
estimate by the fellow eye, and multiplying by 100%. The results were then expressed 
as the percentage difference in BOLD signal change in the affected eye, with respect 
to the fellow. For example, BOLD parameter estimates of 0.8 for the affected eye and 
1.0 for the fellow would be expressed as -20%. The same methodology was used for 
patients’ eyes, with respect to controls.   254
Cross-sectional differences between affected and fellow eyes, and patients and 
controls, were assessed using paired and unpaired t-tests, respectively.  
 
6.2.5.5 Correlation analyses in the acute phase 
6.2.5.5.1 Clinical-electrophysiological correlations 
Multivariable regression models were specified in Stata-9.2 to assess correlations 
between clinical data and each affected eye VEP parameter (amplitude and latency), 
in turn, at the baseline time-point. 
 
6.2.5.5.2 FMRI correlations with clinical and electrophysiological data: voxel-based 
Both voxel-based and region-of-interest approaches were used to assess correlations 
between region-specific fMRI responses and clinical and VEP data, at the baseline 
time-point. 
Voxel-based analyses were performed using group-level multivariable regression 
models in SPM5. Separate models were specified for each condition, entering the 
first-level fMRI contrast images for each patient, together with the corresponding 
clinical or electrophysiological variable: either Humphrey data, VEP amplitude or 
VEP latency from the affected eye. Side of stimulation and the relevant fellow eye 
variable (either clinical or electrophysiological) were added as covariates, in order to 
account for normal inter-individual variability in visual acuity and VEP parameters. 
The clinical or electrophysiological regressor relating to the affected eye was 
interrogated, to identify any positive (1 0 0) or negative (-1 0 0) associations with the 
fMRI data. 
The location of any significant clusters was identified using the SPM5 Anatomy 
toolbox (Eickhoff et al., 2005). 
 
6.2.5.5.3 FMRI correlations with clinical and electrophysiological data: regions-of-
interest  
Separate multivariable regression models were specified to investigate associations 
between the extracted fMRI data, from each region, and each of the corresponding 
clinical and electrophysiological variables, in turn. The relevant, corresponding fellow 
eye data (either clinical or electrophysiological) was again entered into the model, to 
correct for any normal inter-individual variability. 
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6.3 Results 
 
6.3.1 Participants 
 
Clinical data was available for all 99 patient attendances and 9/10 controls. In one 
control, it was not possible to acquire Humphrey data for logistical reasons. 
Quadrant-specific VEP data was available for 96/99 patient attendances, and 10/10 
control time-points. Data was missing for three time-points due to unavailability of 
technical staff. Quadrant-specific fMRI data was available for 123/133 subject 
attendances, and was unavailable for one patient at three months, three patients at six 
months, and six patients at the 12 month time-point. The reasons for missing data 
were as follows: patient pregnancy in five cases, scanner hardware or software 
problems in four cases, and claustrophobia in the scanner in the remaining case. 
Sixteen patients and eight controls had fMRI data available at all time-points, and 
were entered into the additional cross-sectional analysis of fMRI activation patterns, 
as described in section 6.2.5.4.1. The reasons that data was unavailable for at least one 
time-point in the remainder were as follows: four patients and two controls decided 
they did not want to continue in the study, five patients missed at least one visit due to 
pregnancy, one due to claustrophobia, and two due to scanner hardware/software 
failure.  
 
6.3.2 Region-specific clinical data 
 
There were no significant differences between regions in the severity of visual loss in 
the affected eye at any time-point (baseline F=0.33, p=0.854; three months F=0.31, 
p=0.868; six months F=0.89, p=0.473; 12 months F=1.05, p=0.387). In terms of mean 
visual scores, the lowest during the acute episode was in the central field and, 
following recovery at 12 months, was in the right upper quadrant (Table 6.1). 
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Region-of-interest  Controls  Patients 
affected 
Patients 
fellow 
Patients 
differences  
Central circle: BL  0.20 (1.23)  -16.55 (11.30)  0.49 (1.20)  -17.04 
3M   -3.14  (4.11)  0.56  (1.59)  -3.70 
6M   -2.96  (3.13)  0.50  (1.19)  -3.46 
12M   -1.65  (2.45)  0.65  (1.37)  -2.30 
Right upper quadrant: BL  -0.51 (2.18)  -13.78 (10.54)  -0.58 (1.68)  -13.2 
3M    -3.50 (4.72)  -0.10 (1.89)  -3.40 
6M    -3.63 (4.14)  -0.14 (2.03)  -3.49 
12M    -2.76 (3.74)  -0.07 (1.67)  -2.69 
Right lower quadrant: BL  0.12 (1.70)  -14.70 (10.73)  -0.13 (1.62)  -14.57 
3M   -2.42  (3.23)  0.51  (1.83)  -2.93 
6M   -2.05  (2.93)  0.46  (1.17)  -2.51 
12M   -1.81  (2.66)  0.19  (1.38)  -2.00 
Left lower quadrant: BL  0.38 (1.44)  -14.20 (10.66)  -0.49 (1.46)  -13.71 
3M   -2.84  (4.27)  0.34  (1.87)  -3.18 
6M   -2.29  (2.99)  0.36  (1.64)  -2.65 
12M   -1.44  (2.24)  0.25  (1.29)  -1.69 
Left upper quadrant: BL  -0.18 (2.03)  -13.73 (9.91)  -1.23 (1.64)  -12.5 
3M   -3.61  (4.83)  0.02  (1.92)  -3.63 
6M   -2.58  (2.30)  0.09  (1.60)  -2.67 
12M    -2.61 (2.85)  -0.23 (1.72)  -2.38 
Table 6.1 Mean region-specific Humphrey scores for patients’ affected eyes, patients’ fellow eyes, 
controls’ eyes and inter-ocular differences in patients (calculated by subtracting the fellow eye score 
from the affected eye score). Standard deviations are given in brackets. 
  
Changes in the patients’ visual fields in the affected eye over time are illustrated in 
Figure 6.5. The visual score at each point in the field was used to create a grey-scale 
map, with darker regions indicating progressively denser field defects, in which 
progressively higher luminance stimuli were required to elicit a response. 
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Figure 6.5 Visual field data is shown for the 28 patients involved in the study. The four fields in each 
row correspond to the four time-points, in chronological order. A missing time-point is denoted by x. 
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In Figure 6.6, quantitative longitudinal changes in visual field scores are plotted. Most 
of the improvement in the affected eye occurred in the first three months for all 
regions (Table 6.2). There were still significant differences between the affected and 
fellow eye, at 12 months. 
 
 
Figure 6.6 Graphs illustrating changes in region-specific Humphrey deviation scores over time, for 
each of the four quadrants and the central circle. The bars show standard errors.  
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Region  Baseline to 3 months 
Rate of change (HMD 
/month) 
Baseline to 12 months 
Rate of change (HMD 
/month) 
Difference at 
12 months 
(Aff-fell) 
  Rate   95% CI  p value  Rate  95% CI  p value  HMD  p value 
Aff central  +4.39 3.40,  5.39 <0.001  +1.22 0.97,  1.47 <0.001 
Fell central  +0.02  -0.16,0.20     NS  +0.01  -0.03,0.06     NS 
 
-2.30 
 
<0.001 
Aff right upper   +3.32 2.45,  4.20 <0.001  +0.90 0.68,  1.12 <0.001 
Fell right upper   +0.14  -0.08,0.37     NS  +0.04  -0.01,0.10     NS 
 
-2.69 
  
  0.002 
Aff right lower  +4.06 3.10,  5.02 <0.001  +1.07 0.83,  1.31 <0.001 
Fell right lower  +0.20  -0.01,0.10     NS  +0.03  -0.03,0.08     NS 
 
-2.00 
  
  0.001 
Aff left lower  +3.74 2.71,  4.76 <0.001  +1.05 0.80,  1.31 <0.001 
Fell left lower  +0.28  0.06, 0.50    0.013  +0.06  0.01, 1.40    0.029 
 
-1.69 
 
<0.001 
Aff left upper  +3.31 2.44,  4.18 <0.001  +0.90 0.69,1.12  <0.001 
Fell left upper  +0.41  0.15, 0.67    0.002  +0.08  0.02, 0.15    0.013 
 
-2.38 
 
<0.001 
Table 6.2 Rates of change in clinical scores, between baseline and three months, and baseline and 12 
months, derived from the linear regression models. The p-value refers to the significance of the slope. 
The residual difference between affected and fellow eyes at twelve months is reported. The p-values 
are derived from a two-sample t-test. Aff-affected, CI-confidence intervals, Fell-fellow, HMD-
Humphrey mean deviation, NS-non-significant. 
 
There were also some changes in fellow eye scores, which were small in magnitude 
but statistically significant. 
 
6.3.3 Region-specific electrophysiology 
 
Changes in region-specific VEP amplitude over time are illustrated in Figure 6.7, and 
the significance of the regression slopes is reported in Table 6.3. 
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Figure 6.7 Graphs illustrating changes in VEP amplitude over time, for each of the four quadrants and 
the central circle. The graphs show standard errors. All significant (p<0.05) and borderline (p<0.1) p 
values are reported. For clarity, p values >0.1 are not shown.  
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Region  Baseline to 3 months 
Rate of change (μV 
/month) 
Baseline to 12 months 
Rate of change (μV 
/month) 
Difference at 
12 months 
(Aff-fellow) 
  Rate   95% CI  p value  Rate  95% CI  p 
value 
VEP 
amp 
p value 
Aff central   0.44  0.07,0.81    0.019   0.01  -0.08,0.11   NS 
Fell central   0.02  -0.31,0.35      NS  -0.08  -0.17,0.01   NS 
 
-1.93 
 
0.001 
Aff right upper    0.38  0.20,0.55  <0.001   0.08  0.03, 0.12  0.001 
Fell right upper    0.09  -0.07,0.26      NS  -0.02  -0.06,0.02   NS 
 
-0.41 
 
  NS 
Aff right lower   0.42  0.23,0.60  <0.001   0.08  0.03, 0.13  0.002 
Fell right lower   0.04  -0.21,0.28      NS  -0.05  -0.12,0.01   NS 
 
-0.38 
 
  NS 
Aff left lower   0.22  0.02,0.42    0.028   0.05  -0.01,0.10   NS 
Fell left lower   0.01  -0.20,0.21      NS   0.01  -0.05,0.06   NS 
 
-0.87 
 
0.010 
Aff left upper   0.13  -0.06,0.31      NS   0.03  0.02, 0.08   NS 
Fell left upper  -0.05  -0.21,0.11      NS  -0.06 -0.10,-0.02  0.008 
 
-0.23 
 
  NS 
Table 6.3 Rates of change in VEP amplitudes, between baseline and three months, and baseline and 12 
months, derived from the linear regression models. The p-value refers to the significance of the slope. 
The residual difference between affected and fellow eyes at twelve months is reported. The p-values 
are derived from a two-sample t-test. Aff-affected, amp-amplitude, CI-confidence intervals, Fell-
fellow, NS-non-significant, VEP-visual evoked potential. 
 
Affected eye amplitudes increased in all quadrants in the first three months, except for 
the left upper quadrant, which did not improve significantly until six months. After six 
months, affected eye amplitudes generally reached a plateau. Fellow eye VEPs either 
remained stable, or decreased in amplitude over time. 
 
Changes in region-specific VEP latency are illustrated in Figure 6.8. 
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Figure 6.8 Graphs illustrating changes in VEP latency over time, for each of the four quadrants and the 
central circle. The graphs show standard errors. All significant (p<0.05) and borderline (p<0.1) p values 
are shown. For clarity, p values >0.1 are not shown. 
 
There was a decrease in VEP latency, on stimulating the central circle, between 
baseline and 12 months (-0.78ms/month [-0.12, -1.43], p=0.020), but no changes in 
any of the other quadrants. In the fellow eye, VEP latency remained stable or 
marginally increased over time. 
 
6.3.4 Region-specific functional MRI  
 
6.3.4.1 Controls 
6.3.4.1.1 Voxel-based: cross-sectional fMRI responses 
Firstly, in order to demonstrate normal responses to region-specific fMRI stimulation, 
control group activation maps are shown for each of the four quadrants and the central 
circle, at each time-point (Figures 6.9-6.13).    263
 
Figure 6.9 Statistical parametric maps showing fMRI activation in controls, over time, in response to 
upper right quadrant stimulation, overlaid on to an axial section of the SPM5 canonical MNI-152 brain 
template, and a coronal section of the SPM5 glass brain. The graph plots the global maximal parameter 
estimate (PE) at each of the four time-points, and the error bars represent 95% confidence intervals.   264
 
Figure 6.10 Statistical parametric maps showing fMRI activation in controls, over time, in response to 
lower right quadrant stimulation, overlaid on to an axial section of the SPM5 canonical MNI-152 brain 
template, and a coronal section of the SPM5 glass brain. The graph plots the global maximal parameter 
estimate (PE) at each of the four time-points, and the error bars represent 95% confidence intervals.   265
 
Figure 6.11 Statistical parametric maps showing fMRI activation in controls, over time, in response to 
lower left quadrant stimulation, overlaid on to an axial section of the SPM5 canonical MNI-152 brain 
template, and a coronal section of the SPM5 glass brain. The graph plots the global maximal parameter 
estimate (PE) at each of the four time-points, and the error bars represent 95% confidence intervals.   266
 
Figure 6.12 Statistical parametric maps showing fMRI activation in controls, over time, in response to 
upper left quadrant stimulation, overlaid on to an axial section of the SPM5 canonical MNI-152 brain 
template, and a coronal section of the SPM5 glass brain. The graph plots the global maximal parameter 
estimate (PE) at each of the four time-points, and the error bars represent 95% confidence intervals.   267
 
 Figure 6.13 Statistical parametric maps showing fMRI activation in controls, over time, in response to 
stimulation of the central circle, overlaid on to an axial section of the SPM5 canonical MNI-152 brain 
template, and a coronal section of the SPM5 glass brain. The graph plots the global maximal parameter 
estimate (PE) at each of the four time-points, and the error bars represent 95% confidence intervals. 
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Accurate lateralisation was demonstrated and reasonable localisation above, or below, 
the calcarine fissure. The voxel-based longitudinal models, including all available 
data, showed no significant changes over time. Examining the graphs, no clear pattern 
of change in the global maximal signal change was evident. 
 
6.3.4.1.2 Voxel-based: longitudinal changes 
Longitudinal models, including all available data, showed no significant changes over 
time in the control group.  
 
6.3.4.1.3 Voxel-based: differences between eyes 
There were no differences between the two control eyes. 
 
6.3.4.1.4 Regions-of-interest: longitudinal changes 
There were no longitudinal changes over time in the control group. 
 
6.3.4.1.5 Regions-of-interest: differences between eyes 
There were no differences between the two control eyes. 
 
6.3.4.2 Patients: affected and fellow eyes 
6.3.4.2.1 Voxel-based: cross-sectional fMRI responses 
Figures 6.14-6.18 illustrate group activation in patients, for each of the four quadrants 
and the central circle, at each time-point, for both the affected and fellow eye. 
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Figure 6.14 Statistical parametric maps showing fMRI activation in patients, in the affected and fellow 
eyes, over time, in response to stimulation of the right upper quadrant, overlaid on to an axial section of 
the SPM5 canonical MNI-152 brain template, and a coronal section of the SPM5 glass brain. The 
graphs plot the group mean global maximal parameter estimate at each of the four time-points, for the 
affected eye (in blue) and the fellow eye (in pink). The error bars represent 95% confidence intervals.   270
 
Figure 6.15 Statistical parametric maps showing fMRI activation in patients, in the affected and fellow 
eyes, over time, in response to stimulation of the right lower quadrant, overlaid on to an axial section of 
the SPM5 canonical MNI-152 brain template, and a coronal section of the SPM5 glass brain. The 
graphs plot the group mean global maximal parameter estimate at each of the four time-points, for the 
affected eye (in blue) and the fellow eye (in pink). The error bars represent 95% confidence intervals.   271
 
Figure 6.16 Statistical parametric maps showing fMRI activation in patients, in the affected and fellow 
eyes, over time, in response to stimulation of the left lower quadrant, overlaid on to an axial section of 
the SPM5 canonical MNI-152 brain template, and a coronal section of the SPM5 glass brain. The 
graphs plot the group mean global maximal parameter estimate at each of the four time-points, for the 
affected eye (in blue) and the fellow eye (in pink). The error bars represent 95% confidence intervals.   272
 
Figure 6.17 Statistical parametric maps showing MRI activation in patients, in the affected and fellow 
eyes, over time, in response to stimulation of the left upper quadrant, overlaid on to an axial section of 
the SPM5 canonical MNI-152 brain template, and a coronal section of the SPM5 glass brain. The 
graphs plot the group mean global maximal parameter estimate at each of the four time-points, for the 
affected eye (in blue) and the fellow eye (in pink). The error bars represent 95% confidence intervals.   273
 
Figure 6.18 Statistical parametric maps showing MRI activation in patients, in the affected and fellow 
eyes, over time, in response to stimulation of the central circle, overlaid on to an axial section of the 
SPM5 canonical MNI-152 brain template, and a coronal section of the SPM5 glass brain. The graphs 
plot the group mean global maximal parameter estimate at each of the four time-points, for the affected 
eye (in blue) and the fellow eye (in pink). The error bars represent 95% confidence intervals. 
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There were no significant longitudinal changes in the spatial extent of activation and 
no clear evidence of extra-striate activation. The mean global maximal response in the 
affected eye was lower than fellow at baseline, but increased over time, and no 
differences were evident at 12 months. 
 
6.3.4.2.2 Voxel-based: longitudinal changes 
No significant longitudinal changes were seen in the patient group over time, either in 
the affected eye or the fellow eye. 
 
6.3.4.2.3 Voxel-based: affected versus fellow 
No significant differences between patients’ affected and fellow eye responses were 
seen at any time-point. 
 
6.3.4.2.4 Regions-of-interest: longitudinal changes in affected and fellow eyes 
Longitudinal changes in the fMRI response in the regions-of-interest in the patient 
group, on stimulation of the affected and fellow eyes, are summarised in Figure 6.19.  
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Figure 6.19 Graphs illustrate changes in fMRI response over time, for each of the four quadrants and 
the central circle. The bars show standard errors. All significant (p<0.05) and borderline (p<0.1) p 
values are shown. For clarity, p values >0.1 are not shown. The scale on the y axis refers to the group 
mean extracted parameter estimates, a measure of BOLD response. BOLD-blood oxygenation level 
dependent. 
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Region  Baseline to 3 months 
Rate of change (BOLD 
parameter estimate 
/month) 
Baseline to 12 months 
Rate of change (BOLD 
parameter estimate 
/month)  
Difference at 
12 months 
(Aff-fellow) 
  Rate   95% CI  p value  Rate  95% CI  p value  BOLD    p  
Aff central  0.24  -0.03,0.51    NS  0.05  -0.02,0.13    NS 
Fell central  0.04  -0.35,0.27    NS  0.03  -0.05,0.12    NS 
 
-0.73 
 
  NS 
Aff right upper   0.43   0.12,0.74  0.007  0.07  -0.01,0.15    NS 
Fell right upper   0.26  -0.08,0.59    NS  0.01  -0.08,0.11    NS 
 
-0.15 
 
  NS 
Aff right lower  0.29  -0.01,0.59    NS  0.09   0.01,0.17  0.03 
Fell right lower  0.21  -0.15,0.58    NS  0.03  -0.07,0.13    NS 
 
 0.00 
 
  NS 
Aff left lower  0.42   0.10,0.74  0.011  0.09   0.00,0.17    NS 
Fell left lower  0.10  -0.30,0.49    NS  0.08  -0.02,0.19    NS 
 
-0.66 
 
  NS 
Aff left upper  0.14  -0.27,0.56    NS  0.07  -0.04,0.18    NS 
Fell left upper  0.22  -0.09,0.53    NS  0.01  -0.07,0.10    NS 
 
-0.60 
 
  NS 
Table 6.4 Rates of change in fMRI activity between baseline and three months, and baseline and 12 
months, derived from the linear regression models. The p-value refers to the significance of the slope. 
The residual difference between affected and fellow eyes at twelve months is reported. The p-values 
are derived from a two-sample t-test. Aff-affected, BOLD- blood oxygenation level-dependent, CI-
confidence intervals, Fell-fellow, NS-non-significant. 
 
There was at least a trend for an increase in the fMRI response in all regions between 
baseline and three months, except in the left upper quadrant, in which the 
improvement was not significant at three months, and was borderline at six months. 
After six months, increases reached a plateau. The only significant changes in the 
fellow eye were for the lower right quadrant, with an increase between baseline and 
six months. There were no significant decreases in fellow eye fMRI response. 
 
6.3.4.2.5 Regions-of-interest: affected versus fellow eyes 
The magnitude and significance of differences in BOLD response between affected 
and fellow eyes, in each region-of-interest, are summarised in Table 6.5.  
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Region  Baseline % diff 
(p value) 
3 months  
% diff (p value) 
6 months % 
diff (p value) 
12months % 
diff (p value) 
Central circle  -32% (0.017)   -8%      (0.551)   -3%   (0.898)  -22% (0.231)  
Right upper 
quadrant 
-28% (0.025)  -12%    (0.212)  +1%  (0.856)   -8%   (0.794)  
Right lower 
quadrant 
-23% (0.006)   -15%    (0.107)  -17% (0.061)   -4%   (1.000)  
Left lower 
quadrant 
-23%  (0.061)   -1%      (0.656)   -14% (0.269)   -19% (0.124)  
Left upper 
quadrant 
-27% (0.040)   -28% (<0.001)  -12% (0.456)   -13% (0.188)  
Table 6.5 Differences in BOLD fMRI response between affected and fellow eyes, from the region-of-
interest analysis. The percentage mean difference in BOLD change is reported, with respect to the 
affected eye (for example, a difference of -32% indicates that the BOLD signal change was 32% less in 
the affected eye than the fellow). The associated p values are reported in parentheses, which were 
derived from two-sample paired t-tests. Significant results are highlighted in bold. 
 
Fellow eye responses were greater than affected eye responses at baseline. At three 
months, there were no significant differences between the two eyes, except for the left 
upper quadrant, in which recovery of fMRI response appeared to lag behind. This is 
the same quadrant in which recovery of VEP amplitude was slower (Figure 6.7). It 
also had the lowest mean visual score at three months (Table 6.1). There were no 
significant differences between eyes for the other regions at three months, and for any 
regions at six or 12 months. 
 
6.3.4.3 Patients versus controls 
6.3.4.3.1 Voxel-based 
No significant differences were found between controls and patients, for either the 
affected or fellow eye, using the voxel-based analysis approach. 
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6.3.4.3.2 Regions-of-interest 
Differences in BOLD responses for corresponding regions in patients and controls are 
summarised in Table 6.6.  
 
Region  Affected/fellow eye  Baseline 
% diff 
(p value)
3 months 
% diff 
(p value) 
6 months 
% diff  
(p value) 
12months 
% diff 
(p value) 
Central circle  Affected vs controls  -31% 
(0.186) 
-3% 
(0.858) 
+56% 
(0.193) 
-2% 
(0.983) 
  Fellow vs controls  -6% 
(0.783) 
+20% 
(0.514) 
+1% 
(0.960) 
+13% 
(0.639) 
Right upper 
quadrant 
Affected vs controls  -41% 
(0.119) 
+14% 
(0.491) 
-5% 
(0.915) 
-18% 
(0.895) 
  Fellow vs controls  -18% 
(0.396) 
+9% 
(0.590) 
+13% 
(0.465) 
-12% 
(0.957) 
Right lower 
quadrant  
Affected vs controls  -51% 
(0.011) 
-7% 
(0.664) 
+20% 
(0.460) 
+6% 
(0.605) 
  Fellow vs controls  -15% 
(0.575) 
-5% 
(0.874) 
+35% 
(0.247) 
-11% 
(0.831) 
Left lower 
quadrant 
Affected vs controls  -39% 
(0.052) 
-10% 
(0.568) 
-15% 
(0.568) 
-18% 
(0.481) 
  Fellow vs controls  -3% 
(0.898) 
+1% 
(0.892) 
-7% 
(0.724) 
-1% 
(0.990) 
Left upper 
quadrant 
Affected vs controls  -40% 
(0.021) 
-24% 
(0.217) 
+11% 
(0.666) 
0% 
(0.852) 
  Fellow vs controls  +8% 
(0.680) 
+14% 
(0.230) 
+28% 
(0.301) 
+28% 
(0.320) 
Table 6.6 Differences in BOLD fMRI response between patients and controls, from the region-of-
interest analysis. The percentage mean difference in BOLD response is reported, with respect to 
patients (for example, a difference of -31% indicates that the BOLD signal change was 31% less in the 
patients’ eyes than the controls). The associated p value is reported in parentheses, derived from a two-
sample unpaired t-test. Significant results are highlighted in bold font.   279
Differences were identified between patients’ affected eyes and controls at the 
baseline time-point only. At this time, patients’ affected eye responses were smaller 
than controls, although this did not reach statistical significance in all regions.  
There were no significant differences between fellow eye and control responses at any 
time-point.  
 
6.3.5 Correlation analysis 
 
6.3.5.1 Clinical-electrophysiological correlations 
There were strong correlations between region-specific Humphrey visual field scores 
and region-specific VEP amplitude for all of the quadrants and the central circle at the 
baseline time-point (Table 6.7). The direction of the association indicated that greater 
VEP amplitude was associated with better vision. 
 
Region  Partial correlation coefficient (r)  P value 
Central circle  0.83  <0.001 
Right upper quadrant  0.57    0.002 
Right lower quadrant  0.78  <0.001 
Left lower quadrant  0.56    0.003 
Left upper quadrant  0.53    0.006 
Table 6.7 Correlations between region-specific VEP amplitude and region-specific Humphrey scores, 
for each of the four quadrants and the central circle of the affected eye, at baseline. CI-confidence 
interval. 
 
There was borderline significance for an association between baseline VEP latency 
and visual function for the central circle (r=-0.41, p=0.091), with people with shorter 
latencies tending to have better vision. No significant associations were found for the 
quadrants (RUQ p=0.722; RLQ p=0.310, LLQ p=0.783, LUQ p=0.783). 
 
6.3.5.2 FMRI correlations with clinical data 
6.3.5.2.1 Voxel-based 
Using a voxel-based whole brain approach, regions of correlation were found at 
baseline between affected eye region-specific Humphrey scores and affected eye 
region-specific fMRI activation, on stimulating the central circle (Figure 6.20A), left   280
lower quadrant (Figure 6.20D), and left upper quadrant (Figure 6.20E). A greater 
fMRI response was associated with better vision. No significant regions were found 
for the right upper or lower quadrants.  
 
 
Region of 
stimulation 
Figure  MNI 
coordinates 
Region 
Central circle  6.20A  -18 -94 2  Left visual cortex 
Left lower 
quadrant 
6.20D   20 -90 8  Right visual cortex 
Left upper 
quadrant 
6.20E  (upper 
cluster) 
 14 -92 -6  Right visual cortex 
Right fusiform gyrus 
Right inferior occipital gyrus 
Left upper 
quadrant 
6.20E  (lower 
cluster) 
 28 -82 8  Right superior occipital gyrus 
Right middle occipital gyrus 
Figure 6.20 Regression of region-specific Humphrey scores against region-specific fMRI activations, 
for (A) the central circle, (B) upper right, (C) lower right, (D) lower left and (E) upper left quadrants of 
the affected eye, at baseline, overlaid on to the SPM5 glass brain, in coronal, axial and sagittal planes. 
The maps are thresholded at p<0.05 (corrected). The table indicates the location of the clusters. The 
Montreal Neurological Institute (MNI) coordinates refer to the centre of the global maximal cluster.  
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6.3.5.2.2. Regions-of-interest  
There were associations between affected eye vision and affected eye fMRI response 
in all regions at baseline, but not for any regions on fellow eye stimulation (Table 
6.8). A greater fMRI response was associated with better vision.  
 
Stimulation  Partial correlation coefficient 
(r) 
p value 
Affected central circle   0.52    0.005 
Affected right upper 
quadrant 
 0.26    0.016 
Affected right lower 
quadrant 
 0.45    0.018 
Affected left lower 
quadrant 
 0.45    0.004 
Affected left upper 
quadrant 
 0.54  <0.001 
Fellow central circle   0.08    0.694 
Fellow right upper quadrant  -0.14    0.898 
Fellow right lower quadrant   0.26    0.234 
Fellow left lower quadrant  -0.09    0.912 
Fellow left upper quadrant  -0.24    0.530 
Table 6.8 Correlations between region-specific fMRI response and region-specific Humphrey scores, 
for each of the quadrants and the central circle, at baseline. Significant associations are highlighted in 
bold type. 
 
6.3.5.3 FMRI correlations with electrophysiological data 
6.3.5.3.1 Voxel-based  
Associations were found at baseline between region-specific affected eye VEP 
amplitude and region-specific affected eye fMRI response for the central circle 
(Figure 6.21A) and left upper quadrant (Figure 6.21E). A greater fMRI response was 
associated with greater amplitude VEPs.   282
 
Region of 
stimulation 
Figure  MNI 
coordinates 
Region 
Central circle  6.21A  22 -90 -6  Right visual cortex 
Left upper 
quadrant 
6.21E  (upper 
cluster) 
26 -50 54  Right post-central gyrus 
Right precuneus 
Right superior parietal lobule 
Right superior occipital gyrus 
Left upper 
quadrant 
6.21E  (middle 
cluster) 
42 -80 18  Right middle occipital gyrus 
Right middle temporal gyrus 
Left upper 
quadrant 
6.21E  (lower 
cluster) 
22 -84 2  Right visual cortex 
Figure 6.21 Regression of region-specific VEP amplitude against region-specific fMRI activations, for 
(A) the central circle, (B) upper right, (C) lower right, (D) lower left and (E) upper right quadrants of 
the affected eye, at baseline, overlaid on to the SPM5 glass brain, in coronal, axial and sagittal planes. 
The maps are thresholded at p<0.05 (corrected). 
 
The left upper quadrant correlations were right-sided, which is consistent with the 
retinotopic organisation. They were localised above the calcarine sulcus, extending 
into higher processing areas of the parietal lobe. Bilateral occipital activation was seen 
on stimulation of the central circle at lower thresholds, but the left sided occipital 
cluster did not reach statistical significance.  
   283
No significant associations were found between affected eye VEP latency and 
occipital fMRI responses at baseline. 
 
6.3.5.3.2 Regions-of-interest  
Associations were found between affected eye region-specific VEP amplitude and 
region-specific fMRI response, at baseline, on stimulation of the central circle, right 
lower and left upper quadrants (Table 6.9). For all associations, a greater fMRI 
response was associated with greater VEP amplitude. There were no associations 
between fellow eye fMRI responses and affected eye VEP amplitude.  
 
Stimulation  Partial correlation coefficient 
(r) 
p value 
Affected central circle   0.46  0.003 
Affected right upper quadrant   0.33  0.147 
Affected right lower 
quadrant 
 0.33  0.029 
Affected left lower quadrant   0.13  0.675 
Affected left upper quadrant   0.47  0.010 
Fellow central circle   0.03  0.766 
Fellow right upper quadrant  -0.02  0.901 
Fellow right lower quadrant   0.20  0.146 
Fellow left lower quadrant  -0.30  0.135 
Fellow left upper quadrant  -0.15  0.885 
Table 6.9 Correlations between region-specific fMRI response and region-specific VEP amplitude, for 
each of the four quadrants and the central circle, at baseline. Significant associations are highlighted in 
bold type. 
 
No correlations were found with VEP latency in either eye. 
 
6.4 Discussion 
 
In this study, the feasibility of combining region-specific clinical data, 
electrophysiology, and fMRI data was investigated, and used to study recovery from 
visual field defects in ON, including the role of the fellow eye. With regard to the   284
primary hypotheses, these data did not demonstrate any convincing evidence of 
regional susceptibility to damage, extra-striate fMRI activation contributing to visual 
recovery, or supra-normal fMRI activity on stimulating the fellow eye.  
The conclusions that may be drawn from this data are now discussed. In general 
terms, there are two main possibilities for each of the hypotheses investigated; either 
the effect under investigation does not exist, or the methodology used has failed to 
detect it.  
 
6.4.1 No regional susceptibility to damage  
 
There were no differences between the different regions in severity of visual loss, 
either acutely or during follow-up. The central region had the lowest mean visual 
score during the acute stage at baseline, and the upper quadrants the lowest at 12 
months, but there were no statistically significant differences between groups. This is 
in line with previous studies that have shown a wide variety of different defects 
(Keltner et al., 1993b), and suggests that fibres in the optic nerve are affected 
randomly by the patchy inflammatory process, and there is no clear evidence that any 
optic nerve axons are more susceptible to damage or repair than others.  
With regard to clinical testing, the small improvements seen over time in fellow eye 
Humphrey scores are likely to reflect a practice effect. 
 
6.4.2 No evidence for extra-striate responses to region-specific activation 
 
The results of the fMRI experiments are more complex, and could be explained in 
three ways; either region-specific extra-striate plasticity does not contribute to 
recovery from visual field defects, or it occurs but varies in location (and perhaps 
timing) in individual patients, explaining the lack of group effects, or the 
methodology applied has failed to detect it. 
There is a growing body of evidence for the importance of adaptive plasticity in 
recovery from ON (Werring et al., 2000;Toosy et al., 2002;Toosy et al., 2005;Levin et 
al., 2006;Korsholm et al., 2007), and abundant evidence in other neurological 
conditions (Frackowiak, 1997;Comi et al., 2004;Desmurget et al., 2007;Johansen-
Berg, 2007;Di Filippo et al., 2008). Results previously reported from this cohort of 
patients, in Chapters 4 and 5 of this thesis, suggested the occurrence of compensatory   285
neuroplasticity, with areas of commonality detectable at group level, interacting with 
visual function at baseline, and contributing to visual outcome. However, these results 
were obtained using an fMRI visual paradigm comprising whole field stimulation, and 
logMAR acuity as a visual outcome measure. LogMAR acuity is sensitive to 
abnormalities of central vision, which is of primary clinical importance to the patient, 
but is not sensitive to peripheral field pathology. In addition, whole field fMRI 
stimulation results in responses dominated by central field effects. This was the reason 
for including a quadrant-specific paradigm, as it was hypothesised that plastic 
mechanisms might also be important in peripheral recovery.  However, the present 
study failed to demonstrate any convincing evidence of extra-striate fMRI activation 
in response to region-specific stimulation. None was seen on investigating the main 
effect of stimulation in patients, there were no differences between affected and 
fellow eyes, and no differences between patients and controls.  
One possible interpretation of these contrasting results is that neuroplasticity is 
genuinely less important in recovery from peripheral defects than for central vision. 
Previous large studies from the ONTT cohort reported that peripheral defects in 
sensitivity were more frequent than central defects at six months (Fang et al., 1999), 
but after three years the relationship had reversed and residual problems with central 
vision were more common (Keltner et al., 1999), which may suggest a differential 
response to recovery processes in different regions of the visual field, at different 
times. It is possible that reorganisation responses are triggered and modulated in a 
hierarchical manner, depending on functional importance. When plasticity is evident, 
it appears to occur during the acute phase of ON, and if it genuinely does not 
contribute to recovery of the peripheral field, this could explain why recovery was 
less good in the ONTT cohort peripherally at six months. However, this does not 
explain why extra-striate responses were not evident on central field stimulation. In 
addition, a different recovery process would have to be postulated to explain the later 
reversal in frequency of residual defects. It also seems unlikely that mechanisms of 
repair should differ so much, in the absence of any clear evidence of a differential 
susceptibility to damage, either during the acute phase, or following recovery.  
The second possibility is that neuroplasticity in response to peripheral field defects is 
a more heterogeneous process than for central field defects and occurs in different 
anatomical locations, and perhaps at different times, following symptom onset in 
different individuals. The heterogeneity of patterns of visual field defects which is   286
seen clinically could be consistent with this interpretation. For example, if 
neuroplasticity was occurring through a mechanism of map expansion, then the 
anatomical location of fMRI activity might differ greatly depending on the retinotopic 
cortical location of reduced afferent input. Similarly, if cross-modal reassignment was 
occurring, it is possible that the regions of extra-striate cortex recruited might be 
anatomically more adjacent to the region of reduced afferent input. For example, 
ventral stream higher processing areas might be recruited in response to reduced 
neuronal input in infra-calcarine regions (representing upper field defects), and dorsal 
stream areas in response to reduced input in supra-calcarine regions (representing 
lower field defects). Whilst this is a possibility, it remains speculative, and would be 
difficult to confirm or refute experimentally. 
Lastly, there is the possibility that the experimental approach used was insufficiently 
sensitive to detect any effects of interest which may, or may not, have been present. 
This is the first study to apply a quadrant-specific fMRI stimulation paradigm; all 
previous studies have used either whole field (Rombouts et al., 1998;Gareau et al., 
1999;Werring et al., 2000;Russ et al., 2002;Toosy et al., 2002;Langkilde et al., 
2002;Toosy et al., 2005;Levin et al., 2006;Korsholm et al., 2007) or hemi-field 
(Langkilde et al., 2002) stimuli. The idea was that this would address the problem of 
heterogeneity of defects at the stage of data acquisition, rather than the analysis stage. 
However, region-specific stimulation activated a relatively smaller proportion of the 
visual field than either the hemi-field or whole field methods. In particular, selective 
stimulation of the peripheral quadrants tended to result in smaller changes in fMRI 
signal, perhaps because of the lower density of retinal photoreceptors in these regions, 
compared with the macula. However, stimulation with the central circle also resulted 
in relatively less fMRI activity than anticipated. This could also be methodological. A 
fixation cross was presented together with the central circle, as described in Chapter 3, 
and some control subjects in the pilot study reported that it intermittently disappeared. 
This was likely to be due to a phenomenon called background “filling in” 
(Ramachandran and Gregory, 1991;Weil et al., 2007), which may occur in the context 
of two competing stimuli, and it is possible that this affected the fMRI signal. Another 
difficulty that arose using the region-specific approach was the influence of inter-
individual variability, both in severity of visual loss and, more importantly, in visual 
cortical anatomy. This variability is a problem common to all studies in which group 
effects are of interest. However, inter-individual variability in the cortical   287
representation of visual areas may be especially large, which is becoming apparent 
with the increased application of retinotopic mapping techniques. Therefore, together 
these factors may have resulted in a reduction of sensitivity to detect effects of disease 
and responses to them. 
 
This hypothesis is supported by the results of the correlation analyses. The issue of 
multiple comparison testing, previously discussed in section 5.1.4.5, is also relevant 
here. Associations between visual function and fMRI activation were modest using 
both the voxel-based and region-of-interest approaches, and were only evident for 2/5 
conditions using the former method and 3/5 for the latter. These modest region-
specific correlations are in contrast to the results of whole field visual stimulation, 
reported in Appendix III, in which more robust activation and correlations with 
clinical scores were seen. For example, using whole field stimulation, physiologically 
anticipated associations were demonstrated between fMRI signal and vision in 
primary visual areas during the acute phase. This was not apparent for some of the 
quadrants using more localised region-specific stimuli, probably for the reasons 
discussed; relatively low signal-to-noise, high inter-individual anatomical variability 
in cortical representation in those areas, and also possibly the slight inequalities in the 
proportion of the visual field sampled during fMRI, VEP and clinical data acquisition. 
Together, these factors could explain why no evidence for plasticity was 
demonstrated, as this effect might reasonably be expected to be more subtle than 
clinical-fMRI or VEP amplitude-fMRI associations. 
Some of these difficulties were compounded by the mass univariate voxel-based 
analysis approach. In general, the region-of-interest approach appeared more sensitive 
to detecting effects-of-interest, for example, strong correlations were demonstrated 
between extracted fMRI parameters and both VEP amplitude and Humphrey scores in 
all regions. This illustrates some generic difficulties in studying plasticity in a 
condition such as ON. There are only two studies which have detected evidence of 
plasticity using a whole brain voxel-based analysis approach (Werring et al., 
2000;Toosy et al., 2005), and more recent studies have generally focused on regions-
of-interest identified from previous work. It is likely that difficulties in demonstrating 
plasticity using a voxel-based approach are related partly to the subtlety of the effect 
in ON. FMRI detects small increases in local blood flow representing averaged neural 
events occurring at sub-cellular level (Logothetis et al., 2001). In ON, these changes   288
are in response to localised pathology in a remote white matter tract, namely the optic 
nerve. The magnitude of detected cortical responses is smaller in ON than in 
conditions of direct brain injury, such as ischaemic stroke and brain tumours. In 
addition, the disease process in ON results in a direct reduction of afferent input to the 
cortical regions under investigation, resulting in reduced fMRI signal, and 
complicating detection of effects-of-interest. These two-way interactions between 
fMRI response, structural damage and clinical effects have been explored in previous 
chapters of this thesis. These difficulties may be compounded by the multiple 
comparisons corrections necessary using a whole brain voxel-based approach.  
This leads to the issue of thresholding statistical parametric maps. There is no 
universal agreement on what constitutes a “robust” threshold, and the level selected 
has varied considerably in the literature. The decision depends on many factors, 
including sample size, signal characteristics of the effect under investigation (Friston 
et al., 1994), and effect size. The correction for multiple comparisons in SPM is 
implemented using random field theory (Chapter 2). This may be addressed at either 
voxel or cluster level. Cluster-level inference relies on the signal of interest being 
more spatially extended than the noise coherence, and tends to be a more sensitive and 
powerful method (Friston et al., 1996a), as it takes into account information in 
neighbouring voxels. However, at lower thresholds, it is more prone to false positives 
than the more conservative voxel-level inference strategy (Smith and Nichols, 2009). 
Therefore, interpretation of fMRI data can be complex, and requires caution, 
especially for longitudinal analyses. The approach used in this study was to select a 
threshold based on the results of a preliminary analysis of the control data, in order to 
identify a level at which physiologically anticipated fMRI activity was seen and noise 
successfully removed, and then apply it to the patient group. In this longitudinal 
dataset, this empirical solution resulted in the application of a relatively high cluster-
level threshold of p<0.001 (corrected) which may have also contributed to missing 
genuine effects-of-interest in the patient group. 
Therefore, it appears most likely that the results reported in this chapter represent a 
lack of sensitivity of the region-specific stimulation approach, and it remains unclear 
if region-specific responses to visual field defects occur or not. In the future, ongoing 
development and optimisation of fMRI hardware and analysis techniques may help 
address these problems, for example, multi-variate analysis, which has been applied to   289
detect subtle effects in the study of consciousness (Haynes and Rees, 2006). Future 
directions will be discussed in Chapter 7. 
 
6.4.3 No evidence for supra-normal responses in fellow eye 
 
Similarly, with regard to the role of the fellow eye, there are several possible 
interpretations of these results. It could be that fellow eye responses to region-specific 
stimulation are genuinely not important to recovery from localised visual field 
defects, or that they do occur but not in the regions investigated, or occur but have not 
been detected, through a type II error. 
There is evidence from several previous studies (Toosy et al., 2005;Korsholm et al., 
2007), and the previous chapters of this thesis, that fellow eye responses are abnormal 
in ON. However, the precise role of fellow eye responses remains unclear. The 
motivation for this part of the study was to clarify whether a dynamic increase in 
fMRI activity occurred in regions of early retinotopic cortex. However, there was no 
evidence for the occurrence of supra-normal responses in patients’ fellow eyes, either 
in comparison to controls, or during the acute phase relative to later time-points.  
This is less likely to be due to type II error than for the voxel-based analysis, as the 
region-of-interest approach used had greater sensitivity, for example, in detecting 
fMRI correlations with clinical and electrophysiological parameters. However, it 
illustrates the converse problem inherent in the approach. By definition, the extent of 
the brain which is assessed is limited and this could explain the failure to detect any 
differences in the fellow eye. Primary visual areas were selected, as it was possible to 
identify the relevant areas corresponding to the regions of stimulation, but it is 
possible that supra-normal changes were occurring in other brain regions, such as the 
LGN or higher visual areas, that were not studied.  
Therefore, whilst it is possible to conclude with a greater degree of certainty that 
abnormal fellow eye responses genuinely did not occur in the visual cortical areas 
studied, it remains unclear whether undetected effects occurred elsewhere. It is 
interesting to note that for the left upper quadrant, the mean response was actually 
greater than in the control group, but this was not statistically significant and, 
therefore, must be interpreted as a chance effect, and would need to be confirmed by 
future studies in different patient cohorts. Nonetheless, it is mentioned as there were 
anomalies in other tests with regard to this quadrant, which will be discussed further.   290
6.4.4 Slow recovery in the left upper quadrant 
 
During follow-up, recovery of VEP amplitudes in the left upper quadrant lagged 
behind the other regions. This correlated with a lag in improvement in fMRI 
responses, and the lowest mean visual score at three months. In contrast, fellow eye 
VEP amplitude decreased over time, which might be explained by subtle subclinical 
axonal loss, but was not evident on whole field testing, and is more likely to be 
technical, or related to habituation. 
The lagged recovery in affected eye electrophysiology and fMRI in the left upper 
quadrant could be explained through a chance differential effect of damage 
mechanisms; possibly oedema, inflammation and the resulting conduction block took 
slightly longer to resolve in this region, and this also influenced the resulting fMRI 
response. It seems less likely that demyelination was more severe in the fibres of the 
optic nerve related to this region, given that the region-specific VEP latency was not 
prolonged. More severe axonal loss is a possibility that merits consideration. Previous 
studies have found that peripheral areas recover progressively less completely, 
perhaps secondary to reduced axonal redundancy (Fang et al., 1999). However, this 
does not explain why the recovery rate was different from the other quadrants, and 
there were no residual defects.  
Alternatively, the slower recovery observed in this region could be secondary to a 
differential effect of repair mechanisms, either by chance or perhaps for reasons of 
vascular supply, or provision of neurotrophic factors. The upper left quadrant of the 
visual field in each eye is represented by the lower right quadrant of each retina. 
Fibres from this region originating in the left eye decussate in the optic chiasm, whilst 
those from the right eye remain uncrossed. They then run together in the optic tract, 
and synapse in the LGN, with neurons whose axonal processes proceed in the optic 
radiations to the right occipital cortex, inferior to the calcarine fissure. There is no 
clear anatomical explanation why recovery should be slower in fibres which are part 
of this pathway, compared with the other peripheral regions. Therefore, the 
observation is noted, together with the higher mean fellow eye fMRI response than 
controls in this region, but is most likely due to chance. 
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6.4.5 Remyelination only evident on stimulation of central field 
 
VEP latency decreased over 12 months in the central circle, but not in any of the 
quadrants, suggesting remyelination. Although this could indicate that there is 
prioritisation of repair for the most functionally eloquent fibres, it is more likely to 
represent a technical issue; macular stimulation results in greater amplitude responses 
than peripheral stimulation, which facilitates measurement of the P100 segment. 
 
6.4.6 Conclusions and future challenges  
 
Overall, many aspects of the mechanisms of damage and recovery of visual field 
defects in ON remain unclear. This was the first study to investigate this using 
quadrant-specific fMRI, and combining it with quadrant-specific electrophysiology 
and clinical measures. It was anticipated that this method would reduce clinical 
heterogeneity, and refine anatomical localisation, increasing sensitivity to region-
specific effects. However, the approach was somewhat undermined in its ability to 
detect group effects by its sensitivity to inter-individual variability in cortical 
representation and relatively low signal-to-noise, compared with whole field 
stimulation. However, the feasibility of correlating region-specific clinical, VEP and 
fMRI measures was demonstrated, using a region-of-interest approach. Region-
specific longitudinal changes were demonstrated in clinical, VEP and fMRI data, and 
slower recovery was noted in the left upper quadrant in this cohort. In addition, 
although inconclusive with regard to region-specific plasticity, this study found that 
all regions of the visual field are equally susceptible to damage in ON, and recover 
equally well. There was no evidence for supra-normal fMRI activity in regions of 
retinotopic visual cortex, on stimulation of the fellow eye. 
It is possible that the approach used in this study may be optimised further. In 
particular, signal-to-noise may be improved with the development of higher field 
strength MRI, and formal retinotopic mapping may help address issues of inter-
individual variability. Therefore, in the future, technological developments may 
facilitate the investigation of recovery of visual field defects. In the next chapter, 
future directions in the development of MRI technology, and the investigation of 
neuroplasticity, are discussed. Conclusions are drawn regarding the contribution to the 
field of the work described in this thesis.   292
CHAPTER 7 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
In this chapter, the main results and conclusions of this thesis are summarised, and 
novel aspects of methodology are highlighted. The contribution of these investigations 
to the study of mechanisms of damage and recovery in ON is considered. Future 
research directions are identified, from both technological and clinical perspectives. 
 
7.1 Mechanisms of damage 
 
The results of this thesis confirm and extend those of previous studies, with regard to 
mechanisms of damage and visual loss in ON. In the acute stage, inflammation was 
prominent in the optic nerve, with gadolinium enhancement evident in 92% of cases. 
Acute demyelination and conduction block occurred. In most cases, vision improved 
over the following three months, and was paralleled by an increase in VEP amplitude. 
Despite visual recovery, there was evidence of residual demyelination and axonal loss 
in the optic nerve at 12 months, with persistent prolongation of VEP latency, loss of 
macular volume, thinning of the RNFL, optic atrophy and a reduction in VEP 
amplitude. There was a progressive increase in the length of the optic nerve lesion, 
consistent with secondary tract degeneration, of either retrograde or Wallerian type. 
Optic radiation lesion load increased over the course of the year, and localised 
pericalcarine cortical atrophy was evident at presentation, before there was any 
detectable generalised loss of grey matter, and in the absence of associations with 
tract-specific damage. Both the increasing lesion load and pericalcarine cortical 
atrophy were associated with the development of MS. This suggests that this regional 
atrophy might represent an early manifestation of generalised grey matter damage, 
and the visual system may be particularly susceptible to damage in demyelinating 
disease. There was evidence of significant tissue damage in the optic nerve and 
throughout the visual system, even in patients who made a good visual recovery.  
During the acute episode of ON, the inflammatory lesion length in the optic nerve and 
VEP amplitude, reflecting the degree of conduction block, were associated with acute 
visual loss. However, the only structural marker of damage associated with visual   293
outcome at 12 months was macular volume, a marker of secondary retinal neuronal 
loss. 
 
7.2 Mechanisms of recovery 
 
The key findings of this thesis relate to mechanisms of visual recovery, and in 
particular the role of cortical neuroplasticity. During the acute episode, an association 
was identified between acute fMRI activity in the cuneus, part of the dorsal stream of 
visual processing, and visual function at the same time, which was independent of the 
identified structural predictors. It is argued that this suggests a role for the cuneus in 
modulating the degree of acute visual loss, through a mechanism of neuroplastic 
cortical reorganisation. The subsequent longitudinal study identified dynamic changes 
in this region over time. 
The key results from the longitudinal study were an association between a greater 
early fMRI response in the lateral occipital complexes (LOCs) and a better visual 
outcome. This suggests a role for neuroplastic changes in the ventral visual processing 
stream, contributing to recovery. These changes were evident on stimulation of either 
eye, and were independent of markers of acute inflammation, persistent demyelination 
and residual neuroaxonal loss in the optic nerve. A negative fMRI response in the 
LOCs during the acute phase was associated with a poor outcome, with sufficient 
sensitivity and specificity to suggest that it might be useful in a clinical setting, 
although this requires confirmation in larger cohorts.  
The central argument of this thesis is that neuroplastic responses in the grey matter 
may be more important in determining visual outcome following ON than previously 
recognised, and may contribute to clinical recovery despite marked tissue damage. 
This could have implications for future therapeutic strategies in demyelinating 
disease. 
It is interesting that different higher visual processing areas appear to play different 
roles at different times. During the acute phase, the cuneus of the dorsal stream seems 
to modulate the severity of acute visual dysfunction, whilst activity in the lateral 
occipital complexes of the ventral stream appears to be critical for long-term visual 
outcome. The reasons for this are not clear from this study, and further work is 
required to clarify the apparently complex interactions between neuroplasticity, 
structural damage and clinical function.   294
7.3 Novel aspects of methodology 
 
It was necessary to develop several technical innovations during the course of this 
thesis. The visual fMRI paradigm presentation identified and addressed issues of 
attention, adaptation and loss-of-fixation biases that had not been resolved in previous 
studies. The methodology used for tractography was innovative, combining diffusion 
and functional MRI data to define seed-points in the visual system, in order to 
improve reproducibility. The exploration of structure-function interactions required an 
extensive structural protocol and this, combined with visual fMRI, comprised the 
most comprehensive MRI assessment of the visual pathways in ON in the literature. 
This was also the first time that associations have been investigated between OCT and 
fMRI in this condition, and this was a valuable method of elucidating the relative 
influences of neuroaxonal degeneration and plasticity. The acquisition of quadrant-
specific visual, electrophysiological and fMRI data was a novel method of 
investigating visual field defects and the role of the fellow eye in ON. However, this 
approach was undermined by inter-individual variability in the size of V1 (Dougherty 
et al.,2003), which is correlated with the size of other visual areas, such as LGN 
(Andrews et al., 1997). Future studies could apply retinotopic mapping to allow for 
this variability and improve sensitivity in the investigation of visual field defects. 
 
7.4 Future technological directions 
 
One of the difficulties of investigating ON in vivo is that MRI of the optic nerve 
remains challenging, and future technical advances are required in order to broaden 
the applications of some of the more recently developed, quantitative techniques. 
Optic nerve DTI is now feasible (Chabert et al., 2005;Wheeler-Kingshott et al., 
2006;Trip et al., 2006b), and provides a valuable measure of tissue integrity, which 
may prove to be a more sensitive index of damage than either T2-weighted or 
enhancing lesion length. However, at present, acquisition times remain lengthy, in the 
region of 40-45 minutes, and problems remain in achieving adequate signal-to-noise, 
and sampling the whole nerve. A recently developed zonal coronal-oblique single-
shot sequence is an important advance in terms of improving signal-to-noise in a 
tolerable timeframe for patients (Dowell et al., 2009). In the future, this may facilitate 
the integration of optic nerve DTI sequences, and perhaps optic tract DTI, into multi-  295
modal MRI protocols. Recent optic nerve DTI studies have also suggested that 
pathological specificity may be improved by using alternative DTI-derived 
parameters, such as the axial and radial diffusivities (Naismith et al, 2009), and this 
may help distinguish demyelination from axonal damage (Wu et al., 2007;Sun et al., 
2008). Future developments will aim to improve resolution, in order to reduce partial 
volume effects, and to increase signal-to-noise ratio (SNR) and nerve coverage. SNR 
may be improved by the use of higher gradient strengths, multichannel receiver coils, 
parallel imaging techniques and higher field strength scanners, though all require 
detailed evaluation. 
 
This study was the first to combine OCT with fMRI, but OCT data was only available 
at the 12 month time-point. OCT appears a promising technique, in terms of its 
sensitivity to axonal loss, and is probably superior to optic nerve MRI in this regard. 
Combining longitudinal OCT and fMRI, in the first few weeks after acute ON, could 
be used to clarify the temporal relationship between the appearance of retinal 
neuroaxonal loss and cortical plastic responses at that time. 
 
In addition to advances in imaging hardware, more sophisticated analysis techniques 
have been developed recently. A multivariate, rather than mass univariate, approach 
has been applied in recent fMRI studies (Haxby et al., 2001;Cox and Savoy, 
2003;Haynes and Rees, 2005c;Kriegeskorte et al., 2006;Haynes and Rees, 
2006;Hassabis et al., 2009). Multivariate analysis takes into account patterns of 
information present across multiple voxels, and appears to improve sensitivity to 
detect subtle effects. It would be interesting to apply this technique to the visual 
stimulation data from this study. In particular, this might improve the sensitivity to 
detect neuroplastic responses to region-specific visual deficits. 
 
7.5 Future clinical directions 
 
In demyelinating disease, recent therapeutic strategies have started to focus on brain 
repair, for example, stem cells for remyelination (Pluchino and Martino, 
2005;Kolappan et al., 2008a). Therapeutic manipulation of mechanisms of brain 
repair appears to be an area of promise. An important question is whether it might be 
possible to manipulate plastic reorganisation for therapeutic gain. Previous studies   296
have demonstrated benefits of visual restitution therapy in patients with visual field 
defects of heterogeneous aetiology (Kasten et al., 1998). Following daily visual 
stimulation using a computer programme, in which stimuli were presented at the 
border of the normal and abnormal visual fields, improvements of around five degrees 
of visual angle were demonstrated. In order to develop pharmacological treatments, a 
better understanding of the processes that occur within the LOCs during the acute 
episode is necessary. In particular, the pathophysiological correlates of adaptive 
plasticity require clarification and, perhaps more importantly, the correlates of 
maladaptive change in patients who fail to recover need to be identified. It is 
conceivable that cellular factors inhibit important reorganisation responses in a subset 
of patients, and this could provide a therapeutic target. Future in vivo studies could 
focus on the LOCs, in order to define the metabolic substrates of reorganisation, using 
magnetic resonance spectroscopy. This is another quantitative in vivo technique, 
which has contributed to elucidating the pathophysiology of demyelinating disease of 
the brain, by enabling assessment of the composition of living tissues at a molecular 
level. Indices are derived which reflect processes such as axonal damage and gliosis, 
and local levels of neurotransmitters. From this study, it appears that the spectroscopy 
of the LOCs should be targetted during the acute phase of ON, in patients with a 
longitudinal follow-up, to determine clinical recovery. The clinical outcome could 
then be correlated with the acute metabolic findings. Combining spectroscopy data 
with techniques such as DTI, to measure structural integrity, and fMRI, to assess 
plasticity, is an exciting prospect, which could elucidate metabolic correlates of 
structural damage and functional reorganisation at a cellular level. 
An alternative, complementary approach to the investigation of the substrates of 
neuroplasticity at cellular level would be to use animal models, with a focus on the 
key factors triggering successful and unsuccessful reorganisation. This might be 
achieved in a combined fMRI-histopathological correlation study. This approach has 
been previously applied successfully to identify the substrates of conventional MRI-
visible lesions in EAE (Hart et al., 1998;Karlik et al.,1999), gadolinium-enhancing 
lesions (Karlik et al., 1999), MTR, T2 relaxation abnormalities (Gareau et al., 1999) 
and spectroscopic changes (Richards et al., 1995) in the brain, and, more recently, to 
identify DTI parameters specific to axonal injury in the spinal cord (Feng et al., 
2009;Budde et al., 2009). 
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The timing and location of neuroplastic reorganisation identified in this study may 
have other implications for future work. Early reorganisation, during the acute 
episode, appeared to be crucial. The finding of a potential fMRI predictor of visual 
outcome, evident during the acute phase, merits further investigation in larger groups 
of patients. If confirmed, this could prove to be a valuable clinical tool. In particular, 
patient counselling at the time of diagnosis would be facilitated, and the fMRI 
response might be used to help select candidates for clinical trials of emerging 
experimental therapies, such as stem cells. The timing of reorganisation activity may 
have other implications for future potential therapies. Previous authors have 
speculated that a delay between symptom onset and delivery of steroids may explain 
the lack of benefit seen in clinical trials (Compston and Coles, 2002). It may be that 
the visual prognosis is determined early, whether through a mechanism of plasticity or 
severity of damage, and for future therapies to be effective, they will need to be 
delivered during the first few days to weeks. This provides a challenge for health 
service provision, as early assessment and availability of investigations would be 
required, in addition to early provision of treatment.  
The location of the neuroplastic responses in higher visual areas is interesting. The 
results of this thesis suggested that both the ventral and dorsal streams appear to be 
involved, influencing visual function in different ways, at different times. It is unclear 
how this relates to their usual functions in health. It would be interesting to investigate 
whether there are detectable clinical abnormalities specific to a particular region in 
patients with ON, i.e. whether object recognition is especially affected (a ventral 
stream function) or, alternatively, whether there are difficulties with spatial 
localisation of objects in the physical world (a dorsal stream function). This has not 
previously been investigated, and it is conceivable that some of the residual symptoms 
seen following ON might be related to dysfunction of one or other of these regions. 
Patients with recovered ON could have residual, unreported difficulties with object 
recognition. In addition, frequently reported residual symptoms following recovery, 
such as Pulfrich’s phenomenon, in which patients find it difficult to track the 
trajectory of a moving object, could be related to dorsal stream dysfunction, in 
addition to delayed afferent conduction. These hypotheses could be investigated using 
an fMRI approach. 
The varying influence of different regions on vision at different times during the 
recovery process requires further clarification. It will be important to determine   298
whether there is a dynamic changing role of area in neuroplasticity during recovery, 
and whether the dynamics of recovery vary between individuals, or are common 
across different populations of patients. 
 
It is interesting to consider whether the factors associated with recovery from 
clinically isolated ON remain important in established MS. In particular, the effects of 
progressively accumulating demyelination and axonal loss may influence the 
contribution of neuroplastic reorganisation to recovery. A “threshold effect” has been 
reported, in terms of optic nerve axonal damage, below which vision is well 
preserved, and above which dysfunction is clinically eloquent, in previous animal 
(Frisen and Quigley, 1984) and in vivo studies (Costello et al., 2006). In established 
MS, it is possible that recurrent insults, in the context of a more aggressive and 
chronic disease process, begin to overwhelm compensatory responses, such as 
plasticity. This is an area that merits further study, by applying an in vivo 
methodology, similar to the one used in this thesis, to a cohort of patients with acute 
ON, in the context of established MS. 
 
7.6 Summary 
 
In summary, this thesis has elucidated aspects of damage and recovery from clinically 
isolated ON. In particular, the identification of a direct association between acute 
fMRI activity in the LOCs and subsequent visual outcome provides a foundation for 
further investigation. Elucidating the importance of adaptive neuroplasticity, 
independent of structural damage, and the timing and location of compensatory 
responses provides a focus for future investigation of the metabolic correlates of 
plasticity at a cellular level, and a potential target for novel therapeutic approaches.  
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APPENDIX I  
 
VISUAL SCORING CONVERSION TABLE 
 
LogMAR  Snellen (UK)  Snellen (USA) 
1.7 6/300  20/1000 
1.6 6/230  20/800 
1.5 6/190  20/630 
1.4 6/150  20/500 
1.3 6/120  20/400 
1.2 6/90  20/300 
1.1 6/75  20/250 
1.0 6/60  20/200 
0.9 6/48  20/160 
0.8 6/37.5  20/125 
0.7 6/30  20/100 
0.6 6/24  20/80 
0.5 6/18  20/63 
0.4 6/15  20/50 
0.3 6/12  20/40 
0.2 6/10  20/32 
0.1 6/7.5  20/25 
0 6/6  20/20 
-0.1 6/5  20/16 
-0.2 6/4  20/13 
-0.3 6/3  20/10 
Table S1 Conversion from logMAR to Snellen UK and USA visual scoring systems. 
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APPENDIX II  
 
KURTZKE EXPANDED DISABILITY SCALE (EDSS) 
 
Score  Neurological status 
0  Normal neurological examination (all functional systems (FS) grade 0) 
1.0  No disability, minimal signs in one FS (i.e. grade 1) 
1.5  No disability, minimal signs in more than one FS (more than one grade 1) 
2.0  Minimal disability in one FS (one FS grade 2, others 0 or 1) 
2.5  Minimal disability in two FS (two FS grade 2, others 0 or 1) 
3.0  Moderate disability in one FS (one FS grade 3, others 0 or 1), or mild disability 
in three or four FS (three/four FS grade 2, others 0 or 1), though fully 
ambulatory  
3.5  Fully ambulatory but with moderate disability in one FS (one FS grade 3) 
and one or two FS grade 2 
4.0  Ambulatory without aid or rest for >500m; up and about some 12 hours a 
day despite relatively severe disability consisting of one FS grade 4 (others 
0 or 1), or combinations of lower grades exceeding limits of previous steps 
4.5  Ambulatory without aid or rest for >300m; up and about much of the day; 
characterised by relatively severe disability usually consisting of one FS 
grade 4 or combinations of lesser grades exceeding limits of previous steps 
5.0  Ambulatory without aid or rest for >200m (usual FS equivalents are one 
grade 5 alone, others 0 or 1; or combinations of lesser grades usually exceeding 
specifications for step 4.5) 
5.5 Ambulatory  without  aid or rest >100m 
6.0 Unilateral  assistance  (cane  or crutch) required to walk at least 100m with 
or without resting 
6.5   Constant bilateral assistance (canes or crutches) required to walk at least 
20m without resting 
7.0  Unable to walk 5m even with aid, essentially restricted to wheelchair; 
wheels self and transfers alone; up and about in wheelchair some 12 hours 
a day 
7.5  Unable to take more than a few steps; restricted to wheelchair; may need 
some help in transfer and in wheeling self 
8.0  Essentially restricted to bed or chair or perambulated in wheelchair, but 
out of bed most of day; retains many self-care functions; generally has 
effective use of arms 
8.5  Essentially restricted to bed much of the day; has some effective use of 
arm(s); retains some self-care functions 
9.0  Helpless bed patient; can communicate and eat 
9.5  Totally helpless bed patient; unable to communicate effectively or 
eat/swallow 
10.0  Death due to MS 
Table S2 Kurtzke Expanded Disability Status Score (EDSS) scale. The functional systems assessed are 
visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral. Mood alteration does not 
affect the EDSS score. 
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APPENDIX III  
 
VOXEL-BASED LONGITUDINAL FMRI ANALYSIS 
 
Interpretation of longitudinal fMRI data may be complicated by several factors, such 
as varying attention and adaptation/habituation effects. In order to investigate the 
magnitude of these effects in controls, a longitudinal voxel-based analysis approach 
was used, and the results are reported in this appendix. The same approach was 
applied to the patient data, and the resulting difficulties in interpretation are discussed. 
 
The fMRI data for each control and patient were pre-processed in SPM5, as described 
in chapters 3 to 6, and the resulting contrast images, representing whole field 
stimulation through the chromatic goggles, were entered into a second-level analysis. 
Flexible factorial models were specified, as described in Chapter 6. Several different 
second-level models were specified, to investigate different temporal profiles of 
change. In addition to linear changes and second order models, an exponential model 
was estimated, to test for voxels which followed the temporal course of clinical 
recovery in ON. 
 
The contrasts were specified as follows: linear increases (-1.5 -0.5 0.5 1.5), linear 
decreases (1.5 0.5 -0.5 -1.5), second order increases (-1 1 1 -1), second order 
decreases (1 -1 -1 1), exponential increases (-1 0.33 0.33 0.33) and exponential 
decreases (1 -0.33 -0.33 -0.33). The statistical parametric maps were thresholded at 
p<0.05 (corrected). 
 
Occipital regions were identified, in which the fMRI signal decreased over time in a 
linear fashion in the control group (Figure S1), and increased exponentially in the 
patient group (Figure S2). 
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Figure S1 A statistical parametric map showing voxels in which there was a linear decrease in signal 
over time in controls. The results are overlaid on to the SPM5 glass brain in (A) sagittal, (B) axial and 
(C) coronal section, and (D) rendered on to the canonical SPM5 template. The Montreal Neurological 
Institute (MNI) coordinates of the global maximum, z score and cluster-level p value are reported. (E) 
The design matrix is shown. 
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Figure S2 A statistical parametric map showing voxels in which there was an exponential increase in 
signal over time in patients. The results are overlaid on to the SPM5 glass brain in (A) sagittal, (B) 
axial and (C) coronal section, and (D) rendered on to the canonical SPM5 template. The Montreal 
Neurological Institute (MNI) coordinates of the global maximum, z score and cluster-level p value are 
reported. (E) The design matrix is shown. 
 
These results illustrate some of the problems interpreting longitudinal fMRI data. The 
changes in patients are consistent with an increasing neuronal input between baseline 
and three months, as vision improved. However, there were also changes in primary 
visual cortex in the control group, with a linear decrease evident over time. These 
changes probably relate to adaptation/habituation and reduced attention with repeated 
stimuli. The magnitude of these changes can be quite large, but fortunately are in the 
opposite direction to changes relating to improving vision.  
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